data_2kw1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kw1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.224 0.535 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.67 138.31 49.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.6 m -119.89 142.97 48.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -132.69 152.68 51.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.011 1.325 . . . . 0.0 107.562 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.1 119.46 29.51 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -92.4 113.52 25.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 mtm -146.07 137.34 24.68 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.404 1.082 . . . . 0.0 108.627 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.07 37.74 15.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.168 1.387 . . . . 0.0 113.102 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.22 -4.0 60.28 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.125 0.869 . . . . 0.0 114.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.08 164.87 11.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.84 1.656 . . . . 0.0 110.056 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -121.01 124.37 44.68 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -110.57 132.49 54.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.956 1.303 . . . . 0.0 108.352 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.38 131.94 37.15 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.4 mm -110.1 134.36 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.37 121.86 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.85 123.5 32.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -87.92 113.03 23.17 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -75.7 -18.02 59.75 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.831 -0.543 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.27 -35.71 79.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.18 0.445 . . . . 0.0 111.266 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.44 -0.07 8.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.267 1.427 . . . . 0.0 113.434 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.7 mmt 52.14 49.13 21.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.106 0.955 . . . . 0.0 109.267 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -117.53 142.51 47.09 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.211 1.404 . . . . 0.0 107.879 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.78 119.79 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.774 0.797 . . . . 0.0 108.913 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.437 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 20.9 m95 -85.93 129.39 34.85 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.298 1.839 . . . . 0.0 108.994 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.8 t -118.33 119.26 34.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 168.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 47.89 41.52 14.71 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.989 1.316 . . . . 0.0 111.691 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.22 -7.05 61.45 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.603 -1.11 . . . . 0.0 115.221 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.84 137.83 39.62 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.751 1.775 . . . . 0.0 107.539 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -72.93 147.5 45.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.967 1.258 . . . . 0.0 109.997 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pp -117.07 168.58 10.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.953 1.301 . . . . 0.0 110.302 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.05 145.41 48.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.073 0.949 . . . . 0.0 110.138 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -143.13 151.19 40.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.478 1.111 . . . . 0.0 109.875 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.44 136.18 48.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.43 96.22 1.24 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -86.66 146.02 26.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -111.52 134.25 53.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.35 167.56 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.196 1.399 . . . . 0.0 110.116 -172.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.85 49.24 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.241 1.416 . . . . 0.0 110.309 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -159.95 -36.57 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.37 2.268 . . . . 0.0 109.892 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.26 -132.18 3.65 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -120.76 151.54 39.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -129.97 106.48 8.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.6 m -85.76 100.1 11.79 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -84.36 145.44 28.22 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.71 1.204 . . . . 0.0 110.393 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -158.45 -178.25 7.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.14 1.776 . . . . 0.0 108.762 169.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -145.81 150.47 36.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.36 1.064 . . . . 0.0 109.108 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mt -133.66 111.67 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.0 -131.26 51.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -169.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -81.16 -10.5 59.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.609 0.764 . . . . 0.0 112.653 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.78 30.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -171.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.15 26.97 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 109.578 169.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -138.26 152.5 48.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.871 1.668 . . . . 0.0 108.725 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.65 141.32 24.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 121.725 -0.609 . . . . 0.0 109.648 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -88.71 114.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -75.94 126.85 31.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.52 88.69 2.98 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.98 123.33 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.755 1.222 . . . . 0.0 108.381 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 119.313 0.96 . . . . 0.0 109.908 175.243 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.57 120.63 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.057 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -100.3 127.75 46.53 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -139.3 140.31 37.55 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 108.704 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.2 131.85 34.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.82 142.81 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.42 133.3 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t0 49.9 37.09 12.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.293 1.037 . . . . 0.0 111.874 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.2 t30 62.48 9.96 3.71 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.829 2.051 . . . . 0.0 115.444 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.52 150.54 20.21 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 125.063 1.345 . . . . 0.0 109.261 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.81 135.15 34.13 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.719 0.808 . . . . 0.0 110.059 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.8 mm -118.71 113.9 36.05 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.356 1.862 . . . . 0.0 106.922 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -74.64 151.43 41.44 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.948 2.432 . . . . 0.0 110.811 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.294 0.569 . . . . 0.0 109.828 176.464 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.362 0.601 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -121.39 136.95 54.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.0 m -128.43 141.96 51.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -135.66 159.65 40.96 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.874 1.67 . . . . 0.0 107.553 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -124.82 140.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.02 125.78 42.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.821 1.248 . . . . 0.0 108.425 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -84.5 121.11 27.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.4 ttm -158.02 140.29 14.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.414 1.086 . . . . 0.0 108.277 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 51.67 37.43 20.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.163 1.385 . . . . 0.0 113.118 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.02 8.69 83.38 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 123.94 0.781 . . . . 0.0 113.653 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -123.81 173.82 7.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.506 1.922 . . . . 0.0 109.584 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -121.92 122.3 39.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.91 127.12 53.15 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -79.6 139.8 37.35 Favored 'General case' 0 N--CA 1.46 0.054 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -114.72 130.62 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.61 117.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -85.46 122.77 30.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.83 112.9 17.57 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.2 -31.6 67.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 119.205 -0.426 . . . . 0.0 112.095 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.38 -47.34 56.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.327 0.512 . . . . 0.0 110.556 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.66 -18.17 28.5 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.78 0.832 . . . . 0.0 112.946 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.258 51.8 mtp 55.44 30.27 14.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.444 1.497 . . . . 0.0 111.552 -169.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.48 152.91 21.57 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.32 115.77 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -85.28 122.65 29.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.581 1.552 . . . . 0.0 107.355 174.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 t -114.73 125.98 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 49.86 36.83 12.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.293 1.037 . . . . 0.0 111.591 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.51 0.51 84.14 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 118.541 -1.144 . . . . 0.0 115.255 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -113.78 146.38 39.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.825 1.812 . . . . 0.0 109.235 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -66.71 147.04 53.8 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.339 -0.85 . . . . 0.0 108.998 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.35 168.16 12.86 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.618 1.167 . . . . 0.0 110.197 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.16 145.39 44.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.306 1.042 . . . . 0.0 110.117 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -140.85 149.52 42.09 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 109.88 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.3 140.39 48.57 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.8 109.86 2.0 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -175.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.26 149.06 25.07 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.538 0.735 . . . . 0.0 109.563 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.97 141.64 37.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.321 0.649 . . . . 0.0 109.521 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.13 166.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.753 1.621 . . . . 0.0 109.897 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -77.92 48.39 0.71 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.133 1.373 . . . . 0.0 110.443 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -161.31 -31.77 0.05 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.437 2.295 . . . . 0.0 110.856 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.8 -134.85 4.41 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -130.82 151.83 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.39 110.83 12.7 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.5 m -92.17 104.89 17.22 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.72 147.12 24.04 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.807 1.243 . . . . 0.0 110.666 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -157.51 -177.62 6.72 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.059 1.744 . . . . 0.0 108.635 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.93 147.54 31.84 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.346 1.058 . . . . 0.0 109.465 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.5 mt -143.67 130.53 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.98 -131.36 51.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.17 28.92 4.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.702 1.201 . . . . 0.0 111.536 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -124.29 149.26 46.73 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.968 1.307 . . . . 0.0 109.17 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 150.72 24.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.92 152.82 52.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.464 1.506 . . . . 0.0 108.318 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -147.68 143.45 27.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.686 -0.634 . . . . 0.0 109.6 168.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.84 117.49 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 169.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -83.07 115.8 22.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.19 90.59 3.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.98 122.24 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.02 1.328 . . . . 0.0 108.587 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 119.203 0.911 . . . . 0.0 108.884 177.389 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.0 mm -102.46 120.88 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -96.44 125.63 41.07 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -132.69 145.82 51.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.345 1.058 . . . . 0.0 108.547 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 tp -93.44 131.95 38.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.78 141.95 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.6 131.36 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.61 40.47 15.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.282 1.033 . . . . 0.0 111.796 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 66.77 1.36 2.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.857 2.063 . . . . 0.0 115.282 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.55 147.48 23.32 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 120.456 -1.403 . . . . 0.0 109.325 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.05 133.88 34.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.619 0.768 . . . . 0.0 109.822 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.1 mm -118.22 113.38 37.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 107.285 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.19 155.16 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.391 2.727 . . . . 0.0 111.137 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 123.63 0.772 . . . . 0.0 110.897 177.838 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.775 0.798 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -120.44 132.4 55.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.0 m -119.51 143.04 47.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -136.29 156.18 49.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.121 1.368 . . . . 0.0 108.247 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -116.11 134.74 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.62 110.38 15.92 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -82.55 111.25 18.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 53.0 mtm -147.53 139.8 24.46 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.565 1.146 . . . . 0.0 108.687 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 50.15 36.11 11.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.162 1.385 . . . . 0.0 112.914 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.97 -7.29 36.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.536 1.065 . . . . 0.0 113.718 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.55 171.09 9.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.715 1.606 . . . . 0.0 110.706 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -128.62 111.46 13.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.304 1.442 . . . . 0.0 107.17 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -99.07 129.14 45.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -88.42 135.88 33.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.03 133.76 62.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -131.67 122.19 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -88.14 127.4 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -97.01 113.32 24.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -69.39 -25.11 63.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -172.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -37.35 84.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.225 0.466 . . . . 0.0 111.494 -174.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.76 -5.54 11.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.096 1.358 . . . . 0.0 113.018 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 71.8 mtp 54.37 31.03 13.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.845 1.258 . . . . 0.0 110.353 -168.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.36 147.7 32.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.76 119.5 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.4 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 8.2 m95 -85.45 126.65 33.97 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.481 1.513 . . . . 0.0 107.908 172.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.43 121.37 44.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 46.42 38.94 5.87 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.054 1.341 . . . . 0.0 111.832 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.58 62.53 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.901 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.42 141.21 31.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.724 1.762 . . . . 0.0 108.618 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -69.28 143.97 53.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.21 164.79 17.21 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.944 0.898 . . . . 0.0 110.19 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.32 146.17 43.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.155 0.982 . . . . 0.0 110.243 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -139.72 149.85 44.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.624 1.17 . . . . 0.0 109.824 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.88 140.98 49.25 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.44 106.1 1.36 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.43 151.49 19.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.35 139.08 54.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.585 0.754 . . . . 0.0 109.057 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.12 167.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.424 1.49 . . . . 0.0 110.305 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.07 49.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.705 1.24 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -159.09 -35.12 0.06 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.614 2.366 . . . . 0.0 110.191 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.62 -153.06 23.71 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -118.24 150.83 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -126.01 106.74 9.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.55 1.54 . . . . 0.0 107.098 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 m -91.94 102.57 15.14 Favored 'General case' 0 N--CA 1.46 0.041 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -87.76 146.82 25.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.832 1.253 . . . . 0.0 110.662 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.54 -179.89 8.59 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.011 1.724 . . . . 0.0 108.68 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 m -145.76 150.77 36.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.191 0.997 . . . . 0.0 108.941 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.4 mt -133.01 110.85 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.89 -131.46 52.06 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.02 -9.99 59.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.478 0.711 . . . . 0.0 112.578 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.59 29.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.85 147.19 25.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.77 152.34 49.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.168 1.787 . . . . 0.0 108.685 -173.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -149.4 140.57 23.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.761 -0.587 . . . . 0.0 109.838 168.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -87.71 120.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -87.16 122.9 31.59 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.32 93.53 4.16 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -90.18 125.5 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.377 1.071 . . . . 0.0 108.941 -169.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 m . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 124.368 1.067 . . . . 0.0 111.904 -179.813 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.1 mm -88.78 115.03 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.98 127.87 41.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -135.21 144.19 46.81 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.72 130.58 41.18 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.4 142.75 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.77 132.43 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 107.565 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.3 37.71 12.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.084 0.954 . . . . 0.0 111.948 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.62 9.88 3.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.152 2.181 . . . . 0.0 115.542 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.7 150.8 19.97 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.232 1.413 . . . . 0.0 109.578 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.47 136.46 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.346 1.059 . . . . 0.0 110.227 -176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.9 mm -120.65 116.16 31.94 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.3 1.84 . . . . 0.0 107.005 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.8 144.27 19.19 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 111.269 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.237 0.423 0 C-N-CA 123.054 0.542 . . . . 0.0 111.312 -178.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.909 0.862 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -118.32 129.53 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 168.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.8 m -112.52 145.42 40.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -133.92 161.42 34.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.459 1.504 . . . . 0.0 108.0 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.03 137.94 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.3 mt -121.57 113.22 19.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -81.06 122.14 26.95 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 168.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 58.3 mtt -130.42 -173.68 3.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.362 1.865 . . . . 0.0 108.079 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -51.1 90.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.603 1.561 . . . . 0.0 113.369 -169.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 13.12 79.13 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.214 1.388 . . . . 0.0 114.116 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -139.99 162.34 35.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.448 1.624 . . . . 0.0 111.123 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -128.61 119.88 25.58 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 125.612 1.565 . . . . 0.0 106.938 172.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.03 131.53 54.49 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.03 0.932 . . . . 0.0 109.239 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -80.75 145.93 31.27 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 mm -122.39 132.61 70.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.22 119.99 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -88.4 123.13 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -90.89 113.2 25.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 168.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -70.78 -19.98 62.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.128 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.18 -42.36 94.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.869 0.759 . . . . 0.0 111.591 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.42 -1.01 13.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.24 1.416 . . . . 0.0 112.449 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm 53.11 39.35 29.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.008 1.323 . . . . 0.0 109.954 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.37 141.77 31.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.779 1.232 . . . . 0.0 109.098 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.45 116.76 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.837 0.827 . . . . 0.0 109.972 -173.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.423 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -85.18 115.27 22.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.1 m -118.48 125.87 50.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 49.14 39.35 15.1 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.138 0.975 . . . . 0.0 111.914 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.13 3.55 88.39 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.307 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.59 147.26 46.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.541 1.67 . . . . 0.0 108.23 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 147.75 33.85 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.384 0.993 . . . . 0.0 109.551 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.9 166.57 23.01 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.487 1.115 . . . . 0.0 110.458 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.98 148.83 48.41 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.486 0.714 . . . . 0.0 111.675 -172.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 149.93 48.99 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.786 1.634 . . . . 0.0 109.15 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.6 140.54 52.69 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.51 106.98 1.29 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 -173.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -98.32 153.01 18.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 109.374 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.48 138.55 54.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.38 168.28 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.422 1.489 . . . . 0.0 110.325 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.01 48.35 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.061 1.345 . . . . 0.0 110.794 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -159.99 -35.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.502 2.321 . . . . 0.0 110.448 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.0 -153.65 24.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -118.45 152.41 35.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.57 109.73 10.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.767 1.227 . . . . 0.0 107.849 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 m -94.37 105.75 17.72 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -91.17 146.19 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.97 1.308 . . . . 0.0 110.836 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.01 -174.01 4.53 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.61 1.964 . . . . 0.0 108.701 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.1 m -145.71 146.58 31.31 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.53 1.132 . . . . 0.0 109.4 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.3 mt -142.39 130.12 20.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.46 -130.37 50.89 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -101.06 28.6 5.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.68 1.192 . . . . 0.0 111.548 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -128.52 144.31 51.12 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.65 1.18 . . . . 0.0 109.076 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.77 149.9 21.83 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.4 150.51 50.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.364 1.465 . . . . 0.0 108.212 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -146.82 140.36 25.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.3 mt -90.79 115.5 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 170.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -78.85 134.83 36.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.66 94.04 3.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.93 128.42 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.957 1.303 . . . . 0.0 109.539 -169.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 CA--C 1.546 0.817 0 CA-C-N 119.76 1.164 . . . . 0.0 112.436 -177.209 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.8 mm -79.08 116.5 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -96.51 130.85 43.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 tp -93.34 130.72 38.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.84 140.59 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.35 132.22 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.583 1.153 . . . . 0.0 108.132 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.0 t0 45.53 42.35 7.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.337 1.455 . . . . 0.0 111.613 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 t30 64.52 18.21 11.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.563 2.345 . . . . 0.0 116.002 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -115.75 153.42 31.43 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 120.752 -1.218 . . . . 0.0 110.809 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -89.18 138.08 31.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.955 1.302 . . . . 0.0 110.793 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -121.55 118.09 29.88 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.859 2.064 . . . . 0.0 106.596 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.97 143.39 23.01 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.232 2.621 . . . . 0.0 111.357 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--O 1.237 0.422 0 CA-C-O 121.351 0.596 . . . . 0.0 110.359 177.248 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.174 0.512 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -115.9 128.98 56.2 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.4 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.811 0.815 . . . . 0.0 109.249 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -135.07 157.03 47.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.032 1.333 . . . . 0.0 107.491 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -125.06 137.76 56.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 169.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.7 mt -122.16 125.53 46.33 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.833 1.253 . . . . 0.0 107.628 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -93.31 118.07 30.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.7 mtm -146.41 134.87 21.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.638 1.175 . . . . 0.0 108.416 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.29 37.5 11.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.983 1.313 . . . . 0.0 113.496 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.71 8.1 87.24 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.936 -0.925 . . . . 0.0 114.431 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -118.28 155.22 30.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.81 1.644 . . . . 0.0 110.042 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -107.88 123.52 48.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -111.05 122.66 48.46 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.212 1.405 . . . . 0.0 108.382 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.42 142.32 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -120.72 134.32 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.4 t -132.36 118.59 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -87.11 125.94 34.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.79 112.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -70.01 -29.35 66.39 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.791 0.723 . . . . 0.0 111.787 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.42 -43.43 94.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.286 0.494 . . . . 0.0 110.996 -173.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.87 -11.68 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.639 1.176 . . . . 0.0 113.003 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.9 mtp 54.55 34.35 21.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 110.519 -169.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -93.13 150.89 20.19 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.28 117.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.53 121.84 30.47 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.74 1.616 . . . . 0.0 107.604 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -113.63 130.57 56.37 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 52.26 35.51 17.13 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.82 0.848 . . . . 0.0 111.6 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.43 10.17 82.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.209 0.909 . . . . 0.0 114.835 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -124.34 136.58 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.379 1.472 . . . . 0.0 107.221 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -72.18 142.58 49.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.595 1.543 . . . . 0.0 109.438 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -116.2 167.8 10.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.086 0.954 . . . . 0.0 110.989 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.29 146.35 43.25 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 110.352 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -139.55 150.39 45.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.445 1.098 . . . . 0.0 109.697 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.7 141.29 50.93 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.49 106.13 1.21 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -95.64 153.35 17.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -122.66 139.7 53.66 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.62 167.58 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.853 1.661 . . . . 0.0 110.086 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -76.55 48.49 0.55 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.8 1.286 . . . . 0.0 110.927 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.98 -33.61 0.06 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.851 2.46 . . . . 0.0 110.356 -171.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.2 -152.17 23.32 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.52 149.16 40.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -126.56 106.75 9.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 m -92.22 103.6 16.06 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -88.56 146.68 25.0 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.913 1.285 . . . . 0.0 110.335 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.82 179.74 8.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.893 1.677 . . . . 0.0 108.337 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 m -145.81 149.88 35.16 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.907 0.883 . . . . 0.0 108.903 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mt -133.18 110.0 14.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.48 -131.67 52.17 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -81.22 -10.12 59.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.413 0.685 . . . . 0.0 112.803 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -88.8 121.34 31.07 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 147.04 25.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.482 0.658 . . . . 0.0 109.862 170.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.84 153.52 49.6 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.57 1.548 . . . . 0.0 108.508 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -148.09 143.08 26.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.692 -0.63 . . . . 0.0 109.798 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.4 mt -88.31 119.56 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -85.33 110.05 18.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.4 84.83 3.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.61 127.3 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.846 1.659 . . . . 0.0 108.881 -169.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.542 0.643 0 CA-C-N 119.63 1.105 . . . . 0.0 110.273 178.683 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.31 129.72 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -104.73 124.91 50.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -132.59 145.54 51.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.14 0.976 . . . . 0.0 108.775 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 tp -92.42 131.1 37.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.69 142.42 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 169.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -136.94 132.19 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.048 1.339 . . . . 0.0 107.978 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t0 45.4 42.21 7.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.239 1.415 . . . . 0.0 111.539 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.3 t30 64.02 17.33 10.54 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.553 2.341 . . . . 0.0 116.196 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.65 152.09 32.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.84 1.256 . . . . 0.0 110.546 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -88.74 137.96 31.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.372 1.069 . . . . 0.0 110.631 -169.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.49 112.3 37.43 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.611 1.964 . . . . 0.0 106.909 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.43 150.61 36.61 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.19 2.593 . . . . 0.0 110.821 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.238 0.468 0 C-N-CA 123.569 0.748 . . . . 0.0 110.818 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 121.637 0.732 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -89.49 125.36 35.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.5 m -108.6 148.6 30.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -136.5 159.52 41.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.825 1.65 . . . . 0.0 106.689 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.04 140.57 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.17 122.26 36.55 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.834 1.253 . . . . 0.0 107.987 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -91.91 117.81 30.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 56.7 mtm -146.64 134.8 21.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.817 1.247 . . . . 0.0 108.421 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.33 37.83 12.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.141 1.376 . . . . 0.0 113.339 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.3 8.73 87.04 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.236 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.13 155.76 29.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.987 1.715 . . . . 0.0 110.004 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.92 123.84 49.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -110.26 124.02 50.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.26 1.424 . . . . 0.0 107.978 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -84.38 141.34 30.93 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.0 mm -117.34 135.51 57.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.5 t -132.06 120.58 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.57 124.14 33.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -84.71 113.85 21.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -72.58 -26.41 61.7 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.724 -0.61 . . . . 0.0 111.696 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.09 -44.06 77.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.176 0.443 . . . . 0.0 111.287 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.19 -10.85 17.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 113.372 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.263 59.6 mtp 54.96 30.4 13.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.988 1.315 . . . . 0.0 111.861 -169.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.43 150.08 27.28 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.95 117.71 46.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.402 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.2 m95 -85.19 119.21 25.32 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.5 t -110.54 128.74 55.78 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 169.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 52.62 34.92 16.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.702 0.801 . . . . 0.0 111.576 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 11.17 82.15 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.233 0.921 . . . . 0.0 114.768 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -124.8 142.6 51.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.164 1.482 . . . . 0.0 108.187 -174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -69.47 145.06 53.04 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.522 1.055 . . . . 0.0 108.427 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 pp -123.18 167.15 14.08 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.36 144.85 44.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.911 0.884 . . . . 0.0 110.189 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -140.93 149.58 42.05 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.225 1.01 . . . . 0.0 110.011 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.96 138.45 49.72 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.41 111.2 2.2 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -110.37 146.18 36.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.622 0.769 . . . . 0.0 109.87 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.45 142.46 30.04 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.55 166.34 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.693 1.597 . . . . 0.0 109.754 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.57 49.15 0.72 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.982 1.373 . . . . 0.0 110.231 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -159.87 -34.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.64 2.376 . . . . 0.0 110.292 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.4 -130.07 2.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -171.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -131.85 152.2 51.18 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -129.3 117.3 20.43 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 m -95.84 105.58 17.61 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.87 145.36 25.2 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.815 1.246 . . . . 0.0 109.966 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -157.31 -177.81 6.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.507 1.523 . . . . 0.0 109.053 169.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.81 151.54 38.08 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.422 1.089 . . . . 0.0 108.507 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -132.5 108.58 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.44 -130.76 51.48 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -77.94 -16.21 58.37 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.555 0.742 . . . . 0.0 112.578 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -85.84 120.03 26.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.76 147.53 26.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.364 0.529 . . . . 0.0 109.796 170.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.86 153.07 46.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.731 1.612 . . . . 0.0 108.924 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -148.0 141.3 25.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.661 -0.649 . . . . 0.0 109.342 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.8 mt -88.55 117.76 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -81.74 128.11 33.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 90.9 3.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -87.53 121.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 124.103 0.961 . . . . 0.0 108.537 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.237 0.404 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.767 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -90.09 114.35 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.45 125.31 38.0 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -132.83 142.35 48.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.7 tp -94.25 130.33 40.55 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.22 141.96 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -139.07 132.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t0 49.54 37.49 12.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.049 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 62.86 10.17 4.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.774 2.03 . . . . 0.0 115.531 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -96.63 150.47 20.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.265 1.426 . . . . 0.0 109.672 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.22 137.44 32.33 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.263 1.025 . . . . 0.0 110.232 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mm -118.94 118.77 32.79 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.967 1.707 . . . . 0.0 107.952 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -68.12 141.44 52.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.611 2.874 . . . . 0.0 112.33 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.56 0.695 . . . . 0.0 110.622 174.533 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 121.354 0.597 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.76 131.1 55.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.0 m -116.64 141.19 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -131.21 153.69 49.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.601 1.56 . . . . 0.0 107.326 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -114.88 139.4 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.49 112.64 18.76 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.278 1.831 . . . . 0.0 106.591 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -92.44 113.21 25.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.7 mtm -147.31 137.29 23.09 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.43 1.092 . . . . 0.0 108.609 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.3 t70 49.54 37.76 13.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.197 1.399 . . . . 0.0 113.206 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.34 -7.02 48.97 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.518 1.056 . . . . 0.0 113.976 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -95.23 164.99 12.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.731 1.613 . . . . 0.0 110.219 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -123.38 124.44 42.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.8 132.47 54.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.676 1.591 . . . . 0.0 108.132 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.81 138.1 31.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 169.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.5 mm -116.36 131.4 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.3 117.62 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 170.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.1 tp -89.2 123.07 33.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -86.13 110.12 19.33 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 168.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -75.81 -24.76 55.93 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.92 -0.487 . . . . 0.0 111.446 -171.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.29 -42.02 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.134 0.424 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.62 -14.29 22.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.919 1.288 . . . . 0.0 113.106 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm 52.19 49.71 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.317 1.447 . . . . 0.0 109.366 -169.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -123.34 141.97 51.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.372 1.469 . . . . 0.0 108.579 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.93 123.33 68.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.273 0.559 . . . . 0.0 110.221 -172.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.452 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.9 m95 -95.66 114.15 25.87 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.0 m -108.79 120.97 44.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 171.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 47.94 40.94 13.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.33 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.66 -4.41 60.61 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.767 -1.019 . . . . 0.0 114.891 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -111.8 144.21 41.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.446 1.623 . . . . 0.0 108.952 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.29 149.4 47.45 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 110.376 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.96 167.7 21.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.124 1.769 . . . . 0.0 108.41 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.39 143.5 53.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.147 0.499 . . . . 0.0 111.197 -170.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.6 151.08 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.173 1.789 . . . . 0.0 108.815 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.96 134.53 45.73 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.84 90.12 0.81 Allowed Glycine 0 C--N 1.329 0.157 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -78.6 141.43 38.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -106.67 136.11 47.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.91 166.45 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.608 1.163 . . . . 0.0 110.34 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.66 49.26 0.73 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.883 1.325 . . . . 0.0 110.318 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -161.36 -32.66 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.682 2.393 . . . . 0.0 110.874 -169.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.67 -132.99 4.23 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -127.98 151.35 49.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.15 106.59 8.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.8 m -84.52 101.03 11.76 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -85.66 144.52 27.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.774 1.23 . . . . 0.0 110.322 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.85 -178.34 7.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.15 1.78 . . . . 0.0 108.399 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 m -145.23 150.28 36.41 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.993 0.917 . . . . 0.0 109.048 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.6 mt -132.7 115.36 24.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.87 -132.5 52.59 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.14 -4.19 58.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 112.639 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -94.5 121.15 35.76 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -171.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.46 145.3 27.5 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.337 0.589 . . . . 0.0 109.576 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.55 152.3 50.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.482 1.513 . . . . 0.0 108.315 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -147.99 139.67 23.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 110.142 168.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mt -87.89 111.64 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -80.63 127.75 32.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.5 94.1 3.79 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -93.82 126.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.816 -169.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 CA--C 1.542 0.668 0 CA-C-N 119.627 1.103 . . . . 0.0 111.764 178.369 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mm -84.78 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -140.55 138.09 34.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.2 tp -88.99 131.04 35.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.91 147.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.4 129.64 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.83 39.85 11.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.937 0.895 . . . . 0.0 111.572 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 65.9 2.35 2.17 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.76 2.024 . . . . 0.0 115.472 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -90.16 151.21 21.68 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.488 -1.382 . . . . 0.0 109.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -93.0 136.88 32.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.145 0.978 . . . . 0.0 110.538 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 mm -119.27 117.36 33.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.062 1.745 . . . . 0.0 107.01 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.68 152.51 37.74 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.162 2.575 . . . . 0.0 111.044 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 123.206 0.602 . . . . 0.0 109.398 173.217 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -121.71 130.23 53.29 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.7 m -123.51 142.29 51.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.827 0.704 . . . . 0.0 109.415 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -138.8 158.46 44.18 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 0.0 107.971 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 146.61 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.644 0.778 . . . . 0.0 109.298 169.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.55 156.01 46.47 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.089 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -111.5 116.26 30.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtm -144.56 141.56 29.56 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.6 t0 49.21 38.13 12.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.252 1.421 . . . . 0.0 113.546 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.94 6.44 85.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.977 -0.902 . . . . 0.0 113.937 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -118.15 162.8 17.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.149 1.78 . . . . 0.0 110.452 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -111.05 126.27 54.63 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.21 104.32 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.32 142.6 37.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 mm -125.57 131.47 72.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.51 120.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -87.94 124.52 33.78 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.448 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -89.29 108.48 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.96 1.704 . . . . 0.0 109.109 171.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.7 -26.7 63.53 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.055 0.389 . . . . 0.0 111.661 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.83 -39.94 94.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.407 0.283 . . . . 0.0 111.204 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.7 -11.28 17.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 113.218 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.3 42.4 30.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.298 1.439 . . . . 0.0 109.984 -168.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -105.26 160.84 14.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.913 1.285 . . . . 0.0 108.261 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.43 119.08 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.448 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.7 m95 -90.35 121.35 32.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.851 1.661 . . . . 0.0 109.078 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -102.79 116.03 31.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 168.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 46.13 39.78 6.41 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.32 1.048 . . . . 0.0 111.794 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.46 -7.8 67.22 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.312 -1.271 . . . . 0.0 115.343 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.23 140.98 30.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.106 1.953 . . . . 0.0 108.844 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -69.71 142.07 53.39 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.769 1.168 . . . . 0.0 108.442 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.66 166.16 12.02 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.836 0.854 . . . . 0.0 110.288 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.71 146.76 42.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.507 1.123 . . . . 0.0 109.979 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -142.87 150.24 39.59 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 110.091 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.36 134.24 43.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.47 90.32 0.75 Allowed Glycine 0 C--N 1.33 0.21 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -174.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.4 142.2 39.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -108.52 135.68 49.39 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.24 166.84 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 124.815 1.246 . . . . 0.0 110.174 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.71 49.34 0.75 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 123.005 1.383 . . . . 0.0 110.384 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.08 -33.27 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.536 2.335 . . . . 0.0 110.683 -169.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.29 -134.25 4.71 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -171.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -125.63 150.28 47.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.75 106.19 8.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -87.12 100.6 12.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -86.6 144.55 27.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.602 1.161 . . . . 0.0 110.798 -172.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.69 -177.01 6.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.367 1.867 . . . . 0.0 108.879 169.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -144.64 146.61 32.36 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.363 1.065 . . . . 0.0 109.662 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.95 132.5 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.98 -125.92 41.14 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -109.5 33.25 4.44 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.754 1.222 . . . . 0.0 110.714 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -129.53 144.87 51.45 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.178 1.391 . . . . 0.0 108.817 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.31 150.87 21.67 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.68 152.46 50.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.317 1.447 . . . . 0.0 108.295 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -148.69 140.41 23.64 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.785 -0.572 . . . . 0.0 109.647 168.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -88.29 114.13 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -81.96 126.82 32.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.25 92.12 3.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 121.74 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 C--O 1.237 0.417 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.086 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.3 mm -90.21 111.67 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.08 129.76 38.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -137.85 141.24 40.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.907 1.283 . . . . 0.0 108.012 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.9 tp -88.73 132.59 34.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.66 141.9 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.23 133.67 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.5 t0 49.59 37.75 13.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.413 1.085 . . . . 0.0 111.759 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.1 t30 62.72 9.66 3.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.027 2.131 . . . . 0.0 115.431 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.83 149.06 21.95 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.14 1.376 . . . . 0.0 109.387 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -91.13 133.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.457 0.703 . . . . 0.0 110.065 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.06 112.39 40.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.432 1.893 . . . . 0.0 106.801 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.28 152.02 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 110.947 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--O 1.24 0.558 0 C-N-CA 124.187 0.995 . . . . 0.0 110.484 174.501 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.024 0.44 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -117.41 135.61 53.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 m -114.68 147.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -134.55 161.35 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.379 1.472 . . . . 0.0 107.507 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.02 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.44 124.63 34.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.323 1.449 . . . . 0.0 108.581 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -87.63 125.71 34.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 ttm -156.03 132.47 10.19 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.91 38.94 17.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.108 1.363 . . . . 0.0 113.316 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 -1.34 74.81 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.109 0.861 . . . . 0.0 114.151 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.01 167.51 9.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.235 1.814 . . . . 0.0 110.031 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -121.42 124.14 43.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.41 118.44 36.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -86.73 142.37 28.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.05 133.86 67.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 t -133.07 119.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 tp -88.65 120.54 30.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -83.03 111.39 18.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 168.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.99 -26.8 60.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.181 -170.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.08 -43.58 86.96 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.106 0.412 . . . . 0.0 110.735 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.49 -13.75 24.27 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.518 1.127 . . . . 0.0 112.929 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mmm 52.35 45.62 28.15 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.08 1.352 . . . . 0.0 109.581 -169.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -115.83 141.61 47.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.835 1.254 . . . . 0.0 108.391 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.15 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.768 0.794 . . . . 0.0 109.705 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.439 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 22.9 m95 -85.53 111.51 20.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 169.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.1 m -108.5 117.65 34.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 48.01 40.89 14.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.143 1.377 . . . . 0.0 111.022 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.58 -9.31 36.42 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.591 1.091 . . . . 0.0 114.743 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.79 138.82 32.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.75 1.775 . . . . 0.0 108.821 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -71.07 141.33 50.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.9 165.9 24.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.984 0.914 . . . . 0.0 110.075 169.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.41 145.15 53.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.4 0.619 . . . . 0.0 111.167 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -134.36 147.82 50.59 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.845 1.658 . . . . 0.0 108.719 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.23 142.62 46.83 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.33 109.73 1.83 Allowed Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 107.155 -2.378 . . . . 0.0 107.155 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.45 148.52 25.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.07 134.39 55.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.68 167.54 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.548 1.539 . . . . 0.0 110.114 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.95 48.41 0.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.016 1.326 . . . . 0.0 110.465 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.35 -34.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.204 2.202 . . . . 0.0 110.537 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.66 -150.73 20.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -175.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -121.02 152.98 37.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -127.19 109.83 12.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.794 1.638 . . . . 0.0 107.171 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.7 m -92.44 102.57 15.04 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -89.56 146.17 24.76 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.447 1.099 . . . . 0.0 110.958 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -158.47 -173.75 4.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.086 2.154 . . . . 0.0 108.231 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 m -146.57 149.24 33.19 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.534 1.134 . . . . 0.0 109.403 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -138.16 121.64 20.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.33 -134.17 52.42 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -170.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -83.37 -7.56 59.55 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.832 0.853 . . . . 0.0 112.384 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -95.33 133.35 39.35 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.69 150.69 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.71 150.76 50.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.407 1.483 . . . . 0.0 107.866 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -147.41 139.68 24.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.907 -0.496 . . . . 0.0 109.821 168.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.1 mt -88.41 117.73 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -84.36 124.2 31.02 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.9 91.64 3.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.6 126.02 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.324 1.05 . . . . 0.0 108.451 -169.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m . . . . . 0 CA--C 1.54 0.565 0 CA-C-N 119.818 1.19 . . . . 0.0 109.958 176.233 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.17 118.02 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -98.66 124.48 43.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 m -133.47 140.34 47.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.241 1.016 . . . . 0.0 108.408 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 tp -89.33 133.48 34.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.44 141.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.83 131.97 43.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 49.48 38.33 14.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.398 1.079 . . . . 0.0 111.868 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.79 9.6 3.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.014 2.125 . . . . 0.0 115.471 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.75 150.01 20.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.916 1.286 . . . . 0.0 109.192 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -95.02 134.24 37.93 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.769 0.828 . . . . 0.0 110.657 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.1 mm -121.98 113.73 31.27 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.47 1.908 . . . . 0.0 107.722 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.7 149.45 48.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.039 2.492 . . . . 0.0 111.201 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 111.384 179.186 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -120.43 136.53 54.71 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.8 m -129.81 142.92 50.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.402 0.681 . . . . 0.0 109.284 -169.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -136.84 159.62 41.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.038 1.735 . . . . 0.0 107.629 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.13 141.58 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.224 1.01 . . . . 0.0 108.693 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.37 128.81 38.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.327 1.451 . . . . 0.0 109.079 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -83.78 128.94 34.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.8 mtt -144.44 129.65 18.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.087 1.355 . . . . 0.0 108.389 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.01 44.54 18.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 0.0 113.855 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.15 5.02 90.39 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.921 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -118.72 158.88 24.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.896 1.678 . . . . 0.0 109.987 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -115.38 123.7 49.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -108.57 128.28 54.68 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.018 0.927 . . . . 0.0 108.571 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -80.4 147.43 31.01 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mm -122.02 131.28 73.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.96 119.09 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.9 121.89 30.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.81 112.97 20.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -71.87 -31.28 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.97 0.908 . . . . 0.0 111.993 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.75 -46.49 62.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.124 0.42 . . . . 0.0 110.262 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.83 -17.22 33.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.065 0.946 . . . . 0.0 112.57 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.0 mtp 53.41 42.17 32.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.258 1.423 . . . . 0.0 109.884 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -106.66 145.45 31.96 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.056 1.343 . . . . 0.0 107.981 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -114.34 116.94 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.932 0.873 . . . . 0.0 109.618 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.67 111.14 19.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -114.85 127.52 55.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 49.08 36.73 9.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.123 0.969 . . . . 0.0 111.609 -171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.2 5.8 85.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.207 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.78 148.12 45.06 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.878 1.839 . . . . 0.0 109.352 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -69.63 144.53 52.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.77 166.79 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.342 1.057 . . . . 0.0 110.309 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.5 140.61 57.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.576 0.751 . . . . 0.0 111.129 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.94 151.9 49.56 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.965 1.706 . . . . 0.0 108.466 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 135.83 46.76 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.77 95.58 1.28 Allowed Glycine 0 C--N 1.331 0.257 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.29 145.52 28.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -107.45 136.45 47.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.45 167.5 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.141 1.376 . . . . 0.0 109.962 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.78 49.4 0.76 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.249 1.42 . . . . 0.0 110.533 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -160.73 -36.39 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.664 2.386 . . . . 0.0 110.025 -170.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.0 -124.03 1.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -127.5 150.97 49.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.3 106.38 8.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 172.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.4 m -86.26 101.53 13.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -85.7 145.7 27.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.775 1.23 . . . . 0.0 110.557 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -157.33 -176.32 5.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.736 2.014 . . . . 0.0 108.205 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -146.77 150.72 35.89 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.347 1.059 . . . . 0.0 109.099 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.31 122.74 25.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.9 -131.68 52.17 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -87.58 -4.17 58.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.183 0.993 . . . . 0.0 112.458 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -98.52 130.49 45.1 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 109.448 -169.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.1 151.14 27.15 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.182 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -135.32 150.8 50.07 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.749 1.619 . . . . 0.0 107.372 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.99 140.54 26.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.864 -0.522 . . . . 0.0 109.723 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.11 113.99 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -78.57 125.8 29.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.58 90.31 3.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -80.12 122.63 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 119.591 1.087 . . . . 0.0 111.961 -179.349 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.66 116.37 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -97.1 126.89 42.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -135.54 144.15 46.11 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.36 1.064 . . . . 0.0 108.46 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 tp -90.97 132.37 36.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.32 141.72 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.45 132.79 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t0 50.31 37.31 14.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 111.816 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 62.43 9.61 3.47 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.045 2.138 . . . . 0.0 115.614 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.27 147.66 22.97 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.679 -1.263 . . . . 0.0 109.371 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -90.57 133.67 34.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.685 0.794 . . . . 0.0 110.061 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.1 mm -119.36 113.77 35.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.134 1.774 . . . . 0.0 107.44 -174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.31 155.32 36.96 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.197 2.598 . . . . 0.0 111.149 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 123.758 0.823 . . . . 0.0 110.841 178.005 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.693 0.758 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -124.11 129.28 50.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 169.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.8 m -114.27 145.75 41.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -136.64 162.6 32.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.281 1.433 . . . . 0.0 107.551 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.79 147.05 26.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.67 153.78 51.5 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.022 0.929 . . . . 0.0 108.661 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -106.1 119.3 38.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.42 137.79 27.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.756 1.222 . . . . 0.0 108.161 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.91 37.34 9.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.41 10.64 86.04 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.771 -1.016 . . . . 0.0 114.256 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.73 150.95 47.28 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.371 1.586 . . . . 0.0 110.231 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -98.15 122.81 41.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -106.75 113.6 27.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -80.73 142.6 33.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 mm -122.07 133.69 67.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.2 t -131.62 119.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.04 127.43 35.4 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.34 112.36 24.15 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -68.07 -25.0 65.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.454 -0.307 . . . . 0.0 111.66 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.83 -36.6 83.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.835 0.454 . . . . 0.0 111.88 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.74 -2.38 9.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.145 1.378 . . . . 0.0 113.018 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 99.3 mmm 53.97 33.0 16.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.902 1.281 . . . . 0.0 110.789 -169.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -88.9 146.12 25.12 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.84 117.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -85.38 122.6 29.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.636 1.574 . . . . 0.0 107.454 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.04 118.14 36.02 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 42.47 48.95 4.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.128 1.771 . . . . 0.0 112.564 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.28 -4.11 86.13 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.604 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -113.8 142.73 45.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.786 1.793 . . . . 0.0 109.366 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -68.37 149.02 49.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -126.29 165.55 18.77 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.283 1.033 . . . . 0.0 110.55 169.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.35 146.57 40.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 110.199 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -140.33 151.09 44.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.458 1.103 . . . . 0.0 109.958 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.22 138.18 43.34 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.19 97.02 1.21 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.03 143.14 27.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.82 134.13 43.17 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.35 -179.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.653 1.581 . . . . 0.0 108.765 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.69 8.88 8.83 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.76 14.16 0.55 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.523 1.129 . . . . 0.0 113.357 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.93 -149.27 17.54 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.672 -1.267 . . . . 0.0 112.176 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.3 m -131.34 154.88 48.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -126.61 107.11 9.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.9 m -83.87 99.89 10.63 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -85.77 145.4 27.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.737 1.215 . . . . 0.0 110.722 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.85 -178.92 7.6 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.392 1.877 . . . . 0.0 108.945 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -144.7 147.42 32.99 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 109.522 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.5 mt -141.39 133.78 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.38 -123.3 32.77 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -113.33 36.83 3.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.769 1.228 . . . . 0.0 110.492 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.57 141.65 49.73 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.273 1.429 . . . . 0.0 108.213 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.34 149.2 23.39 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 169.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 m -135.6 152.19 51.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.537 1.535 . . . . 0.0 108.191 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -149.25 141.65 24.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 121.859 -0.525 . . . . 0.0 109.89 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.61 115.03 27.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -79.16 98.84 6.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.75 82.64 7.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.96 129.81 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 119.236 0.925 . . . . 0.0 111.038 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.7 mm -77.45 -43.51 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.28 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 63.5 m80 53.23 102.91 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.75 2.02 . . . . 0.0 112.407 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -126.3 141.27 51.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.792 0.837 . . . . 0.0 109.123 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.6 tp -88.46 131.43 34.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.89 142.87 22.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 131.2 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.94 43.82 10.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.463 1.105 . . . . 0.0 111.442 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.4 t30 65.17 4.53 2.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.6 2.36 . . . . 0.0 115.746 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.93 143.71 26.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.11 1.364 . . . . 0.0 109.806 174.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.05 136.07 33.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.145 0.978 . . . . 0.0 110.539 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -119.62 114.64 34.21 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.449 1.9 . . . . 0.0 107.01 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.68 146.94 34.74 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.371 2.714 . . . . 0.0 111.16 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 121.323 0.583 . . . . 0.0 111.43 -177.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 121.05 0.452 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.44 134.57 52.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -128.37 141.04 51.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.479 0.657 . . . . 0.0 109.694 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -136.32 151.93 50.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.301 1.44 . . . . 0.0 107.47 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.28 141.77 37.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.935 0.894 . . . . 0.0 109.035 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.65 125.83 35.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.127 1.371 . . . . 0.0 108.692 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -85.08 127.41 34.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 41.1 ttm -158.0 134.71 9.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.924 1.29 . . . . 0.0 108.189 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.95 37.93 18.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.109 1.364 . . . . 0.0 113.313 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.18 8.8 85.52 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.914 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -120.54 164.05 17.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.15 1.78 . . . . 0.0 109.806 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -113.31 124.2 51.93 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -109.04 128.64 55.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -88.69 132.89 34.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.85 133.11 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.18 131.3 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.57 125.29 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -87.14 115.58 24.63 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.813 -2.292 . . . . 0.0 104.813 168.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.69 -33.33 73.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.12 -43.19 78.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 117.75 0.25 . . . . 0.0 110.529 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.38 -15.03 29.61 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.215 1.006 . . . . 0.0 112.964 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 52.84 38.88 27.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.323 1.449 . . . . 0.0 110.57 -169.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.52 139.99 38.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 108.296 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -113.11 116.3 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 122.106 0.955 . . . . 0.0 109.967 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -93.34 105.01 17.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.948 2.099 . . . . 0.0 105.915 175.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -109.4 123.27 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 51.28 36.24 15.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 111.13 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.44 -2.47 62.37 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.895 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.71 143.75 37.41 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.778 1.789 . . . . 0.0 109.273 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -68.89 146.68 52.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -137.47 166.26 24.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.851 1.261 . . . . 0.0 109.011 169.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.55 144.55 49.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.047 0.539 . . . . 0.0 111.017 -173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -135.5 149.2 49.44 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 109.146 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.39 136.98 54.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.18 95.32 1.15 Allowed Glycine 0 C--N 1.33 0.214 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.91 142.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.26 132.31 55.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.76 167.29 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.079 1.352 . . . . 0.0 110.159 -172.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.93 49.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.261 1.424 . . . . 0.0 109.968 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -162.54 -32.06 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.47 2.308 . . . . 0.0 110.851 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.68 2.5 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -127.43 151.54 48.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.74 106.68 8.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -84.2 102.27 12.48 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -88.1 143.62 26.96 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.516 1.127 . . . . 0.0 110.579 -175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -159.79 -172.43 3.66 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.073 2.149 . . . . 0.0 108.339 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 m -145.29 151.22 38.0 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 0.0 108.818 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.8 mt -136.98 124.08 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.15 -133.37 52.7 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -86.29 -3.86 59.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.174 0.989 . . . . 0.0 112.672 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -98.05 132.61 43.45 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.305 -0.872 . . . . 0.0 109.097 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.55 149.86 28.46 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.5 m -137.02 152.28 49.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.204 1.402 . . . . 0.0 108.009 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.63 139.59 25.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.958 168.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.3 mt -88.19 113.7 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -80.56 128.85 34.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.79 93.56 3.87 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.95 128.32 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.591 1.157 . . . . 0.0 108.755 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 124.762 1.225 . . . . 0.0 113.975 -178.686 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.67 120.02 36.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -98.97 130.85 45.35 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -140.21 139.92 35.74 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.791 1.236 . . . . 0.0 108.412 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.81 133.58 33.63 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.2 141.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.31 132.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 49.63 37.88 13.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.405 1.082 . . . . 0.0 111.85 -175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 62.66 8.83 3.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.985 2.114 . . . . 0.0 115.464 -174.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.24 148.02 22.61 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.059 1.344 . . . . 0.0 109.399 171.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -90.26 134.03 34.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.469 0.708 . . . . 0.0 110.116 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.04 114.52 37.05 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.137 1.775 . . . . 0.0 108.226 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 148.04 88.35 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.91 3.073 . . . . 0.0 112.171 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.239 0.506 0 C-N-CA 123.558 0.743 . . . . 0.0 110.293 169.942 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.05 125.58 54.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -120.31 144.43 47.84 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -140.09 159.39 42.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.878 1.671 . . . . 0.0 108.042 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.49 137.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 168.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.15 123.69 43.92 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.557 1.143 . . . . 0.0 108.155 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.498 ' CD2' HD22 ' A' ' 18' ' ' ASN . 3.7 t-80 -91.91 121.27 33.35 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 170.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 39.6 mtt -107.44 -163.96 0.94 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.06 1.344 . . . . 0.0 108.573 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.47 -27.79 57.93 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.531 1.133 . . . . 0.0 113.593 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.84 17.89 0.12 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.114 -0.825 . . . . 0.0 113.976 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -140.81 155.85 46.28 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.791 1.237 . . . . 0.0 108.957 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.498 HD22 ' CD2' ' A' ' 13' ' ' HIS . 8.1 m-80 -120.0 114.56 22.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.38 115.28 30.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.3 mtm-85 -79.82 139.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.0 mm -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 t -133.17 118.75 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.72 106.64 15.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.357 1.463 . . . . 0.0 107.297 170.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -72.27 -26.67 62.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.382 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.97 -42.76 72.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.175 0.443 . . . . 0.0 110.523 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.98 -16.17 25.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.495 1.118 . . . . 0.0 113.056 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.83 50.21 19.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.82 1.648 . . . . 0.0 110.473 -169.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -116.52 159.32 22.26 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.283 1.433 . . . . 0.0 108.369 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.69 117.98 36.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -88.87 125.55 34.98 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.976 1.711 . . . . 0.0 108.198 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -115.87 128.07 55.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.14 35.04 12.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.116 0.966 . . . . 0.0 111.894 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.05 87.77 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.412 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.05 143.19 45.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.081 1.941 . . . . 0.0 108.563 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -72.18 141.89 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.756 1.162 . . . . 0.0 109.16 175.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.82 169.4 9.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.694 0.798 . . . . 0.0 111.491 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.8 145.67 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.599 1.16 . . . . 0.0 110.075 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 p -141.86 149.86 40.82 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 109.646 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.59 139.68 49.24 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.9 104.93 1.19 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -90.0 149.81 22.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.0 139.41 52.54 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.73 167.91 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.491 1.516 . . . . 0.0 110.134 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -76.5 49.9 0.63 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.062 1.345 . . . . 0.0 110.486 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -160.22 -35.75 0.05 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.86 2.464 . . . . 0.0 109.849 -170.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.28 -150.97 22.43 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.04 148.46 38.83 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -123.59 107.28 11.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -94.02 105.0 17.02 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -90.49 146.65 23.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.062 1.345 . . . . 0.0 111.055 -172.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -157.7 -179.59 8.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.867 2.067 . . . . 0.0 108.185 169.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -144.34 146.55 32.63 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.101 -0.999 . . . . 0.0 109.949 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.4 mt -143.23 131.33 19.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.28 -130.3 50.82 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -104.75 32.0 4.4 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.66 1.184 . . . . 0.0 111.053 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -129.58 146.57 51.37 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.748 1.219 . . . . 0.0 109.271 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.05 150.37 22.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 109.515 170.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.53 151.62 51.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.777 1.631 . . . . 0.0 108.294 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -148.48 142.79 26.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.954 -0.466 . . . . 0.0 110.079 168.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.7 mt -88.05 118.78 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -89.54 101.73 14.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.23 91.14 7.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.85 129.58 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.872 1.669 . . . . 0.0 109.192 -169.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 CA--C 1.543 0.678 0 CA-C-N 119.829 1.195 . . . . 0.0 112.262 -179.692 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.0 135.12 26.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -110.11 126.65 54.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -132.01 142.47 49.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.18 131.58 37.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.84 143.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.4 t -138.49 130.44 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.68 39.74 14.26 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.058 0.943 . . . . 0.0 111.754 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 64.79 3.71 2.13 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.86 2.064 . . . . 0.0 115.001 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -89.89 147.24 23.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.369 -1.457 . . . . 0.0 109.195 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.76 134.28 34.87 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.717 0.807 . . . . 0.0 110.125 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.9 mm -119.24 114.76 34.7 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.816 1.646 . . . . 0.0 108.287 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -67.71 143.37 61.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.049 3.166 . . . . 0.0 111.962 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--O 1.239 0.541 0 C-N-CA 123.284 0.634 . . . . 0.0 109.887 171.323 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.235 0.316 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.85 131.69 54.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -110.49 149.19 30.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -135.19 163.82 29.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.994 1.718 . . . . 0.0 107.196 169.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.12 140.81 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.33 44.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.099 1.359 . . . . 0.0 108.954 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -101.49 125.9 48.2 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.85 0.86 . . . . 0.0 109.018 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.26 139.89 27.44 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.13 0.972 . . . . 0.0 109.059 170.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 45.32 45.97 10.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 114.003 169.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.08 -1.31 80.58 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.042 -0.866 . . . . 0.0 114.313 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -109.77 159.64 17.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.74 1.616 . . . . 0.0 110.429 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -119.77 130.29 54.88 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -110.04 107.07 16.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 107.747 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -73.5 129.69 38.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.1 mm -108.78 136.35 44.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.41 118.82 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.2 tp -88.36 128.53 35.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -85.5 109.46 18.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -72.24 -30.98 65.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.15 0.886 . . . . 0.0 111.865 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.49 -42.83 74.26 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.234 . . . . 0.0 111.047 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.2 -17.0 23.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -173.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 55.6 28.36 11.8 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.943 1.697 . . . . 0.0 112.464 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.79 149.55 25.66 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.05 125.12 67.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -97.22 138.09 35.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.669 1.187 . . . . 0.0 107.947 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -120.99 119.8 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 45.78 41.82 8.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.596 1.558 . . . . 0.0 112.038 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.25 6.71 75.8 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.019 -0.879 . . . . 0.0 114.412 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.24 152.08 23.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.121 1.46 . . . . 0.0 107.74 173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.91 148.19 28.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -129.99 165.04 22.96 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.18 0.992 . . . . 0.0 110.793 170.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.76 148.08 35.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.963 1.305 . . . . 0.0 110.436 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -139.28 149.16 43.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.268 1.027 . . . . 0.0 109.981 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.94 141.68 50.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.99 106.47 1.21 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.08 149.26 21.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -121.27 138.58 54.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.406 0.682 . . . . 0.0 109.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.15 167.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.468 1.507 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.03 48.53 0.6 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.057 1.343 . . . . 0.0 110.594 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -159.88 -31.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.862 2.465 . . . . 0.0 110.713 -171.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.42 -151.93 23.35 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -122.25 151.03 41.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -125.94 106.95 10.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.554 1.542 . . . . 0.0 107.095 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.8 m -92.32 103.54 15.97 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -90.23 147.26 23.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.788 1.235 . . . . 0.0 111.12 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.54 -178.33 7.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 108.37 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.3 m -145.07 149.55 35.28 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.291 1.036 . . . . 0.0 109.375 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.5 mt -134.05 111.21 14.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.65 -134.0 51.48 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -169.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -78.19 -14.09 59.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 112.462 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -88.19 126.74 35.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.61 150.1 24.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.617 0.722 . . . . 0.0 109.311 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -137.15 151.87 49.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.566 1.546 . . . . 0.0 107.919 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -148.18 142.17 25.89 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 168.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.16 120.43 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -85.66 118.23 25.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 170.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.43 92.36 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.18 129.26 41.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.271 1.428 . . . . 0.0 110.735 -168.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.543 0.705 0 C-N-CA 124.746 1.219 . . . . 0.0 112.713 -179.182 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mt . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.15 126.57 40.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -106.8 122.73 46.97 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -133.02 141.09 48.07 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.402 1.081 . . . . 0.0 108.523 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -88.43 133.13 34.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.84 141.04 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -138.18 132.38 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 49.97 37.54 14.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.064 0.935 . . . . 0.0 111.882 -176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.8 t30 62.56 10.17 3.91 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.927 2.091 . . . . 0.0 115.407 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.58 149.13 21.78 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.986 1.315 . . . . 0.0 109.217 171.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -93.21 134.59 35.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.826 0.85 . . . . 0.0 110.094 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.8 mm -121.19 113.67 32.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.532 1.933 . . . . 0.0 107.548 -173.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.91 147.83 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.158 2.572 . . . . 0.0 110.932 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 124.363 1.065 . . . . 0.0 111.012 179.538 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.806 0.336 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.6 129.08 55.12 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 169.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.1 m -120.8 143.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -135.19 155.02 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.214 1.806 . . . . 0.0 107.213 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.41 122.73 66.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 168.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.0 tp -115.69 123.2 47.75 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.332 1.053 . . . . 0.0 109.081 -169.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -91.17 135.5 33.74 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.7 mtt -139.39 106.88 5.56 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 61.81 -33.95 0.1 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.617 3.167 . . . . 0.0 116.849 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.75 -32.28 0.03 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.5 2.0 . . . . 0.0 110.154 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -77.01 156.93 31.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.165 0.986 . . . . 0.0 110.167 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -131.76 115.97 16.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -105.76 122.11 45.42 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.389 1.076 . . . . 0.0 108.563 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -73.44 138.61 45.3 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -117.26 132.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.94 117.88 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -86.06 121.13 28.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.04 113.03 19.64 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 168.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.75 -24.54 56.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 119.116 -0.468 . . . . 0.0 111.254 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.93 -44.3 69.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.712 0.687 . . . . 0.0 110.131 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.14 -15.4 24.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.489 1.115 . . . . 0.0 113.152 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.8 mmm 52.69 45.08 29.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.816 1.247 . . . . 0.0 109.276 -168.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -114.6 146.39 40.86 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.869 1.668 . . . . 0.0 107.148 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.05 117.41 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -84.57 119.31 25.05 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.946 1.698 . . . . 0.0 107.047 172.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.2 t -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.0 36.01 10.96 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.334 1.054 . . . . 0.0 111.919 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.62 3.01 88.8 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.621 -1.1 . . . . 0.0 115.092 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -114.4 145.58 41.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.657 1.728 . . . . 0.0 108.868 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -68.33 141.58 55.76 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.03 163.41 16.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.707 0.803 . . . . 0.0 110.422 169.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -70.87 143.99 50.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 110.199 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -138.52 148.58 44.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 110.162 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.59 143.43 51.17 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.52 108.83 1.47 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -97.76 148.62 23.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.97 135.88 54.74 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.47 167.55 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 110.173 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -77.7 48.1 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.156 1.382 . . . . 0.0 110.554 175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.94 -34.13 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.233 2.213 . . . . 0.0 110.325 -171.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.86 -150.31 20.1 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -121.16 152.11 39.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -125.37 107.16 10.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.794 1.638 . . . . 0.0 106.898 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -91.32 102.7 15.41 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.92 146.43 24.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.674 1.189 . . . . 0.0 110.901 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -158.19 -173.91 4.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.636 1.975 . . . . 0.0 108.646 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 m -144.49 146.75 32.59 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 109.347 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.6 mt -142.18 133.27 25.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.97 -131.07 51.86 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -105.13 34.1 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.511 1.124 . . . . 0.0 110.851 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -131.11 144.32 51.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.733 1.213 . . . . 0.0 109.097 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.35 152.43 19.15 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.502 0.668 . . . . 0.0 109.219 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 m -135.15 151.94 51.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.577 1.551 . . . . 0.0 107.752 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -147.81 140.77 24.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.856 -0.527 . . . . 0.0 109.669 168.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.27 118.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -83.61 120.89 26.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 92.54 3.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.61 125.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.077 1.351 . . . . 0.0 109.373 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 124.496 1.118 . . . . 0.0 110.549 175.618 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.98 125.81 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -105.78 127.3 53.01 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -136.31 141.51 43.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.174 0.99 . . . . 0.0 108.597 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.55 131.1 36.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.89 142.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.0 130.86 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 t70 46.53 43.22 12.04 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.443 1.097 . . . . 0.0 111.448 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 63.69 6.53 2.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.709 2.404 . . . . 0.0 115.828 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -99.41 148.27 24.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.586 1.555 . . . . 0.0 109.918 173.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -91.02 137.31 32.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.525 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.3 mm -119.89 113.36 34.47 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.888 2.075 . . . . 0.0 106.929 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.92 147.06 33.8 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.096 2.53 . . . . 0.0 110.965 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 123.996 0.918 . . . . 0.0 110.493 175.899 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 121.48 0.657 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -117.49 137.85 52.26 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -120.98 149.59 42.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -140.41 151.83 45.23 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.72 1.608 . . . . 0.0 108.337 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -107.34 135.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.85 117.76 29.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -87.54 120.98 29.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 43.2 ttm -155.79 131.5 9.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -170.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 50.5 36.67 14.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 113.072 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.27 74.76 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.039 0.828 . . . . 0.0 113.975 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -108.39 170.62 7.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.489 1.916 . . . . 0.0 109.383 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -131.84 111.58 11.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -102.52 131.24 49.36 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -93.68 124.05 37.41 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.93 138.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.96 125.71 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -90.09 129.99 36.32 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.442 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -98.14 112.47 24.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.355 1.462 . . . . 0.0 107.722 168.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -74.91 -22.18 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.79 -0.569 . . . . 0.0 112.322 -170.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.48 -36.52 80.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.194 0.452 . . . . 0.0 111.207 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.49 -4.35 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 113.052 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.8 mtp 53.35 37.84 26.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.563 1.145 . . . . 0.0 109.564 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -92.34 147.53 22.84 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -129.97 119.42 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.442 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 15.3 m95 -85.42 133.52 34.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.495 1.918 . . . . 0.0 108.448 173.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -128.81 126.51 40.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 168.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 52.08 37.69 22.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.304 1.042 . . . . 0.0 111.981 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.87 2.05 90.64 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.379 -1.234 . . . . 0.0 115.617 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.41 148.12 44.82 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.878 1.839 . . . . 0.0 108.171 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -75.52 151.82 37.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.871 1.214 . . . . 0.0 110.189 173.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.26 167.67 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.23 1.412 . . . . 0.0 110.215 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.95 147.91 44.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.064 0.946 . . . . 0.0 110.358 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 p -138.3 148.83 45.06 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.665 1.186 . . . . 0.0 109.88 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.0 149.52 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.0 109.41 1.03 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.83 151.8 21.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.72 0.808 . . . . 0.0 109.262 170.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -123.99 140.15 53.26 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.87 167.44 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.726 1.61 . . . . 0.0 110.278 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.17 48.71 0.63 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.07 1.348 . . . . 0.0 110.606 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -160.15 -34.49 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.813 2.445 . . . . 0.0 110.276 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.98 -153.39 24.21 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -117.88 150.19 39.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -124.55 106.85 10.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.1 m -90.95 106.22 18.37 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.04 145.82 24.22 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.799 1.239 . . . . 0.0 110.51 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.47 -169.7 2.69 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.226 1.811 . . . . 0.0 108.423 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -150.15 148.2 28.67 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.927 -1.108 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 93.7 mt -141.1 130.69 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.36 -133.4 51.37 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.07 29.11 4.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.251 1.02 . . . . 0.0 111.654 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -124.22 142.97 50.8 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.56 1.144 . . . . 0.0 109.261 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 150.01 21.35 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -134.84 152.04 51.42 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.764 1.226 . . . . 0.0 108.073 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -147.0 141.74 26.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 168.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.94 120.59 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -87.16 114.84 24.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.58 91.86 3.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -87.77 126.22 41.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.017 1.327 . . . . 0.0 109.328 -169.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.535 1.134 . . . . 0.0 110.858 176.522 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.73 125.32 43.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -103.18 127.26 50.53 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -134.66 145.02 48.17 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.375 1.07 . . . . 0.0 108.494 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -93.98 130.41 40.1 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.81 142.48 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 169.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.31 133.19 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.821 1.248 . . . . 0.0 108.088 171.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t0 45.59 42.12 7.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.326 1.451 . . . . 0.0 111.659 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.47 17.64 10.93 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.475 2.31 . . . . 0.0 116.136 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -116.1 152.09 34.32 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.158 169.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -84.73 139.19 32.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.86 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.2 mm -119.53 118.78 32.02 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.358 1.863 . . . . 0.0 106.612 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 142.81 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 111.284 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 C--O 1.236 0.388 0 C-N-CA 124.532 1.133 . . . . 0.0 111.063 178.02 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.89 0.376 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -112.54 137.02 51.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 m -121.85 142.82 49.85 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -133.82 156.43 48.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.193 1.797 . . . . 0.0 107.542 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -124.44 134.4 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -117.94 123.66 46.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.3 113.47 25.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.9 mtm -146.43 138.49 24.92 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.274 1.029 . . . . 0.0 108.449 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.64 36.87 11.45 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.188 1.395 . . . . 0.0 113.249 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.84 -4.16 62.14 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.99 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.41 165.13 11.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.615 1.566 . . . . 0.0 110.348 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -119.67 125.19 48.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.01 123.51 50.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.926 1.291 . . . . 0.0 108.117 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -86.0 123.55 31.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.66 133.23 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 170.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.9 t -128.39 121.43 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.06 121.8 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 1.2 mm-40 -85.05 112.36 20.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.19 -30.28 62.15 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.969 -0.457 . . . . 0.0 111.908 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.95 -41.52 97.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.856 0.298 . . . . 0.0 110.782 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.38 -14.71 22.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.622 1.169 . . . . 0.0 113.178 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtp 52.79 42.67 31.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.343 1.457 . . . . 0.0 109.924 -168.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -107.13 145.32 32.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.54 1.136 . . . . 0.0 108.496 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -116.52 120.86 66.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.662 0.744 . . . . 0.0 109.823 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.467 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 12.0 m95 -93.84 130.11 40.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.054 1.342 . . . . 0.0 108.291 172.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.2 117.94 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.41 40.71 15.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.84 1.256 . . . . 0.0 111.356 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.12 -9.77 52.09 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.511 -1.161 . . . . 0.0 115.129 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -95.8 135.64 37.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.863 1.832 . . . . 0.0 108.226 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -75.09 147.9 40.21 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.56 1.073 . . . . 0.0 109.148 174.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.18 166.58 20.81 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.474 1.11 . . . . 0.0 109.771 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.51 145.98 48.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.156 0.583 . . . . 0.0 111.018 -172.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.92 150.86 48.47 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.843 1.657 . . . . 0.0 109.331 -178.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.6 137.54 52.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.71 100.62 1.62 Allowed Glycine 0 C--N 1.33 0.24 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.62 149.32 22.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.31 126.81 47.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.19 174.74 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.262 1.425 . . . . 0.0 109.59 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -83.64 44.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.896 1.278 . . . . 0.0 110.964 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.39 -31.58 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.872 1.669 . . . . 0.0 111.319 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.78 -157.88 30.42 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.3 150.19 26.19 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -130.73 105.15 7.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.3 m -86.63 99.82 12.0 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -84.29 146.18 27.89 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.922 1.289 . . . . 0.0 110.24 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -158.28 -175.51 5.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.057 1.743 . . . . 0.0 108.469 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -152.16 149.02 28.3 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.784 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -142.32 127.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.14 -126.86 43.33 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -102.68 25.09 9.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -121.07 145.08 48.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.062 1.345 . . . . 0.0 109.048 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.71 147.78 28.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.339 0.656 . . . . 0.0 109.244 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -135.47 151.51 50.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.12 1.368 . . . . 0.0 108.436 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -146.9 141.46 26.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.911 -0.493 . . . . 0.0 109.819 168.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.46 115.18 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -79.23 123.64 27.61 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 169.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.5 92.14 3.86 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 171.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.17 124.56 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.474 1.11 . . . . 0.0 108.214 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 119.137 0.88 . . . . 0.0 110.862 179.77 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 mm -101.42 120.85 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -97.16 130.61 44.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -139.1 143.55 38.32 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.159 0.983 . . . . 0.0 108.528 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -91.23 130.79 37.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.35 143.41 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.3 t -139.87 132.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.146 1.379 . . . . 0.0 107.715 173.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.68 37.65 13.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 111.868 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.6 t30 62.45 10.23 3.86 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.095 2.158 . . . . 0.0 115.295 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.54 149.81 21.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.04 1.336 . . . . 0.0 109.426 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.78 136.17 33.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.825 0.85 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.87 113.9 39.66 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.008 1.723 . . . . 0.0 107.04 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.55 149.4 30.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.072 2.515 . . . . 0.0 110.96 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--O 1.239 0.534 0 C-N-CA 124.264 1.026 . . . . 0.0 110.81 174.944 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.03 130.55 45.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.6 m -122.51 139.58 53.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -133.91 152.53 51.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.192 1.397 . . . . 0.0 107.57 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.03 140.01 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.21 132.89 55.54 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -106.49 109.97 22.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 170.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.0 mtm -146.18 140.86 26.93 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.311 1.045 . . . . 0.0 108.932 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t0 51.23 35.67 14.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.992 1.317 . . . . 0.0 112.738 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.75 -10.52 18.06 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.713 1.149 . . . . 0.0 113.883 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.57 166.52 13.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.405 1.482 . . . . 0.0 111.063 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.81 129.32 52.54 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.65 116.74 27.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.737 1.215 . . . . 0.0 108.161 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -91.19 117.43 29.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -96.26 132.96 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.0 t -127.97 123.71 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.43 122.64 32.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -88.16 109.72 20.12 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.164 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -67.68 -27.52 66.9 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.587 -0.696 . . . . 0.0 111.311 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.46 -30.13 70.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.68 -3.65 9.26 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 113.06 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtp 53.19 37.1 24.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.221 1.409 . . . . 0.0 110.77 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -91.86 146.03 24.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.9 p -117.68 113.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 122.172 0.987 . . . . 0.0 109.714 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.439 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 26.9 m95 -83.15 137.67 33.97 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 169.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.38 113.23 11.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 169.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 46.56 42.84 11.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.166 1.386 . . . . 0.0 111.216 -170.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.88 -12.69 28.44 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.786 1.184 . . . . 0.0 114.996 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.11 135.58 33.92 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.817 1.808 . . . . 0.0 108.254 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -76.87 120.02 21.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 mt -77.55 166.7 22.71 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.819 1.295 . . . . 0.0 111.273 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.65 147.89 39.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 112.934 -1.939 . . . . 0.0 107.062 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -144.73 150.55 37.46 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.075 0.95 . . . . 0.0 109.477 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.68 140.11 46.85 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.67 105.86 1.24 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 -172.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -95.74 152.25 18.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.417 0.687 . . . . 0.0 109.195 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.65 139.71 52.63 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -131.2 167.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.605 1.562 . . . . 0.0 110.079 176.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.01 28.05 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.967 1.707 . . . . 0.0 112.825 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 44' ' ' VAL . 32.2 t70 -141.87 -22.04 0.72 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.568 2.747 . . . . 0.0 111.768 -173.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -155.66 26.26 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.65 150.62 37.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -130.0 107.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.938 1.295 . . . . 0.0 107.714 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.2 m -93.85 104.4 16.47 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.4 146.63 24.53 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.092 1.357 . . . . 0.0 110.625 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.08 -174.39 4.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.224 1.809 . . . . 0.0 108.324 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -144.81 149.7 35.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.352 1.061 . . . . 0.0 108.96 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.6 mt -134.43 113.82 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.2 -135.15 50.3 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.87 -13.45 59.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.608 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -88.51 127.46 35.53 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.531 -0.731 . . . . 0.0 109.472 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.37 149.01 26.31 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 169.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.64 153.32 47.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.686 1.594 . . . . 0.0 108.448 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -147.69 143.67 27.79 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.763 -0.586 . . . . 0.0 109.66 168.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -88.29 117.95 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 169.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -84.55 117.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.62 89.88 3.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.38 126.84 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 109.095 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.539 0.548 0 CA-C-N 120.138 1.335 . . . . 0.0 110.476 175.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.9 mm . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.84 117.34 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -92.07 127.7 37.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -133.59 144.29 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.467 1.107 . . . . 0.0 108.237 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -94.22 129.61 40.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.4 142.35 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.7 t -137.22 131.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.031 1.332 . . . . 0.0 107.84 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t0 45.11 42.36 6.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.281 1.432 . . . . 0.0 111.682 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 64.56 17.09 10.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.711 2.404 . . . . 0.0 116.125 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.11 152.41 31.13 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.643 1.177 . . . . 0.0 111.027 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -85.86 138.82 31.77 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.727 1.211 . . . . 0.0 110.692 -172.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.65 118.44 33.47 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.228 1.811 . . . . 0.0 106.714 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.19 150.43 33.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.861 2.374 . . . . 0.0 111.002 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.238 0.476 0 C-N-CA 123.599 0.76 . . . . 0.0 110.423 172.721 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -125.65 132.52 52.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 m -112.42 142.93 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -132.9 162.33 31.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.856 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 t -128.81 135.32 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.97 117.64 29.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -88.45 114.1 24.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 169.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.5 mtm -146.35 137.26 24.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.446 1.098 . . . . 0.0 108.426 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.24 38.14 12.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.319 1.448 . . . . 0.0 113.22 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.91 -1.07 69.84 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.254 0.93 . . . . 0.0 114.176 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -105.6 166.04 10.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.087 1.755 . . . . 0.0 110.116 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -122.66 121.28 36.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -109.39 120.99 44.21 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.66 1.184 . . . . 0.0 108.308 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -78.06 145.11 36.05 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.9 mm -125.57 133.03 70.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.35 120.48 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -85.91 122.45 29.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -88.78 112.23 22.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -72.56 -21.02 61.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.533 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.69 -35.98 81.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.869 0.759 . . . . 0.0 111.601 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.25 -0.99 9.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.119 1.368 . . . . 0.0 113.285 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.4 mtp 52.72 39.52 28.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.727 1.211 . . . . 0.0 110.592 -169.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.96 144.7 26.62 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.428 1.091 . . . . 0.0 108.245 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -114.02 115.68 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 109.862 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.456 ' CZ3' ' HE2' ' A' ' 36' ' ' LYS . 51.7 m95 -83.2 115.31 21.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 169.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.53 128.47 55.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 52.68 34.95 17.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.542 0.737 . . . . 0.0 111.705 -170.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.25 77.51 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.425 1.012 . . . . 0.0 114.65 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -125.44 138.0 54.0 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HE2' ' CZ3' ' A' ' 31' ' ' TRP 0.3 0.0 OUTLIER -75.71 146.42 40.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.733 1.606 . . . . 0.0 110.068 175.552 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.73 167.93 19.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.007 1.323 . . . . 0.0 110.16 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.48 148.34 49.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.6 0.714 . . . . 0.0 111.531 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -136.38 150.46 48.81 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.067 1.747 . . . . 0.0 108.99 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.31 139.76 52.24 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.49 107.35 1.62 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -96.86 151.15 19.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -117.44 139.59 50.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.401 0.681 . . . . 0.0 109.326 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.97 167.75 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.663 1.585 . . . . 0.0 110.023 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -76.94 49.74 0.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.171 1.388 . . . . 0.0 110.501 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.79 -34.98 0.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.902 2.481 . . . . 0.0 109.991 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.41 -151.58 23.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.75 148.2 40.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -125.83 107.26 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 m -91.03 103.34 16.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -87.29 147.08 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.911 1.284 . . . . 0.0 110.742 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.53 -178.99 7.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.591 1.957 . . . . 0.0 108.062 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 m -146.63 150.73 36.02 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.952 0.901 . . . . 0.0 109.186 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.99 108.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.34 -15.84 59.2 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.688 0.795 . . . . 0.0 112.425 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -85.88 120.81 27.69 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.63 146.4 25.75 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.634 0.73 . . . . 0.0 109.884 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.4 m -136.89 151.78 49.47 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.041 1.736 . . . . 0.0 108.445 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -148.66 142.17 25.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.837 -0.539 . . . . 0.0 109.818 168.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -88.1 119.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -88.75 102.45 15.02 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.28 88.14 6.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.56 134.87 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.263 1.825 . . . . 0.0 110.351 -169.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 123.762 0.825 . . . . 0.0 112.646 179.251 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.15 138.49 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.89 129.57 55.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.485 1.039 . . . . 0.0 108.307 172.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 147.71 51.16 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.81 130.43 44.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.52 143.29 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -140.65 132.35 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 125.009 1.324 . . . . 0.0 107.648 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 48.65 38.24 11.03 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.116 0.96 . . . . 0.0 111.971 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.9 t30 63.7 8.75 3.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.116 2.167 . . . . 0.0 115.428 -175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.25 149.4 21.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.126 1.37 . . . . 0.0 109.781 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.89 136.27 33.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.101 0.96 . . . . 0.0 110.119 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -120.19 116.58 32.4 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.895 1.678 . . . . 0.0 106.901 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.31 143.9 20.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.269 2.646 . . . . 0.0 111.383 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.237 0.424 0 C-N-CA 123.176 0.59 . . . . 0.0 110.666 179.606 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -110.21 130.5 55.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 m -121.64 142.63 49.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.492 0.663 . . . . 0.0 109.584 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -135.57 159.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.468 1.907 . . . . 0.0 106.941 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.42 141.36 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 169.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.51 134.2 46.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.053 1.341 . . . . 0.0 108.94 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -101.52 132.1 47.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.601 0.76 . . . . 0.0 109.278 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -138.24 133.08 32.73 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 56.28 -61.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.392 3.077 . . . . 0.0 115.975 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.97 15.17 0.08 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.323 1.916 . . . . 0.0 112.042 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -130.06 159.17 37.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.954 1.702 . . . . 0.0 109.179 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -121.1 130.93 53.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -110.02 109.51 20.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.656 1.182 . . . . 0.0 107.954 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -74.08 119.68 18.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 mm -96.6 131.2 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.63 116.38 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.94 122.83 31.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -82.59 113.27 20.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -71.75 -27.11 62.75 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.532 0.333 . . . . 0.0 111.634 -169.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.86 -45.63 41.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.38 0.537 . . . . 0.0 110.609 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.28 -17.07 28.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.172 0.989 . . . . 0.0 112.952 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.251 98.8 mmm 55.76 28.81 12.82 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.331 1.452 . . . . 0.0 111.357 -169.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.28 146.32 25.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.04 118.68 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -85.02 132.88 34.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.781 1.633 . . . . 0.0 108.1 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -118.22 116.3 26.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 168.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 46.39 42.4 10.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.859 1.264 . . . . 0.0 111.265 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.51 -11.36 39.29 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.616 1.103 . . . . 0.0 115.004 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.49 138.14 31.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.77 1.785 . . . . 0.0 108.588 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -68.94 145.9 53.24 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.8 163.64 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.944 0.898 . . . . 0.0 110.573 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.18 148.06 39.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.563 1.145 . . . . 0.0 110.285 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -140.62 149.41 42.28 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.399 1.08 . . . . 0.0 109.908 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.65 50.19 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.85 108.35 1.94 Allowed Glycine 0 C--N 1.331 0.263 0 N-CA-C 106.994 -2.442 . . . . 0.0 106.994 -174.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -94.55 148.96 21.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.38 137.16 52.38 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.585 0.754 . . . . 0.0 109.011 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.43 167.9 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.601 1.56 . . . . 0.0 109.919 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.7 47.88 0.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.071 1.348 . . . . 0.0 110.47 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -159.91 -34.9 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.274 2.23 . . . . 0.0 110.165 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.62 12.59 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -120.52 152.59 37.85 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.32 107.56 9.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.713 1.605 . . . . 0.0 106.948 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.9 m -93.93 102.93 15.04 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -89.76 148.15 23.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.907 1.283 . . . . 0.0 111.22 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -158.96 -177.63 6.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.907 2.083 . . . . 0.0 108.26 169.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.0 m -144.91 146.63 32.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.175 0.99 . . . . 0.0 109.709 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.0 mt -142.39 132.83 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.87 -127.19 44.68 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -109.57 36.48 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 110.526 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -131.86 145.99 51.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.043 1.337 . . . . 0.0 108.778 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.96 150.44 21.95 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.37 151.02 51.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.427 1.491 . . . . 0.0 107.839 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -148.66 140.64 23.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 121.804 -0.56 . . . . 0.0 110.285 168.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -87.51 117.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -84.96 127.88 34.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 170.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.46 96.52 4.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.63 125.18 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.104 0.962 . . . . 0.0 109.574 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.543 0.673 0 C-N-CA 124.473 1.109 . . . . 0.0 111.125 175.791 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.4 mm -88.29 113.07 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -95.74 129.18 43.04 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -137.51 140.19 40.97 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 tp -86.55 133.46 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.66 142.63 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 169.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.23 130.46 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.2 39.6 15.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.241 1.016 . . . . 0.0 111.97 -175.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 64.32 4.42 2.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.819 2.047 . . . . 0.0 115.006 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.3 147.21 23.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 120.449 -1.407 . . . . 0.0 109.189 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.95 133.55 35.6 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.371 0.668 . . . . 0.0 109.97 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.0 mm -117.28 111.99 39.88 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.193 1.797 . . . . 0.0 107.081 -175.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -73.23 152.58 50.45 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.908 2.405 . . . . 0.0 110.726 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 C--O 1.237 0.439 0 C-N-CA 124.243 1.017 . . . . 0.0 111.257 174.81 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.6 t70 55.19 -73.72 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.087 2.555 . . . . 0.0 113.684 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -81.12 66.41 6.65 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -98.12 -39.83 8.7 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.091 0.957 . . . . 0.0 110.586 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -85.79 20.41 2.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.005 0.922 . . . . 0.0 112.817 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 m -50.6 124.01 9.98 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.395 1.478 . . . . 0.0 109.579 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -68.76 156.96 37.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.474 1.11 . . . . 0.0 111.365 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.67 138.31 49.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.6 m -119.89 142.97 48.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -132.69 152.68 51.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.011 1.325 . . . . 0.0 107.562 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.1 119.46 29.51 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -92.4 113.52 25.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 mtm -146.07 137.34 24.68 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.404 1.082 . . . . 0.0 108.627 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.07 37.74 15.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.168 1.387 . . . . 0.0 113.102 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.22 -4.0 60.28 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.125 0.869 . . . . 0.0 114.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.08 164.87 11.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.84 1.656 . . . . 0.0 110.056 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -121.01 124.37 44.68 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -110.57 132.49 54.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.956 1.303 . . . . 0.0 108.352 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.38 131.94 37.15 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.4 mm -110.1 134.36 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.37 121.86 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.85 123.5 32.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -87.92 113.03 23.17 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -75.7 -18.02 59.75 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.831 -0.543 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.27 -35.71 79.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.18 0.445 . . . . 0.0 111.266 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.44 -0.07 8.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.267 1.427 . . . . 0.0 113.434 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.7 mmt 52.14 49.13 21.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.106 0.955 . . . . 0.0 109.267 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -117.53 142.51 47.09 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.211 1.404 . . . . 0.0 107.879 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.78 119.79 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.774 0.797 . . . . 0.0 108.913 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.437 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 20.9 m95 -85.93 129.39 34.85 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.298 1.839 . . . . 0.0 108.994 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.8 t -118.33 119.26 34.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 168.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 47.89 41.52 14.71 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.989 1.316 . . . . 0.0 111.691 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.22 -7.05 61.45 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.603 -1.11 . . . . 0.0 115.221 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.84 137.83 39.62 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.751 1.775 . . . . 0.0 107.539 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -72.93 147.5 45.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.967 1.258 . . . . 0.0 109.997 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pp -117.07 168.58 10.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.953 1.301 . . . . 0.0 110.302 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.05 145.41 48.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.073 0.949 . . . . 0.0 110.138 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -143.13 151.19 40.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.478 1.111 . . . . 0.0 109.875 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.44 136.18 48.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.43 96.22 1.24 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -86.66 146.02 26.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -111.52 134.25 53.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.35 167.56 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.196 1.399 . . . . 0.0 110.116 -172.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.85 49.24 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.241 1.416 . . . . 0.0 110.309 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -159.95 -36.57 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.37 2.268 . . . . 0.0 109.892 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.26 -132.18 3.65 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -120.76 151.54 39.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -129.97 106.48 8.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.6 m -85.76 100.1 11.79 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -84.36 145.44 28.22 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.71 1.204 . . . . 0.0 110.393 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -158.45 -178.25 7.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.14 1.776 . . . . 0.0 108.762 169.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -145.81 150.47 36.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.36 1.064 . . . . 0.0 109.108 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mt -133.66 111.67 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.0 -131.26 51.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -169.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -81.16 -10.5 59.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.609 0.764 . . . . 0.0 112.653 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.78 30.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -171.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.15 26.97 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 109.578 169.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -138.26 152.5 48.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.871 1.668 . . . . 0.0 108.725 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.65 141.32 24.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 121.725 -0.609 . . . . 0.0 109.648 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -88.71 114.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -75.94 126.85 31.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.52 88.69 2.98 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.98 123.33 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.755 1.222 . . . . 0.0 108.381 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -79.13 59.08 2.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.313 0.96 . . . . 0.0 109.908 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -72.57 -29.59 63.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.487 1.115 . . . . 0.0 111.643 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.44 144.6 48.66 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -75.34 -30.48 60.27 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.303 -0.528 . . . . 0.0 110.951 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.08 175.77 4.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.62 0.768 . . . . 0.0 109.254 173.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 1.42 4.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.65 176.23 8.89 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.03 1.732 . . . . 0.0 108.717 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.01 46.87 4.34 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp -87.94 127.48 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.57 120.63 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.057 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -100.3 127.75 46.53 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -139.3 140.31 37.55 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 108.704 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.2 131.85 34.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.82 142.81 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.42 133.3 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t0 49.9 37.09 12.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.293 1.037 . . . . 0.0 111.874 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.2 t30 62.48 9.96 3.71 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.829 2.051 . . . . 0.0 115.444 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.52 150.54 20.21 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 125.063 1.345 . . . . 0.0 109.261 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.81 135.15 34.13 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.719 0.808 . . . . 0.0 110.059 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.8 mm -118.71 113.9 36.05 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.356 1.862 . . . . 0.0 106.922 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -74.64 151.43 41.44 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.948 2.432 . . . . 0.0 110.811 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -64.96 162.52 16.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.294 0.569 . . . . 0.0 109.828 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.2 pt -61.82 152.91 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.9 0.88 . . . . 0.0 112.203 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.81 26.01 6.26 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.209 1.404 . . . . 0.0 111.813 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.419 1.487 . . . . 0.0 109.961 179.175 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.44 134.89 35.6 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.731 -0.605 . . . . 0.0 109.836 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -137.64 151.5 48.36 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.49 1.116 . . . . 0.0 108.399 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p -68.18 -45.23 74.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.548 0.739 . . . . 0.0 110.114 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt 51.26 38.41 21.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.69 1.596 . . . . 0.0 111.589 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.36 127.72 33.5 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 p -141.01 154.42 46.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.788 0.835 . . . . 0.0 110.759 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -121.39 136.95 54.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.0 m -128.43 141.96 51.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -135.66 159.65 40.96 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.874 1.67 . . . . 0.0 107.553 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -124.82 140.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.02 125.78 42.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.821 1.248 . . . . 0.0 108.425 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -84.5 121.11 27.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.4 ttm -158.02 140.29 14.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.414 1.086 . . . . 0.0 108.277 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 51.67 37.43 20.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.163 1.385 . . . . 0.0 113.118 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.02 8.69 83.38 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 123.94 0.781 . . . . 0.0 113.653 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -123.81 173.82 7.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.506 1.922 . . . . 0.0 109.584 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -121.92 122.3 39.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.91 127.12 53.15 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -79.6 139.8 37.35 Favored 'General case' 0 N--CA 1.46 0.054 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -114.72 130.62 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.61 117.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -85.46 122.77 30.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.83 112.9 17.57 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.2 -31.6 67.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 119.205 -0.426 . . . . 0.0 112.095 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.38 -47.34 56.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.327 0.512 . . . . 0.0 110.556 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.66 -18.17 28.5 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.78 0.832 . . . . 0.0 112.946 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.258 51.8 mtp 55.44 30.27 14.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.444 1.497 . . . . 0.0 111.552 -169.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.48 152.91 21.57 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.32 115.77 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -85.28 122.65 29.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.581 1.552 . . . . 0.0 107.355 174.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 t -114.73 125.98 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 49.86 36.83 12.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.293 1.037 . . . . 0.0 111.591 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.51 0.51 84.14 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 118.541 -1.144 . . . . 0.0 115.255 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -113.78 146.38 39.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.825 1.812 . . . . 0.0 109.235 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -66.71 147.04 53.8 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.339 -0.85 . . . . 0.0 108.998 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.35 168.16 12.86 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.618 1.167 . . . . 0.0 110.197 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.16 145.39 44.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.306 1.042 . . . . 0.0 110.117 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -140.85 149.52 42.09 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 109.88 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.3 140.39 48.57 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.8 109.86 2.0 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -175.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.26 149.06 25.07 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.538 0.735 . . . . 0.0 109.563 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.97 141.64 37.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.321 0.649 . . . . 0.0 109.521 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.13 166.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.753 1.621 . . . . 0.0 109.897 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -77.92 48.39 0.71 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.133 1.373 . . . . 0.0 110.443 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -161.31 -31.77 0.05 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.437 2.295 . . . . 0.0 110.856 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.8 -134.85 4.41 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -130.82 151.83 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.39 110.83 12.7 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.5 m -92.17 104.89 17.22 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.72 147.12 24.04 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.807 1.243 . . . . 0.0 110.666 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -157.51 -177.62 6.72 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.059 1.744 . . . . 0.0 108.635 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.93 147.54 31.84 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.346 1.058 . . . . 0.0 109.465 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.5 mt -143.67 130.53 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.98 -131.36 51.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.17 28.92 4.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.702 1.201 . . . . 0.0 111.536 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -124.29 149.26 46.73 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.968 1.307 . . . . 0.0 109.17 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 150.72 24.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.92 152.82 52.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.464 1.506 . . . . 0.0 108.318 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -147.68 143.45 27.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.686 -0.634 . . . . 0.0 109.6 168.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.84 117.49 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 169.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -83.07 115.8 22.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.19 90.59 3.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.98 122.24 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.02 1.328 . . . . 0.0 108.587 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -84.39 69.29 10.49 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.203 0.911 . . . . 0.0 108.884 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -73.4 -42.88 61.55 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.818 -0.551 . . . . 0.0 110.829 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.2 155.04 37.72 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.021 0.82 . . . . 0.0 111.758 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -80.92 -24.88 37.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.018 0.527 . . . . 0.0 111.25 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -67.23 151.38 47.62 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -53.63 -49.05 68.7 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.149 0.979 . . . . 0.0 111.221 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -84.92 8.16 18.55 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -170.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.23 41.68 1.83 Allowed Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.968 1.747 . . . . 0.0 114.572 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.6 137.76 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 118.536 1.168 . . . . 0.0 108.785 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.0 mm -102.46 120.88 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -96.44 125.63 41.07 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -132.69 145.82 51.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.345 1.058 . . . . 0.0 108.547 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 tp -93.44 131.95 38.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.78 141.95 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.6 131.36 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.61 40.47 15.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.282 1.033 . . . . 0.0 111.796 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 66.77 1.36 2.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.857 2.063 . . . . 0.0 115.282 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.55 147.48 23.32 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 120.456 -1.403 . . . . 0.0 109.325 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.05 133.88 34.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.619 0.768 . . . . 0.0 109.822 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.1 mm -118.22 113.38 37.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 107.285 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.19 155.16 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.391 2.727 . . . . 0.0 111.137 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -59.11 161.58 5.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.63 0.772 . . . . 0.0 110.897 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.6 pt -62.24 150.77 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.32 1.048 . . . . 0.0 111.845 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.83 104.79 5.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 169.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 123.081 0.552 . . . . 0.0 109.639 176.375 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -145.24 -177.84 5.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.956 1.303 . . . . 0.0 108.465 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? 57.75 30.1 18.41 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.426 1.891 . . . . 0.0 112.404 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.7 m -65.32 145.85 55.67 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.088 0.955 . . . . 0.0 110.52 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -68.19 -54.37 18.33 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m 64.96 -51.13 0.33 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.747 2.019 . . . . 0.0 114.089 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -70.98 169.26 15.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.058 1.343 . . . . 0.0 111.634 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -120.44 132.4 55.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.0 m -119.51 143.04 47.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -136.29 156.18 49.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.121 1.368 . . . . 0.0 108.247 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -116.11 134.74 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.62 110.38 15.92 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -82.55 111.25 18.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 53.0 mtm -147.53 139.8 24.46 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.565 1.146 . . . . 0.0 108.687 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 50.15 36.11 11.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.162 1.385 . . . . 0.0 112.914 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.97 -7.29 36.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.536 1.065 . . . . 0.0 113.718 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.55 171.09 9.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.715 1.606 . . . . 0.0 110.706 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -128.62 111.46 13.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.304 1.442 . . . . 0.0 107.17 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -99.07 129.14 45.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -88.42 135.88 33.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.03 133.76 62.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -131.67 122.19 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -88.14 127.4 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -97.01 113.32 24.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -69.39 -25.11 63.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -172.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -37.35 84.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.225 0.466 . . . . 0.0 111.494 -174.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.76 -5.54 11.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.096 1.358 . . . . 0.0 113.018 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 71.8 mtp 54.37 31.03 13.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.845 1.258 . . . . 0.0 110.353 -168.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.36 147.7 32.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.76 119.5 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.4 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 8.2 m95 -85.45 126.65 33.97 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.481 1.513 . . . . 0.0 107.908 172.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.43 121.37 44.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 46.42 38.94 5.87 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.054 1.341 . . . . 0.0 111.832 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.58 62.53 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.901 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.42 141.21 31.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.724 1.762 . . . . 0.0 108.618 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -69.28 143.97 53.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.21 164.79 17.21 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.944 0.898 . . . . 0.0 110.19 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.32 146.17 43.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.155 0.982 . . . . 0.0 110.243 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -139.72 149.85 44.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.624 1.17 . . . . 0.0 109.824 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.88 140.98 49.25 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.44 106.1 1.36 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.43 151.49 19.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.35 139.08 54.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.585 0.754 . . . . 0.0 109.057 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.12 167.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.424 1.49 . . . . 0.0 110.305 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.07 49.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.705 1.24 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -159.09 -35.12 0.06 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.614 2.366 . . . . 0.0 110.191 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.62 -153.06 23.71 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -118.24 150.83 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -126.01 106.74 9.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.55 1.54 . . . . 0.0 107.098 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 m -91.94 102.57 15.14 Favored 'General case' 0 N--CA 1.46 0.041 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -87.76 146.82 25.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.832 1.253 . . . . 0.0 110.662 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.54 -179.89 8.59 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.011 1.724 . . . . 0.0 108.68 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 m -145.76 150.77 36.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.191 0.997 . . . . 0.0 108.941 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.4 mt -133.01 110.85 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.89 -131.46 52.06 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.02 -9.99 59.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.478 0.711 . . . . 0.0 112.578 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.59 29.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.85 147.19 25.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.77 152.34 49.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.168 1.787 . . . . 0.0 108.685 -173.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -149.4 140.57 23.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.761 -0.587 . . . . 0.0 109.838 168.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -87.71 120.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -87.16 122.9 31.59 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.32 93.53 4.16 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -90.18 125.5 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.377 1.071 . . . . 0.0 108.941 -169.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 m -79.81 45.54 0.71 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.368 1.067 . . . . 0.0 111.904 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 m -69.31 -53.83 17.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.487 1.115 . . . . 0.0 110.425 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.7 148.08 23.42 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -100.76 -7.35 23.81 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -69.78 169.37 13.12 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -52.84 -55.11 25.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.914 0.885 . . . . 0.0 111.133 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -90.2 17.22 7.31 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.092 0.473 . . . . 0.0 111.498 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.25 -17.95 77.79 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.602 1.096 . . . . 0.0 112.782 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.62 124.32 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.1 mm -88.78 115.03 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.98 127.87 41.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -135.21 144.19 46.81 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.72 130.58 41.18 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.4 142.75 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.77 132.43 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 107.565 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.3 37.71 12.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.084 0.954 . . . . 0.0 111.948 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.62 9.88 3.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.152 2.181 . . . . 0.0 115.542 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.7 150.8 19.97 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.232 1.413 . . . . 0.0 109.578 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.47 136.46 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.346 1.059 . . . . 0.0 110.227 -176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.9 mm -120.65 116.16 31.94 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.3 1.84 . . . . 0.0 107.005 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.8 144.27 19.19 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 111.269 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.85 165.29 24.44 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.054 0.542 . . . . 0.0 111.312 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.9 pt -117.36 157.89 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 126.135 1.774 . . . . 0.0 110.194 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.32 27.0 2.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.145 1.378 . . . . 0.0 111.648 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.469 1.508 . . . . 0.0 110.036 179.719 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.15 160.71 37.54 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.489 1.515 . . . . 0.0 108.38 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -141.37 34.12 1.68 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.212 0.605 . . . . 0.0 110.706 171.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -65.12 153.23 41.47 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.135 0.574 . . . . 0.0 110.81 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.7 tttt 54.9 23.89 5.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.319 1.448 . . . . 0.0 112.551 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.1 m -103.25 100.86 10.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -130.13 153.46 48.49 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.909 0.862 . . . . 0.0 112.788 -168.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -118.32 129.53 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 168.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.8 m -112.52 145.42 40.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -133.92 161.42 34.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.459 1.504 . . . . 0.0 108.0 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.03 137.94 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.3 mt -121.57 113.22 19.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -81.06 122.14 26.95 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 168.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 58.3 mtt -130.42 -173.68 3.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.362 1.865 . . . . 0.0 108.079 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -51.1 90.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.603 1.561 . . . . 0.0 113.369 -169.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 13.12 79.13 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.214 1.388 . . . . 0.0 114.116 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -139.99 162.34 35.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.448 1.624 . . . . 0.0 111.123 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -128.61 119.88 25.58 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 125.612 1.565 . . . . 0.0 106.938 172.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.03 131.53 54.49 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.03 0.932 . . . . 0.0 109.239 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -80.75 145.93 31.27 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 mm -122.39 132.61 70.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.22 119.99 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -88.4 123.13 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -90.89 113.2 25.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 168.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -70.78 -19.98 62.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.128 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.18 -42.36 94.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.869 0.759 . . . . 0.0 111.591 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.42 -1.01 13.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.24 1.416 . . . . 0.0 112.449 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm 53.11 39.35 29.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.008 1.323 . . . . 0.0 109.954 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.37 141.77 31.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.779 1.232 . . . . 0.0 109.098 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.45 116.76 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.837 0.827 . . . . 0.0 109.972 -173.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.423 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -85.18 115.27 22.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.1 m -118.48 125.87 50.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 49.14 39.35 15.1 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.138 0.975 . . . . 0.0 111.914 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.13 3.55 88.39 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.307 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.59 147.26 46.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.541 1.67 . . . . 0.0 108.23 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 147.75 33.85 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.384 0.993 . . . . 0.0 109.551 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.9 166.57 23.01 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.487 1.115 . . . . 0.0 110.458 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.98 148.83 48.41 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.486 0.714 . . . . 0.0 111.675 -172.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 149.93 48.99 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.786 1.634 . . . . 0.0 109.15 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.6 140.54 52.69 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.51 106.98 1.29 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 -173.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -98.32 153.01 18.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 109.374 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.48 138.55 54.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.38 168.28 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.422 1.489 . . . . 0.0 110.325 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.01 48.35 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.061 1.345 . . . . 0.0 110.794 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -159.99 -35.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.502 2.321 . . . . 0.0 110.448 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.0 -153.65 24.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -118.45 152.41 35.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.57 109.73 10.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.767 1.227 . . . . 0.0 107.849 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 m -94.37 105.75 17.72 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -91.17 146.19 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.97 1.308 . . . . 0.0 110.836 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.01 -174.01 4.53 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.61 1.964 . . . . 0.0 108.701 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.1 m -145.71 146.58 31.31 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.53 1.132 . . . . 0.0 109.4 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.3 mt -142.39 130.12 20.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.46 -130.37 50.89 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -101.06 28.6 5.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.68 1.192 . . . . 0.0 111.548 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -128.52 144.31 51.12 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.65 1.18 . . . . 0.0 109.076 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.77 149.9 21.83 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.4 150.51 50.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.364 1.465 . . . . 0.0 108.212 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -146.82 140.36 25.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.3 mt -90.79 115.5 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 170.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -78.85 134.83 36.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.66 94.04 3.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.93 128.42 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.957 1.303 . . . . 0.0 109.539 -169.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 m -79.69 47.57 0.86 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.76 1.164 . . . . 0.0 112.436 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.2 m -73.56 -22.11 60.17 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.747 1.219 . . . . 0.0 113.394 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.18 42.86 49.41 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 118.746 0.703 . . . . 0.0 112.759 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -82.44 176.78 9.14 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.84 0.82 . . . . 0.0 110.556 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.87 -66.53 0.46 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.299 1.039 . . . . 0.0 112.665 -169.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -87.83 -70.9 0.6 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 118.64 0.655 . . . . 0.0 109.657 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -71.62 107.37 4.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.72 -58.51 7.57 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp -87.22 125.09 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 169.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.8 mm -79.08 116.5 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -96.51 130.85 43.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 tp -93.34 130.72 38.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.84 140.59 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.35 132.22 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.583 1.153 . . . . 0.0 108.132 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.0 t0 45.53 42.35 7.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.337 1.455 . . . . 0.0 111.613 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 t30 64.52 18.21 11.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.563 2.345 . . . . 0.0 116.002 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -115.75 153.42 31.43 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 120.752 -1.218 . . . . 0.0 110.809 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -89.18 138.08 31.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.955 1.302 . . . . 0.0 110.793 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -121.55 118.09 29.88 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.859 2.064 . . . . 0.0 106.596 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.97 143.39 23.01 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.232 2.621 . . . . 0.0 111.357 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -70.46 160.7 31.91 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.351 0.596 . . . . 0.0 110.359 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.7 pt -117.46 161.03 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 126.475 1.91 . . . . 0.0 108.894 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 51.09 43.92 28.86 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.728 1.211 . . . . 0.0 111.878 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.311 1.844 . . . . 0.0 111.36 -176.189 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -74.8 -41.98 58.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.595 0.758 . . . . 0.0 111.301 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -75.77 149.89 37.87 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -70.88 -25.53 62.84 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.49 0.716 . . . . 0.0 112.438 -176.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 7' ' ' THR . 21.7 tptm 50.74 84.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.833 2.053 . . . . 0.0 110.887 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.9 m -61.16 -31.25 70.98 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.622 1.169 . . . . 0.0 113.097 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.412 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 1.2 p -131.34 152.73 50.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.546 -0.721 . . . . 0.0 110.368 -169.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -115.9 128.98 56.2 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.4 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.811 0.815 . . . . 0.0 109.249 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -135.07 157.03 47.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.032 1.333 . . . . 0.0 107.491 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -125.06 137.76 56.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 169.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.7 mt -122.16 125.53 46.33 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.833 1.253 . . . . 0.0 107.628 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -93.31 118.07 30.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.7 mtm -146.41 134.87 21.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.638 1.175 . . . . 0.0 108.416 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.29 37.5 11.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.983 1.313 . . . . 0.0 113.496 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.71 8.1 87.24 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.936 -0.925 . . . . 0.0 114.431 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -118.28 155.22 30.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.81 1.644 . . . . 0.0 110.042 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -107.88 123.52 48.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -111.05 122.66 48.46 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.212 1.405 . . . . 0.0 108.382 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.42 142.32 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -120.72 134.32 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.4 t -132.36 118.59 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -87.11 125.94 34.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.79 112.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -70.01 -29.35 66.39 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.791 0.723 . . . . 0.0 111.787 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.42 -43.43 94.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.286 0.494 . . . . 0.0 110.996 -173.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.87 -11.68 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.639 1.176 . . . . 0.0 113.003 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.9 mtp 54.55 34.35 21.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 110.519 -169.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -93.13 150.89 20.19 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.28 117.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.53 121.84 30.47 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.74 1.616 . . . . 0.0 107.604 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -113.63 130.57 56.37 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 52.26 35.51 17.13 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.82 0.848 . . . . 0.0 111.6 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.43 10.17 82.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.209 0.909 . . . . 0.0 114.835 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -124.34 136.58 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.379 1.472 . . . . 0.0 107.221 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -72.18 142.58 49.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.595 1.543 . . . . 0.0 109.438 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -116.2 167.8 10.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.086 0.954 . . . . 0.0 110.989 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.29 146.35 43.25 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 110.352 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -139.55 150.39 45.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.445 1.098 . . . . 0.0 109.697 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.7 141.29 50.93 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.49 106.13 1.21 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -95.64 153.35 17.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -122.66 139.7 53.66 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.62 167.58 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.853 1.661 . . . . 0.0 110.086 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -76.55 48.49 0.55 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.8 1.286 . . . . 0.0 110.927 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.98 -33.61 0.06 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.851 2.46 . . . . 0.0 110.356 -171.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.2 -152.17 23.32 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.52 149.16 40.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -126.56 106.75 9.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 m -92.22 103.6 16.06 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -88.56 146.68 25.0 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.913 1.285 . . . . 0.0 110.335 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.82 179.74 8.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.893 1.677 . . . . 0.0 108.337 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 m -145.81 149.88 35.16 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.907 0.883 . . . . 0.0 108.903 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mt -133.18 110.0 14.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.48 -131.67 52.17 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -81.22 -10.12 59.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.413 0.685 . . . . 0.0 112.803 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -88.8 121.34 31.07 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 147.04 25.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.482 0.658 . . . . 0.0 109.862 170.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.84 153.52 49.6 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.57 1.548 . . . . 0.0 108.508 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -148.09 143.08 26.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.692 -0.63 . . . . 0.0 109.798 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.4 mt -88.31 119.56 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -85.33 110.05 18.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.4 84.83 3.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.61 127.3 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.846 1.659 . . . . 0.0 108.881 -169.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -84.55 53.33 2.63 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.63 1.105 . . . . 0.0 110.273 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.1 m -74.57 -26.18 59.78 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.3 140.88 40.07 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 118.698 0.681 . . . . 0.0 111.766 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.79 -28.44 33.19 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.725 0.41 . . . . 0.0 111.322 175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -71.67 168.6 17.38 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -60.25 155.22 18.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 56.86 -124.19 1.8 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -169.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.53 31.69 49.58 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 119.536 1.062 . . . . 0.0 113.141 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.19 139.75 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.31 129.72 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -104.73 124.91 50.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -132.59 145.54 51.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.14 0.976 . . . . 0.0 108.775 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 tp -92.42 131.1 37.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.69 142.42 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 169.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -136.94 132.19 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.048 1.339 . . . . 0.0 107.978 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t0 45.4 42.21 7.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.239 1.415 . . . . 0.0 111.539 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.3 t30 64.02 17.33 10.54 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.553 2.341 . . . . 0.0 116.196 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.65 152.09 32.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.84 1.256 . . . . 0.0 110.546 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -88.74 137.96 31.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.372 1.069 . . . . 0.0 110.631 -169.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.49 112.3 37.43 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.611 1.964 . . . . 0.0 106.909 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.43 150.61 36.61 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.19 2.593 . . . . 0.0 110.821 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.67 157.71 6.91 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.569 0.748 . . . . 0.0 110.818 176.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.1 pt -58.82 153.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.392 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.12 25.99 5.81 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.328 1.451 . . . . 0.0 111.887 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.253 1.264 0 C-N-CA 125.467 1.507 . . . . 0.0 110.059 178.922 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -147.46 153.99 40.25 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.62 1.568 . . . . 0.0 107.902 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -111.6 44.39 1.36 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.83 1.252 . . . . 0.0 108.821 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m 53.2 39.82 30.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.267 1.427 . . . . 0.0 112.317 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -67.17 -28.9 68.49 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 121.534 -0.729 . . . . 0.0 111.152 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.3 m 66.96 -53.98 0.45 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.435 1.894 . . . . 0.0 112.554 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -65.43 146.55 54.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 119.717 1.144 . . . . 0.0 110.661 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -89.49 125.36 35.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.5 m -108.6 148.6 30.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -136.5 159.52 41.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.825 1.65 . . . . 0.0 106.689 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.04 140.57 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.17 122.26 36.55 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.834 1.253 . . . . 0.0 107.987 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -91.91 117.81 30.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 56.7 mtm -146.64 134.8 21.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.817 1.247 . . . . 0.0 108.421 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.33 37.83 12.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.141 1.376 . . . . 0.0 113.339 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.3 8.73 87.04 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.236 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.13 155.76 29.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.987 1.715 . . . . 0.0 110.004 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.92 123.84 49.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -110.26 124.02 50.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.26 1.424 . . . . 0.0 107.978 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -84.38 141.34 30.93 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.0 mm -117.34 135.51 57.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.5 t -132.06 120.58 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.57 124.14 33.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -84.71 113.85 21.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -72.58 -26.41 61.7 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.724 -0.61 . . . . 0.0 111.696 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.09 -44.06 77.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.176 0.443 . . . . 0.0 111.287 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.19 -10.85 17.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 113.372 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.263 59.6 mtp 54.96 30.4 13.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.988 1.315 . . . . 0.0 111.861 -169.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.43 150.08 27.28 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.95 117.71 46.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.402 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.2 m95 -85.19 119.21 25.32 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.5 t -110.54 128.74 55.78 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 169.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 52.62 34.92 16.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.702 0.801 . . . . 0.0 111.576 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 11.17 82.15 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.233 0.921 . . . . 0.0 114.768 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -124.8 142.6 51.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.164 1.482 . . . . 0.0 108.187 -174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -69.47 145.06 53.04 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.522 1.055 . . . . 0.0 108.427 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 pp -123.18 167.15 14.08 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.36 144.85 44.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.911 0.884 . . . . 0.0 110.189 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -140.93 149.58 42.05 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.225 1.01 . . . . 0.0 110.011 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.96 138.45 49.72 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.41 111.2 2.2 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -110.37 146.18 36.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.622 0.769 . . . . 0.0 109.87 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.45 142.46 30.04 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.55 166.34 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.693 1.597 . . . . 0.0 109.754 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.57 49.15 0.72 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.982 1.373 . . . . 0.0 110.231 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -159.87 -34.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.64 2.376 . . . . 0.0 110.292 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.4 -130.07 2.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -171.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -131.85 152.2 51.18 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -129.3 117.3 20.43 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 m -95.84 105.58 17.61 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.87 145.36 25.2 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.815 1.246 . . . . 0.0 109.966 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -157.31 -177.81 6.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.507 1.523 . . . . 0.0 109.053 169.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.81 151.54 38.08 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.422 1.089 . . . . 0.0 108.507 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -132.5 108.58 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.44 -130.76 51.48 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -77.94 -16.21 58.37 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.555 0.742 . . . . 0.0 112.578 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -85.84 120.03 26.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.76 147.53 26.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.364 0.529 . . . . 0.0 109.796 170.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.86 153.07 46.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.731 1.612 . . . . 0.0 108.924 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -148.0 141.3 25.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.661 -0.649 . . . . 0.0 109.342 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.8 mt -88.55 117.76 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -81.74 128.11 33.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 90.9 3.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -87.53 121.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 124.103 0.961 . . . . 0.0 108.537 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 m -75.09 111.7 10.59 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.8 m -144.08 178.52 7.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.541 1.136 . . . . 0.0 110.379 -169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.3 -157.23 33.05 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.561 0.601 . . . . 0.0 112.176 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -72.33 178.27 4.05 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.223 1.009 . . . . 0.0 109.532 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -60.83 -16.31 39.73 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -24.12 67.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.312 0.96 . . . . 0.0 112.388 170.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 58.28 104.21 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 129.593 3.157 . . . . 0.0 113.069 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.7 110.63 4.06 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 106.227 -2.749 . . . . 0.0 106.227 169.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.68 124.81 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -90.09 114.35 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.45 125.31 38.0 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -132.83 142.35 48.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.7 tp -94.25 130.33 40.55 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.22 141.96 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -139.07 132.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t0 49.54 37.49 12.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.049 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 62.86 10.17 4.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.774 2.03 . . . . 0.0 115.531 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -96.63 150.47 20.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.265 1.426 . . . . 0.0 109.672 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.22 137.44 32.33 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.263 1.025 . . . . 0.0 110.232 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mm -118.94 118.77 32.79 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.967 1.707 . . . . 0.0 107.952 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -68.12 141.44 52.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.611 2.874 . . . . 0.0 112.33 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.98 164.62 23.53 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.56 0.695 . . . . 0.0 110.622 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.3 pt -134.02 160.74 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 127.405 2.282 . . . . 0.0 108.233 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.15 23.21 9.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.475 1.11 . . . . 0.0 112.548 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 124.976 1.311 . . . . 0.0 109.742 177.674 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.79 -34.64 69.82 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.093 -1.005 . . . . 0.0 112.204 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -82.44 -7.22 59.64 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -66.3 145.39 55.8 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.346 0.975 . . . . 0.0 110.435 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -77.02 152.05 35.32 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 170.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -129.63 90.17 2.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -130.08 146.16 51.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.568 0.747 . . . . 0.0 111.234 -170.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.76 131.1 55.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.0 m -116.64 141.19 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -131.21 153.69 49.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.601 1.56 . . . . 0.0 107.326 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -114.88 139.4 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.49 112.64 18.76 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.278 1.831 . . . . 0.0 106.591 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -92.44 113.21 25.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.7 mtm -147.31 137.29 23.09 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.43 1.092 . . . . 0.0 108.609 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.3 t70 49.54 37.76 13.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.197 1.399 . . . . 0.0 113.206 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.34 -7.02 48.97 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.518 1.056 . . . . 0.0 113.976 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -95.23 164.99 12.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.731 1.613 . . . . 0.0 110.219 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -123.38 124.44 42.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.8 132.47 54.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.676 1.591 . . . . 0.0 108.132 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.81 138.1 31.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 169.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.5 mm -116.36 131.4 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.3 117.62 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 170.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.1 tp -89.2 123.07 33.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -86.13 110.12 19.33 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 168.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -75.81 -24.76 55.93 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.92 -0.487 . . . . 0.0 111.446 -171.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.29 -42.02 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.134 0.424 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.62 -14.29 22.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.919 1.288 . . . . 0.0 113.106 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm 52.19 49.71 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.317 1.447 . . . . 0.0 109.366 -169.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -123.34 141.97 51.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.372 1.469 . . . . 0.0 108.579 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.93 123.33 68.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.273 0.559 . . . . 0.0 110.221 -172.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.452 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.9 m95 -95.66 114.15 25.87 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.0 m -108.79 120.97 44.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 171.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 47.94 40.94 13.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.33 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.66 -4.41 60.61 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.767 -1.019 . . . . 0.0 114.891 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -111.8 144.21 41.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.446 1.623 . . . . 0.0 108.952 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.29 149.4 47.45 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 110.376 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.96 167.7 21.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.124 1.769 . . . . 0.0 108.41 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.39 143.5 53.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.147 0.499 . . . . 0.0 111.197 -170.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.6 151.08 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.173 1.789 . . . . 0.0 108.815 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.96 134.53 45.73 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.84 90.12 0.81 Allowed Glycine 0 C--N 1.329 0.157 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -78.6 141.43 38.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -106.67 136.11 47.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.91 166.45 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.608 1.163 . . . . 0.0 110.34 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.66 49.26 0.73 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.883 1.325 . . . . 0.0 110.318 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -161.36 -32.66 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.682 2.393 . . . . 0.0 110.874 -169.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.67 -132.99 4.23 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -127.98 151.35 49.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.15 106.59 8.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.8 m -84.52 101.03 11.76 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -85.66 144.52 27.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.774 1.23 . . . . 0.0 110.322 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.85 -178.34 7.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.15 1.78 . . . . 0.0 108.399 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 m -145.23 150.28 36.41 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.993 0.917 . . . . 0.0 109.048 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.6 mt -132.7 115.36 24.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.87 -132.5 52.59 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.14 -4.19 58.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 112.639 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -94.5 121.15 35.76 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -171.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.46 145.3 27.5 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.337 0.589 . . . . 0.0 109.576 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.55 152.3 50.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.482 1.513 . . . . 0.0 108.315 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -147.99 139.67 23.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 110.142 168.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mt -87.89 111.64 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -80.63 127.75 32.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.5 94.1 3.79 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -93.82 126.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.816 -169.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p -84.25 49.48 1.67 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.627 1.103 . . . . 0.0 111.764 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.2 m -110.78 141.69 43.78 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.594 1.158 . . . . 0.0 111.207 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.97 -163.13 38.1 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.135 0.874 . . . . 0.0 112.517 173.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 42.42 57.98 3.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.438 1.895 . . . . 0.0 112.738 169.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 50.22 44.76 26.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.355 1.462 . . . . 0.0 111.566 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? 62.09 -60.34 0.11 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 128.561 2.744 . . . . 0.0 114.038 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.53 -6.17 44.84 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.2 67.5 2.76 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.38 132.61 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mm -84.78 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -140.55 138.09 34.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.2 tp -88.99 131.04 35.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.91 147.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.4 129.64 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.83 39.85 11.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.937 0.895 . . . . 0.0 111.572 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 65.9 2.35 2.17 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.76 2.024 . . . . 0.0 115.472 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -90.16 151.21 21.68 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.488 -1.382 . . . . 0.0 109.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -93.0 136.88 32.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.145 0.978 . . . . 0.0 110.538 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 mm -119.27 117.36 33.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.062 1.745 . . . . 0.0 107.01 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.68 152.51 37.74 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.162 2.575 . . . . 0.0 111.044 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.44 161.62 9.16 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.206 0.602 . . . . 0.0 109.398 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.7 pt -64.32 153.15 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.404 0.621 . . . . 0.0 112.125 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.93 103.95 4.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.035 176.412 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -70.62 143.27 51.54 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.194 0.598 . . . . 0.0 110.087 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -146.54 143.9 29.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.3 m -64.82 155.51 33.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.393 0.677 . . . . 0.0 110.83 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -139.66 152.55 46.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.841 1.256 . . . . 0.0 108.106 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.8 m -127.66 138.76 52.92 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -131.48 157.53 43.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.929 2.092 . . . . 0.0 107.789 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -121.71 130.23 53.29 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.7 m -123.51 142.29 51.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.827 0.704 . . . . 0.0 109.415 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -138.8 158.46 44.18 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 0.0 107.971 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 146.61 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.644 0.778 . . . . 0.0 109.298 169.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.55 156.01 46.47 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.089 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -111.5 116.26 30.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtm -144.56 141.56 29.56 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.6 t0 49.21 38.13 12.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.252 1.421 . . . . 0.0 113.546 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.94 6.44 85.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.977 -0.902 . . . . 0.0 113.937 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -118.15 162.8 17.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.149 1.78 . . . . 0.0 110.452 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -111.05 126.27 54.63 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.21 104.32 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.32 142.6 37.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 mm -125.57 131.47 72.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.51 120.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -87.94 124.52 33.78 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.448 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -89.29 108.48 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.96 1.704 . . . . 0.0 109.109 171.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.7 -26.7 63.53 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.055 0.389 . . . . 0.0 111.661 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.83 -39.94 94.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.407 0.283 . . . . 0.0 111.204 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.7 -11.28 17.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 113.218 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.3 42.4 30.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.298 1.439 . . . . 0.0 109.984 -168.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -105.26 160.84 14.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.913 1.285 . . . . 0.0 108.261 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.43 119.08 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.448 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.7 m95 -90.35 121.35 32.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.851 1.661 . . . . 0.0 109.078 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -102.79 116.03 31.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 168.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 46.13 39.78 6.41 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.32 1.048 . . . . 0.0 111.794 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.46 -7.8 67.22 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.312 -1.271 . . . . 0.0 115.343 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.23 140.98 30.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.106 1.953 . . . . 0.0 108.844 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -69.71 142.07 53.39 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.769 1.168 . . . . 0.0 108.442 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.66 166.16 12.02 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.836 0.854 . . . . 0.0 110.288 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.71 146.76 42.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.507 1.123 . . . . 0.0 109.979 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -142.87 150.24 39.59 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 110.091 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.36 134.24 43.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.47 90.32 0.75 Allowed Glycine 0 C--N 1.33 0.21 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -174.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.4 142.2 39.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -108.52 135.68 49.39 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.24 166.84 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 124.815 1.246 . . . . 0.0 110.174 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.71 49.34 0.75 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 123.005 1.383 . . . . 0.0 110.384 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.08 -33.27 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.536 2.335 . . . . 0.0 110.683 -169.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.29 -134.25 4.71 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -171.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -125.63 150.28 47.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.75 106.19 8.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -87.12 100.6 12.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -86.6 144.55 27.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.602 1.161 . . . . 0.0 110.798 -172.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.69 -177.01 6.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.367 1.867 . . . . 0.0 108.879 169.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -144.64 146.61 32.36 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.363 1.065 . . . . 0.0 109.662 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.95 132.5 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.98 -125.92 41.14 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -109.5 33.25 4.44 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.754 1.222 . . . . 0.0 110.714 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -129.53 144.87 51.45 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.178 1.391 . . . . 0.0 108.817 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.31 150.87 21.67 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.68 152.46 50.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.317 1.447 . . . . 0.0 108.295 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -148.69 140.41 23.64 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.785 -0.572 . . . . 0.0 109.647 168.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -88.29 114.13 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -81.96 126.82 32.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.25 92.12 3.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 121.74 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m -73.87 109.86 7.7 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.4 m -134.58 174.09 10.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.868 1.267 . . . . 0.0 110.544 -171.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.81 -174.54 48.11 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.85 146.37 50.56 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.952 1.301 . . . . 0.0 107.813 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 57.46 -74.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.769 2.027 . . . . 0.0 111.084 -169.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -69.83 130.29 41.87 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 169.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -92.01 112.54 24.51 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.26 111.76 4.26 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 106.377 -2.689 . . . . 0.0 106.377 169.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.46 122.47 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.3 mm -90.21 111.67 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.08 129.76 38.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -137.85 141.24 40.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.907 1.283 . . . . 0.0 108.012 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.9 tp -88.73 132.59 34.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.66 141.9 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.23 133.67 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.5 t0 49.59 37.75 13.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.413 1.085 . . . . 0.0 111.759 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.1 t30 62.72 9.66 3.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.027 2.131 . . . . 0.0 115.431 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.83 149.06 21.95 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.14 1.376 . . . . 0.0 109.387 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -91.13 133.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.457 0.703 . . . . 0.0 110.065 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.06 112.39 40.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.432 1.893 . . . . 0.0 106.801 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.28 152.02 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 110.947 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -55.11 156.81 3.75 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.187 0.995 . . . . 0.0 110.484 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.1 pt -59.3 151.62 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.074 173.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 54.82 25.51 6.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.882 1.673 . . . . 0.0 114.977 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.253 1.247 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 169.671 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -81.17 -59.46 2.64 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 47.02 41.63 11.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.911 1.684 . . . . 0.0 113.073 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.7 m -63.03 155.1 28.64 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.8 -0.562 . . . . 0.0 110.73 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -140.82 143.45 34.83 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.281 1.432 . . . . 0.0 107.533 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.59 114.16 10.36 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -141.74 145.42 34.81 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.2 0.6 . . . . 0.0 111.304 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -117.41 135.61 53.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 m -114.68 147.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -134.55 161.35 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.379 1.472 . . . . 0.0 107.507 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.02 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.44 124.63 34.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.323 1.449 . . . . 0.0 108.581 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -87.63 125.71 34.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 ttm -156.03 132.47 10.19 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.91 38.94 17.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.108 1.363 . . . . 0.0 113.316 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 -1.34 74.81 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.109 0.861 . . . . 0.0 114.151 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.01 167.51 9.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.235 1.814 . . . . 0.0 110.031 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -121.42 124.14 43.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.41 118.44 36.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -86.73 142.37 28.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.05 133.86 67.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 t -133.07 119.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 tp -88.65 120.54 30.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -83.03 111.39 18.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 168.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.99 -26.8 60.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.181 -170.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.08 -43.58 86.96 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.106 0.412 . . . . 0.0 110.735 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.49 -13.75 24.27 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.518 1.127 . . . . 0.0 112.929 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mmm 52.35 45.62 28.15 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.08 1.352 . . . . 0.0 109.581 -169.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -115.83 141.61 47.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.835 1.254 . . . . 0.0 108.391 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.15 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.768 0.794 . . . . 0.0 109.705 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.439 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 22.9 m95 -85.53 111.51 20.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 169.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.1 m -108.5 117.65 34.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 48.01 40.89 14.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.143 1.377 . . . . 0.0 111.022 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.58 -9.31 36.42 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.591 1.091 . . . . 0.0 114.743 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.79 138.82 32.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.75 1.775 . . . . 0.0 108.821 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -71.07 141.33 50.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.9 165.9 24.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.984 0.914 . . . . 0.0 110.075 169.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.41 145.15 53.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.4 0.619 . . . . 0.0 111.167 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -134.36 147.82 50.59 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.845 1.658 . . . . 0.0 108.719 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.23 142.62 46.83 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.33 109.73 1.83 Allowed Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 107.155 -2.378 . . . . 0.0 107.155 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.45 148.52 25.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.07 134.39 55.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.68 167.54 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.548 1.539 . . . . 0.0 110.114 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.95 48.41 0.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.016 1.326 . . . . 0.0 110.465 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.35 -34.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.204 2.202 . . . . 0.0 110.537 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.66 -150.73 20.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -175.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -121.02 152.98 37.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -127.19 109.83 12.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.794 1.638 . . . . 0.0 107.171 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.7 m -92.44 102.57 15.04 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -89.56 146.17 24.76 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.447 1.099 . . . . 0.0 110.958 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -158.47 -173.75 4.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.086 2.154 . . . . 0.0 108.231 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 m -146.57 149.24 33.19 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.534 1.134 . . . . 0.0 109.403 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -138.16 121.64 20.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.33 -134.17 52.42 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -170.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -83.37 -7.56 59.55 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.832 0.853 . . . . 0.0 112.384 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -95.33 133.35 39.35 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.69 150.69 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.71 150.76 50.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.407 1.483 . . . . 0.0 107.866 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -147.41 139.68 24.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.907 -0.496 . . . . 0.0 109.821 168.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.1 mt -88.41 117.73 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -84.36 124.2 31.02 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.9 91.64 3.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.6 126.02 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.324 1.05 . . . . 0.0 108.451 -169.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m -80.82 57.62 3.08 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.818 1.19 . . . . 0.0 109.958 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.8 m -71.9 -37.39 70.11 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.245 1.018 . . . . 0.0 111.159 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.09 132.7 26.04 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -95.38 -66.69 0.89 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.204 0.601 . . . . 0.0 110.098 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -77.63 -50.95 11.45 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -72.54 141.99 48.47 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.24 63.33 2.45 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.538 1.135 . . . . 0.0 110.547 169.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.95 74.48 1.68 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.85 123.58 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.17 118.02 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -98.66 124.48 43.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 m -133.47 140.34 47.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.241 1.016 . . . . 0.0 108.408 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 tp -89.33 133.48 34.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.44 141.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.83 131.97 43.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 49.48 38.33 14.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.398 1.079 . . . . 0.0 111.868 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.79 9.6 3.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.014 2.125 . . . . 0.0 115.471 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.75 150.01 20.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.916 1.286 . . . . 0.0 109.192 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -95.02 134.24 37.93 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.769 0.828 . . . . 0.0 110.657 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.1 mm -121.98 113.73 31.27 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.47 1.908 . . . . 0.0 107.722 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.7 149.45 48.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.039 2.492 . . . . 0.0 111.201 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -70.04 166.6 19.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 111.384 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.55 161.11 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 126.926 2.09 . . . . 0.0 110.094 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.04 112.24 9.75 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 169.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.255 1.358 0 C-N-CA 123.561 0.744 . . . . 0.0 110.932 174.189 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -151.42 167.31 28.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.194 1.398 . . . . 0.0 108.517 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -75.41 144.55 42.15 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 170.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -71.49 155.46 40.56 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.424 0.69 . . . . 0.0 110.611 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -142.22 137.01 30.46 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 170.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.7 m -140.06 93.17 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -131.88 146.32 52.05 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -168.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -120.43 136.53 54.71 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.8 m -129.81 142.92 50.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.402 0.681 . . . . 0.0 109.284 -169.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -136.84 159.62 41.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.038 1.735 . . . . 0.0 107.629 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.13 141.58 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.224 1.01 . . . . 0.0 108.693 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.37 128.81 38.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.327 1.451 . . . . 0.0 109.079 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -83.78 128.94 34.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.8 mtt -144.44 129.65 18.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.087 1.355 . . . . 0.0 108.389 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.01 44.54 18.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 0.0 113.855 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.15 5.02 90.39 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.921 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -118.72 158.88 24.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.896 1.678 . . . . 0.0 109.987 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -115.38 123.7 49.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -108.57 128.28 54.68 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.018 0.927 . . . . 0.0 108.571 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -80.4 147.43 31.01 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mm -122.02 131.28 73.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.96 119.09 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.9 121.89 30.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.81 112.97 20.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -71.87 -31.28 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.97 0.908 . . . . 0.0 111.993 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.75 -46.49 62.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.124 0.42 . . . . 0.0 110.262 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.83 -17.22 33.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.065 0.946 . . . . 0.0 112.57 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.0 mtp 53.41 42.17 32.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.258 1.423 . . . . 0.0 109.884 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -106.66 145.45 31.96 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.056 1.343 . . . . 0.0 107.981 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -114.34 116.94 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.932 0.873 . . . . 0.0 109.618 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.67 111.14 19.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -114.85 127.52 55.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 49.08 36.73 9.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.123 0.969 . . . . 0.0 111.609 -171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.2 5.8 85.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.207 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.78 148.12 45.06 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.878 1.839 . . . . 0.0 109.352 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -69.63 144.53 52.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.77 166.79 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.342 1.057 . . . . 0.0 110.309 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.5 140.61 57.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.576 0.751 . . . . 0.0 111.129 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.94 151.9 49.56 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.965 1.706 . . . . 0.0 108.466 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 135.83 46.76 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.77 95.58 1.28 Allowed Glycine 0 C--N 1.331 0.257 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.29 145.52 28.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -107.45 136.45 47.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.45 167.5 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.141 1.376 . . . . 0.0 109.962 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.78 49.4 0.76 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.249 1.42 . . . . 0.0 110.533 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -160.73 -36.39 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.664 2.386 . . . . 0.0 110.025 -170.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.0 -124.03 1.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -127.5 150.97 49.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.3 106.38 8.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 172.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.4 m -86.26 101.53 13.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -85.7 145.7 27.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.775 1.23 . . . . 0.0 110.557 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -157.33 -176.32 5.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.736 2.014 . . . . 0.0 108.205 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -146.77 150.72 35.89 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.347 1.059 . . . . 0.0 109.099 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.31 122.74 25.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.9 -131.68 52.17 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -87.58 -4.17 58.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.183 0.993 . . . . 0.0 112.458 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -98.52 130.49 45.1 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 109.448 -169.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.1 151.14 27.15 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.182 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -135.32 150.8 50.07 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.749 1.619 . . . . 0.0 107.372 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.99 140.54 26.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.864 -0.522 . . . . 0.0 109.723 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.11 113.99 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -78.57 125.8 29.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.58 90.31 3.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -80.12 122.63 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 m -79.11 45.41 0.63 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.591 1.087 . . . . 0.0 111.961 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.8 m -56.13 144.21 30.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.068 1.347 . . . . 0.0 108.962 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.07 -11.81 52.84 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.434 -170.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 52.16 -97.3 0.06 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 126.512 1.925 . . . . 0.0 112.124 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -68.59 -34.84 76.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.419 0.554 . . . . 0.0 110.569 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -77.05 139.46 40.04 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -83.51 58.69 4.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.071 0.948 . . . . 0.0 110.835 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.01 37.02 3.47 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.187 1.375 . . . . 0.0 111.613 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.69 124.71 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.66 116.37 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -97.1 126.89 42.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -135.54 144.15 46.11 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.36 1.064 . . . . 0.0 108.46 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 tp -90.97 132.37 36.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.32 141.72 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.45 132.79 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t0 50.31 37.31 14.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 111.816 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 62.43 9.61 3.47 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.045 2.138 . . . . 0.0 115.614 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.27 147.66 22.97 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.679 -1.263 . . . . 0.0 109.371 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -90.57 133.67 34.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.685 0.794 . . . . 0.0 110.061 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.1 mm -119.36 113.77 35.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.134 1.774 . . . . 0.0 107.44 -174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.31 155.32 36.96 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.197 2.598 . . . . 0.0 111.149 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -58.51 161.4 4.56 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.758 0.823 . . . . 0.0 110.841 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt -63.42 149.84 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.261 1.025 . . . . 0.0 112.085 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.35 93.31 9.36 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.252 1.196 0 C-N-CA 123.493 0.717 . . . . 0.0 109.744 175.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.92 140.02 56.46 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.912 0.885 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -149.11 147.1 28.09 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 108.274 175.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.1 m -60.55 148.53 37.67 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.521 0.728 . . . . 0.0 110.583 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.44 117.56 19.02 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.5 m -69.04 -33.9 74.34 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.224 0.61 . . . . 0.0 111.862 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 p -127.07 165.88 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.693 0.758 . . . . 0.0 110.972 -169.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -124.11 129.28 50.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 169.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.8 m -114.27 145.75 41.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -136.64 162.6 32.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.281 1.433 . . . . 0.0 107.551 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.79 147.05 26.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.67 153.78 51.5 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.022 0.929 . . . . 0.0 108.661 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -106.1 119.3 38.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.42 137.79 27.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.756 1.222 . . . . 0.0 108.161 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.91 37.34 9.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.41 10.64 86.04 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.771 -1.016 . . . . 0.0 114.256 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.73 150.95 47.28 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.371 1.586 . . . . 0.0 110.231 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -98.15 122.81 41.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -106.75 113.6 27.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -80.73 142.6 33.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 mm -122.07 133.69 67.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.2 t -131.62 119.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.04 127.43 35.4 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.34 112.36 24.15 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -68.07 -25.0 65.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.454 -0.307 . . . . 0.0 111.66 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.83 -36.6 83.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.835 0.454 . . . . 0.0 111.88 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.74 -2.38 9.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.145 1.378 . . . . 0.0 113.018 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 99.3 mmm 53.97 33.0 16.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.902 1.281 . . . . 0.0 110.789 -169.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -88.9 146.12 25.12 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.84 117.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -85.38 122.6 29.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.636 1.574 . . . . 0.0 107.454 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.04 118.14 36.02 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 42.47 48.95 4.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.128 1.771 . . . . 0.0 112.564 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.28 -4.11 86.13 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.604 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -113.8 142.73 45.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.786 1.793 . . . . 0.0 109.366 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -68.37 149.02 49.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -126.29 165.55 18.77 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.283 1.033 . . . . 0.0 110.55 169.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.35 146.57 40.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 110.199 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -140.33 151.09 44.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.458 1.103 . . . . 0.0 109.958 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.22 138.18 43.34 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.19 97.02 1.21 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.03 143.14 27.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.82 134.13 43.17 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.35 -179.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.653 1.581 . . . . 0.0 108.765 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.69 8.88 8.83 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.76 14.16 0.55 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.523 1.129 . . . . 0.0 113.357 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.93 -149.27 17.54 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.672 -1.267 . . . . 0.0 112.176 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.3 m -131.34 154.88 48.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -126.61 107.11 9.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.9 m -83.87 99.89 10.63 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -85.77 145.4 27.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.737 1.215 . . . . 0.0 110.722 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.85 -178.92 7.6 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.392 1.877 . . . . 0.0 108.945 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -144.7 147.42 32.99 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 109.522 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.5 mt -141.39 133.78 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.38 -123.3 32.77 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -113.33 36.83 3.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.769 1.228 . . . . 0.0 110.492 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.57 141.65 49.73 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.273 1.429 . . . . 0.0 108.213 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.34 149.2 23.39 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 169.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 m -135.6 152.19 51.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.537 1.535 . . . . 0.0 108.191 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -149.25 141.65 24.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 121.859 -0.525 . . . . 0.0 109.89 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.61 115.03 27.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -79.16 98.84 6.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.75 82.64 7.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.96 129.81 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 m -88.42 38.04 0.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.236 0.925 . . . . 0.0 111.038 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 m -66.27 160.74 23.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.704 1.202 . . . . 0.0 111.821 -173.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.13 -140.24 35.58 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.62 127.01 29.31 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -67.43 -38.05 83.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 119.413 -0.327 . . . . 0.0 111.224 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -73.25 124.26 25.31 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 58.22 -10.14 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.435 2.694 . . . . 0.0 116.194 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.49 25.85 1.98 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.225 1.393 . . . . 0.0 113.73 -175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.54 134.24 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.7 mm -77.45 -43.51 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.28 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 63.5 m80 53.23 102.91 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.75 2.02 . . . . 0.0 112.407 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -126.3 141.27 51.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.792 0.837 . . . . 0.0 109.123 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.6 tp -88.46 131.43 34.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.89 142.87 22.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 131.2 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.94 43.82 10.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.463 1.105 . . . . 0.0 111.442 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.4 t30 65.17 4.53 2.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.6 2.36 . . . . 0.0 115.746 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.93 143.71 26.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.11 1.364 . . . . 0.0 109.806 174.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.05 136.07 33.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.145 0.978 . . . . 0.0 110.539 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -119.62 114.64 34.21 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.449 1.9 . . . . 0.0 107.01 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.68 146.94 34.74 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.371 2.714 . . . . 0.0 111.16 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.5 165.06 25.77 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.323 0.583 . . . . 0.0 111.43 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.6 pt -128.07 175.7 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 126.456 1.903 . . . . 0.0 110.677 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 59.13 29.05 18.53 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.134 1.774 . . . . 0.0 114.285 170.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.252 1.209 0 C-N-CA 123.925 0.89 . . . . 0.0 108.602 169.511 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -147.57 147.05 29.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.157 1.383 . . . . 0.0 109.154 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -147.16 149.31 32.73 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 p -81.03 -1.62 44.72 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.478 1.111 . . . . 0.0 113.605 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -62.23 132.09 51.58 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.7 m -134.17 128.14 33.43 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -136.39 158.53 44.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.616 0.766 . . . . 0.0 111.617 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.44 134.57 52.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -128.37 141.04 51.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.479 0.657 . . . . 0.0 109.694 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -136.32 151.93 50.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.301 1.44 . . . . 0.0 107.47 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.28 141.77 37.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.935 0.894 . . . . 0.0 109.035 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.65 125.83 35.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.127 1.371 . . . . 0.0 108.692 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -85.08 127.41 34.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 41.1 ttm -158.0 134.71 9.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.924 1.29 . . . . 0.0 108.189 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.95 37.93 18.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.109 1.364 . . . . 0.0 113.313 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.18 8.8 85.52 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.914 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -120.54 164.05 17.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.15 1.78 . . . . 0.0 109.806 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -113.31 124.2 51.93 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -109.04 128.64 55.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -88.69 132.89 34.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.85 133.11 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.18 131.3 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.57 125.29 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -87.14 115.58 24.63 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.813 -2.292 . . . . 0.0 104.813 168.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.69 -33.33 73.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.12 -43.19 78.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 117.75 0.25 . . . . 0.0 110.529 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.38 -15.03 29.61 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.215 1.006 . . . . 0.0 112.964 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 52.84 38.88 27.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.323 1.449 . . . . 0.0 110.57 -169.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.52 139.99 38.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 108.296 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -113.11 116.3 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 122.106 0.955 . . . . 0.0 109.967 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -93.34 105.01 17.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.948 2.099 . . . . 0.0 105.915 175.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -109.4 123.27 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 51.28 36.24 15.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 111.13 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.44 -2.47 62.37 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.895 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.71 143.75 37.41 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.778 1.789 . . . . 0.0 109.273 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -68.89 146.68 52.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -137.47 166.26 24.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.851 1.261 . . . . 0.0 109.011 169.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.55 144.55 49.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.047 0.539 . . . . 0.0 111.017 -173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -135.5 149.2 49.44 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 109.146 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.39 136.98 54.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.18 95.32 1.15 Allowed Glycine 0 C--N 1.33 0.214 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.91 142.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.26 132.31 55.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.76 167.29 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.079 1.352 . . . . 0.0 110.159 -172.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.93 49.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.261 1.424 . . . . 0.0 109.968 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -162.54 -32.06 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.47 2.308 . . . . 0.0 110.851 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.68 2.5 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -127.43 151.54 48.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.74 106.68 8.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -84.2 102.27 12.48 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -88.1 143.62 26.96 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.516 1.127 . . . . 0.0 110.579 -175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -159.79 -172.43 3.66 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.073 2.149 . . . . 0.0 108.339 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 m -145.29 151.22 38.0 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 0.0 108.818 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.8 mt -136.98 124.08 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.15 -133.37 52.7 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -86.29 -3.86 59.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.174 0.989 . . . . 0.0 112.672 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -98.05 132.61 43.45 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.305 -0.872 . . . . 0.0 109.097 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.55 149.86 28.46 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.5 m -137.02 152.28 49.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.204 1.402 . . . . 0.0 108.009 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.63 139.59 25.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.958 168.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.3 mt -88.19 113.7 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -80.56 128.85 34.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.79 93.56 3.87 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.95 128.32 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.591 1.157 . . . . 0.0 108.755 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m -74.83 33.47 0.1 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.762 1.225 . . . . 0.0 113.975 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -66.15 155.01 38.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.768 0.827 . . . . 0.0 109.525 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.76 -152.33 52.54 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -68.42 135.88 52.41 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -72.05 -17.22 62.03 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.721 -0.612 . . . . 0.0 112.197 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -67.99 -54.7 16.5 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.021 0.828 . . . . 0.0 110.629 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -143.47 -0.69 1.07 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.33 -12.99 80.01 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.467 1.03 . . . . 0.0 113.395 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -47.73 126.47 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 127.613 2.365 . . . . 0.0 109.764 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.67 120.02 36.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -98.97 130.85 45.35 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -140.21 139.92 35.74 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.791 1.236 . . . . 0.0 108.412 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.81 133.58 33.63 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.2 141.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.31 132.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 49.63 37.88 13.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.405 1.082 . . . . 0.0 111.85 -175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 62.66 8.83 3.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.985 2.114 . . . . 0.0 115.464 -174.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.24 148.02 22.61 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.059 1.344 . . . . 0.0 109.399 171.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -90.26 134.03 34.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.469 0.708 . . . . 0.0 110.116 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.04 114.52 37.05 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.137 1.775 . . . . 0.0 108.226 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 148.04 88.35 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.91 3.073 . . . . 0.0 112.171 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.52 156.98 5.52 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.558 0.743 . . . . 0.0 110.293 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.8 pt -59.03 153.17 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.41 0.684 . . . . 0.0 111.778 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.85 93.78 9.56 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.494 0.718 . . . . 0.0 109.688 175.424 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.72 -40.38 69.47 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 122.9 0.48 . . . . 0.0 111.442 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -77.18 142.21 39.74 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -72.34 156.15 39.4 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.313 0.645 . . . . 0.0 110.591 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.72 137.51 52.09 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -135.13 92.47 2.87 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -136.47 147.46 47.18 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.921 0.888 . . . . 0.0 110.344 -173.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.05 125.58 54.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -120.31 144.43 47.84 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -140.09 159.39 42.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.878 1.671 . . . . 0.0 108.042 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.49 137.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 168.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.15 123.69 43.92 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.557 1.143 . . . . 0.0 108.155 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.498 ' CD2' HD22 ' A' ' 18' ' ' ASN . 3.7 t-80 -91.91 121.27 33.35 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 170.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 39.6 mtt -107.44 -163.96 0.94 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.06 1.344 . . . . 0.0 108.573 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.47 -27.79 57.93 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.531 1.133 . . . . 0.0 113.593 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.84 17.89 0.12 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.114 -0.825 . . . . 0.0 113.976 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -140.81 155.85 46.28 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.791 1.237 . . . . 0.0 108.957 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.498 HD22 ' CD2' ' A' ' 13' ' ' HIS . 8.1 m-80 -120.0 114.56 22.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.38 115.28 30.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.3 mtm-85 -79.82 139.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.0 mm -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 t -133.17 118.75 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.72 106.64 15.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.357 1.463 . . . . 0.0 107.297 170.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -72.27 -26.67 62.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.382 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.97 -42.76 72.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.175 0.443 . . . . 0.0 110.523 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.98 -16.17 25.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.495 1.118 . . . . 0.0 113.056 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.83 50.21 19.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.82 1.648 . . . . 0.0 110.473 -169.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -116.52 159.32 22.26 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.283 1.433 . . . . 0.0 108.369 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.69 117.98 36.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -88.87 125.55 34.98 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.976 1.711 . . . . 0.0 108.198 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -115.87 128.07 55.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.14 35.04 12.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.116 0.966 . . . . 0.0 111.894 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.05 87.77 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.412 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.05 143.19 45.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.081 1.941 . . . . 0.0 108.563 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -72.18 141.89 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.756 1.162 . . . . 0.0 109.16 175.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.82 169.4 9.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.694 0.798 . . . . 0.0 111.491 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.8 145.67 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.599 1.16 . . . . 0.0 110.075 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 p -141.86 149.86 40.82 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 109.646 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.59 139.68 49.24 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.9 104.93 1.19 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -90.0 149.81 22.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.0 139.41 52.54 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.73 167.91 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.491 1.516 . . . . 0.0 110.134 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -76.5 49.9 0.63 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.062 1.345 . . . . 0.0 110.486 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -160.22 -35.75 0.05 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.86 2.464 . . . . 0.0 109.849 -170.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.28 -150.97 22.43 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.04 148.46 38.83 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -123.59 107.28 11.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -94.02 105.0 17.02 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -90.49 146.65 23.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.062 1.345 . . . . 0.0 111.055 -172.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -157.7 -179.59 8.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.867 2.067 . . . . 0.0 108.185 169.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -144.34 146.55 32.63 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.101 -0.999 . . . . 0.0 109.949 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.4 mt -143.23 131.33 19.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.28 -130.3 50.82 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -104.75 32.0 4.4 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.66 1.184 . . . . 0.0 111.053 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -129.58 146.57 51.37 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.748 1.219 . . . . 0.0 109.271 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.05 150.37 22.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 109.515 170.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.53 151.62 51.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.777 1.631 . . . . 0.0 108.294 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -148.48 142.79 26.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.954 -0.466 . . . . 0.0 110.079 168.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.7 mt -88.05 118.78 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -89.54 101.73 14.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.23 91.14 7.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.85 129.58 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.872 1.669 . . . . 0.0 109.192 -169.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 m -82.35 33.55 0.41 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.829 1.195 . . . . 0.0 112.262 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -60.09 -25.62 65.56 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.031 1.332 . . . . 0.0 114.307 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.88 -20.22 79.77 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.21 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 50.52 38.34 18.3 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.306 1.442 . . . . 0.0 112.191 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -143.15 165.93 26.07 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.78 1.632 . . . . 0.0 107.722 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -57.85 127.44 32.06 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 56.95 21.46 6.22 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.933 1.693 . . . . 0.0 113.398 -176.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.39 33.56 2.73 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.223 1.392 . . . . 0.0 112.343 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.51 131.19 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.0 135.12 26.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -110.11 126.65 54.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -132.01 142.47 49.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.18 131.58 37.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.84 143.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.4 t -138.49 130.44 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.68 39.74 14.26 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.058 0.943 . . . . 0.0 111.754 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 64.79 3.71 2.13 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.86 2.064 . . . . 0.0 115.001 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -89.89 147.24 23.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.369 -1.457 . . . . 0.0 109.195 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.76 134.28 34.87 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.717 0.807 . . . . 0.0 110.125 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.9 mm -119.24 114.76 34.7 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.816 1.646 . . . . 0.0 108.287 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -67.71 143.37 61.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.049 3.166 . . . . 0.0 111.962 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.85 161.16 13.19 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.284 0.634 . . . . 0.0 109.887 171.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 pt -69.72 153.94 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.47 0.708 . . . . 0.0 111.679 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.54 25.44 6.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.055 1.342 . . . . 0.0 111.957 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.391 1.476 . . . . 0.0 109.955 178.526 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 121.172 0.511 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.62 153.44 51.65 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.869 1.668 . . . . 0.0 108.511 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -137.88 149.75 46.53 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.412 1.085 . . . . 0.0 108.496 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.3 m -81.89 45.96 0.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.757 1.223 . . . . 0.0 112.003 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -65.45 -37.13 85.96 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.234 -0.916 . . . . 0.0 111.103 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m 52.11 70.39 0.56 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.174 1.39 . . . . 0.0 110.506 -175.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -137.9 144.43 41.33 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.741 1.216 . . . . 0.0 109.883 -174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.85 131.69 54.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -110.49 149.19 30.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -135.19 163.82 29.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.994 1.718 . . . . 0.0 107.196 169.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.12 140.81 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.33 44.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.099 1.359 . . . . 0.0 108.954 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -101.49 125.9 48.2 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.85 0.86 . . . . 0.0 109.018 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.26 139.89 27.44 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.13 0.972 . . . . 0.0 109.059 170.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 45.32 45.97 10.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 114.003 169.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.08 -1.31 80.58 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.042 -0.866 . . . . 0.0 114.313 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -109.77 159.64 17.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.74 1.616 . . . . 0.0 110.429 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -119.77 130.29 54.88 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -110.04 107.07 16.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 107.747 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -73.5 129.69 38.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.1 mm -108.78 136.35 44.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.41 118.82 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.2 tp -88.36 128.53 35.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -85.5 109.46 18.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -72.24 -30.98 65.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.15 0.886 . . . . 0.0 111.865 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.49 -42.83 74.26 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.234 . . . . 0.0 111.047 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.2 -17.0 23.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -173.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 55.6 28.36 11.8 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.943 1.697 . . . . 0.0 112.464 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.79 149.55 25.66 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.05 125.12 67.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -97.22 138.09 35.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.669 1.187 . . . . 0.0 107.947 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -120.99 119.8 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 45.78 41.82 8.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.596 1.558 . . . . 0.0 112.038 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.25 6.71 75.8 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.019 -0.879 . . . . 0.0 114.412 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.24 152.08 23.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.121 1.46 . . . . 0.0 107.74 173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.91 148.19 28.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -129.99 165.04 22.96 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.18 0.992 . . . . 0.0 110.793 170.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.76 148.08 35.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.963 1.305 . . . . 0.0 110.436 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -139.28 149.16 43.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.268 1.027 . . . . 0.0 109.981 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.94 141.68 50.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.99 106.47 1.21 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.08 149.26 21.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -121.27 138.58 54.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.406 0.682 . . . . 0.0 109.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.15 167.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.468 1.507 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.03 48.53 0.6 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.057 1.343 . . . . 0.0 110.594 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -159.88 -31.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.862 2.465 . . . . 0.0 110.713 -171.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.42 -151.93 23.35 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -122.25 151.03 41.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -125.94 106.95 10.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.554 1.542 . . . . 0.0 107.095 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.8 m -92.32 103.54 15.97 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -90.23 147.26 23.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.788 1.235 . . . . 0.0 111.12 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.54 -178.33 7.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 108.37 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.3 m -145.07 149.55 35.28 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.291 1.036 . . . . 0.0 109.375 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.5 mt -134.05 111.21 14.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.65 -134.0 51.48 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -169.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -78.19 -14.09 59.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 112.462 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -88.19 126.74 35.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.61 150.1 24.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.617 0.722 . . . . 0.0 109.311 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -137.15 151.87 49.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.566 1.546 . . . . 0.0 107.919 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -148.18 142.17 25.89 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 168.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.16 120.43 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -85.66 118.23 25.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 170.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.43 92.36 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.18 129.26 41.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.271 1.428 . . . . 0.0 110.735 -168.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.6 m -81.17 33.28 0.34 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.746 1.219 . . . . 0.0 112.713 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -69.89 -41.32 74.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.08 0.952 . . . . 0.0 110.68 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.22 -168.12 37.27 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -58.44 135.34 57.23 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.136 -0.626 . . . . 0.0 109.467 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.6 -19.59 64.46 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.724 -0.61 . . . . 0.0 112.598 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -66.33 -58.52 5.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.907 0.776 . . . . 0.0 109.679 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -147.8 3.72 0.74 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.15 14.54 61.93 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.266 0.936 . . . . 0.0 113.566 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.24 127.14 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.645 1.578 . . . . 0.0 107.97 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.15 126.57 40.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -106.8 122.73 46.97 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -133.02 141.09 48.07 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.402 1.081 . . . . 0.0 108.523 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -88.43 133.13 34.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.84 141.04 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -138.18 132.38 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 49.97 37.54 14.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.064 0.935 . . . . 0.0 111.882 -176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.8 t30 62.56 10.17 3.91 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.927 2.091 . . . . 0.0 115.407 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.58 149.13 21.78 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.986 1.315 . . . . 0.0 109.217 171.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -93.21 134.59 35.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.826 0.85 . . . . 0.0 110.094 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.8 mm -121.19 113.67 32.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.532 1.933 . . . . 0.0 107.548 -173.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.91 147.83 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.158 2.572 . . . . 0.0 110.932 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -69.59 164.73 22.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.363 1.065 . . . . 0.0 111.012 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.85 158.24 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 127.016 2.126 . . . . 0.0 109.408 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.53 25.88 4.76 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.156 1.382 . . . . 0.0 111.629 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.2 m . . . . . 0 C--O 1.255 1.388 0 C-N-CA 125.269 1.428 . . . . 0.0 109.902 179.218 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.31 134.11 37.53 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 122.789 0.436 . . . . 0.0 109.866 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -138.19 150.53 46.85 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.539 1.136 . . . . 0.0 108.476 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m -66.35 147.33 53.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.124 0.57 . . . . 0.0 110.572 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.03 138.83 52.48 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 m -136.87 125.03 23.01 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.57 150.26 40.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.038 0.535 . . . . 0.0 110.387 -169.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.6 129.08 55.12 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 169.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.1 m -120.8 143.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -135.19 155.02 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.214 1.806 . . . . 0.0 107.213 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.41 122.73 66.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 168.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.0 tp -115.69 123.2 47.75 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.332 1.053 . . . . 0.0 109.081 -169.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -91.17 135.5 33.74 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.7 mtt -139.39 106.88 5.56 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 61.81 -33.95 0.1 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.617 3.167 . . . . 0.0 116.849 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.75 -32.28 0.03 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.5 2.0 . . . . 0.0 110.154 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -77.01 156.93 31.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.165 0.986 . . . . 0.0 110.167 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -131.76 115.97 16.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -105.76 122.11 45.42 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.389 1.076 . . . . 0.0 108.563 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -73.44 138.61 45.3 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -117.26 132.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.94 117.88 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -86.06 121.13 28.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.04 113.03 19.64 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 168.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.75 -24.54 56.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 119.116 -0.468 . . . . 0.0 111.254 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.93 -44.3 69.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.712 0.687 . . . . 0.0 110.131 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.14 -15.4 24.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.489 1.115 . . . . 0.0 113.152 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.8 mmm 52.69 45.08 29.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.816 1.247 . . . . 0.0 109.276 -168.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -114.6 146.39 40.86 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.869 1.668 . . . . 0.0 107.148 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.05 117.41 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -84.57 119.31 25.05 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.946 1.698 . . . . 0.0 107.047 172.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.2 t -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.0 36.01 10.96 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.334 1.054 . . . . 0.0 111.919 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.62 3.01 88.8 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.621 -1.1 . . . . 0.0 115.092 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -114.4 145.58 41.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.657 1.728 . . . . 0.0 108.868 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -68.33 141.58 55.76 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.03 163.41 16.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.707 0.803 . . . . 0.0 110.422 169.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -70.87 143.99 50.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 110.199 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -138.52 148.58 44.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 110.162 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.59 143.43 51.17 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.52 108.83 1.47 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -97.76 148.62 23.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.97 135.88 54.74 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.47 167.55 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 110.173 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -77.7 48.1 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.156 1.382 . . . . 0.0 110.554 175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.94 -34.13 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.233 2.213 . . . . 0.0 110.325 -171.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.86 -150.31 20.1 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -121.16 152.11 39.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -125.37 107.16 10.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.794 1.638 . . . . 0.0 106.898 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -91.32 102.7 15.41 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.92 146.43 24.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.674 1.189 . . . . 0.0 110.901 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -158.19 -173.91 4.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.636 1.975 . . . . 0.0 108.646 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 m -144.49 146.75 32.59 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 109.347 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.6 mt -142.18 133.27 25.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.97 -131.07 51.86 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -105.13 34.1 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.511 1.124 . . . . 0.0 110.851 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -131.11 144.32 51.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.733 1.213 . . . . 0.0 109.097 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.35 152.43 19.15 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.502 0.668 . . . . 0.0 109.219 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 m -135.15 151.94 51.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.577 1.551 . . . . 0.0 107.752 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -147.81 140.77 24.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.856 -0.527 . . . . 0.0 109.669 168.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.27 118.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -83.61 120.89 26.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 92.54 3.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.61 125.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.077 1.351 . . . . 0.0 109.373 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 m -81.44 49.77 1.35 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.496 1.118 . . . . 0.0 110.549 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -65.26 159.42 23.84 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.133 1.373 . . . . 0.0 111.574 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.32 -146.46 33.17 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.653 0.644 . . . . 0.0 111.667 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.04 177.79 4.76 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.252 1.021 . . . . 0.0 110.546 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -69.26 -14.72 63.11 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -58.77 156.13 11.7 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.859 0.754 . . . . 0.0 109.522 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.19 53.8 1.53 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.668 1.187 . . . . 0.0 112.709 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.81 49.13 2.8 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.794 1.664 . . . . 0.0 111.111 173.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.65 128.11 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.98 125.81 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -105.78 127.3 53.01 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -136.31 141.51 43.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.174 0.99 . . . . 0.0 108.597 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.55 131.1 36.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.89 142.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.0 130.86 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 t70 46.53 43.22 12.04 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.443 1.097 . . . . 0.0 111.448 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 63.69 6.53 2.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.709 2.404 . . . . 0.0 115.828 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -99.41 148.27 24.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.586 1.555 . . . . 0.0 109.918 173.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -91.02 137.31 32.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.525 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.3 mm -119.89 113.36 34.47 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.888 2.075 . . . . 0.0 106.929 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.92 147.06 33.8 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.096 2.53 . . . . 0.0 110.965 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.66 164.02 8.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.996 0.918 . . . . 0.0 110.493 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.4 pt -67.12 153.55 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.745 0.818 . . . . 0.0 111.744 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.82 25.78 5.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.091 1.357 . . . . 0.0 111.687 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.252 1.21 0 C-N-CA 125.568 1.547 . . . . 0.0 110.031 179.103 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.61 139.71 57.9 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.509 0.724 . . . . 0.0 111.243 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -141.59 155.63 45.74 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.832 1.253 . . . . 0.0 108.847 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 m -62.48 154.39 28.67 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.651 0.78 . . . . 0.0 110.257 173.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -74.79 120.44 20.34 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.1 m -76.51 -41.71 45.88 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.867 0.467 . . . . 0.0 109.881 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -70.76 155.62 40.54 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.317 1.047 . . . . 0.0 111.122 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -117.49 137.85 52.26 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -120.98 149.59 42.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -140.41 151.83 45.23 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.72 1.608 . . . . 0.0 108.337 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -107.34 135.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.85 117.76 29.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -87.54 120.98 29.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 43.2 ttm -155.79 131.5 9.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -170.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 50.5 36.67 14.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 113.072 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.27 74.76 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.039 0.828 . . . . 0.0 113.975 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -108.39 170.62 7.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.489 1.916 . . . . 0.0 109.383 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -131.84 111.58 11.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -102.52 131.24 49.36 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -93.68 124.05 37.41 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.93 138.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.96 125.71 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -90.09 129.99 36.32 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.442 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -98.14 112.47 24.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.355 1.462 . . . . 0.0 107.722 168.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -74.91 -22.18 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.79 -0.569 . . . . 0.0 112.322 -170.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.48 -36.52 80.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.194 0.452 . . . . 0.0 111.207 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.49 -4.35 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 113.052 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.8 mtp 53.35 37.84 26.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.563 1.145 . . . . 0.0 109.564 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -92.34 147.53 22.84 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -129.97 119.42 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.442 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 15.3 m95 -85.42 133.52 34.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.495 1.918 . . . . 0.0 108.448 173.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -128.81 126.51 40.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 168.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 52.08 37.69 22.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.304 1.042 . . . . 0.0 111.981 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.87 2.05 90.64 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.379 -1.234 . . . . 0.0 115.617 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.41 148.12 44.82 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.878 1.839 . . . . 0.0 108.171 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -75.52 151.82 37.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.871 1.214 . . . . 0.0 110.189 173.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.26 167.67 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.23 1.412 . . . . 0.0 110.215 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.95 147.91 44.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.064 0.946 . . . . 0.0 110.358 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 p -138.3 148.83 45.06 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.665 1.186 . . . . 0.0 109.88 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.0 149.52 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.0 109.41 1.03 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.83 151.8 21.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.72 0.808 . . . . 0.0 109.262 170.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -123.99 140.15 53.26 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.87 167.44 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.726 1.61 . . . . 0.0 110.278 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.17 48.71 0.63 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.07 1.348 . . . . 0.0 110.606 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -160.15 -34.49 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.813 2.445 . . . . 0.0 110.276 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.98 -153.39 24.21 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -117.88 150.19 39.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -124.55 106.85 10.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.1 m -90.95 106.22 18.37 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.04 145.82 24.22 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.799 1.239 . . . . 0.0 110.51 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.47 -169.7 2.69 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.226 1.811 . . . . 0.0 108.423 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -150.15 148.2 28.67 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.927 -1.108 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 93.7 mt -141.1 130.69 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.36 -133.4 51.37 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.07 29.11 4.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.251 1.02 . . . . 0.0 111.654 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -124.22 142.97 50.8 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.56 1.144 . . . . 0.0 109.261 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 150.01 21.35 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -134.84 152.04 51.42 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.764 1.226 . . . . 0.0 108.073 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -147.0 141.74 26.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 168.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.94 120.59 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -87.16 114.84 24.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.58 91.86 3.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -87.77 126.22 41.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.017 1.327 . . . . 0.0 109.328 -169.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -81.6 50.46 1.49 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.535 1.134 . . . . 0.0 110.858 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.8 m -67.86 159.58 30.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.89 1.276 . . . . 0.0 111.776 -177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.63 -164.06 54.51 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.147 0.88 . . . . 0.0 112.707 174.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -65.08 153.89 39.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.98 0.912 . . . . 0.0 109.496 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -73.59 82.85 1.53 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.943 0.897 . . . . 0.0 108.835 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 21.97 2.28 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.697 1.599 . . . . 0.0 111.719 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 54.66 54.65 8.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.118 1.767 . . . . 0.0 112.622 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -98.08 52.61 1.24 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.597 1.094 . . . . 0.0 110.384 171.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.01 129.14 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.73 125.32 43.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -103.18 127.26 50.53 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -134.66 145.02 48.17 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.375 1.07 . . . . 0.0 108.494 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -93.98 130.41 40.1 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.81 142.48 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 169.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.31 133.19 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.821 1.248 . . . . 0.0 108.088 171.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t0 45.59 42.12 7.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.326 1.451 . . . . 0.0 111.659 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.47 17.64 10.93 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.475 2.31 . . . . 0.0 116.136 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -116.1 152.09 34.32 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.158 169.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -84.73 139.19 32.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.86 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.2 mm -119.53 118.78 32.02 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.358 1.863 . . . . 0.0 106.612 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 142.81 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 111.284 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -69.84 165.84 20.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.532 1.133 . . . . 0.0 111.063 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.7 pt -134.06 162.2 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 126.974 2.11 . . . . 0.0 109.139 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.28 24.63 3.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.017 1.327 . . . . 0.0 111.897 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.25 1.091 0 C-N-CA 126.15 1.78 . . . . 0.0 107.979 -176.204 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.45 143.79 54.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.809 0.844 . . . . 0.0 111.072 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -143.21 144.99 32.39 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.693 1.197 . . . . 0.0 108.1 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -61.55 156.99 18.29 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.121 0.569 . . . . 0.0 109.647 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -67.79 122.13 17.45 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.6 m -140.01 92.32 2.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -170.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.71 147.9 38.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.58 0.752 . . . . 0.0 111.43 -170.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -112.54 137.02 51.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 m -121.85 142.82 49.85 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -133.82 156.43 48.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.193 1.797 . . . . 0.0 107.542 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -124.44 134.4 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -117.94 123.66 46.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.3 113.47 25.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.9 mtm -146.43 138.49 24.92 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.274 1.029 . . . . 0.0 108.449 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.64 36.87 11.45 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.188 1.395 . . . . 0.0 113.249 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.84 -4.16 62.14 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.99 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.41 165.13 11.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.615 1.566 . . . . 0.0 110.348 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -119.67 125.19 48.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.01 123.51 50.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.926 1.291 . . . . 0.0 108.117 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -86.0 123.55 31.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.66 133.23 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 170.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.9 t -128.39 121.43 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.06 121.8 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 1.2 mm-40 -85.05 112.36 20.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.19 -30.28 62.15 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.969 -0.457 . . . . 0.0 111.908 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.95 -41.52 97.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.856 0.298 . . . . 0.0 110.782 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.38 -14.71 22.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.622 1.169 . . . . 0.0 113.178 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtp 52.79 42.67 31.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.343 1.457 . . . . 0.0 109.924 -168.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -107.13 145.32 32.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.54 1.136 . . . . 0.0 108.496 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -116.52 120.86 66.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.662 0.744 . . . . 0.0 109.823 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.467 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 12.0 m95 -93.84 130.11 40.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.054 1.342 . . . . 0.0 108.291 172.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.2 117.94 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.41 40.71 15.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.84 1.256 . . . . 0.0 111.356 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.12 -9.77 52.09 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.511 -1.161 . . . . 0.0 115.129 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -95.8 135.64 37.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.863 1.832 . . . . 0.0 108.226 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -75.09 147.9 40.21 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.56 1.073 . . . . 0.0 109.148 174.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.18 166.58 20.81 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.474 1.11 . . . . 0.0 109.771 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.51 145.98 48.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.156 0.583 . . . . 0.0 111.018 -172.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.92 150.86 48.47 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.843 1.657 . . . . 0.0 109.331 -178.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.6 137.54 52.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.71 100.62 1.62 Allowed Glycine 0 C--N 1.33 0.24 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.62 149.32 22.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.31 126.81 47.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.19 174.74 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.262 1.425 . . . . 0.0 109.59 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -83.64 44.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.896 1.278 . . . . 0.0 110.964 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.39 -31.58 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.872 1.669 . . . . 0.0 111.319 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.78 -157.88 30.42 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.3 150.19 26.19 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -130.73 105.15 7.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.3 m -86.63 99.82 12.0 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -84.29 146.18 27.89 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.922 1.289 . . . . 0.0 110.24 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -158.28 -175.51 5.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.057 1.743 . . . . 0.0 108.469 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -152.16 149.02 28.3 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.784 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -142.32 127.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.14 -126.86 43.33 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -102.68 25.09 9.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -121.07 145.08 48.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.062 1.345 . . . . 0.0 109.048 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.71 147.78 28.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.339 0.656 . . . . 0.0 109.244 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -135.47 151.51 50.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.12 1.368 . . . . 0.0 108.436 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -146.9 141.46 26.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.911 -0.493 . . . . 0.0 109.819 168.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.46 115.18 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -79.23 123.64 27.61 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 169.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.5 92.14 3.86 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 171.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.17 124.56 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.474 1.11 . . . . 0.0 108.214 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 m -81.9 46.79 1.03 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.137 0.88 . . . . 0.0 110.862 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.1 m -65.97 -35.72 81.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.347 1.059 . . . . 0.0 112.657 -169.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.66 15.23 80.73 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 119.231 -0.761 . . . . 0.0 113.702 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -100.26 10.81 40.68 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.764 1.282 . . . . 0.0 112.582 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -153.31 166.88 31.22 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.192 0.997 . . . . 0.0 108.631 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -54.72 147.59 14.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 68.83 -3.19 1.5 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.052 2.141 . . . . 0.0 113.515 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.08 -51.83 2.86 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.075 1.798 . . . . 0.0 114.247 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.23 138.1 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 mm -101.42 120.85 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -97.16 130.61 44.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -139.1 143.55 38.32 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.159 0.983 . . . . 0.0 108.528 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -91.23 130.79 37.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.35 143.41 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.3 t -139.87 132.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.146 1.379 . . . . 0.0 107.715 173.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.68 37.65 13.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 111.868 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.6 t30 62.45 10.23 3.86 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.095 2.158 . . . . 0.0 115.295 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.54 149.81 21.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.04 1.336 . . . . 0.0 109.426 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.78 136.17 33.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.825 0.85 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.87 113.9 39.66 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.008 1.723 . . . . 0.0 107.04 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.55 149.4 30.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.072 2.515 . . . . 0.0 110.96 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.69 155.65 5.58 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.264 1.026 . . . . 0.0 110.81 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.4 pt -67.26 158.17 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.613 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.61 101.97 4.48 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.109 0.564 . . . . 0.0 109.886 176.397 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -149.45 163.69 37.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.95 1.3 . . . . 0.0 108.786 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -82.17 124.94 30.34 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -139.5 153.48 47.5 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.699 1.2 . . . . 0.0 109.565 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -155.19 161.49 41.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.194 1.397 . . . . 0.0 109.028 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.6 m -134.79 157.77 45.89 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.494 1.118 . . . . 0.0 108.613 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p -129.34 158.79 38.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.983 1.713 . . . . 0.0 109.299 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.03 130.55 45.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.6 m -122.51 139.58 53.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -133.91 152.53 51.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.192 1.397 . . . . 0.0 107.57 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.03 140.01 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.21 132.89 55.54 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -106.49 109.97 22.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 170.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.0 mtm -146.18 140.86 26.93 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.311 1.045 . . . . 0.0 108.932 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t0 51.23 35.67 14.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.992 1.317 . . . . 0.0 112.738 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.75 -10.52 18.06 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.713 1.149 . . . . 0.0 113.883 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.57 166.52 13.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.405 1.482 . . . . 0.0 111.063 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.81 129.32 52.54 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.65 116.74 27.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.737 1.215 . . . . 0.0 108.161 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -91.19 117.43 29.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -96.26 132.96 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.0 t -127.97 123.71 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.43 122.64 32.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -88.16 109.72 20.12 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.164 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -67.68 -27.52 66.9 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.587 -0.696 . . . . 0.0 111.311 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.46 -30.13 70.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.68 -3.65 9.26 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 113.06 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtp 53.19 37.1 24.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.221 1.409 . . . . 0.0 110.77 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -91.86 146.03 24.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.9 p -117.68 113.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 122.172 0.987 . . . . 0.0 109.714 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.439 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 26.9 m95 -83.15 137.67 33.97 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 169.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.38 113.23 11.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 169.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 46.56 42.84 11.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.166 1.386 . . . . 0.0 111.216 -170.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.88 -12.69 28.44 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.786 1.184 . . . . 0.0 114.996 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.11 135.58 33.92 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.817 1.808 . . . . 0.0 108.254 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -76.87 120.02 21.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 mt -77.55 166.7 22.71 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.819 1.295 . . . . 0.0 111.273 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.65 147.89 39.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 112.934 -1.939 . . . . 0.0 107.062 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -144.73 150.55 37.46 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.075 0.95 . . . . 0.0 109.477 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.68 140.11 46.85 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.67 105.86 1.24 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 -172.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -95.74 152.25 18.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.417 0.687 . . . . 0.0 109.195 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.65 139.71 52.63 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -131.2 167.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.605 1.562 . . . . 0.0 110.079 176.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.01 28.05 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.967 1.707 . . . . 0.0 112.825 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 44' ' ' VAL . 32.2 t70 -141.87 -22.04 0.72 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.568 2.747 . . . . 0.0 111.768 -173.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -155.66 26.26 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.65 150.62 37.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -130.0 107.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.938 1.295 . . . . 0.0 107.714 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.2 m -93.85 104.4 16.47 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.4 146.63 24.53 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.092 1.357 . . . . 0.0 110.625 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.08 -174.39 4.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.224 1.809 . . . . 0.0 108.324 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -144.81 149.7 35.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.352 1.061 . . . . 0.0 108.96 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.6 mt -134.43 113.82 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.2 -135.15 50.3 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.87 -13.45 59.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.608 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -88.51 127.46 35.53 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.531 -0.731 . . . . 0.0 109.472 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.37 149.01 26.31 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 169.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.64 153.32 47.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.686 1.594 . . . . 0.0 108.448 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -147.69 143.67 27.79 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.763 -0.586 . . . . 0.0 109.66 168.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -88.29 117.95 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 169.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -84.55 117.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.62 89.88 3.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.38 126.84 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 109.095 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -83.77 54.91 3.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.138 1.335 . . . . 0.0 110.476 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.8 m -72.52 -36.25 68.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.85 0.86 . . . . 0.0 111.488 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.42 138.85 22.36 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -79.25 -27.94 42.39 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.121 0.569 . . . . 0.0 111.067 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -63.39 155.44 28.94 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.011 0.924 . . . . 0.0 109.657 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -57.09 141.75 44.84 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.21 37.36 28.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.797 1.239 . . . . 0.0 111.061 -175.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.87 21.74 10.79 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.855 1.217 . . . . 0.0 113.488 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.9 mm -68.98 137.0 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.048 0.939 . . . . 0.0 109.422 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.84 117.34 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -92.07 127.7 37.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -133.59 144.29 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.467 1.107 . . . . 0.0 108.237 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -94.22 129.61 40.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.4 142.35 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.7 t -137.22 131.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.031 1.332 . . . . 0.0 107.84 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t0 45.11 42.36 6.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.281 1.432 . . . . 0.0 111.682 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 64.56 17.09 10.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.711 2.404 . . . . 0.0 116.125 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.11 152.41 31.13 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.643 1.177 . . . . 0.0 111.027 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -85.86 138.82 31.77 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.727 1.211 . . . . 0.0 110.692 -172.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.65 118.44 33.47 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.228 1.811 . . . . 0.0 106.714 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.19 150.43 33.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.861 2.374 . . . . 0.0 111.002 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -56.84 158.0 5.11 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.599 0.76 . . . . 0.0 110.423 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.9 pt -59.91 154.31 3.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.584 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.83 93.73 9.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.255 1.353 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.905 175.228 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -149.76 147.25 27.8 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.821 1.248 . . . . 0.0 108.969 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -135.37 147.91 49.21 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.625 1.17 . . . . 0.0 108.875 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 m -64.42 146.35 54.64 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.408 0.683 . . . . 0.0 110.68 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -80.32 158.56 26.06 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.34 125.97 28.69 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -177.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -146.6 157.51 43.73 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.031 1.332 . . . . 0.0 109.061 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -125.65 132.52 52.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 m -112.42 142.93 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -132.9 162.33 31.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.856 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 t -128.81 135.32 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.97 117.64 29.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -88.45 114.1 24.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 169.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.5 mtm -146.35 137.26 24.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.446 1.098 . . . . 0.0 108.426 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.24 38.14 12.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.319 1.448 . . . . 0.0 113.22 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.91 -1.07 69.84 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.254 0.93 . . . . 0.0 114.176 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -105.6 166.04 10.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.087 1.755 . . . . 0.0 110.116 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -122.66 121.28 36.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -109.39 120.99 44.21 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.66 1.184 . . . . 0.0 108.308 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -78.06 145.11 36.05 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.9 mm -125.57 133.03 70.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.35 120.48 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -85.91 122.45 29.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -88.78 112.23 22.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -72.56 -21.02 61.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.533 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.69 -35.98 81.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.869 0.759 . . . . 0.0 111.601 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.25 -0.99 9.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.119 1.368 . . . . 0.0 113.285 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.4 mtp 52.72 39.52 28.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.727 1.211 . . . . 0.0 110.592 -169.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.96 144.7 26.62 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.428 1.091 . . . . 0.0 108.245 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -114.02 115.68 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 109.862 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.456 ' CZ3' ' HE2' ' A' ' 36' ' ' LYS . 51.7 m95 -83.2 115.31 21.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 169.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.53 128.47 55.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 52.68 34.95 17.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.542 0.737 . . . . 0.0 111.705 -170.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.25 77.51 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.425 1.012 . . . . 0.0 114.65 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -125.44 138.0 54.0 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HE2' ' CZ3' ' A' ' 31' ' ' TRP 0.3 0.0 OUTLIER -75.71 146.42 40.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.733 1.606 . . . . 0.0 110.068 175.552 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.73 167.93 19.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.007 1.323 . . . . 0.0 110.16 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.48 148.34 49.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.6 0.714 . . . . 0.0 111.531 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -136.38 150.46 48.81 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.067 1.747 . . . . 0.0 108.99 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.31 139.76 52.24 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.49 107.35 1.62 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -96.86 151.15 19.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -117.44 139.59 50.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.401 0.681 . . . . 0.0 109.326 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.97 167.75 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.663 1.585 . . . . 0.0 110.023 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -76.94 49.74 0.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.171 1.388 . . . . 0.0 110.501 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.79 -34.98 0.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.902 2.481 . . . . 0.0 109.991 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.41 -151.58 23.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.75 148.2 40.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -125.83 107.26 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 m -91.03 103.34 16.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -87.29 147.08 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.911 1.284 . . . . 0.0 110.742 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.53 -178.99 7.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.591 1.957 . . . . 0.0 108.062 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 m -146.63 150.73 36.02 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.952 0.901 . . . . 0.0 109.186 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.99 108.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.34 -15.84 59.2 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.688 0.795 . . . . 0.0 112.425 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -85.88 120.81 27.69 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.63 146.4 25.75 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.634 0.73 . . . . 0.0 109.884 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.4 m -136.89 151.78 49.47 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.041 1.736 . . . . 0.0 108.445 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -148.66 142.17 25.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.837 -0.539 . . . . 0.0 109.818 168.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -88.1 119.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -88.75 102.45 15.02 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.28 88.14 6.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.56 134.87 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.263 1.825 . . . . 0.0 110.351 -169.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m -88.61 28.7 1.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.762 0.825 . . . . 0.0 112.646 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.2 m -66.04 -37.02 84.81 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.66 1.184 . . . . 0.0 111.407 -173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.33 33.42 4.33 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.671 1.129 . . . . 0.0 111.748 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.8 mttm 71.01 173.37 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.715 2.006 . . . . 0.0 110.87 -169.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.34 178.34 7.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.695 1.198 . . . . 0.0 111.132 -169.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.7 tttp 50.93 -119.22 1.37 Allowed 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 126.34 1.856 . . . . 0.0 110.266 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.94 -21.51 64.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.619 1.099 . . . . 0.0 111.858 -169.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.14 -8.18 53.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.348 0.975 . . . . 0.0 114.652 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.3 mt -63.73 133.73 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.282 1.433 . . . . 0.0 109.426 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.15 138.49 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.89 129.57 55.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.485 1.039 . . . . 0.0 108.307 172.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 147.71 51.16 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.81 130.43 44.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.52 143.29 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -140.65 132.35 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 125.009 1.324 . . . . 0.0 107.648 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 48.65 38.24 11.03 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.116 0.96 . . . . 0.0 111.971 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.9 t30 63.7 8.75 3.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.116 2.167 . . . . 0.0 115.428 -175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.25 149.4 21.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.126 1.37 . . . . 0.0 109.781 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.89 136.27 33.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.101 0.96 . . . . 0.0 110.119 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -120.19 116.58 32.4 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.895 1.678 . . . . 0.0 106.901 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.31 143.9 20.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.269 2.646 . . . . 0.0 111.383 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -69.17 162.61 26.68 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.176 0.59 . . . . 0.0 110.666 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.2 pt -113.26 154.47 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 126.016 1.726 . . . . 0.0 109.654 169.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.05 26.35 4.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.138 1.375 . . . . 0.0 111.631 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 C--O 1.256 1.439 0 C-N-CA 125.518 1.527 . . . . 0.0 110.07 179.562 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.75 143.73 51.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.154 0.582 . . . . 0.0 110.23 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -147.5 142.58 27.09 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -65.33 137.93 57.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.102 0.561 . . . . 0.0 109.791 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -74.9 132.61 41.59 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 m -139.42 91.99 2.54 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -139.6 148.21 42.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -110.21 130.5 55.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 m -121.64 142.63 49.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.492 0.663 . . . . 0.0 109.584 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -135.57 159.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.468 1.907 . . . . 0.0 106.941 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.42 141.36 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 169.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.51 134.2 46.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.053 1.341 . . . . 0.0 108.94 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -101.52 132.1 47.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.601 0.76 . . . . 0.0 109.278 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -138.24 133.08 32.73 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 56.28 -61.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.392 3.077 . . . . 0.0 115.975 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.97 15.17 0.08 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.323 1.916 . . . . 0.0 112.042 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -130.06 159.17 37.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.954 1.702 . . . . 0.0 109.179 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -121.1 130.93 53.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -110.02 109.51 20.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.656 1.182 . . . . 0.0 107.954 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -74.08 119.68 18.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 mm -96.6 131.2 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.63 116.38 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.94 122.83 31.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -82.59 113.27 20.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -71.75 -27.11 62.75 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.532 0.333 . . . . 0.0 111.634 -169.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.86 -45.63 41.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.38 0.537 . . . . 0.0 110.609 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.28 -17.07 28.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.172 0.989 . . . . 0.0 112.952 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.251 98.8 mmm 55.76 28.81 12.82 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.331 1.452 . . . . 0.0 111.357 -169.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.28 146.32 25.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.04 118.68 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -85.02 132.88 34.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.781 1.633 . . . . 0.0 108.1 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -118.22 116.3 26.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 168.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 46.39 42.4 10.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.859 1.264 . . . . 0.0 111.265 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.51 -11.36 39.29 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.616 1.103 . . . . 0.0 115.004 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.49 138.14 31.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.77 1.785 . . . . 0.0 108.588 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -68.94 145.9 53.24 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.8 163.64 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.944 0.898 . . . . 0.0 110.573 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.18 148.06 39.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.563 1.145 . . . . 0.0 110.285 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -140.62 149.41 42.28 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.399 1.08 . . . . 0.0 109.908 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.65 50.19 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.85 108.35 1.94 Allowed Glycine 0 C--N 1.331 0.263 0 N-CA-C 106.994 -2.442 . . . . 0.0 106.994 -174.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -94.55 148.96 21.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.38 137.16 52.38 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.585 0.754 . . . . 0.0 109.011 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.43 167.9 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.601 1.56 . . . . 0.0 109.919 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.7 47.88 0.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.071 1.348 . . . . 0.0 110.47 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -159.91 -34.9 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.274 2.23 . . . . 0.0 110.165 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.62 12.59 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -120.52 152.59 37.85 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.32 107.56 9.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.713 1.605 . . . . 0.0 106.948 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.9 m -93.93 102.93 15.04 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -89.76 148.15 23.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.907 1.283 . . . . 0.0 111.22 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -158.96 -177.63 6.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.907 2.083 . . . . 0.0 108.26 169.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.0 m -144.91 146.63 32.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.175 0.99 . . . . 0.0 109.709 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.0 mt -142.39 132.83 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.87 -127.19 44.68 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -109.57 36.48 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 110.526 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -131.86 145.99 51.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.043 1.337 . . . . 0.0 108.778 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.96 150.44 21.95 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.37 151.02 51.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.427 1.491 . . . . 0.0 107.839 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -148.66 140.64 23.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 121.804 -0.56 . . . . 0.0 110.285 168.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -87.51 117.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -84.96 127.88 34.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 170.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.46 96.52 4.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.63 125.18 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.104 0.962 . . . . 0.0 109.574 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -79.22 49.48 0.97 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.473 1.109 . . . . 0.0 111.125 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 m -66.15 160.54 23.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.086 1.354 . . . . 0.0 111.307 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.44 -148.43 37.21 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 123.57 0.605 . . . . 0.0 111.675 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -71.37 173.02 8.39 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.002 0.921 . . . . 0.0 110.642 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -67.67 -26.7 66.33 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.804 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -59.21 145.65 42.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.98 107.67 0.9 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.271 1.028 . . . . 0.0 111.444 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -145.26 43.82 0.92 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.24 1.876 . . . . 0.0 108.477 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.36 128.87 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.4 mm -88.29 113.07 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -95.74 129.18 43.04 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -137.51 140.19 40.97 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 tp -86.55 133.46 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.66 142.63 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 169.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.23 130.46 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.2 39.6 15.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.241 1.016 . . . . 0.0 111.97 -175.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 64.32 4.42 2.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.819 2.047 . . . . 0.0 115.006 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.3 147.21 23.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 120.449 -1.407 . . . . 0.0 109.189 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.95 133.55 35.6 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.371 0.668 . . . . 0.0 109.97 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.0 mm -117.28 111.99 39.88 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.193 1.797 . . . . 0.0 107.081 -175.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -73.23 152.58 50.45 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.908 2.405 . . . . 0.0 110.726 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -54.25 156.94 2.89 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.243 1.017 . . . . 0.0 111.257 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 pt -60.64 155.64 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.406 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.13 103.07 4.84 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.254 1.309 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.149 176.477 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 24' ' ' GLU . 13.8 p . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.224 0.535 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.67 138.31 49.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.6 m -119.89 142.97 48.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -132.69 152.68 51.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.011 1.325 . . . . 0.0 107.562 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.1 119.46 29.51 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -92.4 113.52 25.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 mtm -146.07 137.34 24.68 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.404 1.082 . . . . 0.0 108.627 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.07 37.74 15.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.168 1.387 . . . . 0.0 113.102 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.22 -4.0 60.28 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.125 0.869 . . . . 0.0 114.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.08 164.87 11.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.84 1.656 . . . . 0.0 110.056 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -121.01 124.37 44.68 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -110.57 132.49 54.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.956 1.303 . . . . 0.0 108.352 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.38 131.94 37.15 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.4 mm -110.1 134.36 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.37 121.86 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.85 123.5 32.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.92 113.03 23.17 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.271 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -75.7 -18.02 59.75 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.831 -0.543 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.27 -35.71 79.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.18 0.445 . . . . 0.0 111.266 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.44 -0.07 8.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.267 1.427 . . . . 0.0 113.434 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.7 mmt 52.14 49.13 21.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.106 0.955 . . . . 0.0 109.267 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -117.53 142.51 47.09 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.211 1.404 . . . . 0.0 107.879 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.78 119.79 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.774 0.797 . . . . 0.0 108.913 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.445 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 20.9 m95 -85.93 129.39 34.85 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.298 1.839 . . . . 0.0 108.994 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.8 t -118.33 119.26 34.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 168.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 47.89 41.52 14.71 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.989 1.316 . . . . 0.0 111.691 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.22 -7.05 61.45 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.603 -1.11 . . . . 0.0 115.221 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.84 137.83 39.62 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.751 1.775 . . . . 0.0 107.539 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -72.93 147.5 45.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.967 1.258 . . . . 0.0 109.997 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pp -117.07 168.58 10.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.953 1.301 . . . . 0.0 110.302 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.05 145.41 48.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.073 0.949 . . . . 0.0 110.138 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -143.13 151.19 40.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.478 1.111 . . . . 0.0 109.875 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.44 136.18 48.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.43 96.22 1.24 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -86.66 146.02 26.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -111.52 134.25 53.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.35 167.56 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.196 1.399 . . . . 0.0 110.116 -172.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.85 49.24 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.241 1.416 . . . . 0.0 110.309 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -159.95 -36.57 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.37 2.268 . . . . 0.0 109.892 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.26 -132.18 3.65 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -120.76 151.54 39.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -129.97 106.48 8.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.6 m -85.76 100.1 11.79 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -84.36 145.44 28.22 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.71 1.204 . . . . 0.0 110.393 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -158.45 -178.25 7.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.14 1.776 . . . . 0.0 108.762 169.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -145.81 150.47 36.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.36 1.064 . . . . 0.0 109.108 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mt -133.66 111.67 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.0 -131.26 51.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -169.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -81.16 -10.5 59.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.609 0.764 . . . . 0.0 112.653 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.78 30.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -171.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.15 26.97 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 109.578 169.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -138.26 152.5 48.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.871 1.668 . . . . 0.0 108.725 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.65 141.32 24.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 121.725 -0.609 . . . . 0.0 109.648 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -88.71 114.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -75.94 126.85 31.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.52 88.69 2.98 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.98 123.33 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.755 1.222 . . . . 0.0 108.381 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 119.313 0.96 . . . . 0.0 109.908 175.243 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.57 120.63 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.057 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -100.3 127.75 46.53 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -139.3 140.31 37.55 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 108.704 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.2 131.85 34.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.82 142.81 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.42 133.3 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t0 49.9 37.09 12.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.293 1.037 . . . . 0.0 111.874 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.2 t30 62.48 9.96 3.71 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.829 2.051 . . . . 0.0 115.444 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.52 150.54 20.21 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 125.063 1.345 . . . . 0.0 109.261 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.81 135.15 34.13 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.719 0.808 . . . . 0.0 110.059 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.8 mm -118.71 113.9 36.05 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.356 1.862 . . . . 0.0 106.922 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -74.64 151.43 41.44 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.948 2.432 . . . . 0.0 110.811 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.294 0.569 . . . . 0.0 109.828 176.464 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 24' ' ' GLU . 2.7 p . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.362 0.601 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -121.39 136.95 54.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.0 m -128.43 141.96 51.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -135.66 159.65 40.96 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.874 1.67 . . . . 0.0 107.553 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -124.82 140.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.02 125.78 42.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.821 1.248 . . . . 0.0 108.425 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -84.5 121.11 27.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.4 ttm -158.02 140.29 14.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.414 1.086 . . . . 0.0 108.277 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 51.67 37.43 20.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.163 1.385 . . . . 0.0 113.118 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.02 8.69 83.38 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 123.94 0.781 . . . . 0.0 113.653 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -123.81 173.82 7.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.506 1.922 . . . . 0.0 109.584 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -121.92 122.3 39.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.91 127.12 53.15 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -79.6 139.8 37.35 Favored 'General case' 0 N--CA 1.46 0.054 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -114.72 130.62 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.61 117.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -85.46 122.77 30.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.8 OUTLIER -79.83 112.9 17.57 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.2 -31.6 67.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 119.205 -0.426 . . . . 0.0 112.095 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.38 -47.34 56.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.327 0.512 . . . . 0.0 110.556 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.66 -18.17 28.5 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.78 0.832 . . . . 0.0 112.946 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.258 51.8 mtp 55.44 30.27 14.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.444 1.497 . . . . 0.0 111.552 -169.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.48 152.91 21.57 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.32 115.77 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -85.28 122.65 29.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.581 1.552 . . . . 0.0 107.355 174.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 t -114.73 125.98 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 49.86 36.83 12.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.293 1.037 . . . . 0.0 111.591 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.51 0.51 84.14 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 118.541 -1.144 . . . . 0.0 115.255 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -113.78 146.38 39.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.825 1.812 . . . . 0.0 109.235 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -66.71 147.04 53.8 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.339 -0.85 . . . . 0.0 108.998 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.35 168.16 12.86 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.618 1.167 . . . . 0.0 110.197 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.16 145.39 44.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.306 1.042 . . . . 0.0 110.117 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -140.85 149.52 42.09 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 109.88 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.3 140.39 48.57 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.8 109.86 2.0 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -175.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.26 149.06 25.07 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.538 0.735 . . . . 0.0 109.563 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.97 141.64 37.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.321 0.649 . . . . 0.0 109.521 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.13 166.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.753 1.621 . . . . 0.0 109.897 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -77.92 48.39 0.71 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.133 1.373 . . . . 0.0 110.443 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -161.31 -31.77 0.05 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.437 2.295 . . . . 0.0 110.856 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.8 -134.85 4.41 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -130.82 151.83 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.39 110.83 12.7 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.5 m -92.17 104.89 17.22 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.72 147.12 24.04 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.807 1.243 . . . . 0.0 110.666 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -157.51 -177.62 6.72 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.059 1.744 . . . . 0.0 108.635 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.93 147.54 31.84 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.346 1.058 . . . . 0.0 109.465 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.5 mt -143.67 130.53 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.98 -131.36 51.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.17 28.92 4.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.702 1.201 . . . . 0.0 111.536 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -124.29 149.26 46.73 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.968 1.307 . . . . 0.0 109.17 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 150.72 24.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.92 152.82 52.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.464 1.506 . . . . 0.0 108.318 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -147.68 143.45 27.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.686 -0.634 . . . . 0.0 109.6 168.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.84 117.49 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 169.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -83.07 115.8 22.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.19 90.59 3.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.98 122.24 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.02 1.328 . . . . 0.0 108.587 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 119.203 0.911 . . . . 0.0 108.884 177.389 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.0 mm -102.46 120.88 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -96.44 125.63 41.07 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -132.69 145.82 51.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.345 1.058 . . . . 0.0 108.547 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 tp -93.44 131.95 38.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.78 141.95 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.6 131.36 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.61 40.47 15.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.282 1.033 . . . . 0.0 111.796 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 66.77 1.36 2.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.857 2.063 . . . . 0.0 115.282 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.55 147.48 23.32 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 120.456 -1.403 . . . . 0.0 109.325 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.05 133.88 34.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.619 0.768 . . . . 0.0 109.822 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.1 mm -118.22 113.38 37.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 107.285 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.19 155.16 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.391 2.727 . . . . 0.0 111.137 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 123.63 0.772 . . . . 0.0 110.897 177.838 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 24' ' ' GLU . 24.7 p . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.775 0.798 . . . . 0.0 111.634 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -120.44 132.4 55.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.0 m -119.51 143.04 47.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -136.29 156.18 49.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.121 1.368 . . . . 0.0 108.247 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -116.11 134.74 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.62 110.38 15.92 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -82.55 111.25 18.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 53.0 mtm -147.53 139.8 24.46 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.565 1.146 . . . . 0.0 108.687 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 50.15 36.11 11.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.162 1.385 . . . . 0.0 112.914 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.97 -7.29 36.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.536 1.065 . . . . 0.0 113.718 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.55 171.09 9.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.715 1.606 . . . . 0.0 110.706 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -128.62 111.46 13.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.304 1.442 . . . . 0.0 107.17 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -99.07 129.14 45.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -88.42 135.88 33.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.03 133.76 62.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -131.67 122.19 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -88.14 127.4 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.424 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -97.01 113.32 24.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -69.39 -25.11 63.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -172.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -37.35 84.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.225 0.466 . . . . 0.0 111.494 -174.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.76 -5.54 11.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.096 1.358 . . . . 0.0 113.018 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 71.8 mtp 54.37 31.03 13.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.845 1.258 . . . . 0.0 110.353 -168.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.36 147.7 32.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.76 119.5 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.411 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 8.2 m95 -85.45 126.65 33.97 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.481 1.513 . . . . 0.0 107.908 172.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.43 121.37 44.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 46.42 38.94 5.87 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.054 1.341 . . . . 0.0 111.832 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.58 62.53 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.901 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.42 141.21 31.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.724 1.762 . . . . 0.0 108.618 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -69.28 143.97 53.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.21 164.79 17.21 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.944 0.898 . . . . 0.0 110.19 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.32 146.17 43.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.155 0.982 . . . . 0.0 110.243 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -139.72 149.85 44.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.624 1.17 . . . . 0.0 109.824 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.88 140.98 49.25 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.44 106.1 1.36 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.43 151.49 19.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.35 139.08 54.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.585 0.754 . . . . 0.0 109.057 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.12 167.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.424 1.49 . . . . 0.0 110.305 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.07 49.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.705 1.24 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -159.09 -35.12 0.06 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.614 2.366 . . . . 0.0 110.191 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.62 -153.06 23.71 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -118.24 150.83 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -126.01 106.74 9.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.55 1.54 . . . . 0.0 107.098 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 m -91.94 102.57 15.14 Favored 'General case' 0 N--CA 1.46 0.041 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -87.76 146.82 25.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.832 1.253 . . . . 0.0 110.662 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.54 -179.89 8.59 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.011 1.724 . . . . 0.0 108.68 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 m -145.76 150.77 36.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.191 0.997 . . . . 0.0 108.941 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.4 mt -133.01 110.85 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.89 -131.46 52.06 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.02 -9.99 59.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.478 0.711 . . . . 0.0 112.578 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.59 29.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.85 147.19 25.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.77 152.34 49.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.168 1.787 . . . . 0.0 108.685 -173.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -149.4 140.57 23.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.761 -0.587 . . . . 0.0 109.838 168.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -87.71 120.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -87.16 122.9 31.59 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.32 93.53 4.16 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -90.18 125.5 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.377 1.071 . . . . 0.0 108.941 -169.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 m . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 124.368 1.067 . . . . 0.0 111.904 -179.813 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.1 mm -88.78 115.03 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.98 127.87 41.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -135.21 144.19 46.81 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.72 130.58 41.18 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.4 142.75 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.77 132.43 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 107.565 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.3 37.71 12.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.084 0.954 . . . . 0.0 111.948 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.62 9.88 3.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.152 2.181 . . . . 0.0 115.542 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.7 150.8 19.97 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.232 1.413 . . . . 0.0 109.578 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.47 136.46 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.346 1.059 . . . . 0.0 110.227 -176.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.9 mm -120.65 116.16 31.94 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.3 1.84 . . . . 0.0 107.005 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.8 144.27 19.19 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 111.269 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.237 0.423 0 C-N-CA 123.054 0.542 . . . . 0.0 111.312 -178.775 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.909 0.862 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -118.32 129.53 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 168.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.8 m -112.52 145.42 40.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -133.92 161.42 34.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.459 1.504 . . . . 0.0 108.0 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.03 137.94 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.3 mt -121.57 113.22 19.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -81.06 122.14 26.95 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 168.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 58.3 mtt -130.42 -173.68 3.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.362 1.865 . . . . 0.0 108.079 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -51.1 90.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.603 1.561 . . . . 0.0 113.369 -169.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 13.12 79.13 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.214 1.388 . . . . 0.0 114.116 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -139.99 162.34 35.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.448 1.624 . . . . 0.0 111.123 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -128.61 119.88 25.58 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 125.612 1.565 . . . . 0.0 106.938 172.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.03 131.53 54.49 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.03 0.932 . . . . 0.0 109.239 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -80.75 145.93 31.27 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 mm -122.39 132.61 70.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.22 119.99 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -88.4 123.13 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -90.89 113.2 25.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 168.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -70.78 -19.98 62.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.128 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.18 -42.36 94.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.869 0.759 . . . . 0.0 111.591 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.42 -1.01 13.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.24 1.416 . . . . 0.0 112.449 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm 53.11 39.35 29.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.008 1.323 . . . . 0.0 109.954 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.37 141.77 31.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.779 1.232 . . . . 0.0 109.098 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.45 116.76 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.837 0.827 . . . . 0.0 109.972 -173.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.433 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -85.18 115.27 22.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.1 m -118.48 125.87 50.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 49.14 39.35 15.1 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.138 0.975 . . . . 0.0 111.914 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.13 3.55 88.39 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.307 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.59 147.26 46.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.541 1.67 . . . . 0.0 108.23 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 147.75 33.85 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.384 0.993 . . . . 0.0 109.551 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.9 166.57 23.01 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.487 1.115 . . . . 0.0 110.458 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.98 148.83 48.41 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.486 0.714 . . . . 0.0 111.675 -172.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 149.93 48.99 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.786 1.634 . . . . 0.0 109.15 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.6 140.54 52.69 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.51 106.98 1.29 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 -173.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -98.32 153.01 18.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 109.374 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.48 138.55 54.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.38 168.28 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.422 1.489 . . . . 0.0 110.325 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.01 48.35 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.061 1.345 . . . . 0.0 110.794 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -159.99 -35.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.502 2.321 . . . . 0.0 110.448 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.0 -153.65 24.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -118.45 152.41 35.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.57 109.73 10.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.767 1.227 . . . . 0.0 107.849 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 m -94.37 105.75 17.72 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -91.17 146.19 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.97 1.308 . . . . 0.0 110.836 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.01 -174.01 4.53 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.61 1.964 . . . . 0.0 108.701 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.1 m -145.71 146.58 31.31 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.53 1.132 . . . . 0.0 109.4 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.3 mt -142.39 130.12 20.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.46 -130.37 50.89 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -101.06 28.6 5.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.68 1.192 . . . . 0.0 111.548 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -128.52 144.31 51.12 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.65 1.18 . . . . 0.0 109.076 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.77 149.9 21.83 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.4 150.51 50.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.364 1.465 . . . . 0.0 108.212 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -146.82 140.36 25.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.3 mt -90.79 115.5 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 170.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -78.85 134.83 36.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.66 94.04 3.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.93 128.42 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.957 1.303 . . . . 0.0 109.539 -169.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 CA--C 1.546 0.817 0 CA-C-N 119.76 1.164 . . . . 0.0 112.436 -177.209 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.8 mm -79.08 116.5 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -96.51 130.85 43.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 tp -93.34 130.72 38.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.84 140.59 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.35 132.22 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.583 1.153 . . . . 0.0 108.132 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.0 t0 45.53 42.35 7.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.337 1.455 . . . . 0.0 111.613 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 t30 64.52 18.21 11.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.563 2.345 . . . . 0.0 116.002 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -115.75 153.42 31.43 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 120.752 -1.218 . . . . 0.0 110.809 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -89.18 138.08 31.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.955 1.302 . . . . 0.0 110.793 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -121.55 118.09 29.88 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.859 2.064 . . . . 0.0 106.596 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.97 143.39 23.01 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.232 2.621 . . . . 0.0 111.357 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--O 1.237 0.422 0 CA-C-O 121.351 0.596 . . . . 0.0 110.359 177.248 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.2 p . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.174 0.512 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -115.9 128.98 56.2 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.4 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.811 0.815 . . . . 0.0 109.249 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -135.07 157.03 47.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.032 1.333 . . . . 0.0 107.491 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -125.06 137.76 56.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 169.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.7 mt -122.16 125.53 46.33 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.833 1.253 . . . . 0.0 107.628 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -93.31 118.07 30.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.7 mtm -146.41 134.87 21.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.638 1.175 . . . . 0.0 108.416 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.29 37.5 11.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.983 1.313 . . . . 0.0 113.496 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.71 8.1 87.24 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.936 -0.925 . . . . 0.0 114.431 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -118.28 155.22 30.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.81 1.644 . . . . 0.0 110.042 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -107.88 123.52 48.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -111.05 122.66 48.46 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.212 1.405 . . . . 0.0 108.382 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.42 142.32 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -120.72 134.32 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.4 t -132.36 118.59 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -87.11 125.94 34.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.3 OUTLIER -87.79 112.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.252 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -70.01 -29.35 66.39 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.791 0.723 . . . . 0.0 111.787 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.42 -43.43 94.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.286 0.494 . . . . 0.0 110.996 -173.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.87 -11.68 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.639 1.176 . . . . 0.0 113.003 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.9 mtp 54.55 34.35 21.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 110.519 -169.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -93.13 150.89 20.19 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.28 117.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.53 121.84 30.47 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.74 1.616 . . . . 0.0 107.604 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -113.63 130.57 56.37 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 52.26 35.51 17.13 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.82 0.848 . . . . 0.0 111.6 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.43 10.17 82.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.209 0.909 . . . . 0.0 114.835 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -124.34 136.58 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.379 1.472 . . . . 0.0 107.221 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -72.18 142.58 49.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.595 1.543 . . . . 0.0 109.438 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -116.2 167.8 10.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.086 0.954 . . . . 0.0 110.989 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.29 146.35 43.25 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 110.352 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -139.55 150.39 45.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.445 1.098 . . . . 0.0 109.697 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.7 141.29 50.93 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.49 106.13 1.21 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -95.64 153.35 17.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -122.66 139.7 53.66 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.62 167.58 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.853 1.661 . . . . 0.0 110.086 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -76.55 48.49 0.55 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.8 1.286 . . . . 0.0 110.927 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.98 -33.61 0.06 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.851 2.46 . . . . 0.0 110.356 -171.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.2 -152.17 23.32 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.52 149.16 40.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -126.56 106.75 9.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 m -92.22 103.6 16.06 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -88.56 146.68 25.0 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.913 1.285 . . . . 0.0 110.335 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.82 179.74 8.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.893 1.677 . . . . 0.0 108.337 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 m -145.81 149.88 35.16 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.907 0.883 . . . . 0.0 108.903 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mt -133.18 110.0 14.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.48 -131.67 52.17 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -81.22 -10.12 59.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.413 0.685 . . . . 0.0 112.803 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -88.8 121.34 31.07 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 147.04 25.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.482 0.658 . . . . 0.0 109.862 170.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.84 153.52 49.6 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.57 1.548 . . . . 0.0 108.508 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -148.09 143.08 26.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.692 -0.63 . . . . 0.0 109.798 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.4 mt -88.31 119.56 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -85.33 110.05 18.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.4 84.83 3.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.61 127.3 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.846 1.659 . . . . 0.0 108.881 -169.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.542 0.643 0 CA-C-N 119.63 1.105 . . . . 0.0 110.273 178.683 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.31 129.72 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -104.73 124.91 50.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -132.59 145.54 51.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.14 0.976 . . . . 0.0 108.775 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 tp -92.42 131.1 37.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.69 142.42 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 169.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -136.94 132.19 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.048 1.339 . . . . 0.0 107.978 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t0 45.4 42.21 7.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.239 1.415 . . . . 0.0 111.539 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.3 t30 64.02 17.33 10.54 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.553 2.341 . . . . 0.0 116.196 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.65 152.09 32.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.84 1.256 . . . . 0.0 110.546 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -88.74 137.96 31.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.372 1.069 . . . . 0.0 110.631 -169.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.49 112.3 37.43 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.611 1.964 . . . . 0.0 106.909 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.43 150.61 36.61 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.19 2.593 . . . . 0.0 110.821 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.238 0.468 0 C-N-CA 123.569 0.748 . . . . 0.0 110.818 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 24' ' ' GLU . 19.7 p . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 121.637 0.732 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -89.49 125.36 35.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.5 m -108.6 148.6 30.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -136.5 159.52 41.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.825 1.65 . . . . 0.0 106.689 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.04 140.57 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.17 122.26 36.55 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.834 1.253 . . . . 0.0 107.987 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -91.91 117.81 30.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 56.7 mtm -146.64 134.8 21.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.817 1.247 . . . . 0.0 108.421 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.33 37.83 12.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.141 1.376 . . . . 0.0 113.339 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.3 8.73 87.04 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.236 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.13 155.76 29.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.987 1.715 . . . . 0.0 110.004 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.92 123.84 49.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -110.26 124.02 50.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.26 1.424 . . . . 0.0 107.978 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -84.38 141.34 30.93 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.0 mm -117.34 135.51 57.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.5 t -132.06 120.58 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.57 124.14 33.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.71 113.85 21.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -72.58 -26.41 61.7 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.724 -0.61 . . . . 0.0 111.696 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.09 -44.06 77.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.176 0.443 . . . . 0.0 111.287 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.19 -10.85 17.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 113.372 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.263 59.6 mtp 54.96 30.4 13.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.988 1.315 . . . . 0.0 111.861 -169.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.43 150.08 27.28 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.95 117.71 46.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.428 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.2 m95 -85.19 119.21 25.32 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.5 t -110.54 128.74 55.78 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 169.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 52.62 34.92 16.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.702 0.801 . . . . 0.0 111.576 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 11.17 82.15 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.233 0.921 . . . . 0.0 114.768 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -124.8 142.6 51.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.164 1.482 . . . . 0.0 108.187 -174.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -69.47 145.06 53.04 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.522 1.055 . . . . 0.0 108.427 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 pp -123.18 167.15 14.08 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.36 144.85 44.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.911 0.884 . . . . 0.0 110.189 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -140.93 149.58 42.05 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.225 1.01 . . . . 0.0 110.011 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.96 138.45 49.72 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.41 111.2 2.2 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -110.37 146.18 36.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.622 0.769 . . . . 0.0 109.87 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.45 142.46 30.04 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.55 166.34 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.693 1.597 . . . . 0.0 109.754 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.57 49.15 0.72 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.982 1.373 . . . . 0.0 110.231 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -159.87 -34.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.64 2.376 . . . . 0.0 110.292 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.4 -130.07 2.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -171.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -131.85 152.2 51.18 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -129.3 117.3 20.43 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 m -95.84 105.58 17.61 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.87 145.36 25.2 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.815 1.246 . . . . 0.0 109.966 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -157.31 -177.81 6.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.507 1.523 . . . . 0.0 109.053 169.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.81 151.54 38.08 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.422 1.089 . . . . 0.0 108.507 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -132.5 108.58 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.44 -130.76 51.48 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -77.94 -16.21 58.37 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.555 0.742 . . . . 0.0 112.578 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -85.84 120.03 26.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.76 147.53 26.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.364 0.529 . . . . 0.0 109.796 170.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.86 153.07 46.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.731 1.612 . . . . 0.0 108.924 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -148.0 141.3 25.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.661 -0.649 . . . . 0.0 109.342 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.8 mt -88.55 117.76 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -81.74 128.11 33.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 90.9 3.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -87.53 121.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 124.103 0.961 . . . . 0.0 108.537 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.237 0.404 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.767 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -90.09 114.35 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.45 125.31 38.0 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -132.83 142.35 48.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.7 tp -94.25 130.33 40.55 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.22 141.96 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -139.07 132.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t0 49.54 37.49 12.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.049 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 62.86 10.17 4.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.774 2.03 . . . . 0.0 115.531 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -96.63 150.47 20.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.265 1.426 . . . . 0.0 109.672 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.22 137.44 32.33 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.263 1.025 . . . . 0.0 110.232 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mm -118.94 118.77 32.79 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.967 1.707 . . . . 0.0 107.952 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -68.12 141.44 52.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.611 2.874 . . . . 0.0 112.33 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.56 0.695 . . . . 0.0 110.622 174.533 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 121.354 0.597 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.76 131.1 55.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.0 m -116.64 141.19 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -131.21 153.69 49.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.601 1.56 . . . . 0.0 107.326 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -114.88 139.4 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.49 112.64 18.76 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.278 1.831 . . . . 0.0 106.591 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -92.44 113.21 25.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.7 mtm -147.31 137.29 23.09 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.43 1.092 . . . . 0.0 108.609 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.3 t70 49.54 37.76 13.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.197 1.399 . . . . 0.0 113.206 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.34 -7.02 48.97 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.518 1.056 . . . . 0.0 113.976 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -95.23 164.99 12.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.731 1.613 . . . . 0.0 110.219 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -123.38 124.44 42.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.8 132.47 54.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.676 1.591 . . . . 0.0 108.132 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.81 138.1 31.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 169.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.5 mm -116.36 131.4 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.3 117.62 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 170.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.1 tp -89.2 123.07 33.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -86.13 110.12 19.33 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 168.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -75.81 -24.76 55.93 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.92 -0.487 . . . . 0.0 111.446 -171.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.29 -42.02 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.134 0.424 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.62 -14.29 22.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.919 1.288 . . . . 0.0 113.106 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm 52.19 49.71 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.317 1.447 . . . . 0.0 109.366 -169.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -123.34 141.97 51.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.372 1.469 . . . . 0.0 108.579 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.93 123.33 68.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.273 0.559 . . . . 0.0 110.221 -172.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.459 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.9 m95 -95.66 114.15 25.87 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.0 m -108.79 120.97 44.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 171.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 47.94 40.94 13.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.33 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.66 -4.41 60.61 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.767 -1.019 . . . . 0.0 114.891 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -111.8 144.21 41.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.446 1.623 . . . . 0.0 108.952 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.29 149.4 47.45 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 110.376 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.96 167.7 21.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.124 1.769 . . . . 0.0 108.41 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.39 143.5 53.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.147 0.499 . . . . 0.0 111.197 -170.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.6 151.08 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.173 1.789 . . . . 0.0 108.815 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.96 134.53 45.73 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.84 90.12 0.81 Allowed Glycine 0 C--N 1.329 0.157 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -78.6 141.43 38.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -106.67 136.11 47.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.91 166.45 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.608 1.163 . . . . 0.0 110.34 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.66 49.26 0.73 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.883 1.325 . . . . 0.0 110.318 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -161.36 -32.66 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.682 2.393 . . . . 0.0 110.874 -169.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.67 -132.99 4.23 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -127.98 151.35 49.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.15 106.59 8.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.8 m -84.52 101.03 11.76 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -85.66 144.52 27.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.774 1.23 . . . . 0.0 110.322 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.85 -178.34 7.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.15 1.78 . . . . 0.0 108.399 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 m -145.23 150.28 36.41 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.993 0.917 . . . . 0.0 109.048 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.6 mt -132.7 115.36 24.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.87 -132.5 52.59 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.14 -4.19 58.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 112.639 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -94.5 121.15 35.76 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -171.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.46 145.3 27.5 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.337 0.589 . . . . 0.0 109.576 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.55 152.3 50.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.482 1.513 . . . . 0.0 108.315 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 26.4 p90 -147.99 139.67 23.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 110.142 168.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mt -87.89 111.64 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -80.63 127.75 32.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.5 94.1 3.79 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -93.82 126.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.816 -169.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 CA--C 1.542 0.668 0 CA-C-N 119.627 1.103 . . . . 0.0 111.764 178.369 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mm -84.78 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -140.55 138.09 34.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.2 tp -88.99 131.04 35.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.6 mp -111.91 147.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.4 129.64 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.83 39.85 11.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.937 0.895 . . . . 0.0 111.572 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 65.9 2.35 2.17 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.76 2.024 . . . . 0.0 115.472 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -90.16 151.21 21.68 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.488 -1.382 . . . . 0.0 109.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -93.0 136.88 32.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.145 0.978 . . . . 0.0 110.538 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 mm -119.27 117.36 33.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.062 1.745 . . . . 0.0 107.01 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.68 152.51 37.74 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.162 2.575 . . . . 0.0 111.044 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 123.206 0.602 . . . . 0.0 109.398 173.217 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.2 p . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -121.71 130.23 53.29 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.7 m -123.51 142.29 51.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.827 0.704 . . . . 0.0 109.415 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -138.8 158.46 44.18 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 0.0 107.971 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 146.61 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.644 0.778 . . . . 0.0 109.298 169.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.55 156.01 46.47 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.089 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -111.5 116.26 30.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtm -144.56 141.56 29.56 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.6 t0 49.21 38.13 12.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.252 1.421 . . . . 0.0 113.546 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.94 6.44 85.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.977 -0.902 . . . . 0.0 113.937 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -118.15 162.8 17.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.149 1.78 . . . . 0.0 110.452 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -111.05 126.27 54.63 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.21 104.32 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.32 142.6 37.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 mm -125.57 131.47 72.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.51 120.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -87.94 124.52 33.78 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -89.29 108.48 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.96 1.704 . . . . 0.0 109.109 171.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.7 -26.7 63.53 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.055 0.389 . . . . 0.0 111.661 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.83 -39.94 94.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.407 0.283 . . . . 0.0 111.204 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.7 -11.28 17.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 113.218 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.3 42.4 30.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.298 1.439 . . . . 0.0 109.984 -168.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -105.26 160.84 14.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.913 1.285 . . . . 0.0 108.261 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.43 119.08 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.465 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.7 m95 -90.35 121.35 32.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.851 1.661 . . . . 0.0 109.078 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -102.79 116.03 31.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 168.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 46.13 39.78 6.41 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.32 1.048 . . . . 0.0 111.794 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.46 -7.8 67.22 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.312 -1.271 . . . . 0.0 115.343 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.23 140.98 30.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.106 1.953 . . . . 0.0 108.844 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -69.71 142.07 53.39 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.769 1.168 . . . . 0.0 108.442 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.66 166.16 12.02 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.836 0.854 . . . . 0.0 110.288 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.71 146.76 42.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.507 1.123 . . . . 0.0 109.979 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -142.87 150.24 39.59 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 110.091 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.36 134.24 43.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.47 90.32 0.75 Allowed Glycine 0 C--N 1.33 0.21 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -174.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.4 142.2 39.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -108.52 135.68 49.39 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.24 166.84 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 124.815 1.246 . . . . 0.0 110.174 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.71 49.34 0.75 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 123.005 1.383 . . . . 0.0 110.384 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.08 -33.27 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.536 2.335 . . . . 0.0 110.683 -169.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.29 -134.25 4.71 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -171.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -125.63 150.28 47.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.75 106.19 8.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -87.12 100.6 12.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -86.6 144.55 27.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.602 1.161 . . . . 0.0 110.798 -172.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.69 -177.01 6.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.367 1.867 . . . . 0.0 108.879 169.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -144.64 146.61 32.36 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.363 1.065 . . . . 0.0 109.662 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.95 132.5 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.98 -125.92 41.14 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -109.5 33.25 4.44 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.754 1.222 . . . . 0.0 110.714 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -129.53 144.87 51.45 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.178 1.391 . . . . 0.0 108.817 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.31 150.87 21.67 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.68 152.46 50.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.317 1.447 . . . . 0.0 108.295 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 24.2 p90 -148.69 140.41 23.64 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.785 -0.572 . . . . 0.0 109.647 168.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -88.29 114.13 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -81.96 126.82 32.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.25 92.12 3.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 121.74 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 C--O 1.237 0.417 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.086 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.3 mm -90.21 111.67 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.08 129.76 38.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -137.85 141.24 40.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.907 1.283 . . . . 0.0 108.012 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.9 tp -88.73 132.59 34.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.46 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.66 141.9 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.23 133.67 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.5 t0 49.59 37.75 13.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.413 1.085 . . . . 0.0 111.759 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.1 t30 62.72 9.66 3.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.027 2.131 . . . . 0.0 115.431 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.83 149.06 21.95 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.14 1.376 . . . . 0.0 109.387 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -91.13 133.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.457 0.703 . . . . 0.0 110.065 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.06 112.39 40.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.432 1.893 . . . . 0.0 106.801 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.28 152.02 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 110.947 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--O 1.24 0.558 0 C-N-CA 124.187 0.995 . . . . 0.0 110.484 174.501 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.024 0.44 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -117.41 135.61 53.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 m -114.68 147.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -134.55 161.35 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.379 1.472 . . . . 0.0 107.507 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.02 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.44 124.63 34.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.323 1.449 . . . . 0.0 108.581 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -87.63 125.71 34.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 ttm -156.03 132.47 10.19 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.91 38.94 17.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.108 1.363 . . . . 0.0 113.316 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 -1.34 74.81 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.109 0.861 . . . . 0.0 114.151 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.01 167.51 9.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.235 1.814 . . . . 0.0 110.031 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -121.42 124.14 43.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.41 118.44 36.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -86.73 142.37 28.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.05 133.86 67.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 t -133.07 119.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 tp -88.65 120.54 30.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -83.03 111.39 18.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 168.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.99 -26.8 60.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.181 -170.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.08 -43.58 86.96 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.106 0.412 . . . . 0.0 110.735 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.49 -13.75 24.27 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.518 1.127 . . . . 0.0 112.929 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mmm 52.35 45.62 28.15 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.08 1.352 . . . . 0.0 109.581 -169.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -115.83 141.61 47.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.835 1.254 . . . . 0.0 108.391 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.15 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.768 0.794 . . . . 0.0 109.705 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.451 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 22.9 m95 -85.53 111.51 20.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 169.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.1 m -108.5 117.65 34.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 48.01 40.89 14.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.143 1.377 . . . . 0.0 111.022 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.58 -9.31 36.42 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.591 1.091 . . . . 0.0 114.743 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.79 138.82 32.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.75 1.775 . . . . 0.0 108.821 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -71.07 141.33 50.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.9 165.9 24.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.984 0.914 . . . . 0.0 110.075 169.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.41 145.15 53.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.4 0.619 . . . . 0.0 111.167 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -134.36 147.82 50.59 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.845 1.658 . . . . 0.0 108.719 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.23 142.62 46.83 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.33 109.73 1.83 Allowed Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 107.155 -2.378 . . . . 0.0 107.155 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.45 148.52 25.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.07 134.39 55.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.68 167.54 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.548 1.539 . . . . 0.0 110.114 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.95 48.41 0.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.016 1.326 . . . . 0.0 110.465 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.35 -34.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.204 2.202 . . . . 0.0 110.537 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.66 -150.73 20.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -175.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -121.02 152.98 37.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -127.19 109.83 12.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.794 1.638 . . . . 0.0 107.171 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.7 m -92.44 102.57 15.04 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -89.56 146.17 24.76 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.447 1.099 . . . . 0.0 110.958 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -158.47 -173.75 4.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.086 2.154 . . . . 0.0 108.231 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 m -146.57 149.24 33.19 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.534 1.134 . . . . 0.0 109.403 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -138.16 121.64 20.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.33 -134.17 52.42 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -170.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -83.37 -7.56 59.55 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.832 0.853 . . . . 0.0 112.384 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -95.33 133.35 39.35 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.69 150.69 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.71 150.76 50.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.407 1.483 . . . . 0.0 107.866 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.419 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 17.2 p90 -147.41 139.68 24.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.907 -0.496 . . . . 0.0 109.821 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.1 mt -88.41 117.73 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -84.36 124.2 31.02 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.9 91.64 3.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.6 126.02 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.324 1.05 . . . . 0.0 108.451 -169.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m . . . . . 0 CA--C 1.54 0.565 0 CA-C-N 119.818 1.19 . . . . 0.0 109.958 176.233 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.17 118.02 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -98.66 124.48 43.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 m -133.47 140.34 47.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.241 1.016 . . . . 0.0 108.408 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 tp -89.33 133.48 34.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.419 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.44 141.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 169.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.83 131.97 43.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 49.48 38.33 14.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.398 1.079 . . . . 0.0 111.868 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.79 9.6 3.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.014 2.125 . . . . 0.0 115.471 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.75 150.01 20.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.916 1.286 . . . . 0.0 109.192 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -95.02 134.24 37.93 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.769 0.828 . . . . 0.0 110.657 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.1 mm -121.98 113.73 31.27 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.47 1.908 . . . . 0.0 107.722 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.7 149.45 48.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.039 2.492 . . . . 0.0 111.201 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 111.384 179.186 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -120.43 136.53 54.71 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.8 m -129.81 142.92 50.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.402 0.681 . . . . 0.0 109.284 -169.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -136.84 159.62 41.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.038 1.735 . . . . 0.0 107.629 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.13 141.58 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.224 1.01 . . . . 0.0 108.693 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.37 128.81 38.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.327 1.451 . . . . 0.0 109.079 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -83.78 128.94 34.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.8 mtt -144.44 129.65 18.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.087 1.355 . . . . 0.0 108.389 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.01 44.54 18.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 0.0 113.855 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.15 5.02 90.39 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.921 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -118.72 158.88 24.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.896 1.678 . . . . 0.0 109.987 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -115.38 123.7 49.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -108.57 128.28 54.68 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.018 0.927 . . . . 0.0 108.571 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -80.4 147.43 31.01 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mm -122.02 131.28 73.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.96 119.09 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.9 121.89 30.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.81 112.97 20.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -71.87 -31.28 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.97 0.908 . . . . 0.0 111.993 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.75 -46.49 62.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.124 0.42 . . . . 0.0 110.262 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.83 -17.22 33.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.065 0.946 . . . . 0.0 112.57 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.0 mtp 53.41 42.17 32.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.258 1.423 . . . . 0.0 109.884 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -106.66 145.45 31.96 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.056 1.343 . . . . 0.0 107.981 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -114.34 116.94 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.932 0.873 . . . . 0.0 109.618 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.67 111.14 19.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -114.85 127.52 55.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 49.08 36.73 9.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.123 0.969 . . . . 0.0 111.609 -171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.2 5.8 85.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.207 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.78 148.12 45.06 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.878 1.839 . . . . 0.0 109.352 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -69.63 144.53 52.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.77 166.79 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.342 1.057 . . . . 0.0 110.309 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.5 140.61 57.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.576 0.751 . . . . 0.0 111.129 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.94 151.9 49.56 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.965 1.706 . . . . 0.0 108.466 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 135.83 46.76 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.77 95.58 1.28 Allowed Glycine 0 C--N 1.331 0.257 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.29 145.52 28.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -107.45 136.45 47.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.45 167.5 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.141 1.376 . . . . 0.0 109.962 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.78 49.4 0.76 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.249 1.42 . . . . 0.0 110.533 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -160.73 -36.39 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.664 2.386 . . . . 0.0 110.025 -170.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.0 -124.03 1.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -127.5 150.97 49.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.3 106.38 8.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 172.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.4 m -86.26 101.53 13.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -85.7 145.7 27.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.775 1.23 . . . . 0.0 110.557 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -157.33 -176.32 5.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.736 2.014 . . . . 0.0 108.205 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -146.77 150.72 35.89 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.347 1.059 . . . . 0.0 109.099 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.31 122.74 25.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.9 -131.68 52.17 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -87.58 -4.17 58.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.183 0.993 . . . . 0.0 112.458 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -98.52 130.49 45.1 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 109.448 -169.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.1 151.14 27.15 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.182 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -135.32 150.8 50.07 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.749 1.619 . . . . 0.0 107.372 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.99 140.54 26.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.864 -0.522 . . . . 0.0 109.723 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.11 113.99 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -78.57 125.8 29.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.58 90.31 3.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -80.12 122.63 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 119.591 1.087 . . . . 0.0 111.961 -179.349 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.66 116.37 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -97.1 126.89 42.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -135.54 144.15 46.11 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.36 1.064 . . . . 0.0 108.46 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 tp -90.97 132.37 36.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.32 141.72 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.45 132.79 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t0 50.31 37.31 14.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 111.816 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 62.43 9.61 3.47 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.045 2.138 . . . . 0.0 115.614 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.27 147.66 22.97 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.679 -1.263 . . . . 0.0 109.371 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -90.57 133.67 34.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.685 0.794 . . . . 0.0 110.061 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.1 mm -119.36 113.77 35.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.134 1.774 . . . . 0.0 107.44 -174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.31 155.32 36.96 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.197 2.598 . . . . 0.0 111.149 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 123.758 0.823 . . . . 0.0 110.841 178.005 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 24' ' ' GLU . 25.9 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.693 0.758 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -124.11 129.28 50.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 169.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.8 m -114.27 145.75 41.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -136.64 162.6 32.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.281 1.433 . . . . 0.0 107.551 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.79 147.05 26.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.67 153.78 51.5 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.022 0.929 . . . . 0.0 108.661 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -106.1 119.3 38.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.42 137.79 27.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.756 1.222 . . . . 0.0 108.161 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.91 37.34 9.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.41 10.64 86.04 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.771 -1.016 . . . . 0.0 114.256 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.73 150.95 47.28 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.371 1.586 . . . . 0.0 110.231 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -98.15 122.81 41.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -106.75 113.6 27.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -80.73 142.6 33.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 mm -122.07 133.69 67.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.2 t -131.62 119.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.04 127.43 35.4 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -94.34 112.36 24.15 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -68.07 -25.0 65.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.454 -0.307 . . . . 0.0 111.66 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.83 -36.6 83.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.835 0.454 . . . . 0.0 111.88 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.74 -2.38 9.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.145 1.378 . . . . 0.0 113.018 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 99.3 mmm 53.97 33.0 16.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.902 1.281 . . . . 0.0 110.789 -169.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -88.9 146.12 25.12 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.84 117.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.403 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 9.2 m95 -85.38 122.6 29.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.636 1.574 . . . . 0.0 107.454 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.04 118.14 36.02 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 42.47 48.95 4.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.128 1.771 . . . . 0.0 112.564 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.28 -4.11 86.13 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.604 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -113.8 142.73 45.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.786 1.793 . . . . 0.0 109.366 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -68.37 149.02 49.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -126.29 165.55 18.77 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.283 1.033 . . . . 0.0 110.55 169.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.35 146.57 40.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 110.199 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -140.33 151.09 44.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.458 1.103 . . . . 0.0 109.958 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.22 138.18 43.34 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.19 97.02 1.21 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.03 143.14 27.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.82 134.13 43.17 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.35 -179.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.653 1.581 . . . . 0.0 108.765 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.69 8.88 8.83 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.76 14.16 0.55 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.523 1.129 . . . . 0.0 113.357 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.93 -149.27 17.54 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.672 -1.267 . . . . 0.0 112.176 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.3 m -131.34 154.88 48.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -126.61 107.11 9.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.9 m -83.87 99.89 10.63 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -85.77 145.4 27.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.737 1.215 . . . . 0.0 110.722 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.85 -178.92 7.6 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.392 1.877 . . . . 0.0 108.945 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -144.7 147.42 32.99 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 109.522 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.5 mt -141.39 133.78 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.38 -123.3 32.77 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -113.33 36.83 3.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.769 1.228 . . . . 0.0 110.492 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.57 141.65 49.73 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.273 1.429 . . . . 0.0 108.213 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.34 149.2 23.39 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 169.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 m -135.6 152.19 51.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.537 1.535 . . . . 0.0 108.191 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -149.25 141.65 24.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 121.859 -0.525 . . . . 0.0 109.89 168.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.61 115.03 27.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -79.16 98.84 6.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.75 82.64 7.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.96 129.81 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 119.236 0.925 . . . . 0.0 111.038 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.7 mm -77.45 -43.51 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.28 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 63.5 m80 53.23 102.91 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.75 2.02 . . . . 0.0 112.407 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -126.3 141.27 51.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.792 0.837 . . . . 0.0 109.123 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.6 tp -88.46 131.43 34.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.412 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.89 142.87 22.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 131.2 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.94 43.82 10.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.463 1.105 . . . . 0.0 111.442 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.4 t30 65.17 4.53 2.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.6 2.36 . . . . 0.0 115.746 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.93 143.71 26.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.11 1.364 . . . . 0.0 109.806 174.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.05 136.07 33.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.145 0.978 . . . . 0.0 110.539 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -119.62 114.64 34.21 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.449 1.9 . . . . 0.0 107.01 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.68 146.94 34.74 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.371 2.714 . . . . 0.0 111.16 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 121.323 0.583 . . . . 0.0 111.43 -177.945 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 121.05 0.452 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.44 134.57 52.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -128.37 141.04 51.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.479 0.657 . . . . 0.0 109.694 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -136.32 151.93 50.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.301 1.44 . . . . 0.0 107.47 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.28 141.77 37.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.935 0.894 . . . . 0.0 109.035 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.65 125.83 35.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.127 1.371 . . . . 0.0 108.692 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -85.08 127.41 34.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 41.1 ttm -158.0 134.71 9.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.924 1.29 . . . . 0.0 108.189 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.95 37.93 18.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.109 1.364 . . . . 0.0 113.313 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.18 8.8 85.52 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.914 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -120.54 164.05 17.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.15 1.78 . . . . 0.0 109.806 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -113.31 124.2 51.93 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -109.04 128.64 55.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -88.69 132.89 34.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.85 133.11 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.18 131.3 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.57 125.29 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB2' ' HE1' ' A' ' 31' ' ' TRP . 12.0 mt-10 -87.14 115.58 24.63 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.813 -2.292 . . . . 0.0 104.813 168.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.69 -33.33 73.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.12 -43.19 78.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 117.75 0.25 . . . . 0.0 110.529 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.38 -15.03 29.61 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.215 1.006 . . . . 0.0 112.964 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 52.84 38.88 27.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.323 1.449 . . . . 0.0 110.57 -169.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.52 139.99 38.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 108.296 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -113.11 116.3 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 122.106 0.955 . . . . 0.0 109.967 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m95 -93.34 105.01 17.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.948 2.099 . . . . 0.0 105.915 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -109.4 123.27 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 51.28 36.24 15.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 111.13 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.44 -2.47 62.37 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.895 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.71 143.75 37.41 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.778 1.789 . . . . 0.0 109.273 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -68.89 146.68 52.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -137.47 166.26 24.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.851 1.261 . . . . 0.0 109.011 169.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.55 144.55 49.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.047 0.539 . . . . 0.0 111.017 -173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -135.5 149.2 49.44 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 109.146 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.39 136.98 54.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.18 95.32 1.15 Allowed Glycine 0 C--N 1.33 0.214 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.91 142.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.26 132.31 55.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.76 167.29 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.079 1.352 . . . . 0.0 110.159 -172.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.93 49.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.261 1.424 . . . . 0.0 109.968 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -162.54 -32.06 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.47 2.308 . . . . 0.0 110.851 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.68 2.5 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -127.43 151.54 48.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.74 106.68 8.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -84.2 102.27 12.48 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -88.1 143.62 26.96 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.516 1.127 . . . . 0.0 110.579 -175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -159.79 -172.43 3.66 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.073 2.149 . . . . 0.0 108.339 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 m -145.29 151.22 38.0 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 0.0 108.818 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.8 mt -136.98 124.08 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.15 -133.37 52.7 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -86.29 -3.86 59.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.174 0.989 . . . . 0.0 112.672 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -98.05 132.61 43.45 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.305 -0.872 . . . . 0.0 109.097 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.55 149.86 28.46 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.5 m -137.02 152.28 49.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.204 1.402 . . . . 0.0 108.009 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 25.3 p90 -146.63 139.59 25.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.958 168.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.3 mt -88.19 113.7 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -80.56 128.85 34.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.79 93.56 3.87 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.95 128.32 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.591 1.157 . . . . 0.0 108.755 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 124.762 1.225 . . . . 0.0 113.975 -178.686 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.67 120.02 36.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -98.97 130.85 45.35 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -140.21 139.92 35.74 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.791 1.236 . . . . 0.0 108.412 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.81 133.58 33.63 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -112.2 141.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.31 132.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 49.63 37.88 13.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.405 1.082 . . . . 0.0 111.85 -175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 62.66 8.83 3.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.985 2.114 . . . . 0.0 115.464 -174.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.24 148.02 22.61 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.059 1.344 . . . . 0.0 109.399 171.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -90.26 134.03 34.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.469 0.708 . . . . 0.0 110.116 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.04 114.52 37.05 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.137 1.775 . . . . 0.0 108.226 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 148.04 88.35 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.91 3.073 . . . . 0.0 112.171 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.239 0.506 0 C-N-CA 123.558 0.743 . . . . 0.0 110.293 169.942 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.05 125.58 54.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -120.31 144.43 47.84 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -140.09 159.39 42.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.878 1.671 . . . . 0.0 108.042 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.49 137.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 168.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.15 123.69 43.92 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.557 1.143 . . . . 0.0 108.155 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.478 ' CD2' HD21 ' A' ' 18' ' ' ASN . 3.7 t-80 -91.91 121.27 33.35 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 170.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 39.6 mtt -107.44 -163.96 0.94 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.06 1.344 . . . . 0.0 108.573 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.47 -27.79 57.93 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.531 1.133 . . . . 0.0 113.593 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.84 17.89 0.12 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.114 -0.825 . . . . 0.0 113.976 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -140.81 155.85 46.28 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.791 1.237 . . . . 0.0 108.957 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.478 HD21 ' CD2' ' A' ' 13' ' ' HIS . 8.1 m-80 -120.0 114.56 22.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.38 115.28 30.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.3 mtm-85 -79.82 139.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.0 mm -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 t -133.17 118.75 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -83.72 106.64 15.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.357 1.463 . . . . 0.0 107.297 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -72.27 -26.67 62.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.382 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.97 -42.76 72.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.175 0.443 . . . . 0.0 110.523 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.98 -16.17 25.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.495 1.118 . . . . 0.0 113.056 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.83 50.21 19.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.82 1.648 . . . . 0.0 110.473 -169.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -116.52 159.32 22.26 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.283 1.433 . . . . 0.0 108.369 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.69 117.98 36.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.404 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.4 m95 -88.87 125.55 34.98 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.976 1.711 . . . . 0.0 108.198 171.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -115.87 128.07 55.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.14 35.04 12.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.116 0.966 . . . . 0.0 111.894 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.05 87.77 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.412 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.05 143.19 45.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.081 1.941 . . . . 0.0 108.563 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -72.18 141.89 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.756 1.162 . . . . 0.0 109.16 175.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.82 169.4 9.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.694 0.798 . . . . 0.0 111.491 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.8 145.67 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.599 1.16 . . . . 0.0 110.075 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 p -141.86 149.86 40.82 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 109.646 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.59 139.68 49.24 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.9 104.93 1.19 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -90.0 149.81 22.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.0 139.41 52.54 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.73 167.91 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.491 1.516 . . . . 0.0 110.134 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -76.5 49.9 0.63 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.062 1.345 . . . . 0.0 110.486 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -160.22 -35.75 0.05 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.86 2.464 . . . . 0.0 109.849 -170.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.28 -150.97 22.43 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.04 148.46 38.83 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -123.59 107.28 11.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -94.02 105.0 17.02 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -90.49 146.65 23.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.062 1.345 . . . . 0.0 111.055 -172.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -157.7 -179.59 8.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.867 2.067 . . . . 0.0 108.185 169.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -144.34 146.55 32.63 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.101 -0.999 . . . . 0.0 109.949 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.4 mt -143.23 131.33 19.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.28 -130.3 50.82 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -104.75 32.0 4.4 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.66 1.184 . . . . 0.0 111.053 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -129.58 146.57 51.37 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.748 1.219 . . . . 0.0 109.271 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.05 150.37 22.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 109.515 170.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.53 151.62 51.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.777 1.631 . . . . 0.0 108.294 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.501 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 23.2 p90 -148.48 142.79 26.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.954 -0.466 . . . . 0.0 110.079 168.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.7 mt -88.05 118.78 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -89.54 101.73 14.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.23 91.14 7.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.85 129.58 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.872 1.669 . . . . 0.0 109.192 -169.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 CA--C 1.543 0.678 0 CA-C-N 119.829 1.195 . . . . 0.0 112.262 -179.692 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.0 135.12 26.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -110.11 126.65 54.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -132.01 142.47 49.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.18 131.58 37.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.501 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.84 143.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.4 t -138.49 130.44 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.68 39.74 14.26 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.058 0.943 . . . . 0.0 111.754 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 64.79 3.71 2.13 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.86 2.064 . . . . 0.0 115.001 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -89.89 147.24 23.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.369 -1.457 . . . . 0.0 109.195 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.76 134.28 34.87 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.717 0.807 . . . . 0.0 110.125 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.9 mm -119.24 114.76 34.7 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.816 1.646 . . . . 0.0 108.287 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -67.71 143.37 61.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.049 3.166 . . . . 0.0 111.962 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--O 1.239 0.541 0 C-N-CA 123.284 0.634 . . . . 0.0 109.887 171.323 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.4 p . . . . . 0 C--O 1.235 0.316 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.85 131.69 54.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -110.49 149.19 30.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -135.19 163.82 29.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.994 1.718 . . . . 0.0 107.196 169.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.12 140.81 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.33 44.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.099 1.359 . . . . 0.0 108.954 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -101.49 125.9 48.2 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.85 0.86 . . . . 0.0 109.018 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.26 139.89 27.44 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.13 0.972 . . . . 0.0 109.059 170.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 45.32 45.97 10.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 114.003 169.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.08 -1.31 80.58 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.042 -0.866 . . . . 0.0 114.313 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -109.77 159.64 17.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.74 1.616 . . . . 0.0 110.429 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -119.77 130.29 54.88 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -110.04 107.07 16.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 107.747 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -73.5 129.69 38.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.1 mm -108.78 136.35 44.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.41 118.82 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.2 tp -88.36 128.53 35.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HA ' HG22 ' A' ' 7' ' ' THR . 44.7 mm-40 -85.5 109.46 18.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 169.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -72.24 -30.98 65.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.15 0.886 . . . . 0.0 111.865 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.49 -42.83 74.26 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.234 . . . . 0.0 111.047 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.2 -17.0 23.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -173.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 55.6 28.36 11.8 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.943 1.697 . . . . 0.0 112.464 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.79 149.55 25.66 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.05 125.12 67.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -97.22 138.09 35.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.669 1.187 . . . . 0.0 107.947 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -120.99 119.8 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 45.78 41.82 8.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.596 1.558 . . . . 0.0 112.038 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.25 6.71 75.8 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.019 -0.879 . . . . 0.0 114.412 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.24 152.08 23.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.121 1.46 . . . . 0.0 107.74 173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.91 148.19 28.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -129.99 165.04 22.96 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.18 0.992 . . . . 0.0 110.793 170.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.76 148.08 35.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.963 1.305 . . . . 0.0 110.436 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -139.28 149.16 43.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.268 1.027 . . . . 0.0 109.981 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.94 141.68 50.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.99 106.47 1.21 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.08 149.26 21.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -121.27 138.58 54.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.406 0.682 . . . . 0.0 109.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.15 167.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.468 1.507 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.03 48.53 0.6 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.057 1.343 . . . . 0.0 110.594 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -159.88 -31.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.862 2.465 . . . . 0.0 110.713 -171.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.42 -151.93 23.35 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -122.25 151.03 41.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -125.94 106.95 10.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.554 1.542 . . . . 0.0 107.095 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.8 m -92.32 103.54 15.97 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -90.23 147.26 23.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.788 1.235 . . . . 0.0 111.12 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.54 -178.33 7.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 108.37 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.3 m -145.07 149.55 35.28 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.291 1.036 . . . . 0.0 109.375 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.5 mt -134.05 111.21 14.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.65 -134.0 51.48 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -169.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -78.19 -14.09 59.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 112.462 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -88.19 126.74 35.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.61 150.1 24.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.617 0.722 . . . . 0.0 109.311 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -137.15 151.87 49.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.566 1.546 . . . . 0.0 107.919 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.432 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 15.9 p90 -148.18 142.17 25.89 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 168.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.16 120.43 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -85.66 118.23 25.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 170.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.43 92.36 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.18 129.26 41.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.271 1.428 . . . . 0.0 110.735 -168.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.543 0.705 0 C-N-CA 124.746 1.219 . . . . 0.0 112.713 -179.182 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mt . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.15 126.57 40.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -106.8 122.73 46.97 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -133.02 141.09 48.07 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.402 1.081 . . . . 0.0 108.523 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -88.43 133.13 34.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.432 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.84 141.04 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 169.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -138.18 132.38 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 49.97 37.54 14.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.064 0.935 . . . . 0.0 111.882 -176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.8 t30 62.56 10.17 3.91 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.927 2.091 . . . . 0.0 115.407 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.58 149.13 21.78 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.986 1.315 . . . . 0.0 109.217 171.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -93.21 134.59 35.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.826 0.85 . . . . 0.0 110.094 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.8 mm -121.19 113.67 32.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.532 1.933 . . . . 0.0 107.548 -173.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.91 147.83 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.158 2.572 . . . . 0.0 110.932 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 124.363 1.065 . . . . 0.0 111.012 179.538 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.806 0.336 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.6 129.08 55.12 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 169.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.1 m -120.8 143.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -135.19 155.02 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.214 1.806 . . . . 0.0 107.213 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.41 122.73 66.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 168.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.0 tp -115.69 123.2 47.75 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.332 1.053 . . . . 0.0 109.081 -169.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -91.17 135.5 33.74 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.7 mtt -139.39 106.88 5.56 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 61.81 -33.95 0.1 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.617 3.167 . . . . 0.0 116.849 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.75 -32.28 0.03 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.5 2.0 . . . . 0.0 110.154 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -77.01 156.93 31.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.165 0.986 . . . . 0.0 110.167 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -131.76 115.97 16.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -105.76 122.11 45.42 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.389 1.076 . . . . 0.0 108.563 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -73.44 138.61 45.3 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -117.26 132.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.94 117.88 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -86.06 121.13 28.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -82.04 113.03 19.64 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 168.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.75 -24.54 56.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 119.116 -0.468 . . . . 0.0 111.254 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.93 -44.3 69.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.712 0.687 . . . . 0.0 110.131 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.14 -15.4 24.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.489 1.115 . . . . 0.0 113.152 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.8 mmm 52.69 45.08 29.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.816 1.247 . . . . 0.0 109.276 -168.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -114.6 146.39 40.86 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.869 1.668 . . . . 0.0 107.148 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.05 117.41 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.407 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -84.57 119.31 25.05 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.946 1.698 . . . . 0.0 107.047 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.2 t -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.0 36.01 10.96 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.334 1.054 . . . . 0.0 111.919 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.62 3.01 88.8 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.621 -1.1 . . . . 0.0 115.092 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -114.4 145.58 41.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.657 1.728 . . . . 0.0 108.868 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -68.33 141.58 55.76 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.03 163.41 16.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.707 0.803 . . . . 0.0 110.422 169.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -70.87 143.99 50.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 110.199 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -138.52 148.58 44.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 110.162 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.59 143.43 51.17 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.52 108.83 1.47 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -97.76 148.62 23.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.97 135.88 54.74 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.47 167.55 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 110.173 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -77.7 48.1 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.156 1.382 . . . . 0.0 110.554 175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.94 -34.13 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.233 2.213 . . . . 0.0 110.325 -171.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.86 -150.31 20.1 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -121.16 152.11 39.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -125.37 107.16 10.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.794 1.638 . . . . 0.0 106.898 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -91.32 102.7 15.41 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.92 146.43 24.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.674 1.189 . . . . 0.0 110.901 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -158.19 -173.91 4.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.636 1.975 . . . . 0.0 108.646 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 m -144.49 146.75 32.59 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 109.347 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.6 mt -142.18 133.27 25.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.97 -131.07 51.86 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -105.13 34.1 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.511 1.124 . . . . 0.0 110.851 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -131.11 144.32 51.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.733 1.213 . . . . 0.0 109.097 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.35 152.43 19.15 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.502 0.668 . . . . 0.0 109.219 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 m -135.15 151.94 51.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.577 1.551 . . . . 0.0 107.752 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 15.9 p90 -147.81 140.77 24.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.856 -0.527 . . . . 0.0 109.669 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.27 118.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -83.61 120.89 26.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 92.54 3.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.61 125.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.077 1.351 . . . . 0.0 109.373 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 124.496 1.118 . . . . 0.0 110.549 175.618 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.98 125.81 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -105.78 127.3 53.01 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -136.31 141.51 43.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.174 0.99 . . . . 0.0 108.597 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.55 131.1 36.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.427 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.89 142.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 169.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.0 130.86 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 t70 46.53 43.22 12.04 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.443 1.097 . . . . 0.0 111.448 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 63.69 6.53 2.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.709 2.404 . . . . 0.0 115.828 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -99.41 148.27 24.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.586 1.555 . . . . 0.0 109.918 173.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -91.02 137.31 32.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.525 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.3 mm -119.89 113.36 34.47 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.888 2.075 . . . . 0.0 106.929 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.92 147.06 33.8 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.096 2.53 . . . . 0.0 110.965 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 123.996 0.918 . . . . 0.0 110.493 175.899 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 121.48 0.657 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -117.49 137.85 52.26 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -120.98 149.59 42.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -140.41 151.83 45.23 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.72 1.608 . . . . 0.0 108.337 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -107.34 135.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.85 117.76 29.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -87.54 120.98 29.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 43.2 ttm -155.79 131.5 9.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -170.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 50.5 36.67 14.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 113.072 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.27 74.76 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.039 0.828 . . . . 0.0 113.975 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -108.39 170.62 7.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.489 1.916 . . . . 0.0 109.383 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -131.84 111.58 11.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -102.52 131.24 49.36 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -93.68 124.05 37.41 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.93 138.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.96 125.71 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -90.09 129.99 36.32 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -98.14 112.47 24.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.355 1.462 . . . . 0.0 107.722 168.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -74.91 -22.18 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.79 -0.569 . . . . 0.0 112.322 -170.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.48 -36.52 80.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.194 0.452 . . . . 0.0 111.207 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.49 -4.35 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 113.052 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.8 mtp 53.35 37.84 26.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.563 1.145 . . . . 0.0 109.564 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -92.34 147.53 22.84 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -129.97 119.42 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.451 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 15.3 m95 -85.42 133.52 34.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.495 1.918 . . . . 0.0 108.448 173.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -128.81 126.51 40.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 168.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 52.08 37.69 22.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.304 1.042 . . . . 0.0 111.981 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.87 2.05 90.64 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.379 -1.234 . . . . 0.0 115.617 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.41 148.12 44.82 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.878 1.839 . . . . 0.0 108.171 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -75.52 151.82 37.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.871 1.214 . . . . 0.0 110.189 173.011 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.26 167.67 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.23 1.412 . . . . 0.0 110.215 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.95 147.91 44.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.064 0.946 . . . . 0.0 110.358 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 p -138.3 148.83 45.06 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.665 1.186 . . . . 0.0 109.88 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.0 149.52 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.0 109.41 1.03 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.83 151.8 21.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.72 0.808 . . . . 0.0 109.262 170.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -123.99 140.15 53.26 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.87 167.44 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.726 1.61 . . . . 0.0 110.278 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.17 48.71 0.63 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.07 1.348 . . . . 0.0 110.606 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -160.15 -34.49 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.813 2.445 . . . . 0.0 110.276 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.98 -153.39 24.21 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -117.88 150.19 39.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -124.55 106.85 10.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.1 m -90.95 106.22 18.37 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.04 145.82 24.22 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.799 1.239 . . . . 0.0 110.51 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.47 -169.7 2.69 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.226 1.811 . . . . 0.0 108.423 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -150.15 148.2 28.67 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.927 -1.108 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 93.7 mt -141.1 130.69 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.36 -133.4 51.37 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.07 29.11 4.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.251 1.02 . . . . 0.0 111.654 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -124.22 142.97 50.8 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.56 1.144 . . . . 0.0 109.261 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 150.01 21.35 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -134.84 152.04 51.42 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.764 1.226 . . . . 0.0 108.073 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.42 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 14.2 p90 -147.0 141.74 26.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 168.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.94 120.59 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -87.16 114.84 24.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.58 91.86 3.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -87.77 126.22 41.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.017 1.327 . . . . 0.0 109.328 -169.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.535 1.134 . . . . 0.0 110.858 176.522 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.73 125.32 43.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -103.18 127.26 50.53 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -134.66 145.02 48.17 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.375 1.07 . . . . 0.0 108.494 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -93.98 130.41 40.1 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.42 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.81 142.48 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 169.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.31 133.19 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.821 1.248 . . . . 0.0 108.088 171.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t0 45.59 42.12 7.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.326 1.451 . . . . 0.0 111.659 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.47 17.64 10.93 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.475 2.31 . . . . 0.0 116.136 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -116.1 152.09 34.32 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.158 169.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -84.73 139.19 32.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.86 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.2 mm -119.53 118.78 32.02 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.358 1.863 . . . . 0.0 106.612 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 142.81 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 111.284 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 C--O 1.236 0.388 0 C-N-CA 124.532 1.133 . . . . 0.0 111.063 178.02 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.89 0.376 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -112.54 137.02 51.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 m -121.85 142.82 49.85 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -133.82 156.43 48.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.193 1.797 . . . . 0.0 107.542 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -124.44 134.4 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -117.94 123.66 46.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.3 113.47 25.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.9 mtm -146.43 138.49 24.92 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.274 1.029 . . . . 0.0 108.449 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.64 36.87 11.45 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.188 1.395 . . . . 0.0 113.249 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.84 -4.16 62.14 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.99 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.41 165.13 11.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.615 1.566 . . . . 0.0 110.348 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -119.67 125.19 48.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.01 123.51 50.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.926 1.291 . . . . 0.0 108.117 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -86.0 123.55 31.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.66 133.23 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 170.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.9 t -128.39 121.43 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.06 121.8 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.483 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 1.2 mm-40 -85.05 112.36 20.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.19 -30.28 62.15 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.969 -0.457 . . . . 0.0 111.908 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.95 -41.52 97.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.856 0.298 . . . . 0.0 110.782 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.38 -14.71 22.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.622 1.169 . . . . 0.0 113.178 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtp 52.79 42.67 31.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.343 1.457 . . . . 0.0 109.924 -168.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -107.13 145.32 32.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.54 1.136 . . . . 0.0 108.496 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -116.52 120.86 66.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.662 0.744 . . . . 0.0 109.823 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.483 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 12.0 m95 -93.84 130.11 40.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.054 1.342 . . . . 0.0 108.291 172.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.2 117.94 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.41 40.71 15.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.84 1.256 . . . . 0.0 111.356 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.12 -9.77 52.09 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.511 -1.161 . . . . 0.0 115.129 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -95.8 135.64 37.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.863 1.832 . . . . 0.0 108.226 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -75.09 147.9 40.21 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.56 1.073 . . . . 0.0 109.148 174.039 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.18 166.58 20.81 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.474 1.11 . . . . 0.0 109.771 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.51 145.98 48.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.156 0.583 . . . . 0.0 111.018 -172.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.92 150.86 48.47 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.843 1.657 . . . . 0.0 109.331 -178.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.6 137.54 52.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.71 100.62 1.62 Allowed Glycine 0 C--N 1.33 0.24 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.62 149.32 22.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.31 126.81 47.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.19 174.74 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.262 1.425 . . . . 0.0 109.59 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -83.64 44.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.896 1.278 . . . . 0.0 110.964 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.39 -31.58 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.872 1.669 . . . . 0.0 111.319 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.78 -157.88 30.42 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.3 150.19 26.19 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -130.73 105.15 7.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.3 m -86.63 99.82 12.0 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -84.29 146.18 27.89 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.922 1.289 . . . . 0.0 110.24 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -158.28 -175.51 5.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.057 1.743 . . . . 0.0 108.469 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -152.16 149.02 28.3 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.784 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -142.32 127.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.14 -126.86 43.33 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -102.68 25.09 9.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -121.07 145.08 48.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.062 1.345 . . . . 0.0 109.048 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.71 147.78 28.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.339 0.656 . . . . 0.0 109.244 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -135.47 151.51 50.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.12 1.368 . . . . 0.0 108.436 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -146.9 141.46 26.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.911 -0.493 . . . . 0.0 109.819 168.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.46 115.18 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -79.23 123.64 27.61 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 169.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.5 92.14 3.86 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 171.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.17 124.56 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.474 1.11 . . . . 0.0 108.214 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 119.137 0.88 . . . . 0.0 110.862 179.77 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 mm -101.42 120.85 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -97.16 130.61 44.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -139.1 143.55 38.32 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.159 0.983 . . . . 0.0 108.528 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -91.23 130.79 37.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.35 143.41 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.3 t -139.87 132.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.146 1.379 . . . . 0.0 107.715 173.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.68 37.65 13.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 111.868 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.6 t30 62.45 10.23 3.86 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.095 2.158 . . . . 0.0 115.295 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.54 149.81 21.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.04 1.336 . . . . 0.0 109.426 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.78 136.17 33.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.825 0.85 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.87 113.9 39.66 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.008 1.723 . . . . 0.0 107.04 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.55 149.4 30.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.072 2.515 . . . . 0.0 110.96 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--O 1.239 0.534 0 C-N-CA 124.264 1.026 . . . . 0.0 110.81 174.944 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.6 p . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.03 130.55 45.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.6 m -122.51 139.58 53.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -133.91 152.53 51.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.192 1.397 . . . . 0.0 107.57 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.03 140.01 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.21 132.89 55.54 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -106.49 109.97 22.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 170.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.0 mtm -146.18 140.86 26.93 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.311 1.045 . . . . 0.0 108.932 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t0 51.23 35.67 14.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.992 1.317 . . . . 0.0 112.738 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.75 -10.52 18.06 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.713 1.149 . . . . 0.0 113.883 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.57 166.52 13.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.405 1.482 . . . . 0.0 111.063 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.81 129.32 52.54 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.65 116.74 27.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.737 1.215 . . . . 0.0 108.161 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -91.19 117.43 29.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -96.26 132.96 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.0 t -127.97 123.71 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.43 122.64 32.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.16 109.72 20.12 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.164 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -67.68 -27.52 66.9 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.587 -0.696 . . . . 0.0 111.311 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.46 -30.13 70.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.68 -3.65 9.26 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 113.06 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtp 53.19 37.1 24.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.221 1.409 . . . . 0.0 110.77 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -91.86 146.03 24.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.9 p -117.68 113.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 122.172 0.987 . . . . 0.0 109.714 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.449 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 26.9 m95 -83.15 137.67 33.97 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 169.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.38 113.23 11.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 169.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 46.56 42.84 11.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.166 1.386 . . . . 0.0 111.216 -170.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.88 -12.69 28.44 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.786 1.184 . . . . 0.0 114.996 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.11 135.58 33.92 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.817 1.808 . . . . 0.0 108.254 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -76.87 120.02 21.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 mt -77.55 166.7 22.71 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.819 1.295 . . . . 0.0 111.273 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.65 147.89 39.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 112.934 -1.939 . . . . 0.0 107.062 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -144.73 150.55 37.46 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.075 0.95 . . . . 0.0 109.477 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.68 140.11 46.85 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.67 105.86 1.24 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 -172.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -95.74 152.25 18.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.417 0.687 . . . . 0.0 109.195 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.65 139.71 52.63 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -131.2 167.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.605 1.562 . . . . 0.0 110.079 176.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.01 28.05 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.967 1.707 . . . . 0.0 112.825 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' VAL . 32.2 t70 -141.87 -22.04 0.72 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.568 2.747 . . . . 0.0 111.768 -173.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -155.66 26.26 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.65 150.62 37.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -130.0 107.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.938 1.295 . . . . 0.0 107.714 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.2 m -93.85 104.4 16.47 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.4 146.63 24.53 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.092 1.357 . . . . 0.0 110.625 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.08 -174.39 4.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.224 1.809 . . . . 0.0 108.324 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -144.81 149.7 35.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.352 1.061 . . . . 0.0 108.96 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.6 mt -134.43 113.82 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.2 -135.15 50.3 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.87 -13.45 59.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.608 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -88.51 127.46 35.53 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.531 -0.731 . . . . 0.0 109.472 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.37 149.01 26.31 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 169.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.64 153.32 47.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.686 1.594 . . . . 0.0 108.448 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -147.69 143.67 27.79 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.763 -0.586 . . . . 0.0 109.66 168.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -88.29 117.95 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 169.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -84.55 117.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.62 89.88 3.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.38 126.84 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 109.095 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.539 0.548 0 CA-C-N 120.138 1.335 . . . . 0.0 110.476 175.954 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.9 mm . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.84 117.34 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -92.07 127.7 37.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -133.59 144.29 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.467 1.107 . . . . 0.0 108.237 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -94.22 129.61 40.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.4 142.35 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.7 t -137.22 131.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.031 1.332 . . . . 0.0 107.84 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t0 45.11 42.36 6.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.281 1.432 . . . . 0.0 111.682 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 64.56 17.09 10.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.711 2.404 . . . . 0.0 116.125 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.11 152.41 31.13 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.643 1.177 . . . . 0.0 111.027 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -85.86 138.82 31.77 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.727 1.211 . . . . 0.0 110.692 -172.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.65 118.44 33.47 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.228 1.811 . . . . 0.0 106.714 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.19 150.43 33.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.861 2.374 . . . . 0.0 111.002 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.238 0.476 0 C-N-CA 123.599 0.76 . . . . 0.0 110.423 172.721 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -125.65 132.52 52.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 m -112.42 142.93 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -132.9 162.33 31.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.856 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 t -128.81 135.32 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.97 117.64 29.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -88.45 114.1 24.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 169.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.5 mtm -146.35 137.26 24.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.446 1.098 . . . . 0.0 108.426 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.24 38.14 12.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.319 1.448 . . . . 0.0 113.22 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.91 -1.07 69.84 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.254 0.93 . . . . 0.0 114.176 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -105.6 166.04 10.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.087 1.755 . . . . 0.0 110.116 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -122.66 121.28 36.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -109.39 120.99 44.21 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.66 1.184 . . . . 0.0 108.308 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -78.06 145.11 36.05 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.9 mm -125.57 133.03 70.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.35 120.48 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -85.91 122.45 29.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -88.78 112.23 22.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.202 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -72.56 -21.02 61.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.533 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.69 -35.98 81.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.869 0.759 . . . . 0.0 111.601 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.25 -0.99 9.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.119 1.368 . . . . 0.0 113.285 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.4 mtp 52.72 39.52 28.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.727 1.211 . . . . 0.0 110.592 -169.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.96 144.7 26.62 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.428 1.091 . . . . 0.0 108.245 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -114.02 115.68 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 109.862 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.457 ' CZ3' ' HE2' ' A' ' 36' ' ' LYS . 51.7 m95 -83.2 115.31 21.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 169.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.53 128.47 55.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 52.68 34.95 17.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.542 0.737 . . . . 0.0 111.705 -170.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.25 77.51 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.425 1.012 . . . . 0.0 114.65 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -125.44 138.0 54.0 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.457 ' HE2' ' CZ3' ' A' ' 31' ' ' TRP 0.3 0.0 OUTLIER -75.71 146.42 40.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.733 1.606 . . . . 0.0 110.068 175.552 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.73 167.93 19.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.007 1.323 . . . . 0.0 110.16 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.48 148.34 49.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.6 0.714 . . . . 0.0 111.531 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -136.38 150.46 48.81 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.067 1.747 . . . . 0.0 108.99 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.31 139.76 52.24 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.49 107.35 1.62 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -96.86 151.15 19.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -117.44 139.59 50.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.401 0.681 . . . . 0.0 109.326 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.97 167.75 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.663 1.585 . . . . 0.0 110.023 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -76.94 49.74 0.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.171 1.388 . . . . 0.0 110.501 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.79 -34.98 0.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.902 2.481 . . . . 0.0 109.991 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.41 -151.58 23.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.75 148.2 40.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -125.83 107.26 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 m -91.03 103.34 16.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -87.29 147.08 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.911 1.284 . . . . 0.0 110.742 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.53 -178.99 7.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.591 1.957 . . . . 0.0 108.062 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 m -146.63 150.73 36.02 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.952 0.901 . . . . 0.0 109.186 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.99 108.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.34 -15.84 59.2 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.688 0.795 . . . . 0.0 112.425 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -85.88 120.81 27.69 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.63 146.4 25.75 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.634 0.73 . . . . 0.0 109.884 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.4 m -136.89 151.78 49.47 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.041 1.736 . . . . 0.0 108.445 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -148.66 142.17 25.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.837 -0.539 . . . . 0.0 109.818 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -88.1 119.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -88.75 102.45 15.02 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.28 88.14 6.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.56 134.87 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.263 1.825 . . . . 0.0 110.351 -169.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 123.762 0.825 . . . . 0.0 112.646 179.251 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.15 138.49 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.89 129.57 55.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.485 1.039 . . . . 0.0 108.307 172.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 147.71 51.16 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.81 130.43 44.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.431 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.52 143.29 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -140.65 132.35 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 125.009 1.324 . . . . 0.0 107.648 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 48.65 38.24 11.03 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.116 0.96 . . . . 0.0 111.971 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.9 t30 63.7 8.75 3.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.116 2.167 . . . . 0.0 115.428 -175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.25 149.4 21.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.126 1.37 . . . . 0.0 109.781 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.89 136.27 33.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.101 0.96 . . . . 0.0 110.119 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -120.19 116.58 32.4 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.895 1.678 . . . . 0.0 106.901 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.31 143.9 20.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.269 2.646 . . . . 0.0 111.383 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.237 0.424 0 C-N-CA 123.176 0.59 . . . . 0.0 110.666 179.606 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -110.21 130.5 55.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 m -121.64 142.63 49.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.492 0.663 . . . . 0.0 109.584 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -135.57 159.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.468 1.907 . . . . 0.0 106.941 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.42 141.36 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 169.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.51 134.2 46.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.053 1.341 . . . . 0.0 108.94 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -101.52 132.1 47.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.601 0.76 . . . . 0.0 109.278 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -138.24 133.08 32.73 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 56.28 -61.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.392 3.077 . . . . 0.0 115.975 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.97 15.17 0.08 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.323 1.916 . . . . 0.0 112.042 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -130.06 159.17 37.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.954 1.702 . . . . 0.0 109.179 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -121.1 130.93 53.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -110.02 109.51 20.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.656 1.182 . . . . 0.0 107.954 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -74.08 119.68 18.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 mm -96.6 131.2 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.63 116.38 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.94 122.83 31.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -82.59 113.27 20.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -71.75 -27.11 62.75 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.532 0.333 . . . . 0.0 111.634 -169.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.86 -45.63 41.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.38 0.537 . . . . 0.0 110.609 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.28 -17.07 28.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.172 0.989 . . . . 0.0 112.952 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.251 98.8 mmm 55.76 28.81 12.82 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.331 1.452 . . . . 0.0 111.357 -169.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.28 146.32 25.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.04 118.68 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -85.02 132.88 34.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.781 1.633 . . . . 0.0 108.1 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -118.22 116.3 26.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 168.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 46.39 42.4 10.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.859 1.264 . . . . 0.0 111.265 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.51 -11.36 39.29 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.616 1.103 . . . . 0.0 115.004 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.49 138.14 31.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.77 1.785 . . . . 0.0 108.588 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -68.94 145.9 53.24 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.8 163.64 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.944 0.898 . . . . 0.0 110.573 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.18 148.06 39.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.563 1.145 . . . . 0.0 110.285 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -140.62 149.41 42.28 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.399 1.08 . . . . 0.0 109.908 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.65 50.19 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.85 108.35 1.94 Allowed Glycine 0 C--N 1.331 0.263 0 N-CA-C 106.994 -2.442 . . . . 0.0 106.994 -174.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -94.55 148.96 21.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.38 137.16 52.38 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.585 0.754 . . . . 0.0 109.011 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.43 167.9 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.601 1.56 . . . . 0.0 109.919 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.7 47.88 0.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.071 1.348 . . . . 0.0 110.47 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -159.91 -34.9 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.274 2.23 . . . . 0.0 110.165 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.62 12.59 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -120.52 152.59 37.85 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.32 107.56 9.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.713 1.605 . . . . 0.0 106.948 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.9 m -93.93 102.93 15.04 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -89.76 148.15 23.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.907 1.283 . . . . 0.0 111.22 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -158.96 -177.63 6.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.907 2.083 . . . . 0.0 108.26 169.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.0 m -144.91 146.63 32.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.175 0.99 . . . . 0.0 109.709 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.0 mt -142.39 132.83 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.87 -127.19 44.68 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -109.57 36.48 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 110.526 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -131.86 145.99 51.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.043 1.337 . . . . 0.0 108.778 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.96 150.44 21.95 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.37 151.02 51.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.427 1.491 . . . . 0.0 107.839 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 29.7 p90 -148.66 140.64 23.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 121.804 -0.56 . . . . 0.0 110.285 168.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -87.51 117.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -84.96 127.88 34.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 170.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.46 96.52 4.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.63 125.18 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.104 0.962 . . . . 0.0 109.574 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.543 0.673 0 C-N-CA 124.473 1.109 . . . . 0.0 111.125 175.791 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.4 mm -88.29 113.07 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -95.74 129.18 43.04 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -137.51 140.19 40.97 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 tp -86.55 133.46 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.528 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -112.66 142.63 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 169.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.23 130.46 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.2 39.6 15.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.241 1.016 . . . . 0.0 111.97 -175.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 64.32 4.42 2.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.819 2.047 . . . . 0.0 115.006 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.3 147.21 23.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 120.449 -1.407 . . . . 0.0 109.189 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.95 133.55 35.6 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.371 0.668 . . . . 0.0 109.97 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.0 mm -117.28 111.99 39.88 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.193 1.797 . . . . 0.0 107.081 -175.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -73.23 152.58 50.45 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.908 2.405 . . . . 0.0 110.726 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 C--O 1.237 0.439 0 C-N-CA 124.243 1.017 . . . . 0.0 111.257 174.81 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.6 t70 55.19 -73.72 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.087 2.555 . . . . 0.0 113.684 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -81.12 66.41 6.65 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -98.12 -39.83 8.7 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.091 0.957 . . . . 0.0 110.586 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -85.79 20.41 2.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.005 0.922 . . . . 0.0 112.817 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 m -50.6 124.01 9.98 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.395 1.478 . . . . 0.0 109.579 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 24' ' ' GLU . 13.8 p -68.76 156.96 37.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.474 1.11 . . . . 0.0 111.365 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.67 138.31 49.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.6 m -119.89 142.97 48.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -132.69 152.68 51.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.011 1.325 . . . . 0.0 107.562 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.1 119.46 29.51 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -92.4 113.52 25.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 mtm -146.07 137.34 24.68 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.404 1.082 . . . . 0.0 108.627 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.07 37.74 15.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.168 1.387 . . . . 0.0 113.102 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.22 -4.0 60.28 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.125 0.869 . . . . 0.0 114.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.08 164.87 11.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.84 1.656 . . . . 0.0 110.056 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -121.01 124.37 44.68 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -110.57 132.49 54.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.956 1.303 . . . . 0.0 108.352 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.38 131.94 37.15 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.4 mm -110.1 134.36 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.37 121.86 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.85 123.5 32.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.92 113.03 23.17 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.271 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -75.7 -18.02 59.75 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.831 -0.543 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.27 -35.71 79.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.18 0.445 . . . . 0.0 111.266 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.44 -0.07 8.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.267 1.427 . . . . 0.0 113.434 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.7 mmt 52.14 49.13 21.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.106 0.955 . . . . 0.0 109.267 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -117.53 142.51 47.09 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.211 1.404 . . . . 0.0 107.879 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.78 119.79 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.774 0.797 . . . . 0.0 108.913 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.445 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 20.9 m95 -85.93 129.39 34.85 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.298 1.839 . . . . 0.0 108.994 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.8 t -118.33 119.26 34.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 168.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 47.89 41.52 14.71 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.989 1.316 . . . . 0.0 111.691 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.22 -7.05 61.45 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.603 -1.11 . . . . 0.0 115.221 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.84 137.83 39.62 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.751 1.775 . . . . 0.0 107.539 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -72.93 147.5 45.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.967 1.258 . . . . 0.0 109.997 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pp -117.07 168.58 10.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.953 1.301 . . . . 0.0 110.302 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.05 145.41 48.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.073 0.949 . . . . 0.0 110.138 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -143.13 151.19 40.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.478 1.111 . . . . 0.0 109.875 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.44 136.18 48.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.43 96.22 1.24 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -86.66 146.02 26.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -111.52 134.25 53.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.35 167.56 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.196 1.399 . . . . 0.0 110.116 -172.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.85 49.24 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.241 1.416 . . . . 0.0 110.309 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -159.95 -36.57 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.37 2.268 . . . . 0.0 109.892 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.26 -132.18 3.65 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -120.76 151.54 39.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -129.97 106.48 8.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.6 m -85.76 100.1 11.79 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -84.36 145.44 28.22 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.71 1.204 . . . . 0.0 110.393 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -158.45 -178.25 7.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.14 1.776 . . . . 0.0 108.762 169.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -145.81 150.47 36.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.36 1.064 . . . . 0.0 109.108 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mt -133.66 111.67 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.0 -131.26 51.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -169.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -81.16 -10.5 59.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.609 0.764 . . . . 0.0 112.653 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.78 30.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -171.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.15 26.97 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 109.578 169.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -138.26 152.5 48.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.871 1.668 . . . . 0.0 108.725 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.65 141.32 24.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 121.725 -0.609 . . . . 0.0 109.648 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -88.71 114.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -75.94 126.85 31.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.52 88.69 2.98 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.98 123.33 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.755 1.222 . . . . 0.0 108.381 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -79.13 59.08 2.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.313 0.96 . . . . 0.0 109.908 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -72.57 -29.59 63.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.487 1.115 . . . . 0.0 111.643 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.44 144.6 48.66 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -75.34 -30.48 60.27 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.303 -0.528 . . . . 0.0 110.951 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.08 175.77 4.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.62 0.768 . . . . 0.0 109.254 173.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 1.42 4.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.65 176.23 8.89 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.03 1.732 . . . . 0.0 108.717 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.01 46.87 4.34 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp -87.94 127.48 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.57 120.63 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.057 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -100.3 127.75 46.53 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -139.3 140.31 37.55 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 108.704 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.2 131.85 34.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.82 142.81 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.42 133.3 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t0 49.9 37.09 12.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.293 1.037 . . . . 0.0 111.874 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.2 t30 62.48 9.96 3.71 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.829 2.051 . . . . 0.0 115.444 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.52 150.54 20.21 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 125.063 1.345 . . . . 0.0 109.261 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.81 135.15 34.13 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.719 0.808 . . . . 0.0 110.059 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.8 mm -118.71 113.9 36.05 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.356 1.862 . . . . 0.0 106.922 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -74.64 151.43 41.44 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.948 2.432 . . . . 0.0 110.811 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -64.96 162.52 16.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.294 0.569 . . . . 0.0 109.828 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.2 pt -61.82 152.91 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.9 0.88 . . . . 0.0 112.203 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.81 26.01 6.26 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.209 1.404 . . . . 0.0 111.813 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.419 1.487 . . . . 0.0 109.961 179.175 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.44 134.89 35.6 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.731 -0.605 . . . . 0.0 109.836 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -137.64 151.5 48.36 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.49 1.116 . . . . 0.0 108.399 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p -68.18 -45.23 74.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.548 0.739 . . . . 0.0 110.114 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt 51.26 38.41 21.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.69 1.596 . . . . 0.0 111.589 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.36 127.72 33.5 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 24' ' ' GLU . 2.7 p -141.01 154.42 46.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.788 0.835 . . . . 0.0 110.759 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -121.39 136.95 54.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.0 m -128.43 141.96 51.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -135.66 159.65 40.96 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.874 1.67 . . . . 0.0 107.553 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -124.82 140.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.02 125.78 42.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.821 1.248 . . . . 0.0 108.425 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -84.5 121.11 27.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.4 ttm -158.02 140.29 14.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.414 1.086 . . . . 0.0 108.277 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 51.67 37.43 20.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.163 1.385 . . . . 0.0 113.118 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.02 8.69 83.38 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 123.94 0.781 . . . . 0.0 113.653 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -123.81 173.82 7.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.506 1.922 . . . . 0.0 109.584 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -121.92 122.3 39.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.91 127.12 53.15 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -79.6 139.8 37.35 Favored 'General case' 0 N--CA 1.46 0.054 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -114.72 130.62 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.61 117.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -85.46 122.77 30.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.8 OUTLIER -79.83 112.9 17.57 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.2 -31.6 67.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 119.205 -0.426 . . . . 0.0 112.095 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.38 -47.34 56.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.327 0.512 . . . . 0.0 110.556 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.66 -18.17 28.5 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.78 0.832 . . . . 0.0 112.946 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.258 51.8 mtp 55.44 30.27 14.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.444 1.497 . . . . 0.0 111.552 -169.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.48 152.91 21.57 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.32 115.77 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -85.28 122.65 29.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.581 1.552 . . . . 0.0 107.355 174.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 t -114.73 125.98 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 49.86 36.83 12.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.293 1.037 . . . . 0.0 111.591 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.51 0.51 84.14 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 118.541 -1.144 . . . . 0.0 115.255 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -113.78 146.38 39.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.825 1.812 . . . . 0.0 109.235 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -66.71 147.04 53.8 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.339 -0.85 . . . . 0.0 108.998 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.35 168.16 12.86 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.618 1.167 . . . . 0.0 110.197 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.16 145.39 44.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.306 1.042 . . . . 0.0 110.117 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -140.85 149.52 42.09 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 109.88 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.3 140.39 48.57 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.8 109.86 2.0 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -175.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.26 149.06 25.07 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.538 0.735 . . . . 0.0 109.563 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.97 141.64 37.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.321 0.649 . . . . 0.0 109.521 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.13 166.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.753 1.621 . . . . 0.0 109.897 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -77.92 48.39 0.71 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.133 1.373 . . . . 0.0 110.443 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -161.31 -31.77 0.05 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.437 2.295 . . . . 0.0 110.856 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.8 -134.85 4.41 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -130.82 151.83 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.39 110.83 12.7 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.5 m -92.17 104.89 17.22 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.72 147.12 24.04 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.807 1.243 . . . . 0.0 110.666 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -157.51 -177.62 6.72 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.059 1.744 . . . . 0.0 108.635 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.93 147.54 31.84 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.346 1.058 . . . . 0.0 109.465 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.5 mt -143.67 130.53 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.98 -131.36 51.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.17 28.92 4.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.702 1.201 . . . . 0.0 111.536 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -124.29 149.26 46.73 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.968 1.307 . . . . 0.0 109.17 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 150.72 24.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.92 152.82 52.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.464 1.506 . . . . 0.0 108.318 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -147.68 143.45 27.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.686 -0.634 . . . . 0.0 109.6 168.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.84 117.49 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 169.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -83.07 115.8 22.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.19 90.59 3.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.98 122.24 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.02 1.328 . . . . 0.0 108.587 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -84.39 69.29 10.49 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.203 0.911 . . . . 0.0 108.884 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -73.4 -42.88 61.55 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.818 -0.551 . . . . 0.0 110.829 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.2 155.04 37.72 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.021 0.82 . . . . 0.0 111.758 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -80.92 -24.88 37.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.018 0.527 . . . . 0.0 111.25 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -67.23 151.38 47.62 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -53.63 -49.05 68.7 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.149 0.979 . . . . 0.0 111.221 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -84.92 8.16 18.55 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -170.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.23 41.68 1.83 Allowed Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.968 1.747 . . . . 0.0 114.572 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.6 137.76 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 118.536 1.168 . . . . 0.0 108.785 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.0 mm -102.46 120.88 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -96.44 125.63 41.07 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -132.69 145.82 51.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.345 1.058 . . . . 0.0 108.547 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 tp -93.44 131.95 38.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.78 141.95 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.6 131.36 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.61 40.47 15.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.282 1.033 . . . . 0.0 111.796 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 66.77 1.36 2.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.857 2.063 . . . . 0.0 115.282 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.55 147.48 23.32 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 120.456 -1.403 . . . . 0.0 109.325 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.05 133.88 34.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.619 0.768 . . . . 0.0 109.822 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.1 mm -118.22 113.38 37.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 107.285 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.19 155.16 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.391 2.727 . . . . 0.0 111.137 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -59.11 161.58 5.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.63 0.772 . . . . 0.0 110.897 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.6 pt -62.24 150.77 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.32 1.048 . . . . 0.0 111.845 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.83 104.79 5.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 169.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 123.081 0.552 . . . . 0.0 109.639 176.375 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -145.24 -177.84 5.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.956 1.303 . . . . 0.0 108.465 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? 57.75 30.1 18.41 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.426 1.891 . . . . 0.0 112.404 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.7 m -65.32 145.85 55.67 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.088 0.955 . . . . 0.0 110.52 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -68.19 -54.37 18.33 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m 64.96 -51.13 0.33 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.747 2.019 . . . . 0.0 114.089 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 24' ' ' GLU . 24.7 p -70.98 169.26 15.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.058 1.343 . . . . 0.0 111.634 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -120.44 132.4 55.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.0 m -119.51 143.04 47.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -136.29 156.18 49.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.121 1.368 . . . . 0.0 108.247 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -116.11 134.74 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.62 110.38 15.92 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -82.55 111.25 18.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 53.0 mtm -147.53 139.8 24.46 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.565 1.146 . . . . 0.0 108.687 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 50.15 36.11 11.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.162 1.385 . . . . 0.0 112.914 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.97 -7.29 36.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.536 1.065 . . . . 0.0 113.718 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.55 171.09 9.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.715 1.606 . . . . 0.0 110.706 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -128.62 111.46 13.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.304 1.442 . . . . 0.0 107.17 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -99.07 129.14 45.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -88.42 135.88 33.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.03 133.76 62.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -131.67 122.19 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -88.14 127.4 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.424 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -97.01 113.32 24.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -69.39 -25.11 63.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -172.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -37.35 84.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.225 0.466 . . . . 0.0 111.494 -174.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.76 -5.54 11.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.096 1.358 . . . . 0.0 113.018 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 71.8 mtp 54.37 31.03 13.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.845 1.258 . . . . 0.0 110.353 -168.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.36 147.7 32.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.76 119.5 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.411 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 8.2 m95 -85.45 126.65 33.97 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.481 1.513 . . . . 0.0 107.908 172.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.43 121.37 44.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 46.42 38.94 5.87 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.054 1.341 . . . . 0.0 111.832 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.58 62.53 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.901 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.42 141.21 31.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.724 1.762 . . . . 0.0 108.618 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -69.28 143.97 53.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.21 164.79 17.21 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.944 0.898 . . . . 0.0 110.19 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.32 146.17 43.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.155 0.982 . . . . 0.0 110.243 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -139.72 149.85 44.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.624 1.17 . . . . 0.0 109.824 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.88 140.98 49.25 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.44 106.1 1.36 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.43 151.49 19.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.35 139.08 54.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.585 0.754 . . . . 0.0 109.057 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.12 167.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.424 1.49 . . . . 0.0 110.305 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.07 49.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.705 1.24 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -159.09 -35.12 0.06 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.614 2.366 . . . . 0.0 110.191 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.62 -153.06 23.71 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -118.24 150.83 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -126.01 106.74 9.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.55 1.54 . . . . 0.0 107.098 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 m -91.94 102.57 15.14 Favored 'General case' 0 N--CA 1.46 0.041 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -87.76 146.82 25.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.832 1.253 . . . . 0.0 110.662 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.54 -179.89 8.59 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.011 1.724 . . . . 0.0 108.68 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 m -145.76 150.77 36.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.191 0.997 . . . . 0.0 108.941 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.4 mt -133.01 110.85 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.89 -131.46 52.06 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.02 -9.99 59.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.478 0.711 . . . . 0.0 112.578 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.59 29.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.85 147.19 25.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.77 152.34 49.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.168 1.787 . . . . 0.0 108.685 -173.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -149.4 140.57 23.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.761 -0.587 . . . . 0.0 109.838 168.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -87.71 120.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -87.16 122.9 31.59 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.32 93.53 4.16 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -90.18 125.5 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.377 1.071 . . . . 0.0 108.941 -169.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 m -79.81 45.54 0.71 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.368 1.067 . . . . 0.0 111.904 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 m -69.31 -53.83 17.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.487 1.115 . . . . 0.0 110.425 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.7 148.08 23.42 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -100.76 -7.35 23.81 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -69.78 169.37 13.12 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -52.84 -55.11 25.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.914 0.885 . . . . 0.0 111.133 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -90.2 17.22 7.31 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.092 0.473 . . . . 0.0 111.498 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.25 -17.95 77.79 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.602 1.096 . . . . 0.0 112.782 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.62 124.32 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.1 mm -88.78 115.03 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.98 127.87 41.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -135.21 144.19 46.81 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.72 130.58 41.18 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.4 142.75 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.77 132.43 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 107.565 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.3 37.71 12.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.084 0.954 . . . . 0.0 111.948 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.62 9.88 3.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.152 2.181 . . . . 0.0 115.542 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.7 150.8 19.97 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.232 1.413 . . . . 0.0 109.578 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.47 136.46 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.346 1.059 . . . . 0.0 110.227 -176.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.9 mm -120.65 116.16 31.94 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.3 1.84 . . . . 0.0 107.005 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.8 144.27 19.19 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 111.269 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.85 165.29 24.44 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.054 0.542 . . . . 0.0 111.312 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.9 pt -117.36 157.89 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 126.135 1.774 . . . . 0.0 110.194 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.32 27.0 2.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.145 1.378 . . . . 0.0 111.648 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.469 1.508 . . . . 0.0 110.036 179.719 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.15 160.71 37.54 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.489 1.515 . . . . 0.0 108.38 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -141.37 34.12 1.68 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.212 0.605 . . . . 0.0 110.706 171.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -65.12 153.23 41.47 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.135 0.574 . . . . 0.0 110.81 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.7 tttt 54.9 23.89 5.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.319 1.448 . . . . 0.0 112.551 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.42 HG22 ' HD2' ' A' ' 25' ' ' LYS . 16.1 m -103.25 100.86 10.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 169.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -130.13 153.46 48.49 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.909 0.862 . . . . 0.0 112.788 -168.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -118.32 129.53 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 168.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.8 m -112.52 145.42 40.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -133.92 161.42 34.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.459 1.504 . . . . 0.0 108.0 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.03 137.94 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.3 mt -121.57 113.22 19.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -81.06 122.14 26.95 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 168.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 58.3 mtt -130.42 -173.68 3.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.362 1.865 . . . . 0.0 108.079 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -51.1 90.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.603 1.561 . . . . 0.0 113.369 -169.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 13.12 79.13 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.214 1.388 . . . . 0.0 114.116 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -139.99 162.34 35.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.448 1.624 . . . . 0.0 111.123 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -128.61 119.88 25.58 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 125.612 1.565 . . . . 0.0 106.938 172.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.03 131.53 54.49 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.03 0.932 . . . . 0.0 109.239 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -80.75 145.93 31.27 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 mm -122.39 132.61 70.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.22 119.99 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -88.4 123.13 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -90.89 113.2 25.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 168.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 6' ' ' THR . 94.8 mttt -70.78 -19.98 62.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.128 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.18 -42.36 94.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.869 0.759 . . . . 0.0 111.591 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.42 -1.01 13.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.24 1.416 . . . . 0.0 112.449 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm 53.11 39.35 29.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.008 1.323 . . . . 0.0 109.954 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.37 141.77 31.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.779 1.232 . . . . 0.0 109.098 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.45 116.76 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.837 0.827 . . . . 0.0 109.972 -173.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.433 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -85.18 115.27 22.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.1 m -118.48 125.87 50.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 49.14 39.35 15.1 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.138 0.975 . . . . 0.0 111.914 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.13 3.55 88.39 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.307 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.59 147.26 46.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.541 1.67 . . . . 0.0 108.23 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 147.75 33.85 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.384 0.993 . . . . 0.0 109.551 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.9 166.57 23.01 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.487 1.115 . . . . 0.0 110.458 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.98 148.83 48.41 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.486 0.714 . . . . 0.0 111.675 -172.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 149.93 48.99 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.786 1.634 . . . . 0.0 109.15 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.6 140.54 52.69 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.51 106.98 1.29 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 -173.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -98.32 153.01 18.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 109.374 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.48 138.55 54.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.38 168.28 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.422 1.489 . . . . 0.0 110.325 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.01 48.35 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.061 1.345 . . . . 0.0 110.794 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -159.99 -35.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.502 2.321 . . . . 0.0 110.448 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.0 -153.65 24.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -118.45 152.41 35.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.57 109.73 10.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.767 1.227 . . . . 0.0 107.849 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 m -94.37 105.75 17.72 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -91.17 146.19 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.97 1.308 . . . . 0.0 110.836 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.01 -174.01 4.53 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.61 1.964 . . . . 0.0 108.701 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.1 m -145.71 146.58 31.31 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.53 1.132 . . . . 0.0 109.4 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.3 mt -142.39 130.12 20.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.46 -130.37 50.89 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -101.06 28.6 5.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.68 1.192 . . . . 0.0 111.548 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -128.52 144.31 51.12 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.65 1.18 . . . . 0.0 109.076 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.77 149.9 21.83 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.4 150.51 50.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.364 1.465 . . . . 0.0 108.212 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -146.82 140.36 25.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.3 mt -90.79 115.5 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 170.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -78.85 134.83 36.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.66 94.04 3.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.93 128.42 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.957 1.303 . . . . 0.0 109.539 -169.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 m -79.69 47.57 0.86 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.76 1.164 . . . . 0.0 112.436 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.2 m -73.56 -22.11 60.17 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.747 1.219 . . . . 0.0 113.394 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.18 42.86 49.41 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 118.746 0.703 . . . . 0.0 112.759 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -82.44 176.78 9.14 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.84 0.82 . . . . 0.0 110.556 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.87 -66.53 0.46 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.299 1.039 . . . . 0.0 112.665 -169.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -87.83 -70.9 0.6 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 118.64 0.655 . . . . 0.0 109.657 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -71.62 107.37 4.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.72 -58.51 7.57 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp -87.22 125.09 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 169.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.8 mm -79.08 116.5 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -96.51 130.85 43.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 tp -93.34 130.72 38.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.84 140.59 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.35 132.22 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.583 1.153 . . . . 0.0 108.132 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.0 t0 45.53 42.35 7.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.337 1.455 . . . . 0.0 111.613 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 t30 64.52 18.21 11.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.563 2.345 . . . . 0.0 116.002 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -115.75 153.42 31.43 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 120.752 -1.218 . . . . 0.0 110.809 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -89.18 138.08 31.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.955 1.302 . . . . 0.0 110.793 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -121.55 118.09 29.88 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.859 2.064 . . . . 0.0 106.596 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.97 143.39 23.01 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.232 2.621 . . . . 0.0 111.357 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -70.46 160.7 31.91 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.351 0.596 . . . . 0.0 110.359 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.7 pt -117.46 161.03 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 126.475 1.91 . . . . 0.0 108.894 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 51.09 43.92 28.86 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.728 1.211 . . . . 0.0 111.878 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.311 1.844 . . . . 0.0 111.36 -176.189 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -74.8 -41.98 58.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.595 0.758 . . . . 0.0 111.301 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -75.77 149.89 37.87 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -70.88 -25.53 62.84 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.49 0.716 . . . . 0.0 112.438 -176.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 7' ' ' THR . 21.7 tptm 50.74 84.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.833 2.053 . . . . 0.0 110.887 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.9 m -61.16 -31.25 70.98 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.622 1.169 . . . . 0.0 113.097 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.2 p -131.34 152.73 50.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.546 -0.721 . . . . 0.0 110.368 -169.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -115.9 128.98 56.2 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.4 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.811 0.815 . . . . 0.0 109.249 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -135.07 157.03 47.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.032 1.333 . . . . 0.0 107.491 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -125.06 137.76 56.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 169.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.7 mt -122.16 125.53 46.33 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.833 1.253 . . . . 0.0 107.628 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -93.31 118.07 30.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.7 mtm -146.41 134.87 21.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.638 1.175 . . . . 0.0 108.416 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.29 37.5 11.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.983 1.313 . . . . 0.0 113.496 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.71 8.1 87.24 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.936 -0.925 . . . . 0.0 114.431 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -118.28 155.22 30.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.81 1.644 . . . . 0.0 110.042 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -107.88 123.52 48.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -111.05 122.66 48.46 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.212 1.405 . . . . 0.0 108.382 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.42 142.32 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -120.72 134.32 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.4 t -132.36 118.59 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -87.11 125.94 34.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.3 OUTLIER -87.79 112.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.252 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -70.01 -29.35 66.39 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.791 0.723 . . . . 0.0 111.787 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.42 -43.43 94.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.286 0.494 . . . . 0.0 110.996 -173.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.87 -11.68 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.639 1.176 . . . . 0.0 113.003 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.9 mtp 54.55 34.35 21.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 110.519 -169.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -93.13 150.89 20.19 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.28 117.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.53 121.84 30.47 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.74 1.616 . . . . 0.0 107.604 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -113.63 130.57 56.37 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 52.26 35.51 17.13 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.82 0.848 . . . . 0.0 111.6 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.43 10.17 82.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.209 0.909 . . . . 0.0 114.835 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -124.34 136.58 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.379 1.472 . . . . 0.0 107.221 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -72.18 142.58 49.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.595 1.543 . . . . 0.0 109.438 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -116.2 167.8 10.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.086 0.954 . . . . 0.0 110.989 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.29 146.35 43.25 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 110.352 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -139.55 150.39 45.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.445 1.098 . . . . 0.0 109.697 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.7 141.29 50.93 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.49 106.13 1.21 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -95.64 153.35 17.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -122.66 139.7 53.66 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.62 167.58 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.853 1.661 . . . . 0.0 110.086 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -76.55 48.49 0.55 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.8 1.286 . . . . 0.0 110.927 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.98 -33.61 0.06 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.851 2.46 . . . . 0.0 110.356 -171.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.2 -152.17 23.32 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.52 149.16 40.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -126.56 106.75 9.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 m -92.22 103.6 16.06 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -88.56 146.68 25.0 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.913 1.285 . . . . 0.0 110.335 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.82 179.74 8.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.893 1.677 . . . . 0.0 108.337 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 m -145.81 149.88 35.16 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.907 0.883 . . . . 0.0 108.903 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mt -133.18 110.0 14.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.48 -131.67 52.17 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -81.22 -10.12 59.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.413 0.685 . . . . 0.0 112.803 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -88.8 121.34 31.07 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 147.04 25.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.482 0.658 . . . . 0.0 109.862 170.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.84 153.52 49.6 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.57 1.548 . . . . 0.0 108.508 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -148.09 143.08 26.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.692 -0.63 . . . . 0.0 109.798 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.4 mt -88.31 119.56 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -85.33 110.05 18.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.4 84.83 3.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.61 127.3 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.846 1.659 . . . . 0.0 108.881 -169.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -84.55 53.33 2.63 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.63 1.105 . . . . 0.0 110.273 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.1 m -74.57 -26.18 59.78 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.3 140.88 40.07 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 118.698 0.681 . . . . 0.0 111.766 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.79 -28.44 33.19 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.725 0.41 . . . . 0.0 111.322 175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -71.67 168.6 17.38 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -60.25 155.22 18.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 56.86 -124.19 1.8 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -169.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.53 31.69 49.58 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 119.536 1.062 . . . . 0.0 113.141 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.19 139.75 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.31 129.72 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -104.73 124.91 50.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -132.59 145.54 51.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.14 0.976 . . . . 0.0 108.775 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 tp -92.42 131.1 37.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.69 142.42 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 169.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -136.94 132.19 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.048 1.339 . . . . 0.0 107.978 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t0 45.4 42.21 7.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.239 1.415 . . . . 0.0 111.539 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.3 t30 64.02 17.33 10.54 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.553 2.341 . . . . 0.0 116.196 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.65 152.09 32.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.84 1.256 . . . . 0.0 110.546 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -88.74 137.96 31.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.372 1.069 . . . . 0.0 110.631 -169.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.49 112.3 37.43 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.611 1.964 . . . . 0.0 106.909 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.43 150.61 36.61 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.19 2.593 . . . . 0.0 110.821 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.67 157.71 6.91 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.569 0.748 . . . . 0.0 110.818 176.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.1 pt -58.82 153.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.392 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.12 25.99 5.81 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.328 1.451 . . . . 0.0 111.887 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.253 1.264 0 C-N-CA 125.467 1.507 . . . . 0.0 110.059 178.922 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -147.46 153.99 40.25 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.62 1.568 . . . . 0.0 107.902 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -111.6 44.39 1.36 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.83 1.252 . . . . 0.0 108.821 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m 53.2 39.82 30.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.267 1.427 . . . . 0.0 112.317 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -67.17 -28.9 68.49 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 121.534 -0.729 . . . . 0.0 111.152 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.3 m 66.96 -53.98 0.45 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.435 1.894 . . . . 0.0 112.554 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 24' ' ' GLU . 19.7 p -65.43 146.55 54.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 119.717 1.144 . . . . 0.0 110.661 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -89.49 125.36 35.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.5 m -108.6 148.6 30.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -136.5 159.52 41.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.825 1.65 . . . . 0.0 106.689 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.04 140.57 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.17 122.26 36.55 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.834 1.253 . . . . 0.0 107.987 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -91.91 117.81 30.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 56.7 mtm -146.64 134.8 21.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.817 1.247 . . . . 0.0 108.421 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.33 37.83 12.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.141 1.376 . . . . 0.0 113.339 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.3 8.73 87.04 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.236 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.13 155.76 29.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.987 1.715 . . . . 0.0 110.004 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.92 123.84 49.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -110.26 124.02 50.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.26 1.424 . . . . 0.0 107.978 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -84.38 141.34 30.93 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.0 mm -117.34 135.51 57.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.5 t -132.06 120.58 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.57 124.14 33.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.71 113.85 21.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -72.58 -26.41 61.7 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.724 -0.61 . . . . 0.0 111.696 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.09 -44.06 77.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.176 0.443 . . . . 0.0 111.287 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.19 -10.85 17.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 113.372 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.263 59.6 mtp 54.96 30.4 13.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.988 1.315 . . . . 0.0 111.861 -169.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.43 150.08 27.28 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.95 117.71 46.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.428 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.2 m95 -85.19 119.21 25.32 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.5 t -110.54 128.74 55.78 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 169.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 52.62 34.92 16.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.702 0.801 . . . . 0.0 111.576 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 11.17 82.15 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.233 0.921 . . . . 0.0 114.768 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -124.8 142.6 51.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.164 1.482 . . . . 0.0 108.187 -174.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -69.47 145.06 53.04 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.522 1.055 . . . . 0.0 108.427 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 pp -123.18 167.15 14.08 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.36 144.85 44.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.911 0.884 . . . . 0.0 110.189 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -140.93 149.58 42.05 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.225 1.01 . . . . 0.0 110.011 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.96 138.45 49.72 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.41 111.2 2.2 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -110.37 146.18 36.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.622 0.769 . . . . 0.0 109.87 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.45 142.46 30.04 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.55 166.34 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.693 1.597 . . . . 0.0 109.754 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.57 49.15 0.72 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.982 1.373 . . . . 0.0 110.231 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -159.87 -34.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.64 2.376 . . . . 0.0 110.292 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.4 -130.07 2.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -171.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -131.85 152.2 51.18 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -129.3 117.3 20.43 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 m -95.84 105.58 17.61 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.87 145.36 25.2 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.815 1.246 . . . . 0.0 109.966 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -157.31 -177.81 6.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.507 1.523 . . . . 0.0 109.053 169.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.81 151.54 38.08 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.422 1.089 . . . . 0.0 108.507 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -132.5 108.58 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.44 -130.76 51.48 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -77.94 -16.21 58.37 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.555 0.742 . . . . 0.0 112.578 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -85.84 120.03 26.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.76 147.53 26.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.364 0.529 . . . . 0.0 109.796 170.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.86 153.07 46.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.731 1.612 . . . . 0.0 108.924 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -148.0 141.3 25.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.661 -0.649 . . . . 0.0 109.342 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.8 mt -88.55 117.76 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -81.74 128.11 33.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 90.9 3.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -87.53 121.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 124.103 0.961 . . . . 0.0 108.537 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 m -75.09 111.7 10.59 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.8 m -144.08 178.52 7.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.541 1.136 . . . . 0.0 110.379 -169.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.3 -157.23 33.05 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.561 0.601 . . . . 0.0 112.176 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -72.33 178.27 4.05 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.223 1.009 . . . . 0.0 109.532 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -60.83 -16.31 39.73 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -24.12 67.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.312 0.96 . . . . 0.0 112.388 170.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 58.28 104.21 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 129.593 3.157 . . . . 0.0 113.069 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.7 110.63 4.06 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 106.227 -2.749 . . . . 0.0 106.227 169.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.68 124.81 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -90.09 114.35 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.45 125.31 38.0 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -132.83 142.35 48.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.7 tp -94.25 130.33 40.55 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.22 141.96 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -139.07 132.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t0 49.54 37.49 12.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.049 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 62.86 10.17 4.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.774 2.03 . . . . 0.0 115.531 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -96.63 150.47 20.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.265 1.426 . . . . 0.0 109.672 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.22 137.44 32.33 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.263 1.025 . . . . 0.0 110.232 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mm -118.94 118.77 32.79 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.967 1.707 . . . . 0.0 107.952 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -68.12 141.44 52.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.611 2.874 . . . . 0.0 112.33 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.98 164.62 23.53 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.56 0.695 . . . . 0.0 110.622 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.3 pt -134.02 160.74 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 127.405 2.282 . . . . 0.0 108.233 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.15 23.21 9.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.475 1.11 . . . . 0.0 112.548 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 124.976 1.311 . . . . 0.0 109.742 177.674 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.79 -34.64 69.82 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.093 -1.005 . . . . 0.0 112.204 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -82.44 -7.22 59.64 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -66.3 145.39 55.8 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.346 0.975 . . . . 0.0 110.435 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -77.02 152.05 35.32 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 170.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -129.63 90.17 2.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -130.08 146.16 51.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.568 0.747 . . . . 0.0 111.234 -170.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.76 131.1 55.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.0 m -116.64 141.19 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -131.21 153.69 49.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.601 1.56 . . . . 0.0 107.326 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -114.88 139.4 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.49 112.64 18.76 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.278 1.831 . . . . 0.0 106.591 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -92.44 113.21 25.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.7 mtm -147.31 137.29 23.09 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.43 1.092 . . . . 0.0 108.609 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.3 t70 49.54 37.76 13.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.197 1.399 . . . . 0.0 113.206 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.34 -7.02 48.97 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.518 1.056 . . . . 0.0 113.976 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -95.23 164.99 12.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.731 1.613 . . . . 0.0 110.219 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -123.38 124.44 42.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.8 132.47 54.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.676 1.591 . . . . 0.0 108.132 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.81 138.1 31.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 169.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.5 mm -116.36 131.4 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.3 117.62 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 170.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.1 tp -89.2 123.07 33.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -86.13 110.12 19.33 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 168.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -75.81 -24.76 55.93 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.92 -0.487 . . . . 0.0 111.446 -171.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.29 -42.02 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.134 0.424 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.62 -14.29 22.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.919 1.288 . . . . 0.0 113.106 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm 52.19 49.71 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.317 1.447 . . . . 0.0 109.366 -169.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -123.34 141.97 51.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.372 1.469 . . . . 0.0 108.579 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.93 123.33 68.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.273 0.559 . . . . 0.0 110.221 -172.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.459 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.9 m95 -95.66 114.15 25.87 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.0 m -108.79 120.97 44.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 171.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 47.94 40.94 13.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.33 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.66 -4.41 60.61 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.767 -1.019 . . . . 0.0 114.891 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -111.8 144.21 41.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.446 1.623 . . . . 0.0 108.952 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.29 149.4 47.45 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 110.376 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.96 167.7 21.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.124 1.769 . . . . 0.0 108.41 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.39 143.5 53.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.147 0.499 . . . . 0.0 111.197 -170.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.6 151.08 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.173 1.789 . . . . 0.0 108.815 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.96 134.53 45.73 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.84 90.12 0.81 Allowed Glycine 0 C--N 1.329 0.157 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -78.6 141.43 38.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -106.67 136.11 47.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.91 166.45 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.608 1.163 . . . . 0.0 110.34 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.66 49.26 0.73 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.883 1.325 . . . . 0.0 110.318 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -161.36 -32.66 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.682 2.393 . . . . 0.0 110.874 -169.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.67 -132.99 4.23 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -127.98 151.35 49.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.15 106.59 8.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.8 m -84.52 101.03 11.76 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -85.66 144.52 27.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.774 1.23 . . . . 0.0 110.322 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.85 -178.34 7.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.15 1.78 . . . . 0.0 108.399 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 m -145.23 150.28 36.41 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.993 0.917 . . . . 0.0 109.048 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.6 mt -132.7 115.36 24.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.87 -132.5 52.59 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.14 -4.19 58.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 112.639 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -94.5 121.15 35.76 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -171.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.46 145.3 27.5 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.337 0.589 . . . . 0.0 109.576 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.55 152.3 50.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.482 1.513 . . . . 0.0 108.315 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 26.4 p90 -147.99 139.67 23.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 110.142 168.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mt -87.89 111.64 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -80.63 127.75 32.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.5 94.1 3.79 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -93.82 126.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.816 -169.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p -84.25 49.48 1.67 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.627 1.103 . . . . 0.0 111.764 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.2 m -110.78 141.69 43.78 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.594 1.158 . . . . 0.0 111.207 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.97 -163.13 38.1 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.135 0.874 . . . . 0.0 112.517 173.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 42.42 57.98 3.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.438 1.895 . . . . 0.0 112.738 169.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 50.22 44.76 26.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.355 1.462 . . . . 0.0 111.566 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? 62.09 -60.34 0.11 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 128.561 2.744 . . . . 0.0 114.038 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.53 -6.17 44.84 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.2 67.5 2.76 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.38 132.61 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mm -84.78 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -140.55 138.09 34.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.2 tp -88.99 131.04 35.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.6 mp -111.91 147.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.4 129.64 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.83 39.85 11.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.937 0.895 . . . . 0.0 111.572 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 65.9 2.35 2.17 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.76 2.024 . . . . 0.0 115.472 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -90.16 151.21 21.68 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.488 -1.382 . . . . 0.0 109.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -93.0 136.88 32.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.145 0.978 . . . . 0.0 110.538 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 mm -119.27 117.36 33.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.062 1.745 . . . . 0.0 107.01 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.68 152.51 37.74 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.162 2.575 . . . . 0.0 111.044 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.44 161.62 9.16 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.206 0.602 . . . . 0.0 109.398 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.7 pt -64.32 153.15 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.404 0.621 . . . . 0.0 112.125 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.93 103.95 4.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.035 176.412 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -70.62 143.27 51.54 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.194 0.598 . . . . 0.0 110.087 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -146.54 143.9 29.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.3 m -64.82 155.51 33.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.393 0.677 . . . . 0.0 110.83 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -139.66 152.55 46.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.841 1.256 . . . . 0.0 108.106 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.8 m -127.66 138.76 52.92 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.2 p -131.48 157.53 43.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.929 2.092 . . . . 0.0 107.789 175.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -121.71 130.23 53.29 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.7 m -123.51 142.29 51.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.827 0.704 . . . . 0.0 109.415 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -138.8 158.46 44.18 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 0.0 107.971 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 146.61 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.644 0.778 . . . . 0.0 109.298 169.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.55 156.01 46.47 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.089 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -111.5 116.26 30.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtm -144.56 141.56 29.56 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.6 t0 49.21 38.13 12.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.252 1.421 . . . . 0.0 113.546 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.94 6.44 85.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.977 -0.902 . . . . 0.0 113.937 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -118.15 162.8 17.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.149 1.78 . . . . 0.0 110.452 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -111.05 126.27 54.63 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.21 104.32 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.32 142.6 37.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 mm -125.57 131.47 72.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.51 120.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -87.94 124.52 33.78 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -89.29 108.48 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.96 1.704 . . . . 0.0 109.109 171.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.7 -26.7 63.53 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.055 0.389 . . . . 0.0 111.661 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.83 -39.94 94.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.407 0.283 . . . . 0.0 111.204 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.7 -11.28 17.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 113.218 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.3 42.4 30.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.298 1.439 . . . . 0.0 109.984 -168.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -105.26 160.84 14.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.913 1.285 . . . . 0.0 108.261 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.43 119.08 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.465 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.7 m95 -90.35 121.35 32.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.851 1.661 . . . . 0.0 109.078 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -102.79 116.03 31.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 168.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 46.13 39.78 6.41 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.32 1.048 . . . . 0.0 111.794 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.46 -7.8 67.22 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.312 -1.271 . . . . 0.0 115.343 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.23 140.98 30.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.106 1.953 . . . . 0.0 108.844 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -69.71 142.07 53.39 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.769 1.168 . . . . 0.0 108.442 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.66 166.16 12.02 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.836 0.854 . . . . 0.0 110.288 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.71 146.76 42.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.507 1.123 . . . . 0.0 109.979 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -142.87 150.24 39.59 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 110.091 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.36 134.24 43.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.47 90.32 0.75 Allowed Glycine 0 C--N 1.33 0.21 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -174.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.4 142.2 39.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -108.52 135.68 49.39 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.24 166.84 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 124.815 1.246 . . . . 0.0 110.174 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.71 49.34 0.75 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 123.005 1.383 . . . . 0.0 110.384 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.08 -33.27 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.536 2.335 . . . . 0.0 110.683 -169.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.29 -134.25 4.71 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -171.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -125.63 150.28 47.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.75 106.19 8.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -87.12 100.6 12.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -86.6 144.55 27.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.602 1.161 . . . . 0.0 110.798 -172.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.69 -177.01 6.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.367 1.867 . . . . 0.0 108.879 169.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -144.64 146.61 32.36 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.363 1.065 . . . . 0.0 109.662 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.95 132.5 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.98 -125.92 41.14 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -109.5 33.25 4.44 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.754 1.222 . . . . 0.0 110.714 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -129.53 144.87 51.45 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.178 1.391 . . . . 0.0 108.817 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.31 150.87 21.67 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.68 152.46 50.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.317 1.447 . . . . 0.0 108.295 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 24.2 p90 -148.69 140.41 23.64 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.785 -0.572 . . . . 0.0 109.647 168.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -88.29 114.13 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -81.96 126.82 32.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.25 92.12 3.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 121.74 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m -73.87 109.86 7.7 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.4 m -134.58 174.09 10.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.868 1.267 . . . . 0.0 110.544 -171.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.81 -174.54 48.11 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.85 146.37 50.56 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.952 1.301 . . . . 0.0 107.813 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 57.46 -74.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.769 2.027 . . . . 0.0 111.084 -169.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -69.83 130.29 41.87 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 169.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -92.01 112.54 24.51 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.26 111.76 4.26 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 106.377 -2.689 . . . . 0.0 106.377 169.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.46 122.47 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.3 mm -90.21 111.67 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.08 129.76 38.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -137.85 141.24 40.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.907 1.283 . . . . 0.0 108.012 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.9 tp -88.73 132.59 34.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.46 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.66 141.9 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.23 133.67 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.5 t0 49.59 37.75 13.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.413 1.085 . . . . 0.0 111.759 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.1 t30 62.72 9.66 3.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.027 2.131 . . . . 0.0 115.431 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.83 149.06 21.95 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.14 1.376 . . . . 0.0 109.387 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -91.13 133.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.457 0.703 . . . . 0.0 110.065 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.06 112.39 40.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.432 1.893 . . . . 0.0 106.801 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.28 152.02 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 110.947 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -55.11 156.81 3.75 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.187 0.995 . . . . 0.0 110.484 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.1 pt -59.3 151.62 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.074 173.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 54.82 25.51 6.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.882 1.673 . . . . 0.0 114.977 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.253 1.247 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 169.671 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -81.17 -59.46 2.64 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 47.02 41.63 11.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.911 1.684 . . . . 0.0 113.073 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.7 m -63.03 155.1 28.64 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.8 -0.562 . . . . 0.0 110.73 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -140.82 143.45 34.83 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.281 1.432 . . . . 0.0 107.533 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.59 114.16 10.36 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -141.74 145.42 34.81 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.2 0.6 . . . . 0.0 111.304 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -117.41 135.61 53.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 m -114.68 147.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -134.55 161.35 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.379 1.472 . . . . 0.0 107.507 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.02 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.44 124.63 34.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.323 1.449 . . . . 0.0 108.581 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -87.63 125.71 34.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 ttm -156.03 132.47 10.19 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.91 38.94 17.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.108 1.363 . . . . 0.0 113.316 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 -1.34 74.81 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.109 0.861 . . . . 0.0 114.151 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.01 167.51 9.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.235 1.814 . . . . 0.0 110.031 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -121.42 124.14 43.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.41 118.44 36.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -86.73 142.37 28.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.05 133.86 67.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 t -133.07 119.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 tp -88.65 120.54 30.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -83.03 111.39 18.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 168.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.99 -26.8 60.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.181 -170.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.08 -43.58 86.96 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.106 0.412 . . . . 0.0 110.735 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.49 -13.75 24.27 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.518 1.127 . . . . 0.0 112.929 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mmm 52.35 45.62 28.15 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.08 1.352 . . . . 0.0 109.581 -169.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -115.83 141.61 47.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.835 1.254 . . . . 0.0 108.391 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.15 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.768 0.794 . . . . 0.0 109.705 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.451 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 22.9 m95 -85.53 111.51 20.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 169.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.1 m -108.5 117.65 34.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 48.01 40.89 14.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.143 1.377 . . . . 0.0 111.022 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.58 -9.31 36.42 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.591 1.091 . . . . 0.0 114.743 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.79 138.82 32.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.75 1.775 . . . . 0.0 108.821 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -71.07 141.33 50.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.9 165.9 24.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.984 0.914 . . . . 0.0 110.075 169.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.41 145.15 53.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.4 0.619 . . . . 0.0 111.167 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -134.36 147.82 50.59 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.845 1.658 . . . . 0.0 108.719 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.23 142.62 46.83 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.33 109.73 1.83 Allowed Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 107.155 -2.378 . . . . 0.0 107.155 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.45 148.52 25.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.07 134.39 55.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.68 167.54 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.548 1.539 . . . . 0.0 110.114 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.95 48.41 0.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.016 1.326 . . . . 0.0 110.465 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.35 -34.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.204 2.202 . . . . 0.0 110.537 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.66 -150.73 20.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -175.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -121.02 152.98 37.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -127.19 109.83 12.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.794 1.638 . . . . 0.0 107.171 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.7 m -92.44 102.57 15.04 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -89.56 146.17 24.76 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.447 1.099 . . . . 0.0 110.958 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -158.47 -173.75 4.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.086 2.154 . . . . 0.0 108.231 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 m -146.57 149.24 33.19 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.534 1.134 . . . . 0.0 109.403 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -138.16 121.64 20.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.33 -134.17 52.42 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -170.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -83.37 -7.56 59.55 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.832 0.853 . . . . 0.0 112.384 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -95.33 133.35 39.35 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.69 150.69 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.71 150.76 50.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.407 1.483 . . . . 0.0 107.866 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.419 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 17.2 p90 -147.41 139.68 24.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.907 -0.496 . . . . 0.0 109.821 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.1 mt -88.41 117.73 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -84.36 124.2 31.02 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.9 91.64 3.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.6 126.02 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.324 1.05 . . . . 0.0 108.451 -169.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m -80.82 57.62 3.08 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.818 1.19 . . . . 0.0 109.958 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.8 m -71.9 -37.39 70.11 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.245 1.018 . . . . 0.0 111.159 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.09 132.7 26.04 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -95.38 -66.69 0.89 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.204 0.601 . . . . 0.0 110.098 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -77.63 -50.95 11.45 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -72.54 141.99 48.47 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.24 63.33 2.45 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.538 1.135 . . . . 0.0 110.547 169.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.95 74.48 1.68 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.85 123.58 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.17 118.02 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -98.66 124.48 43.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 m -133.47 140.34 47.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.241 1.016 . . . . 0.0 108.408 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 tp -89.33 133.48 34.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.419 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.44 141.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 169.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.83 131.97 43.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 49.48 38.33 14.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.398 1.079 . . . . 0.0 111.868 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.79 9.6 3.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.014 2.125 . . . . 0.0 115.471 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.75 150.01 20.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.916 1.286 . . . . 0.0 109.192 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -95.02 134.24 37.93 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.769 0.828 . . . . 0.0 110.657 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.1 mm -121.98 113.73 31.27 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.47 1.908 . . . . 0.0 107.722 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.7 149.45 48.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.039 2.492 . . . . 0.0 111.201 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -70.04 166.6 19.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 111.384 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.55 161.11 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 126.926 2.09 . . . . 0.0 110.094 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.04 112.24 9.75 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 169.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.255 1.358 0 C-N-CA 123.561 0.744 . . . . 0.0 110.932 174.189 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -151.42 167.31 28.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.194 1.398 . . . . 0.0 108.517 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -75.41 144.55 42.15 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 170.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -71.49 155.46 40.56 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.424 0.69 . . . . 0.0 110.611 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -142.22 137.01 30.46 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 170.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.7 m -140.06 93.17 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -131.88 146.32 52.05 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -168.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -120.43 136.53 54.71 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.8 m -129.81 142.92 50.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.402 0.681 . . . . 0.0 109.284 -169.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -136.84 159.62 41.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.038 1.735 . . . . 0.0 107.629 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.13 141.58 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.224 1.01 . . . . 0.0 108.693 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.37 128.81 38.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.327 1.451 . . . . 0.0 109.079 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -83.78 128.94 34.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.8 mtt -144.44 129.65 18.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.087 1.355 . . . . 0.0 108.389 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.01 44.54 18.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 0.0 113.855 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.15 5.02 90.39 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.921 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -118.72 158.88 24.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.896 1.678 . . . . 0.0 109.987 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -115.38 123.7 49.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -108.57 128.28 54.68 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.018 0.927 . . . . 0.0 108.571 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -80.4 147.43 31.01 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mm -122.02 131.28 73.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.96 119.09 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.9 121.89 30.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.81 112.97 20.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -71.87 -31.28 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.97 0.908 . . . . 0.0 111.993 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.75 -46.49 62.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.124 0.42 . . . . 0.0 110.262 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.83 -17.22 33.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.065 0.946 . . . . 0.0 112.57 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.0 mtp 53.41 42.17 32.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.258 1.423 . . . . 0.0 109.884 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -106.66 145.45 31.96 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.056 1.343 . . . . 0.0 107.981 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -114.34 116.94 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.932 0.873 . . . . 0.0 109.618 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.67 111.14 19.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -114.85 127.52 55.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 49.08 36.73 9.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.123 0.969 . . . . 0.0 111.609 -171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.2 5.8 85.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.207 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.78 148.12 45.06 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.878 1.839 . . . . 0.0 109.352 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -69.63 144.53 52.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.77 166.79 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.342 1.057 . . . . 0.0 110.309 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.5 140.61 57.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.576 0.751 . . . . 0.0 111.129 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.94 151.9 49.56 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.965 1.706 . . . . 0.0 108.466 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 135.83 46.76 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.77 95.58 1.28 Allowed Glycine 0 C--N 1.331 0.257 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.29 145.52 28.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -107.45 136.45 47.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.45 167.5 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.141 1.376 . . . . 0.0 109.962 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.78 49.4 0.76 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.249 1.42 . . . . 0.0 110.533 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -160.73 -36.39 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.664 2.386 . . . . 0.0 110.025 -170.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.0 -124.03 1.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -127.5 150.97 49.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.3 106.38 8.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 172.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.4 m -86.26 101.53 13.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -85.7 145.7 27.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.775 1.23 . . . . 0.0 110.557 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -157.33 -176.32 5.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.736 2.014 . . . . 0.0 108.205 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -146.77 150.72 35.89 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.347 1.059 . . . . 0.0 109.099 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.31 122.74 25.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.9 -131.68 52.17 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -87.58 -4.17 58.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.183 0.993 . . . . 0.0 112.458 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -98.52 130.49 45.1 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 109.448 -169.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.1 151.14 27.15 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.182 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -135.32 150.8 50.07 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.749 1.619 . . . . 0.0 107.372 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.99 140.54 26.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.864 -0.522 . . . . 0.0 109.723 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.11 113.99 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -78.57 125.8 29.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.58 90.31 3.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -80.12 122.63 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 m -79.11 45.41 0.63 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.591 1.087 . . . . 0.0 111.961 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.8 m -56.13 144.21 30.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.068 1.347 . . . . 0.0 108.962 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.07 -11.81 52.84 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.434 -170.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 52.16 -97.3 0.06 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 126.512 1.925 . . . . 0.0 112.124 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -68.59 -34.84 76.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.419 0.554 . . . . 0.0 110.569 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -77.05 139.46 40.04 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -83.51 58.69 4.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.071 0.948 . . . . 0.0 110.835 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.01 37.02 3.47 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.187 1.375 . . . . 0.0 111.613 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.69 124.71 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.66 116.37 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -97.1 126.89 42.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -135.54 144.15 46.11 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.36 1.064 . . . . 0.0 108.46 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 tp -90.97 132.37 36.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.32 141.72 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.45 132.79 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t0 50.31 37.31 14.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 111.816 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 62.43 9.61 3.47 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.045 2.138 . . . . 0.0 115.614 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.27 147.66 22.97 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.679 -1.263 . . . . 0.0 109.371 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -90.57 133.67 34.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.685 0.794 . . . . 0.0 110.061 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.1 mm -119.36 113.77 35.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.134 1.774 . . . . 0.0 107.44 -174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.31 155.32 36.96 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.197 2.598 . . . . 0.0 111.149 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -58.51 161.4 4.56 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.758 0.823 . . . . 0.0 110.841 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt -63.42 149.84 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.261 1.025 . . . . 0.0 112.085 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.35 93.31 9.36 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.252 1.196 0 C-N-CA 123.493 0.717 . . . . 0.0 109.744 175.93 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.92 140.02 56.46 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.912 0.885 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -149.11 147.1 28.09 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 108.274 175.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.1 m -60.55 148.53 37.67 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.521 0.728 . . . . 0.0 110.583 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.44 117.56 19.02 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.5 m -69.04 -33.9 74.34 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.224 0.61 . . . . 0.0 111.862 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 24' ' ' GLU . 25.9 p -127.07 165.88 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.693 0.758 . . . . 0.0 110.972 -169.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -124.11 129.28 50.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 169.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.8 m -114.27 145.75 41.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -136.64 162.6 32.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.281 1.433 . . . . 0.0 107.551 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.79 147.05 26.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.67 153.78 51.5 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.022 0.929 . . . . 0.0 108.661 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -106.1 119.3 38.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.42 137.79 27.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.756 1.222 . . . . 0.0 108.161 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.91 37.34 9.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.41 10.64 86.04 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.771 -1.016 . . . . 0.0 114.256 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.73 150.95 47.28 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.371 1.586 . . . . 0.0 110.231 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -98.15 122.81 41.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -106.75 113.6 27.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -80.73 142.6 33.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 mm -122.07 133.69 67.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.2 t -131.62 119.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.04 127.43 35.4 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -94.34 112.36 24.15 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -68.07 -25.0 65.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.454 -0.307 . . . . 0.0 111.66 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.83 -36.6 83.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.835 0.454 . . . . 0.0 111.88 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.74 -2.38 9.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.145 1.378 . . . . 0.0 113.018 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 99.3 mmm 53.97 33.0 16.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.902 1.281 . . . . 0.0 110.789 -169.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -88.9 146.12 25.12 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.84 117.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.403 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 9.2 m95 -85.38 122.6 29.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.636 1.574 . . . . 0.0 107.454 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.04 118.14 36.02 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 42.47 48.95 4.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.128 1.771 . . . . 0.0 112.564 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.28 -4.11 86.13 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.604 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -113.8 142.73 45.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.786 1.793 . . . . 0.0 109.366 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -68.37 149.02 49.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -126.29 165.55 18.77 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.283 1.033 . . . . 0.0 110.55 169.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.35 146.57 40.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 110.199 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -140.33 151.09 44.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.458 1.103 . . . . 0.0 109.958 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.22 138.18 43.34 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.19 97.02 1.21 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.03 143.14 27.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.82 134.13 43.17 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.35 -179.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.653 1.581 . . . . 0.0 108.765 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.69 8.88 8.83 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.76 14.16 0.55 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.523 1.129 . . . . 0.0 113.357 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.93 -149.27 17.54 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.672 -1.267 . . . . 0.0 112.176 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.3 m -131.34 154.88 48.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -126.61 107.11 9.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.9 m -83.87 99.89 10.63 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -85.77 145.4 27.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.737 1.215 . . . . 0.0 110.722 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.85 -178.92 7.6 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.392 1.877 . . . . 0.0 108.945 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -144.7 147.42 32.99 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 109.522 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.5 mt -141.39 133.78 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.38 -123.3 32.77 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -113.33 36.83 3.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.769 1.228 . . . . 0.0 110.492 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.57 141.65 49.73 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.273 1.429 . . . . 0.0 108.213 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.34 149.2 23.39 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 169.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 m -135.6 152.19 51.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.537 1.535 . . . . 0.0 108.191 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -149.25 141.65 24.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 121.859 -0.525 . . . . 0.0 109.89 168.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.61 115.03 27.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -79.16 98.84 6.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.75 82.64 7.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.96 129.81 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 m -88.42 38.04 0.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.236 0.925 . . . . 0.0 111.038 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 m -66.27 160.74 23.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.704 1.202 . . . . 0.0 111.821 -173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.13 -140.24 35.58 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.62 127.01 29.31 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -67.43 -38.05 83.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 119.413 -0.327 . . . . 0.0 111.224 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -73.25 124.26 25.31 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 58.22 -10.14 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.435 2.694 . . . . 0.0 116.194 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.49 25.85 1.98 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.225 1.393 . . . . 0.0 113.73 -175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.54 134.24 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.7 mm -77.45 -43.51 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.28 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 63.5 m80 53.23 102.91 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.75 2.02 . . . . 0.0 112.407 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -126.3 141.27 51.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.792 0.837 . . . . 0.0 109.123 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.6 tp -88.46 131.43 34.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.412 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.89 142.87 22.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 131.2 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.94 43.82 10.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.463 1.105 . . . . 0.0 111.442 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.4 t30 65.17 4.53 2.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.6 2.36 . . . . 0.0 115.746 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.93 143.71 26.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.11 1.364 . . . . 0.0 109.806 174.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.05 136.07 33.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.145 0.978 . . . . 0.0 110.539 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -119.62 114.64 34.21 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.449 1.9 . . . . 0.0 107.01 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.68 146.94 34.74 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.371 2.714 . . . . 0.0 111.16 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.5 165.06 25.77 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.323 0.583 . . . . 0.0 111.43 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.6 pt -128.07 175.7 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 126.456 1.903 . . . . 0.0 110.677 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 59.13 29.05 18.53 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.134 1.774 . . . . 0.0 114.285 170.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.252 1.209 0 C-N-CA 123.925 0.89 . . . . 0.0 108.602 169.511 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -147.57 147.05 29.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.157 1.383 . . . . 0.0 109.154 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -147.16 149.31 32.73 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 p -81.03 -1.62 44.72 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.478 1.111 . . . . 0.0 113.605 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -62.23 132.09 51.58 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.7 m -134.17 128.14 33.43 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -136.39 158.53 44.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.616 0.766 . . . . 0.0 111.617 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.44 134.57 52.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -128.37 141.04 51.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.479 0.657 . . . . 0.0 109.694 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -136.32 151.93 50.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.301 1.44 . . . . 0.0 107.47 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.28 141.77 37.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.935 0.894 . . . . 0.0 109.035 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.65 125.83 35.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.127 1.371 . . . . 0.0 108.692 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -85.08 127.41 34.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 41.1 ttm -158.0 134.71 9.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.924 1.29 . . . . 0.0 108.189 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.95 37.93 18.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.109 1.364 . . . . 0.0 113.313 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.18 8.8 85.52 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.914 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -120.54 164.05 17.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.15 1.78 . . . . 0.0 109.806 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -113.31 124.2 51.93 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -109.04 128.64 55.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -88.69 132.89 34.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.85 133.11 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.18 131.3 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.57 125.29 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB2' ' HE1' ' A' ' 31' ' ' TRP . 12.0 mt-10 -87.14 115.58 24.63 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.813 -2.292 . . . . 0.0 104.813 168.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.69 -33.33 73.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.12 -43.19 78.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 117.75 0.25 . . . . 0.0 110.529 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.38 -15.03 29.61 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.215 1.006 . . . . 0.0 112.964 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 52.84 38.88 27.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.323 1.449 . . . . 0.0 110.57 -169.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.52 139.99 38.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 108.296 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -113.11 116.3 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 122.106 0.955 . . . . 0.0 109.967 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m95 -93.34 105.01 17.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.948 2.099 . . . . 0.0 105.915 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -109.4 123.27 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 51.28 36.24 15.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 111.13 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.44 -2.47 62.37 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.895 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.71 143.75 37.41 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.778 1.789 . . . . 0.0 109.273 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -68.89 146.68 52.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -137.47 166.26 24.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.851 1.261 . . . . 0.0 109.011 169.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.55 144.55 49.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.047 0.539 . . . . 0.0 111.017 -173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -135.5 149.2 49.44 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 109.146 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.39 136.98 54.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.18 95.32 1.15 Allowed Glycine 0 C--N 1.33 0.214 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.91 142.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.26 132.31 55.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.76 167.29 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.079 1.352 . . . . 0.0 110.159 -172.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.93 49.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.261 1.424 . . . . 0.0 109.968 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -162.54 -32.06 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.47 2.308 . . . . 0.0 110.851 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.68 2.5 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -127.43 151.54 48.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.74 106.68 8.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -84.2 102.27 12.48 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -88.1 143.62 26.96 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.516 1.127 . . . . 0.0 110.579 -175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -159.79 -172.43 3.66 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.073 2.149 . . . . 0.0 108.339 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 m -145.29 151.22 38.0 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 0.0 108.818 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.8 mt -136.98 124.08 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.15 -133.37 52.7 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -86.29 -3.86 59.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.174 0.989 . . . . 0.0 112.672 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -98.05 132.61 43.45 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.305 -0.872 . . . . 0.0 109.097 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.55 149.86 28.46 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.5 m -137.02 152.28 49.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.204 1.402 . . . . 0.0 108.009 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 25.3 p90 -146.63 139.59 25.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.958 168.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.3 mt -88.19 113.7 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -80.56 128.85 34.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.79 93.56 3.87 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.95 128.32 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.591 1.157 . . . . 0.0 108.755 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m -74.83 33.47 0.1 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.762 1.225 . . . . 0.0 113.975 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -66.15 155.01 38.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.768 0.827 . . . . 0.0 109.525 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.76 -152.33 52.54 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -68.42 135.88 52.41 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -72.05 -17.22 62.03 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.721 -0.612 . . . . 0.0 112.197 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -67.99 -54.7 16.5 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.021 0.828 . . . . 0.0 110.629 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -143.47 -0.69 1.07 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.33 -12.99 80.01 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.467 1.03 . . . . 0.0 113.395 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -47.73 126.47 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 127.613 2.365 . . . . 0.0 109.764 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.67 120.02 36.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -98.97 130.85 45.35 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -140.21 139.92 35.74 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.791 1.236 . . . . 0.0 108.412 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.81 133.58 33.63 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -112.2 141.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.31 132.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 49.63 37.88 13.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.405 1.082 . . . . 0.0 111.85 -175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 62.66 8.83 3.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.985 2.114 . . . . 0.0 115.464 -174.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.24 148.02 22.61 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.059 1.344 . . . . 0.0 109.399 171.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -90.26 134.03 34.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.469 0.708 . . . . 0.0 110.116 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.04 114.52 37.05 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.137 1.775 . . . . 0.0 108.226 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 148.04 88.35 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.91 3.073 . . . . 0.0 112.171 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.52 156.98 5.52 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.558 0.743 . . . . 0.0 110.293 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.8 pt -59.03 153.17 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.41 0.684 . . . . 0.0 111.778 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.85 93.78 9.56 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.494 0.718 . . . . 0.0 109.688 175.424 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.72 -40.38 69.47 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 122.9 0.48 . . . . 0.0 111.442 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -77.18 142.21 39.74 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -72.34 156.15 39.4 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.313 0.645 . . . . 0.0 110.591 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.72 137.51 52.09 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -135.13 92.47 2.87 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -136.47 147.46 47.18 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.921 0.888 . . . . 0.0 110.344 -173.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.05 125.58 54.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -120.31 144.43 47.84 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -140.09 159.39 42.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.878 1.671 . . . . 0.0 108.042 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.49 137.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 168.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.15 123.69 43.92 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.557 1.143 . . . . 0.0 108.155 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.478 ' CD2' HD21 ' A' ' 18' ' ' ASN . 3.7 t-80 -91.91 121.27 33.35 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 170.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 39.6 mtt -107.44 -163.96 0.94 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.06 1.344 . . . . 0.0 108.573 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.47 -27.79 57.93 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.531 1.133 . . . . 0.0 113.593 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.84 17.89 0.12 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.114 -0.825 . . . . 0.0 113.976 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -140.81 155.85 46.28 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.791 1.237 . . . . 0.0 108.957 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.478 HD21 ' CD2' ' A' ' 13' ' ' HIS . 8.1 m-80 -120.0 114.56 22.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.38 115.28 30.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.3 mtm-85 -79.82 139.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.0 mm -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 t -133.17 118.75 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -83.72 106.64 15.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.357 1.463 . . . . 0.0 107.297 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -72.27 -26.67 62.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.382 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.97 -42.76 72.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.175 0.443 . . . . 0.0 110.523 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.98 -16.17 25.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.495 1.118 . . . . 0.0 113.056 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.83 50.21 19.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.82 1.648 . . . . 0.0 110.473 -169.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -116.52 159.32 22.26 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.283 1.433 . . . . 0.0 108.369 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.69 117.98 36.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.404 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.4 m95 -88.87 125.55 34.98 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.976 1.711 . . . . 0.0 108.198 171.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -115.87 128.07 55.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.14 35.04 12.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.116 0.966 . . . . 0.0 111.894 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.05 87.77 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.412 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.05 143.19 45.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.081 1.941 . . . . 0.0 108.563 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -72.18 141.89 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.756 1.162 . . . . 0.0 109.16 175.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.82 169.4 9.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.694 0.798 . . . . 0.0 111.491 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.8 145.67 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.599 1.16 . . . . 0.0 110.075 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 p -141.86 149.86 40.82 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 109.646 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.59 139.68 49.24 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.9 104.93 1.19 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -90.0 149.81 22.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.0 139.41 52.54 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.73 167.91 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.491 1.516 . . . . 0.0 110.134 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -76.5 49.9 0.63 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.062 1.345 . . . . 0.0 110.486 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -160.22 -35.75 0.05 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.86 2.464 . . . . 0.0 109.849 -170.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.28 -150.97 22.43 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.04 148.46 38.83 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -123.59 107.28 11.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -94.02 105.0 17.02 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -90.49 146.65 23.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.062 1.345 . . . . 0.0 111.055 -172.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -157.7 -179.59 8.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.867 2.067 . . . . 0.0 108.185 169.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -144.34 146.55 32.63 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.101 -0.999 . . . . 0.0 109.949 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.4 mt -143.23 131.33 19.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.28 -130.3 50.82 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -104.75 32.0 4.4 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.66 1.184 . . . . 0.0 111.053 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -129.58 146.57 51.37 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.748 1.219 . . . . 0.0 109.271 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.05 150.37 22.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 109.515 170.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.53 151.62 51.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.777 1.631 . . . . 0.0 108.294 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.501 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 23.2 p90 -148.48 142.79 26.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.954 -0.466 . . . . 0.0 110.079 168.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.7 mt -88.05 118.78 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -89.54 101.73 14.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.23 91.14 7.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.85 129.58 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.872 1.669 . . . . 0.0 109.192 -169.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 m -82.35 33.55 0.41 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.829 1.195 . . . . 0.0 112.262 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -60.09 -25.62 65.56 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.031 1.332 . . . . 0.0 114.307 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.88 -20.22 79.77 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.21 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 50.52 38.34 18.3 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.306 1.442 . . . . 0.0 112.191 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -143.15 165.93 26.07 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.78 1.632 . . . . 0.0 107.722 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -57.85 127.44 32.06 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 56.95 21.46 6.22 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.933 1.693 . . . . 0.0 113.398 -176.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.39 33.56 2.73 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.223 1.392 . . . . 0.0 112.343 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.51 131.19 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.0 135.12 26.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -110.11 126.65 54.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -132.01 142.47 49.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.18 131.58 37.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.501 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.84 143.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.4 t -138.49 130.44 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.68 39.74 14.26 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.058 0.943 . . . . 0.0 111.754 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 64.79 3.71 2.13 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.86 2.064 . . . . 0.0 115.001 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -89.89 147.24 23.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.369 -1.457 . . . . 0.0 109.195 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.76 134.28 34.87 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.717 0.807 . . . . 0.0 110.125 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.9 mm -119.24 114.76 34.7 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.816 1.646 . . . . 0.0 108.287 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -67.71 143.37 61.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.049 3.166 . . . . 0.0 111.962 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.85 161.16 13.19 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.284 0.634 . . . . 0.0 109.887 171.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 pt -69.72 153.94 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.47 0.708 . . . . 0.0 111.679 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.54 25.44 6.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.055 1.342 . . . . 0.0 111.957 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.391 1.476 . . . . 0.0 109.955 178.526 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 121.172 0.511 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.62 153.44 51.65 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.869 1.668 . . . . 0.0 108.511 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -137.88 149.75 46.53 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.412 1.085 . . . . 0.0 108.496 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.3 m -81.89 45.96 0.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.757 1.223 . . . . 0.0 112.003 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -65.45 -37.13 85.96 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.234 -0.916 . . . . 0.0 111.103 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m 52.11 70.39 0.56 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.174 1.39 . . . . 0.0 110.506 -175.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.4 p -137.9 144.43 41.33 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.741 1.216 . . . . 0.0 109.883 -174.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.85 131.69 54.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -110.49 149.19 30.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -135.19 163.82 29.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.994 1.718 . . . . 0.0 107.196 169.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.12 140.81 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.33 44.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.099 1.359 . . . . 0.0 108.954 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -101.49 125.9 48.2 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.85 0.86 . . . . 0.0 109.018 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.26 139.89 27.44 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.13 0.972 . . . . 0.0 109.059 170.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 45.32 45.97 10.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 114.003 169.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.08 -1.31 80.58 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.042 -0.866 . . . . 0.0 114.313 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -109.77 159.64 17.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.74 1.616 . . . . 0.0 110.429 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -119.77 130.29 54.88 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -110.04 107.07 16.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 107.747 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -73.5 129.69 38.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.1 mm -108.78 136.35 44.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.41 118.82 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.2 tp -88.36 128.53 35.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HA ' HG22 ' A' ' 7' ' ' THR . 44.7 mm-40 -85.5 109.46 18.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 169.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -72.24 -30.98 65.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.15 0.886 . . . . 0.0 111.865 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.49 -42.83 74.26 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.234 . . . . 0.0 111.047 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.2 -17.0 23.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -173.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 55.6 28.36 11.8 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.943 1.697 . . . . 0.0 112.464 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.79 149.55 25.66 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.05 125.12 67.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -97.22 138.09 35.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.669 1.187 . . . . 0.0 107.947 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -120.99 119.8 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 45.78 41.82 8.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.596 1.558 . . . . 0.0 112.038 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.25 6.71 75.8 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.019 -0.879 . . . . 0.0 114.412 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.24 152.08 23.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.121 1.46 . . . . 0.0 107.74 173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.91 148.19 28.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -129.99 165.04 22.96 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.18 0.992 . . . . 0.0 110.793 170.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.76 148.08 35.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.963 1.305 . . . . 0.0 110.436 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -139.28 149.16 43.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.268 1.027 . . . . 0.0 109.981 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.94 141.68 50.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.99 106.47 1.21 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.08 149.26 21.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -121.27 138.58 54.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.406 0.682 . . . . 0.0 109.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.15 167.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.468 1.507 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.03 48.53 0.6 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.057 1.343 . . . . 0.0 110.594 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -159.88 -31.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.862 2.465 . . . . 0.0 110.713 -171.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.42 -151.93 23.35 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -122.25 151.03 41.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -125.94 106.95 10.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.554 1.542 . . . . 0.0 107.095 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.8 m -92.32 103.54 15.97 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -90.23 147.26 23.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.788 1.235 . . . . 0.0 111.12 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.54 -178.33 7.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 108.37 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.3 m -145.07 149.55 35.28 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.291 1.036 . . . . 0.0 109.375 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.5 mt -134.05 111.21 14.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.65 -134.0 51.48 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -169.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -78.19 -14.09 59.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 112.462 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -88.19 126.74 35.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.61 150.1 24.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.617 0.722 . . . . 0.0 109.311 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -137.15 151.87 49.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.566 1.546 . . . . 0.0 107.919 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.432 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 15.9 p90 -148.18 142.17 25.89 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 168.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.16 120.43 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -85.66 118.23 25.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 170.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.43 92.36 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.18 129.26 41.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.271 1.428 . . . . 0.0 110.735 -168.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.6 m -81.17 33.28 0.34 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.746 1.219 . . . . 0.0 112.713 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -69.89 -41.32 74.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.08 0.952 . . . . 0.0 110.68 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.22 -168.12 37.27 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -58.44 135.34 57.23 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.136 -0.626 . . . . 0.0 109.467 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.6 -19.59 64.46 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.724 -0.61 . . . . 0.0 112.598 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -66.33 -58.52 5.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.907 0.776 . . . . 0.0 109.679 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -147.8 3.72 0.74 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.15 14.54 61.93 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.266 0.936 . . . . 0.0 113.566 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.24 127.14 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.645 1.578 . . . . 0.0 107.97 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.15 126.57 40.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -106.8 122.73 46.97 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -133.02 141.09 48.07 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.402 1.081 . . . . 0.0 108.523 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -88.43 133.13 34.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.432 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.84 141.04 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 169.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -138.18 132.38 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 49.97 37.54 14.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.064 0.935 . . . . 0.0 111.882 -176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.8 t30 62.56 10.17 3.91 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.927 2.091 . . . . 0.0 115.407 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.58 149.13 21.78 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.986 1.315 . . . . 0.0 109.217 171.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -93.21 134.59 35.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.826 0.85 . . . . 0.0 110.094 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.8 mm -121.19 113.67 32.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.532 1.933 . . . . 0.0 107.548 -173.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.91 147.83 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.158 2.572 . . . . 0.0 110.932 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -69.59 164.73 22.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.363 1.065 . . . . 0.0 111.012 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.85 158.24 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 127.016 2.126 . . . . 0.0 109.408 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.53 25.88 4.76 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.156 1.382 . . . . 0.0 111.629 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.2 m . . . . . 0 C--O 1.255 1.388 0 C-N-CA 125.269 1.428 . . . . 0.0 109.902 179.218 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.31 134.11 37.53 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 122.789 0.436 . . . . 0.0 109.866 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -138.19 150.53 46.85 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.539 1.136 . . . . 0.0 108.476 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m -66.35 147.33 53.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.124 0.57 . . . . 0.0 110.572 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.03 138.83 52.48 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 m -136.87 125.03 23.01 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.57 150.26 40.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.038 0.535 . . . . 0.0 110.387 -169.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.6 129.08 55.12 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 169.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.1 m -120.8 143.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -135.19 155.02 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.214 1.806 . . . . 0.0 107.213 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.41 122.73 66.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 168.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.0 tp -115.69 123.2 47.75 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.332 1.053 . . . . 0.0 109.081 -169.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -91.17 135.5 33.74 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.7 mtt -139.39 106.88 5.56 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 61.81 -33.95 0.1 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.617 3.167 . . . . 0.0 116.849 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.75 -32.28 0.03 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.5 2.0 . . . . 0.0 110.154 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -77.01 156.93 31.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.165 0.986 . . . . 0.0 110.167 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -131.76 115.97 16.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -105.76 122.11 45.42 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.389 1.076 . . . . 0.0 108.563 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -73.44 138.61 45.3 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -117.26 132.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.94 117.88 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -86.06 121.13 28.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -82.04 113.03 19.64 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 168.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.75 -24.54 56.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 119.116 -0.468 . . . . 0.0 111.254 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.93 -44.3 69.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.712 0.687 . . . . 0.0 110.131 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.14 -15.4 24.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.489 1.115 . . . . 0.0 113.152 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.8 mmm 52.69 45.08 29.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.816 1.247 . . . . 0.0 109.276 -168.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -114.6 146.39 40.86 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.869 1.668 . . . . 0.0 107.148 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.05 117.41 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.407 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -84.57 119.31 25.05 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.946 1.698 . . . . 0.0 107.047 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.2 t -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.0 36.01 10.96 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.334 1.054 . . . . 0.0 111.919 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.62 3.01 88.8 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.621 -1.1 . . . . 0.0 115.092 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -114.4 145.58 41.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.657 1.728 . . . . 0.0 108.868 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -68.33 141.58 55.76 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.03 163.41 16.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.707 0.803 . . . . 0.0 110.422 169.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -70.87 143.99 50.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 110.199 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -138.52 148.58 44.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 110.162 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.59 143.43 51.17 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.52 108.83 1.47 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -97.76 148.62 23.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.97 135.88 54.74 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.47 167.55 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 110.173 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -77.7 48.1 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.156 1.382 . . . . 0.0 110.554 175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.94 -34.13 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.233 2.213 . . . . 0.0 110.325 -171.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.86 -150.31 20.1 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -121.16 152.11 39.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -125.37 107.16 10.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.794 1.638 . . . . 0.0 106.898 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -91.32 102.7 15.41 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.92 146.43 24.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.674 1.189 . . . . 0.0 110.901 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -158.19 -173.91 4.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.636 1.975 . . . . 0.0 108.646 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 m -144.49 146.75 32.59 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 109.347 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.6 mt -142.18 133.27 25.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.97 -131.07 51.86 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -105.13 34.1 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.511 1.124 . . . . 0.0 110.851 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -131.11 144.32 51.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.733 1.213 . . . . 0.0 109.097 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.35 152.43 19.15 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.502 0.668 . . . . 0.0 109.219 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 m -135.15 151.94 51.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.577 1.551 . . . . 0.0 107.752 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 15.9 p90 -147.81 140.77 24.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.856 -0.527 . . . . 0.0 109.669 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.27 118.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -83.61 120.89 26.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 92.54 3.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.61 125.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.077 1.351 . . . . 0.0 109.373 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 m -81.44 49.77 1.35 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.496 1.118 . . . . 0.0 110.549 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -65.26 159.42 23.84 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.133 1.373 . . . . 0.0 111.574 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.32 -146.46 33.17 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.653 0.644 . . . . 0.0 111.667 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.04 177.79 4.76 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.252 1.021 . . . . 0.0 110.546 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -69.26 -14.72 63.11 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -58.77 156.13 11.7 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.859 0.754 . . . . 0.0 109.522 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.19 53.8 1.53 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.668 1.187 . . . . 0.0 112.709 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.81 49.13 2.8 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.794 1.664 . . . . 0.0 111.111 173.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.65 128.11 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.98 125.81 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -105.78 127.3 53.01 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -136.31 141.51 43.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.174 0.99 . . . . 0.0 108.597 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.55 131.1 36.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.427 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.89 142.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 169.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.0 130.86 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 t70 46.53 43.22 12.04 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.443 1.097 . . . . 0.0 111.448 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 63.69 6.53 2.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.709 2.404 . . . . 0.0 115.828 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -99.41 148.27 24.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.586 1.555 . . . . 0.0 109.918 173.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -91.02 137.31 32.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.525 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.3 mm -119.89 113.36 34.47 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.888 2.075 . . . . 0.0 106.929 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.92 147.06 33.8 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.096 2.53 . . . . 0.0 110.965 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.66 164.02 8.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.996 0.918 . . . . 0.0 110.493 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.4 pt -67.12 153.55 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.745 0.818 . . . . 0.0 111.744 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.82 25.78 5.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.091 1.357 . . . . 0.0 111.687 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.252 1.21 0 C-N-CA 125.568 1.547 . . . . 0.0 110.031 179.103 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.61 139.71 57.9 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.509 0.724 . . . . 0.0 111.243 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -141.59 155.63 45.74 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.832 1.253 . . . . 0.0 108.847 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 m -62.48 154.39 28.67 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.651 0.78 . . . . 0.0 110.257 173.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -74.79 120.44 20.34 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.1 m -76.51 -41.71 45.88 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.867 0.467 . . . . 0.0 109.881 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -70.76 155.62 40.54 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.317 1.047 . . . . 0.0 111.122 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -117.49 137.85 52.26 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -120.98 149.59 42.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -140.41 151.83 45.23 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.72 1.608 . . . . 0.0 108.337 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -107.34 135.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.85 117.76 29.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -87.54 120.98 29.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 43.2 ttm -155.79 131.5 9.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -170.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 50.5 36.67 14.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 113.072 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.27 74.76 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.039 0.828 . . . . 0.0 113.975 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -108.39 170.62 7.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.489 1.916 . . . . 0.0 109.383 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -131.84 111.58 11.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -102.52 131.24 49.36 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -93.68 124.05 37.41 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.93 138.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.96 125.71 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -90.09 129.99 36.32 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -98.14 112.47 24.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.355 1.462 . . . . 0.0 107.722 168.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -74.91 -22.18 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.79 -0.569 . . . . 0.0 112.322 -170.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.48 -36.52 80.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.194 0.452 . . . . 0.0 111.207 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.49 -4.35 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 113.052 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.8 mtp 53.35 37.84 26.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.563 1.145 . . . . 0.0 109.564 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -92.34 147.53 22.84 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -129.97 119.42 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.451 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 15.3 m95 -85.42 133.52 34.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.495 1.918 . . . . 0.0 108.448 173.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -128.81 126.51 40.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 168.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 52.08 37.69 22.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.304 1.042 . . . . 0.0 111.981 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.87 2.05 90.64 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.379 -1.234 . . . . 0.0 115.617 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.41 148.12 44.82 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.878 1.839 . . . . 0.0 108.171 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -75.52 151.82 37.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.871 1.214 . . . . 0.0 110.189 173.011 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.26 167.67 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.23 1.412 . . . . 0.0 110.215 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.95 147.91 44.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.064 0.946 . . . . 0.0 110.358 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 p -138.3 148.83 45.06 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.665 1.186 . . . . 0.0 109.88 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.0 149.52 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.0 109.41 1.03 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.83 151.8 21.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.72 0.808 . . . . 0.0 109.262 170.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -123.99 140.15 53.26 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.87 167.44 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.726 1.61 . . . . 0.0 110.278 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.17 48.71 0.63 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.07 1.348 . . . . 0.0 110.606 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -160.15 -34.49 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.813 2.445 . . . . 0.0 110.276 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.98 -153.39 24.21 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -117.88 150.19 39.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -124.55 106.85 10.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.1 m -90.95 106.22 18.37 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.04 145.82 24.22 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.799 1.239 . . . . 0.0 110.51 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.47 -169.7 2.69 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.226 1.811 . . . . 0.0 108.423 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -150.15 148.2 28.67 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.927 -1.108 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 93.7 mt -141.1 130.69 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.36 -133.4 51.37 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.07 29.11 4.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.251 1.02 . . . . 0.0 111.654 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -124.22 142.97 50.8 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.56 1.144 . . . . 0.0 109.261 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 150.01 21.35 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -134.84 152.04 51.42 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.764 1.226 . . . . 0.0 108.073 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.42 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 14.2 p90 -147.0 141.74 26.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 168.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.94 120.59 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -87.16 114.84 24.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.58 91.86 3.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -87.77 126.22 41.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.017 1.327 . . . . 0.0 109.328 -169.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -81.6 50.46 1.49 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.535 1.134 . . . . 0.0 110.858 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.8 m -67.86 159.58 30.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.89 1.276 . . . . 0.0 111.776 -177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.63 -164.06 54.51 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.147 0.88 . . . . 0.0 112.707 174.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -65.08 153.89 39.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.98 0.912 . . . . 0.0 109.496 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -73.59 82.85 1.53 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.943 0.897 . . . . 0.0 108.835 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 21.97 2.28 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.697 1.599 . . . . 0.0 111.719 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 54.66 54.65 8.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.118 1.767 . . . . 0.0 112.622 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -98.08 52.61 1.24 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.597 1.094 . . . . 0.0 110.384 171.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.01 129.14 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.73 125.32 43.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -103.18 127.26 50.53 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -134.66 145.02 48.17 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.375 1.07 . . . . 0.0 108.494 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -93.98 130.41 40.1 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.42 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.81 142.48 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 169.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.31 133.19 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.821 1.248 . . . . 0.0 108.088 171.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t0 45.59 42.12 7.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.326 1.451 . . . . 0.0 111.659 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.47 17.64 10.93 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.475 2.31 . . . . 0.0 116.136 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -116.1 152.09 34.32 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.158 169.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -84.73 139.19 32.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.86 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.2 mm -119.53 118.78 32.02 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.358 1.863 . . . . 0.0 106.612 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 142.81 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 111.284 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -69.84 165.84 20.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.532 1.133 . . . . 0.0 111.063 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.7 pt -134.06 162.2 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 126.974 2.11 . . . . 0.0 109.139 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.28 24.63 3.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.017 1.327 . . . . 0.0 111.897 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.25 1.091 0 C-N-CA 126.15 1.78 . . . . 0.0 107.979 -176.204 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.45 143.79 54.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.809 0.844 . . . . 0.0 111.072 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -143.21 144.99 32.39 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.693 1.197 . . . . 0.0 108.1 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -61.55 156.99 18.29 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.121 0.569 . . . . 0.0 109.647 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -67.79 122.13 17.45 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.6 m -140.01 92.32 2.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -170.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.71 147.9 38.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.58 0.752 . . . . 0.0 111.43 -170.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -112.54 137.02 51.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 m -121.85 142.82 49.85 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -133.82 156.43 48.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.193 1.797 . . . . 0.0 107.542 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -124.44 134.4 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -117.94 123.66 46.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.3 113.47 25.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.9 mtm -146.43 138.49 24.92 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.274 1.029 . . . . 0.0 108.449 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.64 36.87 11.45 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.188 1.395 . . . . 0.0 113.249 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.84 -4.16 62.14 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.99 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.41 165.13 11.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.615 1.566 . . . . 0.0 110.348 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -119.67 125.19 48.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.01 123.51 50.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.926 1.291 . . . . 0.0 108.117 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -86.0 123.55 31.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.66 133.23 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 170.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.9 t -128.39 121.43 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.06 121.8 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.483 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 1.2 mm-40 -85.05 112.36 20.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.19 -30.28 62.15 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.969 -0.457 . . . . 0.0 111.908 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.95 -41.52 97.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.856 0.298 . . . . 0.0 110.782 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.38 -14.71 22.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.622 1.169 . . . . 0.0 113.178 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtp 52.79 42.67 31.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.343 1.457 . . . . 0.0 109.924 -168.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -107.13 145.32 32.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.54 1.136 . . . . 0.0 108.496 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -116.52 120.86 66.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.662 0.744 . . . . 0.0 109.823 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.483 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 12.0 m95 -93.84 130.11 40.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.054 1.342 . . . . 0.0 108.291 172.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.2 117.94 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.41 40.71 15.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.84 1.256 . . . . 0.0 111.356 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.12 -9.77 52.09 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.511 -1.161 . . . . 0.0 115.129 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -95.8 135.64 37.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.863 1.832 . . . . 0.0 108.226 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -75.09 147.9 40.21 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.56 1.073 . . . . 0.0 109.148 174.039 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.18 166.58 20.81 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.474 1.11 . . . . 0.0 109.771 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.51 145.98 48.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.156 0.583 . . . . 0.0 111.018 -172.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.92 150.86 48.47 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.843 1.657 . . . . 0.0 109.331 -178.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.6 137.54 52.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.71 100.62 1.62 Allowed Glycine 0 C--N 1.33 0.24 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.62 149.32 22.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.31 126.81 47.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.19 174.74 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.262 1.425 . . . . 0.0 109.59 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -83.64 44.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.896 1.278 . . . . 0.0 110.964 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.39 -31.58 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.872 1.669 . . . . 0.0 111.319 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.78 -157.88 30.42 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.3 150.19 26.19 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -130.73 105.15 7.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.3 m -86.63 99.82 12.0 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -84.29 146.18 27.89 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.922 1.289 . . . . 0.0 110.24 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -158.28 -175.51 5.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.057 1.743 . . . . 0.0 108.469 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -152.16 149.02 28.3 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.784 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -142.32 127.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.14 -126.86 43.33 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -102.68 25.09 9.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -121.07 145.08 48.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.062 1.345 . . . . 0.0 109.048 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.71 147.78 28.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.339 0.656 . . . . 0.0 109.244 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -135.47 151.51 50.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.12 1.368 . . . . 0.0 108.436 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -146.9 141.46 26.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.911 -0.493 . . . . 0.0 109.819 168.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.46 115.18 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -79.23 123.64 27.61 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 169.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.5 92.14 3.86 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 171.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.17 124.56 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.474 1.11 . . . . 0.0 108.214 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 m -81.9 46.79 1.03 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.137 0.88 . . . . 0.0 110.862 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.1 m -65.97 -35.72 81.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.347 1.059 . . . . 0.0 112.657 -169.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.66 15.23 80.73 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 119.231 -0.761 . . . . 0.0 113.702 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -100.26 10.81 40.68 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.764 1.282 . . . . 0.0 112.582 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -153.31 166.88 31.22 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.192 0.997 . . . . 0.0 108.631 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -54.72 147.59 14.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 68.83 -3.19 1.5 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.052 2.141 . . . . 0.0 113.515 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.08 -51.83 2.86 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.075 1.798 . . . . 0.0 114.247 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.23 138.1 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 mm -101.42 120.85 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -97.16 130.61 44.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -139.1 143.55 38.32 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.159 0.983 . . . . 0.0 108.528 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -91.23 130.79 37.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.35 143.41 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.3 t -139.87 132.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.146 1.379 . . . . 0.0 107.715 173.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.68 37.65 13.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 111.868 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.6 t30 62.45 10.23 3.86 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.095 2.158 . . . . 0.0 115.295 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.54 149.81 21.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.04 1.336 . . . . 0.0 109.426 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.78 136.17 33.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.825 0.85 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.87 113.9 39.66 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.008 1.723 . . . . 0.0 107.04 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.55 149.4 30.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.072 2.515 . . . . 0.0 110.96 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.69 155.65 5.58 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.264 1.026 . . . . 0.0 110.81 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.4 pt -67.26 158.17 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.613 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.61 101.97 4.48 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.109 0.564 . . . . 0.0 109.886 176.397 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -149.45 163.69 37.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.95 1.3 . . . . 0.0 108.786 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -82.17 124.94 30.34 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -139.5 153.48 47.5 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.699 1.2 . . . . 0.0 109.565 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -155.19 161.49 41.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.194 1.397 . . . . 0.0 109.028 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.6 m -134.79 157.77 45.89 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.494 1.118 . . . . 0.0 108.613 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.6 p -129.34 158.79 38.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.983 1.713 . . . . 0.0 109.299 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.03 130.55 45.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.6 m -122.51 139.58 53.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -133.91 152.53 51.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.192 1.397 . . . . 0.0 107.57 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.03 140.01 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.21 132.89 55.54 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -106.49 109.97 22.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 170.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.0 mtm -146.18 140.86 26.93 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.311 1.045 . . . . 0.0 108.932 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t0 51.23 35.67 14.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.992 1.317 . . . . 0.0 112.738 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.75 -10.52 18.06 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.713 1.149 . . . . 0.0 113.883 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.57 166.52 13.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.405 1.482 . . . . 0.0 111.063 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.81 129.32 52.54 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.65 116.74 27.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.737 1.215 . . . . 0.0 108.161 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -91.19 117.43 29.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -96.26 132.96 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.0 t -127.97 123.71 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.43 122.64 32.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.16 109.72 20.12 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.164 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -67.68 -27.52 66.9 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.587 -0.696 . . . . 0.0 111.311 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.46 -30.13 70.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.68 -3.65 9.26 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 113.06 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtp 53.19 37.1 24.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.221 1.409 . . . . 0.0 110.77 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -91.86 146.03 24.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.9 p -117.68 113.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 122.172 0.987 . . . . 0.0 109.714 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.449 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 26.9 m95 -83.15 137.67 33.97 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 169.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.38 113.23 11.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 169.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 46.56 42.84 11.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.166 1.386 . . . . 0.0 111.216 -170.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.88 -12.69 28.44 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.786 1.184 . . . . 0.0 114.996 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.11 135.58 33.92 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.817 1.808 . . . . 0.0 108.254 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -76.87 120.02 21.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 mt -77.55 166.7 22.71 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.819 1.295 . . . . 0.0 111.273 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.65 147.89 39.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 112.934 -1.939 . . . . 0.0 107.062 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -144.73 150.55 37.46 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.075 0.95 . . . . 0.0 109.477 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.68 140.11 46.85 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.67 105.86 1.24 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 -172.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -95.74 152.25 18.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.417 0.687 . . . . 0.0 109.195 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.65 139.71 52.63 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -131.2 167.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.605 1.562 . . . . 0.0 110.079 176.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.01 28.05 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.967 1.707 . . . . 0.0 112.825 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' VAL . 32.2 t70 -141.87 -22.04 0.72 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.568 2.747 . . . . 0.0 111.768 -173.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -155.66 26.26 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.65 150.62 37.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -130.0 107.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.938 1.295 . . . . 0.0 107.714 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.2 m -93.85 104.4 16.47 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.4 146.63 24.53 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.092 1.357 . . . . 0.0 110.625 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.08 -174.39 4.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.224 1.809 . . . . 0.0 108.324 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -144.81 149.7 35.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.352 1.061 . . . . 0.0 108.96 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.6 mt -134.43 113.82 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.2 -135.15 50.3 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.87 -13.45 59.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.608 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -88.51 127.46 35.53 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.531 -0.731 . . . . 0.0 109.472 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.37 149.01 26.31 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 169.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.64 153.32 47.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.686 1.594 . . . . 0.0 108.448 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -147.69 143.67 27.79 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.763 -0.586 . . . . 0.0 109.66 168.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -88.29 117.95 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 169.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -84.55 117.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.62 89.88 3.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.38 126.84 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 109.095 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -83.77 54.91 3.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.138 1.335 . . . . 0.0 110.476 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.8 m -72.52 -36.25 68.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.85 0.86 . . . . 0.0 111.488 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.42 138.85 22.36 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -79.25 -27.94 42.39 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.121 0.569 . . . . 0.0 111.067 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -63.39 155.44 28.94 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.011 0.924 . . . . 0.0 109.657 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -57.09 141.75 44.84 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.21 37.36 28.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.797 1.239 . . . . 0.0 111.061 -175.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.87 21.74 10.79 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.855 1.217 . . . . 0.0 113.488 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.9 mm -68.98 137.0 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.048 0.939 . . . . 0.0 109.422 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.84 117.34 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -92.07 127.7 37.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -133.59 144.29 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.467 1.107 . . . . 0.0 108.237 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -94.22 129.61 40.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.4 142.35 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.7 t -137.22 131.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.031 1.332 . . . . 0.0 107.84 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t0 45.11 42.36 6.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.281 1.432 . . . . 0.0 111.682 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 64.56 17.09 10.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.711 2.404 . . . . 0.0 116.125 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.11 152.41 31.13 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.643 1.177 . . . . 0.0 111.027 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -85.86 138.82 31.77 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.727 1.211 . . . . 0.0 110.692 -172.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.65 118.44 33.47 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.228 1.811 . . . . 0.0 106.714 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.19 150.43 33.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.861 2.374 . . . . 0.0 111.002 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -56.84 158.0 5.11 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.599 0.76 . . . . 0.0 110.423 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.9 pt -59.91 154.31 3.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.584 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.83 93.73 9.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.255 1.353 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.905 175.228 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -149.76 147.25 27.8 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.821 1.248 . . . . 0.0 108.969 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -135.37 147.91 49.21 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.625 1.17 . . . . 0.0 108.875 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 m -64.42 146.35 54.64 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.408 0.683 . . . . 0.0 110.68 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -80.32 158.56 26.06 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.34 125.97 28.69 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -177.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -146.6 157.51 43.73 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.031 1.332 . . . . 0.0 109.061 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -125.65 132.52 52.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 m -112.42 142.93 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -132.9 162.33 31.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.856 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 t -128.81 135.32 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.97 117.64 29.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -88.45 114.1 24.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 169.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.5 mtm -146.35 137.26 24.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.446 1.098 . . . . 0.0 108.426 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.24 38.14 12.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.319 1.448 . . . . 0.0 113.22 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.91 -1.07 69.84 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.254 0.93 . . . . 0.0 114.176 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -105.6 166.04 10.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.087 1.755 . . . . 0.0 110.116 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -122.66 121.28 36.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -109.39 120.99 44.21 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.66 1.184 . . . . 0.0 108.308 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -78.06 145.11 36.05 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.9 mm -125.57 133.03 70.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.35 120.48 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -85.91 122.45 29.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -88.78 112.23 22.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -72.56 -21.02 61.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.533 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.69 -35.98 81.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.869 0.759 . . . . 0.0 111.601 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.25 -0.99 9.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.119 1.368 . . . . 0.0 113.285 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.4 mtp 52.72 39.52 28.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.727 1.211 . . . . 0.0 110.592 -169.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.96 144.7 26.62 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.428 1.091 . . . . 0.0 108.245 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -114.02 115.68 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 109.862 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.457 ' CZ3' ' HE2' ' A' ' 36' ' ' LYS . 51.7 m95 -83.2 115.31 21.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 169.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.53 128.47 55.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 52.68 34.95 17.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.542 0.737 . . . . 0.0 111.705 -170.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.25 77.51 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.425 1.012 . . . . 0.0 114.65 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -125.44 138.0 54.0 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' HE2' ' CZ3' ' A' ' 31' ' ' TRP 0.3 0.0 OUTLIER -75.71 146.42 40.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.733 1.606 . . . . 0.0 110.068 175.552 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.73 167.93 19.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.007 1.323 . . . . 0.0 110.16 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.48 148.34 49.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.6 0.714 . . . . 0.0 111.531 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -136.38 150.46 48.81 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.067 1.747 . . . . 0.0 108.99 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.31 139.76 52.24 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.49 107.35 1.62 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -96.86 151.15 19.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -117.44 139.59 50.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.401 0.681 . . . . 0.0 109.326 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.97 167.75 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.663 1.585 . . . . 0.0 110.023 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -76.94 49.74 0.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.171 1.388 . . . . 0.0 110.501 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.79 -34.98 0.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.902 2.481 . . . . 0.0 109.991 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.41 -151.58 23.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.75 148.2 40.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -125.83 107.26 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 m -91.03 103.34 16.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -87.29 147.08 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.911 1.284 . . . . 0.0 110.742 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.53 -178.99 7.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.591 1.957 . . . . 0.0 108.062 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 m -146.63 150.73 36.02 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.952 0.901 . . . . 0.0 109.186 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.99 108.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.34 -15.84 59.2 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.688 0.795 . . . . 0.0 112.425 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -85.88 120.81 27.69 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.63 146.4 25.75 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.634 0.73 . . . . 0.0 109.884 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.4 m -136.89 151.78 49.47 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.041 1.736 . . . . 0.0 108.445 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -148.66 142.17 25.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.837 -0.539 . . . . 0.0 109.818 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -88.1 119.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -88.75 102.45 15.02 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.28 88.14 6.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.56 134.87 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.263 1.825 . . . . 0.0 110.351 -169.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m -88.61 28.7 1.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.762 0.825 . . . . 0.0 112.646 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.2 m -66.04 -37.02 84.81 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.66 1.184 . . . . 0.0 111.407 -173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.33 33.42 4.33 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.671 1.129 . . . . 0.0 111.748 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.8 mttm 71.01 173.37 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.715 2.006 . . . . 0.0 110.87 -169.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.34 178.34 7.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.695 1.198 . . . . 0.0 111.132 -169.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.7 tttp 50.93 -119.22 1.37 Allowed 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 126.34 1.856 . . . . 0.0 110.266 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.94 -21.51 64.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.619 1.099 . . . . 0.0 111.858 -169.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.14 -8.18 53.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.348 0.975 . . . . 0.0 114.652 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.3 mt -63.73 133.73 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.282 1.433 . . . . 0.0 109.426 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.15 138.49 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.89 129.57 55.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.485 1.039 . . . . 0.0 108.307 172.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 147.71 51.16 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.81 130.43 44.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.431 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.52 143.29 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -140.65 132.35 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 125.009 1.324 . . . . 0.0 107.648 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 48.65 38.24 11.03 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.116 0.96 . . . . 0.0 111.971 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.9 t30 63.7 8.75 3.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.116 2.167 . . . . 0.0 115.428 -175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.25 149.4 21.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.126 1.37 . . . . 0.0 109.781 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.89 136.27 33.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.101 0.96 . . . . 0.0 110.119 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -120.19 116.58 32.4 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.895 1.678 . . . . 0.0 106.901 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.31 143.9 20.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.269 2.646 . . . . 0.0 111.383 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -69.17 162.61 26.68 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.176 0.59 . . . . 0.0 110.666 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.2 pt -113.26 154.47 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 126.016 1.726 . . . . 0.0 109.654 169.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.05 26.35 4.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.138 1.375 . . . . 0.0 111.631 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 C--O 1.256 1.439 0 C-N-CA 125.518 1.527 . . . . 0.0 110.07 179.562 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.75 143.73 51.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.154 0.582 . . . . 0.0 110.23 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -147.5 142.58 27.09 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -65.33 137.93 57.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.102 0.561 . . . . 0.0 109.791 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -74.9 132.61 41.59 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 m -139.42 91.99 2.54 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -139.6 148.21 42.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -110.21 130.5 55.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 m -121.64 142.63 49.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.492 0.663 . . . . 0.0 109.584 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -135.57 159.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.468 1.907 . . . . 0.0 106.941 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.42 141.36 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 169.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.51 134.2 46.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.053 1.341 . . . . 0.0 108.94 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -101.52 132.1 47.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.601 0.76 . . . . 0.0 109.278 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -138.24 133.08 32.73 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 56.28 -61.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.392 3.077 . . . . 0.0 115.975 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.97 15.17 0.08 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.323 1.916 . . . . 0.0 112.042 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -130.06 159.17 37.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.954 1.702 . . . . 0.0 109.179 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -121.1 130.93 53.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -110.02 109.51 20.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.656 1.182 . . . . 0.0 107.954 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -74.08 119.68 18.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 mm -96.6 131.2 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.63 116.38 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.94 122.83 31.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -82.59 113.27 20.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -71.75 -27.11 62.75 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.532 0.333 . . . . 0.0 111.634 -169.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.86 -45.63 41.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.38 0.537 . . . . 0.0 110.609 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.28 -17.07 28.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.172 0.989 . . . . 0.0 112.952 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.251 98.8 mmm 55.76 28.81 12.82 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.331 1.452 . . . . 0.0 111.357 -169.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.28 146.32 25.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.04 118.68 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -85.02 132.88 34.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.781 1.633 . . . . 0.0 108.1 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -118.22 116.3 26.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 168.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 46.39 42.4 10.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.859 1.264 . . . . 0.0 111.265 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.51 -11.36 39.29 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.616 1.103 . . . . 0.0 115.004 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.49 138.14 31.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.77 1.785 . . . . 0.0 108.588 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -68.94 145.9 53.24 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.8 163.64 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.944 0.898 . . . . 0.0 110.573 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.18 148.06 39.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.563 1.145 . . . . 0.0 110.285 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -140.62 149.41 42.28 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.399 1.08 . . . . 0.0 109.908 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.65 50.19 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.85 108.35 1.94 Allowed Glycine 0 C--N 1.331 0.263 0 N-CA-C 106.994 -2.442 . . . . 0.0 106.994 -174.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -94.55 148.96 21.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.38 137.16 52.38 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.585 0.754 . . . . 0.0 109.011 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.43 167.9 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.601 1.56 . . . . 0.0 109.919 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.7 47.88 0.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.071 1.348 . . . . 0.0 110.47 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -159.91 -34.9 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.274 2.23 . . . . 0.0 110.165 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.62 12.59 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -120.52 152.59 37.85 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.32 107.56 9.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.713 1.605 . . . . 0.0 106.948 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.9 m -93.93 102.93 15.04 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -89.76 148.15 23.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.907 1.283 . . . . 0.0 111.22 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -158.96 -177.63 6.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.907 2.083 . . . . 0.0 108.26 169.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.0 m -144.91 146.63 32.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.175 0.99 . . . . 0.0 109.709 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.0 mt -142.39 132.83 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.87 -127.19 44.68 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -109.57 36.48 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 110.526 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -131.86 145.99 51.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.043 1.337 . . . . 0.0 108.778 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.96 150.44 21.95 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.37 151.02 51.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.427 1.491 . . . . 0.0 107.839 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 29.7 p90 -148.66 140.64 23.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 121.804 -0.56 . . . . 0.0 110.285 168.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -87.51 117.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -84.96 127.88 34.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 170.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.46 96.52 4.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.63 125.18 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.104 0.962 . . . . 0.0 109.574 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -79.22 49.48 0.97 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.473 1.109 . . . . 0.0 111.125 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 m -66.15 160.54 23.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.086 1.354 . . . . 0.0 111.307 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.44 -148.43 37.21 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 123.57 0.605 . . . . 0.0 111.675 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -71.37 173.02 8.39 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.002 0.921 . . . . 0.0 110.642 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -67.67 -26.7 66.33 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.804 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -59.21 145.65 42.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.98 107.67 0.9 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.271 1.028 . . . . 0.0 111.444 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -145.26 43.82 0.92 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.24 1.876 . . . . 0.0 108.477 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.36 128.87 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.4 mm -88.29 113.07 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -95.74 129.18 43.04 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -137.51 140.19 40.97 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 tp -86.55 133.46 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.528 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -112.66 142.63 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 169.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.23 130.46 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.2 39.6 15.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.241 1.016 . . . . 0.0 111.97 -175.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 64.32 4.42 2.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.819 2.047 . . . . 0.0 115.006 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.3 147.21 23.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 120.449 -1.407 . . . . 0.0 109.189 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.95 133.55 35.6 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.371 0.668 . . . . 0.0 109.97 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.0 mm -117.28 111.99 39.88 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.193 1.797 . . . . 0.0 107.081 -175.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -73.23 152.58 50.45 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.908 2.405 . . . . 0.0 110.726 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -54.25 156.94 2.89 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.243 1.017 . . . . 0.0 111.257 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 pt -60.64 155.64 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.406 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.13 103.07 4.84 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.254 1.309 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.149 176.477 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 24' ' ' GLU . 13.8 p . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.224 0.535 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.67 138.31 49.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.6 m -119.89 142.97 48.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -132.69 152.68 51.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.011 1.325 . . . . 0.0 107.562 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.1 119.46 29.51 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -92.4 113.52 25.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 mtm -146.07 137.34 24.68 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.404 1.082 . . . . 0.0 108.627 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.07 37.74 15.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.168 1.387 . . . . 0.0 113.102 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.22 -4.0 60.28 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.125 0.869 . . . . 0.0 114.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.08 164.87 11.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.84 1.656 . . . . 0.0 110.056 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -121.01 124.37 44.68 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -110.57 132.49 54.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.956 1.303 . . . . 0.0 108.352 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.38 131.94 37.15 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.4 mm -110.1 134.36 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.37 121.86 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.85 123.5 32.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.92 113.03 23.17 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -75.7 -18.02 59.75 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.831 -0.543 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.27 -35.71 79.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.18 0.445 . . . . 0.0 111.266 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.44 -0.07 8.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.267 1.427 . . . . 0.0 113.434 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.7 mmt 52.14 49.13 21.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.106 0.955 . . . . 0.0 109.267 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -117.53 142.51 47.09 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.211 1.404 . . . . 0.0 107.879 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.78 119.79 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.774 0.797 . . . . 0.0 108.913 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.445 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 20.9 m95 -85.93 129.39 34.85 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.298 1.839 . . . . 0.0 108.994 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.8 t -118.33 119.26 34.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 168.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 47.89 41.52 14.71 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.989 1.316 . . . . 0.0 111.691 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.22 -7.05 61.45 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.603 -1.11 . . . . 0.0 115.221 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.84 137.83 39.62 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.751 1.775 . . . . 0.0 107.539 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -72.93 147.5 45.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.967 1.258 . . . . 0.0 109.997 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pp -117.07 168.58 10.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.953 1.301 . . . . 0.0 110.302 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.05 145.41 48.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.073 0.949 . . . . 0.0 110.138 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -143.13 151.19 40.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.478 1.111 . . . . 0.0 109.875 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.44 136.18 48.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.43 96.22 1.24 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -86.66 146.02 26.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -111.52 134.25 53.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.35 167.56 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.196 1.399 . . . . 0.0 110.116 -172.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.85 49.24 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.241 1.416 . . . . 0.0 110.309 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -159.95 -36.57 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.37 2.268 . . . . 0.0 109.892 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.26 -132.18 3.65 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -120.76 151.54 39.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -129.97 106.48 8.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.6 m -85.76 100.1 11.79 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -84.36 145.44 28.22 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.71 1.204 . . . . 0.0 110.393 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -158.45 -178.25 7.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.14 1.776 . . . . 0.0 108.762 169.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -145.81 150.47 36.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.36 1.064 . . . . 0.0 109.108 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mt -133.66 111.67 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.0 -131.26 51.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -169.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -81.16 -10.5 59.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.609 0.764 . . . . 0.0 112.653 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.78 30.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -171.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.15 26.97 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 109.578 169.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -138.26 152.5 48.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.871 1.668 . . . . 0.0 108.725 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.65 141.32 24.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 121.725 -0.609 . . . . 0.0 109.648 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -88.71 114.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -75.94 126.85 31.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.52 88.69 2.98 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.98 123.33 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.755 1.222 . . . . 0.0 108.381 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 119.313 0.96 . . . . 0.0 109.908 175.243 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.57 120.63 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.057 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -100.3 127.75 46.53 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -139.3 140.31 37.55 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 108.704 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.2 131.85 34.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.82 142.81 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.42 133.3 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t0 49.9 37.09 12.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.293 1.037 . . . . 0.0 111.874 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.2 t30 62.48 9.96 3.71 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.829 2.051 . . . . 0.0 115.444 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.52 150.54 20.21 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 125.063 1.345 . . . . 0.0 109.261 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.81 135.15 34.13 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.719 0.808 . . . . 0.0 110.059 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.8 mm -118.71 113.9 36.05 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.356 1.862 . . . . 0.0 106.922 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -74.64 151.43 41.44 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.948 2.432 . . . . 0.0 110.811 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.294 0.569 . . . . 0.0 109.828 176.464 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 24' ' ' GLU . 2.7 p . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.362 0.601 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -121.39 136.95 54.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.0 m -128.43 141.96 51.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -135.66 159.65 40.96 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.874 1.67 . . . . 0.0 107.553 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -124.82 140.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.02 125.78 42.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.821 1.248 . . . . 0.0 108.425 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -84.5 121.11 27.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.4 ttm -158.02 140.29 14.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.414 1.086 . . . . 0.0 108.277 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 51.67 37.43 20.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.163 1.385 . . . . 0.0 113.118 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.02 8.69 83.38 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 123.94 0.781 . . . . 0.0 113.653 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -123.81 173.82 7.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.506 1.922 . . . . 0.0 109.584 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -121.92 122.3 39.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.91 127.12 53.15 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -79.6 139.8 37.35 Favored 'General case' 0 N--CA 1.46 0.054 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -114.72 130.62 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.61 117.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -85.46 122.77 30.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.8 OUTLIER -79.83 112.9 17.57 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.2 -31.6 67.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 119.205 -0.426 . . . . 0.0 112.095 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.38 -47.34 56.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.327 0.512 . . . . 0.0 110.556 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.66 -18.17 28.5 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.78 0.832 . . . . 0.0 112.946 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.258 51.8 mtp 55.44 30.27 14.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.444 1.497 . . . . 0.0 111.552 -169.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.48 152.91 21.57 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.32 115.77 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -85.28 122.65 29.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.581 1.552 . . . . 0.0 107.355 174.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 t -114.73 125.98 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 49.86 36.83 12.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.293 1.037 . . . . 0.0 111.591 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.51 0.51 84.14 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 118.541 -1.144 . . . . 0.0 115.255 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -113.78 146.38 39.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.825 1.812 . . . . 0.0 109.235 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -66.71 147.04 53.8 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.339 -0.85 . . . . 0.0 108.998 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.35 168.16 12.86 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.618 1.167 . . . . 0.0 110.197 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.16 145.39 44.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.306 1.042 . . . . 0.0 110.117 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -140.85 149.52 42.09 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 109.88 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.3 140.39 48.57 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.8 109.86 2.0 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -175.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.26 149.06 25.07 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.538 0.735 . . . . 0.0 109.563 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.97 141.64 37.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.321 0.649 . . . . 0.0 109.521 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.13 166.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.753 1.621 . . . . 0.0 109.897 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -77.92 48.39 0.71 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.133 1.373 . . . . 0.0 110.443 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -161.31 -31.77 0.05 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.437 2.295 . . . . 0.0 110.856 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.8 -134.85 4.41 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -130.82 151.83 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.39 110.83 12.7 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.5 m -92.17 104.89 17.22 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.72 147.12 24.04 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.807 1.243 . . . . 0.0 110.666 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -157.51 -177.62 6.72 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.059 1.744 . . . . 0.0 108.635 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.93 147.54 31.84 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.346 1.058 . . . . 0.0 109.465 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.5 mt -143.67 130.53 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.98 -131.36 51.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.17 28.92 4.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.702 1.201 . . . . 0.0 111.536 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -124.29 149.26 46.73 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.968 1.307 . . . . 0.0 109.17 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 150.72 24.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.92 152.82 52.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.464 1.506 . . . . 0.0 108.318 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -147.68 143.45 27.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.686 -0.634 . . . . 0.0 109.6 168.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.84 117.49 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 169.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -83.07 115.8 22.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.19 90.59 3.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.98 122.24 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.02 1.328 . . . . 0.0 108.587 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 119.203 0.911 . . . . 0.0 108.884 177.389 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.0 mm -102.46 120.88 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -96.44 125.63 41.07 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -132.69 145.82 51.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.345 1.058 . . . . 0.0 108.547 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 tp -93.44 131.95 38.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.78 141.95 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.6 131.36 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.61 40.47 15.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.282 1.033 . . . . 0.0 111.796 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 66.77 1.36 2.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.857 2.063 . . . . 0.0 115.282 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.55 147.48 23.32 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 120.456 -1.403 . . . . 0.0 109.325 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.05 133.88 34.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.619 0.768 . . . . 0.0 109.822 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.1 mm -118.22 113.38 37.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 107.285 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.19 155.16 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.391 2.727 . . . . 0.0 111.137 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 123.63 0.772 . . . . 0.0 110.897 177.838 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 24' ' ' GLU . 24.7 p . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.775 0.798 . . . . 0.0 111.634 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -120.44 132.4 55.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.0 m -119.51 143.04 47.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -136.29 156.18 49.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.121 1.368 . . . . 0.0 108.247 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -116.11 134.74 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.62 110.38 15.92 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -82.55 111.25 18.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 53.0 mtm -147.53 139.8 24.46 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.565 1.146 . . . . 0.0 108.687 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 50.15 36.11 11.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.162 1.385 . . . . 0.0 112.914 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.97 -7.29 36.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.536 1.065 . . . . 0.0 113.718 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.55 171.09 9.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.715 1.606 . . . . 0.0 110.706 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -128.62 111.46 13.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.304 1.442 . . . . 0.0 107.17 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -99.07 129.14 45.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -88.42 135.88 33.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.03 133.76 62.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -131.67 122.19 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -88.14 127.4 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.424 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -97.01 113.32 24.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -69.39 -25.11 63.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -172.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -37.35 84.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.225 0.466 . . . . 0.0 111.494 -174.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.76 -5.54 11.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.096 1.358 . . . . 0.0 113.018 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 71.8 mtp 54.37 31.03 13.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.845 1.258 . . . . 0.0 110.353 -168.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.36 147.7 32.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.76 119.5 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.411 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 8.2 m95 -85.45 126.65 33.97 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.481 1.513 . . . . 0.0 107.908 172.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.43 121.37 44.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 46.42 38.94 5.87 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.054 1.341 . . . . 0.0 111.832 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.58 62.53 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.901 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.42 141.21 31.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.724 1.762 . . . . 0.0 108.618 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -69.28 143.97 53.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.21 164.79 17.21 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.944 0.898 . . . . 0.0 110.19 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.32 146.17 43.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.155 0.982 . . . . 0.0 110.243 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -139.72 149.85 44.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.624 1.17 . . . . 0.0 109.824 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.88 140.98 49.25 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.44 106.1 1.36 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.43 151.49 19.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.35 139.08 54.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.585 0.754 . . . . 0.0 109.057 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.12 167.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.424 1.49 . . . . 0.0 110.305 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.07 49.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.705 1.24 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -159.09 -35.12 0.06 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.614 2.366 . . . . 0.0 110.191 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.62 -153.06 23.71 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -118.24 150.83 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -126.01 106.74 9.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.55 1.54 . . . . 0.0 107.098 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 m -91.94 102.57 15.14 Favored 'General case' 0 N--CA 1.46 0.041 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -87.76 146.82 25.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.832 1.253 . . . . 0.0 110.662 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.54 -179.89 8.59 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.011 1.724 . . . . 0.0 108.68 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 m -145.76 150.77 36.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.191 0.997 . . . . 0.0 108.941 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.4 mt -133.01 110.85 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.89 -131.46 52.06 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.02 -9.99 59.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.478 0.711 . . . . 0.0 112.578 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.59 29.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.85 147.19 25.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.77 152.34 49.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.168 1.787 . . . . 0.0 108.685 -173.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -149.4 140.57 23.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.761 -0.587 . . . . 0.0 109.838 168.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -87.71 120.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -87.16 122.9 31.59 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.32 93.53 4.16 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -90.18 125.5 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.377 1.071 . . . . 0.0 108.941 -169.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 m . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 124.368 1.067 . . . . 0.0 111.904 -179.813 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.1 mm -88.78 115.03 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.98 127.87 41.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -135.21 144.19 46.81 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.72 130.58 41.18 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.4 142.75 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.77 132.43 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 107.565 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.3 37.71 12.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.084 0.954 . . . . 0.0 111.948 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.62 9.88 3.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.152 2.181 . . . . 0.0 115.542 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.7 150.8 19.97 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.232 1.413 . . . . 0.0 109.578 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.47 136.46 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.346 1.059 . . . . 0.0 110.227 -176.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.9 mm -120.65 116.16 31.94 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.3 1.84 . . . . 0.0 107.005 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.8 144.27 19.19 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 111.269 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.237 0.423 0 C-N-CA 123.054 0.542 . . . . 0.0 111.312 -178.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.909 0.862 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -118.32 129.53 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 168.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.8 m -112.52 145.42 40.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -133.92 161.42 34.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.459 1.504 . . . . 0.0 108.0 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.03 137.94 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.3 mt -121.57 113.22 19.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -81.06 122.14 26.95 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 168.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 58.3 mtt -130.42 -173.68 3.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.362 1.865 . . . . 0.0 108.079 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -51.1 90.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.603 1.561 . . . . 0.0 113.369 -169.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 13.12 79.13 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.214 1.388 . . . . 0.0 114.116 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -139.99 162.34 35.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.448 1.624 . . . . 0.0 111.123 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -128.61 119.88 25.58 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 125.612 1.565 . . . . 0.0 106.938 172.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.03 131.53 54.49 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.03 0.932 . . . . 0.0 109.239 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -80.75 145.93 31.27 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 mm -122.39 132.61 70.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.22 119.99 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -88.4 123.13 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -90.89 113.2 25.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 168.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -70.78 -19.98 62.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.128 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.18 -42.36 94.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.869 0.759 . . . . 0.0 111.591 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.42 -1.01 13.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.24 1.416 . . . . 0.0 112.449 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm 53.11 39.35 29.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.008 1.323 . . . . 0.0 109.954 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.37 141.77 31.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.779 1.232 . . . . 0.0 109.098 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.45 116.76 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.837 0.827 . . . . 0.0 109.972 -173.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.433 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -85.18 115.27 22.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.1 m -118.48 125.87 50.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 49.14 39.35 15.1 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.138 0.975 . . . . 0.0 111.914 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.13 3.55 88.39 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.307 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.59 147.26 46.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.541 1.67 . . . . 0.0 108.23 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 147.75 33.85 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.384 0.993 . . . . 0.0 109.551 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.9 166.57 23.01 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.487 1.115 . . . . 0.0 110.458 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.98 148.83 48.41 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.486 0.714 . . . . 0.0 111.675 -172.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 149.93 48.99 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.786 1.634 . . . . 0.0 109.15 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.6 140.54 52.69 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.51 106.98 1.29 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 -173.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -98.32 153.01 18.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 109.374 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.48 138.55 54.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.38 168.28 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.422 1.489 . . . . 0.0 110.325 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.01 48.35 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.061 1.345 . . . . 0.0 110.794 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -159.99 -35.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.502 2.321 . . . . 0.0 110.448 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.0 -153.65 24.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -118.45 152.41 35.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.57 109.73 10.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.767 1.227 . . . . 0.0 107.849 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 m -94.37 105.75 17.72 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -91.17 146.19 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.97 1.308 . . . . 0.0 110.836 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.01 -174.01 4.53 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.61 1.964 . . . . 0.0 108.701 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.1 m -145.71 146.58 31.31 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.53 1.132 . . . . 0.0 109.4 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.3 mt -142.39 130.12 20.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.46 -130.37 50.89 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -101.06 28.6 5.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.68 1.192 . . . . 0.0 111.548 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -128.52 144.31 51.12 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.65 1.18 . . . . 0.0 109.076 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.77 149.9 21.83 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.4 150.51 50.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.364 1.465 . . . . 0.0 108.212 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -146.82 140.36 25.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.3 mt -90.79 115.5 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 170.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -78.85 134.83 36.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.66 94.04 3.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.93 128.42 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.957 1.303 . . . . 0.0 109.539 -169.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 CA--C 1.546 0.817 0 CA-C-N 119.76 1.164 . . . . 0.0 112.436 -177.209 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.8 mm -79.08 116.5 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -96.51 130.85 43.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 tp -93.34 130.72 38.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.84 140.59 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.35 132.22 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.583 1.153 . . . . 0.0 108.132 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.0 t0 45.53 42.35 7.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.337 1.455 . . . . 0.0 111.613 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 t30 64.52 18.21 11.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.563 2.345 . . . . 0.0 116.002 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -115.75 153.42 31.43 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 120.752 -1.218 . . . . 0.0 110.809 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -89.18 138.08 31.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.955 1.302 . . . . 0.0 110.793 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -121.55 118.09 29.88 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.859 2.064 . . . . 0.0 106.596 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.97 143.39 23.01 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.232 2.621 . . . . 0.0 111.357 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--O 1.237 0.422 0 CA-C-O 121.351 0.596 . . . . 0.0 110.359 177.248 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.2 p . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.174 0.512 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -115.9 128.98 56.2 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.4 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.811 0.815 . . . . 0.0 109.249 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -135.07 157.03 47.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.032 1.333 . . . . 0.0 107.491 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -125.06 137.76 56.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 169.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.7 mt -122.16 125.53 46.33 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.833 1.253 . . . . 0.0 107.628 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -93.31 118.07 30.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.7 mtm -146.41 134.87 21.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.638 1.175 . . . . 0.0 108.416 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.29 37.5 11.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.983 1.313 . . . . 0.0 113.496 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.71 8.1 87.24 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.936 -0.925 . . . . 0.0 114.431 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -118.28 155.22 30.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.81 1.644 . . . . 0.0 110.042 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -107.88 123.52 48.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -111.05 122.66 48.46 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.212 1.405 . . . . 0.0 108.382 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.42 142.32 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -120.72 134.32 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.4 t -132.36 118.59 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -87.11 125.94 34.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.3 OUTLIER -87.79 112.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -70.01 -29.35 66.39 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.791 0.723 . . . . 0.0 111.787 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.42 -43.43 94.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.286 0.494 . . . . 0.0 110.996 -173.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.87 -11.68 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.639 1.176 . . . . 0.0 113.003 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.9 mtp 54.55 34.35 21.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 110.519 -169.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -93.13 150.89 20.19 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.28 117.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.53 121.84 30.47 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.74 1.616 . . . . 0.0 107.604 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -113.63 130.57 56.37 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 52.26 35.51 17.13 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.82 0.848 . . . . 0.0 111.6 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.43 10.17 82.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.209 0.909 . . . . 0.0 114.835 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -124.34 136.58 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.379 1.472 . . . . 0.0 107.221 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -72.18 142.58 49.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.595 1.543 . . . . 0.0 109.438 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -116.2 167.8 10.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.086 0.954 . . . . 0.0 110.989 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.29 146.35 43.25 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 110.352 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -139.55 150.39 45.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.445 1.098 . . . . 0.0 109.697 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.7 141.29 50.93 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.49 106.13 1.21 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -95.64 153.35 17.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -122.66 139.7 53.66 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.62 167.58 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.853 1.661 . . . . 0.0 110.086 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -76.55 48.49 0.55 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.8 1.286 . . . . 0.0 110.927 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.98 -33.61 0.06 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.851 2.46 . . . . 0.0 110.356 -171.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.2 -152.17 23.32 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.52 149.16 40.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -126.56 106.75 9.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 m -92.22 103.6 16.06 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -88.56 146.68 25.0 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.913 1.285 . . . . 0.0 110.335 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.82 179.74 8.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.893 1.677 . . . . 0.0 108.337 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 m -145.81 149.88 35.16 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.907 0.883 . . . . 0.0 108.903 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mt -133.18 110.0 14.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.48 -131.67 52.17 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -81.22 -10.12 59.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.413 0.685 . . . . 0.0 112.803 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -88.8 121.34 31.07 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 147.04 25.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.482 0.658 . . . . 0.0 109.862 170.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.84 153.52 49.6 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.57 1.548 . . . . 0.0 108.508 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -148.09 143.08 26.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.692 -0.63 . . . . 0.0 109.798 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.4 mt -88.31 119.56 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -85.33 110.05 18.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.4 84.83 3.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.61 127.3 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.846 1.659 . . . . 0.0 108.881 -169.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.542 0.643 0 CA-C-N 119.63 1.105 . . . . 0.0 110.273 178.683 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.31 129.72 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -104.73 124.91 50.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -132.59 145.54 51.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.14 0.976 . . . . 0.0 108.775 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 tp -92.42 131.1 37.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.69 142.42 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 169.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -136.94 132.19 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.048 1.339 . . . . 0.0 107.978 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t0 45.4 42.21 7.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.239 1.415 . . . . 0.0 111.539 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.3 t30 64.02 17.33 10.54 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.553 2.341 . . . . 0.0 116.196 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.65 152.09 32.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.84 1.256 . . . . 0.0 110.546 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -88.74 137.96 31.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.372 1.069 . . . . 0.0 110.631 -169.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.49 112.3 37.43 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.611 1.964 . . . . 0.0 106.909 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.43 150.61 36.61 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.19 2.593 . . . . 0.0 110.821 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.238 0.468 0 C-N-CA 123.569 0.748 . . . . 0.0 110.818 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 24' ' ' GLU . 19.7 p . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 121.637 0.732 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -89.49 125.36 35.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.5 m -108.6 148.6 30.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -136.5 159.52 41.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.825 1.65 . . . . 0.0 106.689 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.04 140.57 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.17 122.26 36.55 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.834 1.253 . . . . 0.0 107.987 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -91.91 117.81 30.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 56.7 mtm -146.64 134.8 21.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.817 1.247 . . . . 0.0 108.421 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.33 37.83 12.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.141 1.376 . . . . 0.0 113.339 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.3 8.73 87.04 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.236 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.13 155.76 29.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.987 1.715 . . . . 0.0 110.004 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.92 123.84 49.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -110.26 124.02 50.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.26 1.424 . . . . 0.0 107.978 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -84.38 141.34 30.93 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.0 mm -117.34 135.51 57.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.5 t -132.06 120.58 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.57 124.14 33.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.71 113.85 21.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -72.58 -26.41 61.7 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.724 -0.61 . . . . 0.0 111.696 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.09 -44.06 77.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.176 0.443 . . . . 0.0 111.287 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.19 -10.85 17.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 113.372 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.263 59.6 mtp 54.96 30.4 13.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.988 1.315 . . . . 0.0 111.861 -169.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.43 150.08 27.28 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.95 117.71 46.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.428 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.2 m95 -85.19 119.21 25.32 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.5 t -110.54 128.74 55.78 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 169.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 52.62 34.92 16.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.702 0.801 . . . . 0.0 111.576 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 11.17 82.15 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.233 0.921 . . . . 0.0 114.768 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -124.8 142.6 51.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.164 1.482 . . . . 0.0 108.187 -174.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -69.47 145.06 53.04 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.522 1.055 . . . . 0.0 108.427 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 pp -123.18 167.15 14.08 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.36 144.85 44.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.911 0.884 . . . . 0.0 110.189 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -140.93 149.58 42.05 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.225 1.01 . . . . 0.0 110.011 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.96 138.45 49.72 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.41 111.2 2.2 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -110.37 146.18 36.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.622 0.769 . . . . 0.0 109.87 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.45 142.46 30.04 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.55 166.34 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.693 1.597 . . . . 0.0 109.754 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.57 49.15 0.72 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.982 1.373 . . . . 0.0 110.231 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -159.87 -34.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.64 2.376 . . . . 0.0 110.292 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.4 -130.07 2.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -171.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -131.85 152.2 51.18 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -129.3 117.3 20.43 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 m -95.84 105.58 17.61 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.87 145.36 25.2 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.815 1.246 . . . . 0.0 109.966 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -157.31 -177.81 6.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.507 1.523 . . . . 0.0 109.053 169.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.81 151.54 38.08 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.422 1.089 . . . . 0.0 108.507 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -132.5 108.58 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.44 -130.76 51.48 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -77.94 -16.21 58.37 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.555 0.742 . . . . 0.0 112.578 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -85.84 120.03 26.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.76 147.53 26.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.364 0.529 . . . . 0.0 109.796 170.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.86 153.07 46.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.731 1.612 . . . . 0.0 108.924 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -148.0 141.3 25.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.661 -0.649 . . . . 0.0 109.342 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.8 mt -88.55 117.76 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -81.74 128.11 33.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 90.9 3.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -87.53 121.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 124.103 0.961 . . . . 0.0 108.537 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.237 0.404 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.767 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -90.09 114.35 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.45 125.31 38.0 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -132.83 142.35 48.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.7 tp -94.25 130.33 40.55 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.22 141.96 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -139.07 132.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t0 49.54 37.49 12.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.049 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 62.86 10.17 4.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.774 2.03 . . . . 0.0 115.531 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -96.63 150.47 20.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.265 1.426 . . . . 0.0 109.672 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.22 137.44 32.33 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.263 1.025 . . . . 0.0 110.232 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mm -118.94 118.77 32.79 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.967 1.707 . . . . 0.0 107.952 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -68.12 141.44 52.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.611 2.874 . . . . 0.0 112.33 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.56 0.695 . . . . 0.0 110.622 174.533 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 121.354 0.597 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.76 131.1 55.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.0 m -116.64 141.19 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -131.21 153.69 49.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.601 1.56 . . . . 0.0 107.326 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -114.88 139.4 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.49 112.64 18.76 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.278 1.831 . . . . 0.0 106.591 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -92.44 113.21 25.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.7 mtm -147.31 137.29 23.09 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.43 1.092 . . . . 0.0 108.609 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.3 t70 49.54 37.76 13.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.197 1.399 . . . . 0.0 113.206 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.34 -7.02 48.97 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.518 1.056 . . . . 0.0 113.976 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -95.23 164.99 12.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.731 1.613 . . . . 0.0 110.219 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -123.38 124.44 42.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.8 132.47 54.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.676 1.591 . . . . 0.0 108.132 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.81 138.1 31.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 169.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.5 mm -116.36 131.4 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.3 117.62 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 170.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.1 tp -89.2 123.07 33.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -86.13 110.12 19.33 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 168.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -75.81 -24.76 55.93 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.92 -0.487 . . . . 0.0 111.446 -171.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.29 -42.02 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.134 0.424 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.62 -14.29 22.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.919 1.288 . . . . 0.0 113.106 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm 52.19 49.71 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.317 1.447 . . . . 0.0 109.366 -169.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -123.34 141.97 51.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.372 1.469 . . . . 0.0 108.579 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.93 123.33 68.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.273 0.559 . . . . 0.0 110.221 -172.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.459 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.9 m95 -95.66 114.15 25.87 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.0 m -108.79 120.97 44.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 171.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 47.94 40.94 13.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.33 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.66 -4.41 60.61 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.767 -1.019 . . . . 0.0 114.891 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -111.8 144.21 41.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.446 1.623 . . . . 0.0 108.952 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.29 149.4 47.45 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 110.376 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.96 167.7 21.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.124 1.769 . . . . 0.0 108.41 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.39 143.5 53.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.147 0.499 . . . . 0.0 111.197 -170.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.6 151.08 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.173 1.789 . . . . 0.0 108.815 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.96 134.53 45.73 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.84 90.12 0.81 Allowed Glycine 0 C--N 1.329 0.157 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -78.6 141.43 38.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -106.67 136.11 47.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.91 166.45 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.608 1.163 . . . . 0.0 110.34 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.66 49.26 0.73 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.883 1.325 . . . . 0.0 110.318 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -161.36 -32.66 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.682 2.393 . . . . 0.0 110.874 -169.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.67 -132.99 4.23 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -127.98 151.35 49.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.15 106.59 8.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.8 m -84.52 101.03 11.76 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -85.66 144.52 27.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.774 1.23 . . . . 0.0 110.322 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.85 -178.34 7.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.15 1.78 . . . . 0.0 108.399 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 m -145.23 150.28 36.41 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.993 0.917 . . . . 0.0 109.048 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.6 mt -132.7 115.36 24.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.87 -132.5 52.59 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.14 -4.19 58.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 112.639 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -94.5 121.15 35.76 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -171.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.46 145.3 27.5 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.337 0.589 . . . . 0.0 109.576 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.55 152.3 50.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.482 1.513 . . . . 0.0 108.315 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 26.4 p90 -147.99 139.67 23.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 110.142 168.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mt -87.89 111.64 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -80.63 127.75 32.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.5 94.1 3.79 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -93.82 126.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.816 -169.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 CA--C 1.542 0.668 0 CA-C-N 119.627 1.103 . . . . 0.0 111.764 178.369 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mm -84.78 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -140.55 138.09 34.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.2 tp -88.99 131.04 35.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.6 mp -111.91 147.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.4 129.64 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.83 39.85 11.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.937 0.895 . . . . 0.0 111.572 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 65.9 2.35 2.17 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.76 2.024 . . . . 0.0 115.472 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -90.16 151.21 21.68 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.488 -1.382 . . . . 0.0 109.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -93.0 136.88 32.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.145 0.978 . . . . 0.0 110.538 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 mm -119.27 117.36 33.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.062 1.745 . . . . 0.0 107.01 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.68 152.51 37.74 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.162 2.575 . . . . 0.0 111.044 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 123.206 0.602 . . . . 0.0 109.398 173.217 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.2 p . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -121.71 130.23 53.29 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.7 m -123.51 142.29 51.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.827 0.704 . . . . 0.0 109.415 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -138.8 158.46 44.18 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 0.0 107.971 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 146.61 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.644 0.778 . . . . 0.0 109.298 169.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.55 156.01 46.47 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.089 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -111.5 116.26 30.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtm -144.56 141.56 29.56 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.6 t0 49.21 38.13 12.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.252 1.421 . . . . 0.0 113.546 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.94 6.44 85.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.977 -0.902 . . . . 0.0 113.937 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -118.15 162.8 17.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.149 1.78 . . . . 0.0 110.452 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -111.05 126.27 54.63 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.21 104.32 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.32 142.6 37.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 mm -125.57 131.47 72.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.51 120.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -87.94 124.52 33.78 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -89.29 108.48 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.96 1.704 . . . . 0.0 109.109 171.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.7 -26.7 63.53 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.055 0.389 . . . . 0.0 111.661 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.83 -39.94 94.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.407 0.283 . . . . 0.0 111.204 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.7 -11.28 17.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 113.218 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.3 42.4 30.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.298 1.439 . . . . 0.0 109.984 -168.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -105.26 160.84 14.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.913 1.285 . . . . 0.0 108.261 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.43 119.08 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.465 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.7 m95 -90.35 121.35 32.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.851 1.661 . . . . 0.0 109.078 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -102.79 116.03 31.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 168.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 46.13 39.78 6.41 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.32 1.048 . . . . 0.0 111.794 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.46 -7.8 67.22 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.312 -1.271 . . . . 0.0 115.343 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.23 140.98 30.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.106 1.953 . . . . 0.0 108.844 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -69.71 142.07 53.39 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.769 1.168 . . . . 0.0 108.442 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.66 166.16 12.02 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.836 0.854 . . . . 0.0 110.288 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.71 146.76 42.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.507 1.123 . . . . 0.0 109.979 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -142.87 150.24 39.59 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 110.091 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.36 134.24 43.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.47 90.32 0.75 Allowed Glycine 0 C--N 1.33 0.21 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -174.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.4 142.2 39.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -108.52 135.68 49.39 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.24 166.84 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 124.815 1.246 . . . . 0.0 110.174 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.71 49.34 0.75 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 123.005 1.383 . . . . 0.0 110.384 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.08 -33.27 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.536 2.335 . . . . 0.0 110.683 -169.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.29 -134.25 4.71 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -171.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -125.63 150.28 47.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.75 106.19 8.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -87.12 100.6 12.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -86.6 144.55 27.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.602 1.161 . . . . 0.0 110.798 -172.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.69 -177.01 6.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.367 1.867 . . . . 0.0 108.879 169.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -144.64 146.61 32.36 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.363 1.065 . . . . 0.0 109.662 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.95 132.5 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.98 -125.92 41.14 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -109.5 33.25 4.44 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.754 1.222 . . . . 0.0 110.714 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -129.53 144.87 51.45 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.178 1.391 . . . . 0.0 108.817 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.31 150.87 21.67 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.68 152.46 50.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.317 1.447 . . . . 0.0 108.295 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 24.2 p90 -148.69 140.41 23.64 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.785 -0.572 . . . . 0.0 109.647 168.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -88.29 114.13 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -81.96 126.82 32.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.25 92.12 3.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 121.74 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 C--O 1.237 0.417 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.086 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.3 mm -90.21 111.67 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.08 129.76 38.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -137.85 141.24 40.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.907 1.283 . . . . 0.0 108.012 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.9 tp -88.73 132.59 34.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.46 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.66 141.9 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.23 133.67 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.5 t0 49.59 37.75 13.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.413 1.085 . . . . 0.0 111.759 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.1 t30 62.72 9.66 3.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.027 2.131 . . . . 0.0 115.431 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.83 149.06 21.95 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.14 1.376 . . . . 0.0 109.387 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -91.13 133.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.457 0.703 . . . . 0.0 110.065 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.06 112.39 40.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.432 1.893 . . . . 0.0 106.801 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.28 152.02 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 110.947 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--O 1.24 0.558 0 C-N-CA 124.187 0.995 . . . . 0.0 110.484 174.501 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.024 0.44 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -117.41 135.61 53.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 m -114.68 147.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -134.55 161.35 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.379 1.472 . . . . 0.0 107.507 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.02 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.44 124.63 34.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.323 1.449 . . . . 0.0 108.581 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -87.63 125.71 34.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 ttm -156.03 132.47 10.19 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.91 38.94 17.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.108 1.363 . . . . 0.0 113.316 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 -1.34 74.81 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.109 0.861 . . . . 0.0 114.151 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.01 167.51 9.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.235 1.814 . . . . 0.0 110.031 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -121.42 124.14 43.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.41 118.44 36.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -86.73 142.37 28.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.05 133.86 67.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 t -133.07 119.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 tp -88.65 120.54 30.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -83.03 111.39 18.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 168.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.99 -26.8 60.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.181 -170.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.08 -43.58 86.96 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.106 0.412 . . . . 0.0 110.735 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.49 -13.75 24.27 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.518 1.127 . . . . 0.0 112.929 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mmm 52.35 45.62 28.15 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.08 1.352 . . . . 0.0 109.581 -169.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -115.83 141.61 47.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.835 1.254 . . . . 0.0 108.391 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.15 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.768 0.794 . . . . 0.0 109.705 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.451 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 22.9 m95 -85.53 111.51 20.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 169.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.1 m -108.5 117.65 34.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 48.01 40.89 14.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.143 1.377 . . . . 0.0 111.022 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.58 -9.31 36.42 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.591 1.091 . . . . 0.0 114.743 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.79 138.82 32.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.75 1.775 . . . . 0.0 108.821 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -71.07 141.33 50.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.9 165.9 24.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.984 0.914 . . . . 0.0 110.075 169.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.41 145.15 53.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.4 0.619 . . . . 0.0 111.167 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -134.36 147.82 50.59 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.845 1.658 . . . . 0.0 108.719 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.23 142.62 46.83 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.33 109.73 1.83 Allowed Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 107.155 -2.378 . . . . 0.0 107.155 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.45 148.52 25.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.07 134.39 55.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.68 167.54 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.548 1.539 . . . . 0.0 110.114 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.95 48.41 0.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.016 1.326 . . . . 0.0 110.465 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.35 -34.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.204 2.202 . . . . 0.0 110.537 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.66 -150.73 20.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -175.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -121.02 152.98 37.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -127.19 109.83 12.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.794 1.638 . . . . 0.0 107.171 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.7 m -92.44 102.57 15.04 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -89.56 146.17 24.76 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.447 1.099 . . . . 0.0 110.958 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -158.47 -173.75 4.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.086 2.154 . . . . 0.0 108.231 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 m -146.57 149.24 33.19 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.534 1.134 . . . . 0.0 109.403 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -138.16 121.64 20.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.33 -134.17 52.42 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -170.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -83.37 -7.56 59.55 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.832 0.853 . . . . 0.0 112.384 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -95.33 133.35 39.35 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.69 150.69 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.71 150.76 50.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.407 1.483 . . . . 0.0 107.866 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.419 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 17.2 p90 -147.41 139.68 24.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.907 -0.496 . . . . 0.0 109.821 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.1 mt -88.41 117.73 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -84.36 124.2 31.02 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.9 91.64 3.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.6 126.02 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.324 1.05 . . . . 0.0 108.451 -169.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m . . . . . 0 CA--C 1.54 0.565 0 CA-C-N 119.818 1.19 . . . . 0.0 109.958 176.233 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.17 118.02 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -98.66 124.48 43.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 m -133.47 140.34 47.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.241 1.016 . . . . 0.0 108.408 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 tp -89.33 133.48 34.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.419 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.44 141.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 169.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.83 131.97 43.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 49.48 38.33 14.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.398 1.079 . . . . 0.0 111.868 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.79 9.6 3.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.014 2.125 . . . . 0.0 115.471 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.75 150.01 20.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.916 1.286 . . . . 0.0 109.192 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -95.02 134.24 37.93 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.769 0.828 . . . . 0.0 110.657 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.1 mm -121.98 113.73 31.27 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.47 1.908 . . . . 0.0 107.722 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.7 149.45 48.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.039 2.492 . . . . 0.0 111.201 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 111.384 179.186 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -120.43 136.53 54.71 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.8 m -129.81 142.92 50.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.402 0.681 . . . . 0.0 109.284 -169.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -136.84 159.62 41.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.038 1.735 . . . . 0.0 107.629 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.13 141.58 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.224 1.01 . . . . 0.0 108.693 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.37 128.81 38.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.327 1.451 . . . . 0.0 109.079 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -83.78 128.94 34.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.8 mtt -144.44 129.65 18.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.087 1.355 . . . . 0.0 108.389 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.01 44.54 18.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 0.0 113.855 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.15 5.02 90.39 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.921 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -118.72 158.88 24.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.896 1.678 . . . . 0.0 109.987 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -115.38 123.7 49.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -108.57 128.28 54.68 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.018 0.927 . . . . 0.0 108.571 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -80.4 147.43 31.01 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mm -122.02 131.28 73.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.96 119.09 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.9 121.89 30.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.81 112.97 20.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -71.87 -31.28 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.97 0.908 . . . . 0.0 111.993 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.75 -46.49 62.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.124 0.42 . . . . 0.0 110.262 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.83 -17.22 33.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.065 0.946 . . . . 0.0 112.57 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.0 mtp 53.41 42.17 32.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.258 1.423 . . . . 0.0 109.884 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -106.66 145.45 31.96 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.056 1.343 . . . . 0.0 107.981 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -114.34 116.94 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.932 0.873 . . . . 0.0 109.618 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.67 111.14 19.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -114.85 127.52 55.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 49.08 36.73 9.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.123 0.969 . . . . 0.0 111.609 -171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.2 5.8 85.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.207 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.78 148.12 45.06 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.878 1.839 . . . . 0.0 109.352 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -69.63 144.53 52.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.77 166.79 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.342 1.057 . . . . 0.0 110.309 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.5 140.61 57.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.576 0.751 . . . . 0.0 111.129 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.94 151.9 49.56 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.965 1.706 . . . . 0.0 108.466 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 135.83 46.76 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.77 95.58 1.28 Allowed Glycine 0 C--N 1.331 0.257 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.29 145.52 28.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -107.45 136.45 47.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.45 167.5 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.141 1.376 . . . . 0.0 109.962 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.78 49.4 0.76 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.249 1.42 . . . . 0.0 110.533 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -160.73 -36.39 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.664 2.386 . . . . 0.0 110.025 -170.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.0 -124.03 1.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -127.5 150.97 49.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.3 106.38 8.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 172.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.4 m -86.26 101.53 13.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -85.7 145.7 27.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.775 1.23 . . . . 0.0 110.557 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -157.33 -176.32 5.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.736 2.014 . . . . 0.0 108.205 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -146.77 150.72 35.89 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.347 1.059 . . . . 0.0 109.099 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.31 122.74 25.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.9 -131.68 52.17 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -87.58 -4.17 58.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.183 0.993 . . . . 0.0 112.458 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -98.52 130.49 45.1 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 109.448 -169.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.1 151.14 27.15 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.182 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -135.32 150.8 50.07 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.749 1.619 . . . . 0.0 107.372 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.99 140.54 26.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.864 -0.522 . . . . 0.0 109.723 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.11 113.99 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -78.57 125.8 29.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.58 90.31 3.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -80.12 122.63 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 119.591 1.087 . . . . 0.0 111.961 -179.349 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.66 116.37 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -97.1 126.89 42.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -135.54 144.15 46.11 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.36 1.064 . . . . 0.0 108.46 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 tp -90.97 132.37 36.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.32 141.72 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.45 132.79 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t0 50.31 37.31 14.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 111.816 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 62.43 9.61 3.47 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.045 2.138 . . . . 0.0 115.614 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.27 147.66 22.97 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.679 -1.263 . . . . 0.0 109.371 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -90.57 133.67 34.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.685 0.794 . . . . 0.0 110.061 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.1 mm -119.36 113.77 35.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.134 1.774 . . . . 0.0 107.44 -174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.31 155.32 36.96 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.197 2.598 . . . . 0.0 111.149 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 123.758 0.823 . . . . 0.0 110.841 178.005 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 24' ' ' GLU . 25.9 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.693 0.758 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -124.11 129.28 50.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 169.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.8 m -114.27 145.75 41.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -136.64 162.6 32.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.281 1.433 . . . . 0.0 107.551 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.79 147.05 26.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.67 153.78 51.5 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.022 0.929 . . . . 0.0 108.661 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -106.1 119.3 38.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.42 137.79 27.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.756 1.222 . . . . 0.0 108.161 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.91 37.34 9.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.41 10.64 86.04 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.771 -1.016 . . . . 0.0 114.256 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.73 150.95 47.28 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.371 1.586 . . . . 0.0 110.231 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -98.15 122.81 41.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -106.75 113.6 27.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -80.73 142.6 33.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 mm -122.07 133.69 67.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.2 t -131.62 119.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.04 127.43 35.4 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -94.34 112.36 24.15 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -68.07 -25.0 65.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.454 -0.307 . . . . 0.0 111.66 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.83 -36.6 83.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.835 0.454 . . . . 0.0 111.88 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.74 -2.38 9.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.145 1.378 . . . . 0.0 113.018 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 99.3 mmm 53.97 33.0 16.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.902 1.281 . . . . 0.0 110.789 -169.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -88.9 146.12 25.12 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.84 117.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.403 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 9.2 m95 -85.38 122.6 29.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.636 1.574 . . . . 0.0 107.454 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.04 118.14 36.02 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 42.47 48.95 4.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.128 1.771 . . . . 0.0 112.564 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.28 -4.11 86.13 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.604 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -113.8 142.73 45.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.786 1.793 . . . . 0.0 109.366 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -68.37 149.02 49.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -126.29 165.55 18.77 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.283 1.033 . . . . 0.0 110.55 169.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.35 146.57 40.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 110.199 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -140.33 151.09 44.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.458 1.103 . . . . 0.0 109.958 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.22 138.18 43.34 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.19 97.02 1.21 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.03 143.14 27.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.82 134.13 43.17 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.35 -179.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.653 1.581 . . . . 0.0 108.765 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.69 8.88 8.83 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.76 14.16 0.55 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.523 1.129 . . . . 0.0 113.357 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.93 -149.27 17.54 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.672 -1.267 . . . . 0.0 112.176 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.3 m -131.34 154.88 48.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -126.61 107.11 9.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.9 m -83.87 99.89 10.63 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -85.77 145.4 27.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.737 1.215 . . . . 0.0 110.722 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.85 -178.92 7.6 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.392 1.877 . . . . 0.0 108.945 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -144.7 147.42 32.99 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 109.522 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.5 mt -141.39 133.78 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.38 -123.3 32.77 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -113.33 36.83 3.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.769 1.228 . . . . 0.0 110.492 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.57 141.65 49.73 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.273 1.429 . . . . 0.0 108.213 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.34 149.2 23.39 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 169.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 m -135.6 152.19 51.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.537 1.535 . . . . 0.0 108.191 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -149.25 141.65 24.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 121.859 -0.525 . . . . 0.0 109.89 168.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.61 115.03 27.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -79.16 98.84 6.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.75 82.64 7.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.96 129.81 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 119.236 0.925 . . . . 0.0 111.038 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.7 mm -77.45 -43.51 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.28 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 63.5 m80 53.23 102.91 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.75 2.02 . . . . 0.0 112.407 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -126.3 141.27 51.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.792 0.837 . . . . 0.0 109.123 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.6 tp -88.46 131.43 34.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.412 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.89 142.87 22.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 131.2 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.94 43.82 10.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.463 1.105 . . . . 0.0 111.442 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.4 t30 65.17 4.53 2.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.6 2.36 . . . . 0.0 115.746 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.93 143.71 26.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.11 1.364 . . . . 0.0 109.806 174.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.05 136.07 33.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.145 0.978 . . . . 0.0 110.539 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -119.62 114.64 34.21 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.449 1.9 . . . . 0.0 107.01 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.68 146.94 34.74 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.371 2.714 . . . . 0.0 111.16 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 121.323 0.583 . . . . 0.0 111.43 -177.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 121.05 0.452 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.44 134.57 52.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -128.37 141.04 51.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.479 0.657 . . . . 0.0 109.694 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -136.32 151.93 50.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.301 1.44 . . . . 0.0 107.47 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.28 141.77 37.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.935 0.894 . . . . 0.0 109.035 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.65 125.83 35.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.127 1.371 . . . . 0.0 108.692 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -85.08 127.41 34.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 41.1 ttm -158.0 134.71 9.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.924 1.29 . . . . 0.0 108.189 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.95 37.93 18.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.109 1.364 . . . . 0.0 113.313 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.18 8.8 85.52 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.914 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -120.54 164.05 17.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.15 1.78 . . . . 0.0 109.806 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -113.31 124.2 51.93 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -109.04 128.64 55.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -88.69 132.89 34.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.85 133.11 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.18 131.3 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.57 125.29 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB2' ' HE1' ' A' ' 31' ' ' TRP . 12.0 mt-10 -87.14 115.58 24.63 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.813 -2.292 . . . . 0.0 104.813 168.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.69 -33.33 73.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.12 -43.19 78.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 117.75 0.25 . . . . 0.0 110.529 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.38 -15.03 29.61 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.215 1.006 . . . . 0.0 112.964 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 52.84 38.88 27.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.323 1.449 . . . . 0.0 110.57 -169.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.52 139.99 38.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 108.296 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -113.11 116.3 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 122.106 0.955 . . . . 0.0 109.967 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m95 -93.34 105.01 17.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.948 2.099 . . . . 0.0 105.915 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -109.4 123.27 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 51.28 36.24 15.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 111.13 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.44 -2.47 62.37 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.895 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.71 143.75 37.41 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.778 1.789 . . . . 0.0 109.273 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -68.89 146.68 52.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -137.47 166.26 24.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.851 1.261 . . . . 0.0 109.011 169.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.55 144.55 49.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.047 0.539 . . . . 0.0 111.017 -173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -135.5 149.2 49.44 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 109.146 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.39 136.98 54.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.18 95.32 1.15 Allowed Glycine 0 C--N 1.33 0.214 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.91 142.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.26 132.31 55.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.76 167.29 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.079 1.352 . . . . 0.0 110.159 -172.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.93 49.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.261 1.424 . . . . 0.0 109.968 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -162.54 -32.06 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.47 2.308 . . . . 0.0 110.851 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.68 2.5 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -127.43 151.54 48.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.74 106.68 8.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -84.2 102.27 12.48 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -88.1 143.62 26.96 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.516 1.127 . . . . 0.0 110.579 -175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -159.79 -172.43 3.66 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.073 2.149 . . . . 0.0 108.339 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 m -145.29 151.22 38.0 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 0.0 108.818 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.8 mt -136.98 124.08 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.15 -133.37 52.7 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -86.29 -3.86 59.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.174 0.989 . . . . 0.0 112.672 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -98.05 132.61 43.45 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.305 -0.872 . . . . 0.0 109.097 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.55 149.86 28.46 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.5 m -137.02 152.28 49.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.204 1.402 . . . . 0.0 108.009 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 25.3 p90 -146.63 139.59 25.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.958 168.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.3 mt -88.19 113.7 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -80.56 128.85 34.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.79 93.56 3.87 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.95 128.32 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.591 1.157 . . . . 0.0 108.755 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 124.762 1.225 . . . . 0.0 113.975 -178.686 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.67 120.02 36.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -98.97 130.85 45.35 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -140.21 139.92 35.74 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.791 1.236 . . . . 0.0 108.412 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.81 133.58 33.63 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -112.2 141.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.31 132.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 49.63 37.88 13.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.405 1.082 . . . . 0.0 111.85 -175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 62.66 8.83 3.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.985 2.114 . . . . 0.0 115.464 -174.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.24 148.02 22.61 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.059 1.344 . . . . 0.0 109.399 171.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -90.26 134.03 34.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.469 0.708 . . . . 0.0 110.116 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.04 114.52 37.05 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.137 1.775 . . . . 0.0 108.226 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 148.04 88.35 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.91 3.073 . . . . 0.0 112.171 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.239 0.506 0 C-N-CA 123.558 0.743 . . . . 0.0 110.293 169.942 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.05 125.58 54.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -120.31 144.43 47.84 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -140.09 159.39 42.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.878 1.671 . . . . 0.0 108.042 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.49 137.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 168.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.15 123.69 43.92 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.557 1.143 . . . . 0.0 108.155 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.478 ' CD2' HD21 ' A' ' 18' ' ' ASN . 3.7 t-80 -91.91 121.27 33.35 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 170.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 39.6 mtt -107.44 -163.96 0.94 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.06 1.344 . . . . 0.0 108.573 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.47 -27.79 57.93 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.531 1.133 . . . . 0.0 113.593 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.84 17.89 0.12 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.114 -0.825 . . . . 0.0 113.976 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -140.81 155.85 46.28 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.791 1.237 . . . . 0.0 108.957 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.478 HD21 ' CD2' ' A' ' 13' ' ' HIS . 8.1 m-80 -120.0 114.56 22.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.38 115.28 30.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.3 mtm-85 -79.82 139.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.0 mm -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 t -133.17 118.75 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -83.72 106.64 15.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.357 1.463 . . . . 0.0 107.297 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -72.27 -26.67 62.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.382 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.97 -42.76 72.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.175 0.443 . . . . 0.0 110.523 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.98 -16.17 25.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.495 1.118 . . . . 0.0 113.056 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.83 50.21 19.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.82 1.648 . . . . 0.0 110.473 -169.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -116.52 159.32 22.26 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.283 1.433 . . . . 0.0 108.369 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.69 117.98 36.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.404 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.4 m95 -88.87 125.55 34.98 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.976 1.711 . . . . 0.0 108.198 171.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -115.87 128.07 55.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.14 35.04 12.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.116 0.966 . . . . 0.0 111.894 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.05 87.77 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.412 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.05 143.19 45.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.081 1.941 . . . . 0.0 108.563 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -72.18 141.89 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.756 1.162 . . . . 0.0 109.16 175.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.82 169.4 9.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.694 0.798 . . . . 0.0 111.491 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.8 145.67 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.599 1.16 . . . . 0.0 110.075 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 p -141.86 149.86 40.82 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 109.646 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.59 139.68 49.24 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.9 104.93 1.19 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -90.0 149.81 22.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.0 139.41 52.54 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.73 167.91 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.491 1.516 . . . . 0.0 110.134 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -76.5 49.9 0.63 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.062 1.345 . . . . 0.0 110.486 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -160.22 -35.75 0.05 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.86 2.464 . . . . 0.0 109.849 -170.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.28 -150.97 22.43 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.04 148.46 38.83 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -123.59 107.28 11.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -94.02 105.0 17.02 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -90.49 146.65 23.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.062 1.345 . . . . 0.0 111.055 -172.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -157.7 -179.59 8.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.867 2.067 . . . . 0.0 108.185 169.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -144.34 146.55 32.63 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.101 -0.999 . . . . 0.0 109.949 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.4 mt -143.23 131.33 19.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.28 -130.3 50.82 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -104.75 32.0 4.4 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.66 1.184 . . . . 0.0 111.053 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -129.58 146.57 51.37 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.748 1.219 . . . . 0.0 109.271 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.05 150.37 22.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 109.515 170.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.53 151.62 51.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.777 1.631 . . . . 0.0 108.294 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.501 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 23.2 p90 -148.48 142.79 26.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.954 -0.466 . . . . 0.0 110.079 168.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.7 mt -88.05 118.78 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -89.54 101.73 14.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.23 91.14 7.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.85 129.58 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.872 1.669 . . . . 0.0 109.192 -169.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 CA--C 1.543 0.678 0 CA-C-N 119.829 1.195 . . . . 0.0 112.262 -179.692 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.0 135.12 26.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -110.11 126.65 54.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -132.01 142.47 49.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.18 131.58 37.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.501 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.84 143.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.4 t -138.49 130.44 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.68 39.74 14.26 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.058 0.943 . . . . 0.0 111.754 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 64.79 3.71 2.13 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.86 2.064 . . . . 0.0 115.001 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -89.89 147.24 23.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.369 -1.457 . . . . 0.0 109.195 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.76 134.28 34.87 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.717 0.807 . . . . 0.0 110.125 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.9 mm -119.24 114.76 34.7 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.816 1.646 . . . . 0.0 108.287 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -67.71 143.37 61.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.049 3.166 . . . . 0.0 111.962 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--O 1.239 0.541 0 C-N-CA 123.284 0.634 . . . . 0.0 109.887 171.323 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.4 p . . . . . 0 C--O 1.235 0.316 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.85 131.69 54.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -110.49 149.19 30.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -135.19 163.82 29.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.994 1.718 . . . . 0.0 107.196 169.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.12 140.81 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.33 44.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.099 1.359 . . . . 0.0 108.954 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -101.49 125.9 48.2 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.85 0.86 . . . . 0.0 109.018 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.26 139.89 27.44 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.13 0.972 . . . . 0.0 109.059 170.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 45.32 45.97 10.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 114.003 169.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.08 -1.31 80.58 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.042 -0.866 . . . . 0.0 114.313 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -109.77 159.64 17.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.74 1.616 . . . . 0.0 110.429 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -119.77 130.29 54.88 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -110.04 107.07 16.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 107.747 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -73.5 129.69 38.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.1 mm -108.78 136.35 44.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.41 118.82 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.2 tp -88.36 128.53 35.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HA ' HG22 ' A' ' 7' ' ' THR . 44.7 mm-40 -85.5 109.46 18.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 169.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -72.24 -30.98 65.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.15 0.886 . . . . 0.0 111.865 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.49 -42.83 74.26 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.234 . . . . 0.0 111.047 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.2 -17.0 23.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -173.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 55.6 28.36 11.8 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.943 1.697 . . . . 0.0 112.464 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.79 149.55 25.66 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.05 125.12 67.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -97.22 138.09 35.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.669 1.187 . . . . 0.0 107.947 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -120.99 119.8 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 45.78 41.82 8.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.596 1.558 . . . . 0.0 112.038 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.25 6.71 75.8 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.019 -0.879 . . . . 0.0 114.412 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.24 152.08 23.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.121 1.46 . . . . 0.0 107.74 173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.91 148.19 28.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -129.99 165.04 22.96 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.18 0.992 . . . . 0.0 110.793 170.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.76 148.08 35.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.963 1.305 . . . . 0.0 110.436 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -139.28 149.16 43.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.268 1.027 . . . . 0.0 109.981 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.94 141.68 50.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.99 106.47 1.21 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.08 149.26 21.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -121.27 138.58 54.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.406 0.682 . . . . 0.0 109.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.15 167.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.468 1.507 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.03 48.53 0.6 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.057 1.343 . . . . 0.0 110.594 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -159.88 -31.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.862 2.465 . . . . 0.0 110.713 -171.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.42 -151.93 23.35 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -122.25 151.03 41.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -125.94 106.95 10.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.554 1.542 . . . . 0.0 107.095 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.8 m -92.32 103.54 15.97 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -90.23 147.26 23.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.788 1.235 . . . . 0.0 111.12 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.54 -178.33 7.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 108.37 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.3 m -145.07 149.55 35.28 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.291 1.036 . . . . 0.0 109.375 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.5 mt -134.05 111.21 14.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.65 -134.0 51.48 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -169.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -78.19 -14.09 59.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 112.462 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -88.19 126.74 35.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.61 150.1 24.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.617 0.722 . . . . 0.0 109.311 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -137.15 151.87 49.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.566 1.546 . . . . 0.0 107.919 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.432 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 15.9 p90 -148.18 142.17 25.89 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 168.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.16 120.43 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -85.66 118.23 25.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 170.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.43 92.36 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.18 129.26 41.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.271 1.428 . . . . 0.0 110.735 -168.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.543 0.705 0 C-N-CA 124.746 1.219 . . . . 0.0 112.713 -179.182 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mt . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.15 126.57 40.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -106.8 122.73 46.97 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -133.02 141.09 48.07 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.402 1.081 . . . . 0.0 108.523 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -88.43 133.13 34.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.432 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.84 141.04 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 169.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -138.18 132.38 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 49.97 37.54 14.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.064 0.935 . . . . 0.0 111.882 -176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.8 t30 62.56 10.17 3.91 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.927 2.091 . . . . 0.0 115.407 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.58 149.13 21.78 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.986 1.315 . . . . 0.0 109.217 171.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -93.21 134.59 35.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.826 0.85 . . . . 0.0 110.094 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.8 mm -121.19 113.67 32.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.532 1.933 . . . . 0.0 107.548 -173.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.91 147.83 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.158 2.572 . . . . 0.0 110.932 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 124.363 1.065 . . . . 0.0 111.012 179.538 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.806 0.336 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.6 129.08 55.12 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 169.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.1 m -120.8 143.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -135.19 155.02 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.214 1.806 . . . . 0.0 107.213 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.41 122.73 66.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 168.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.0 tp -115.69 123.2 47.75 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.332 1.053 . . . . 0.0 109.081 -169.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -91.17 135.5 33.74 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.7 mtt -139.39 106.88 5.56 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 61.81 -33.95 0.1 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.617 3.167 . . . . 0.0 116.849 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.75 -32.28 0.03 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.5 2.0 . . . . 0.0 110.154 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -77.01 156.93 31.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.165 0.986 . . . . 0.0 110.167 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -131.76 115.97 16.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -105.76 122.11 45.42 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.389 1.076 . . . . 0.0 108.563 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -73.44 138.61 45.3 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -117.26 132.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.94 117.88 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -86.06 121.13 28.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -82.04 113.03 19.64 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 168.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.75 -24.54 56.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 119.116 -0.468 . . . . 0.0 111.254 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.93 -44.3 69.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.712 0.687 . . . . 0.0 110.131 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.14 -15.4 24.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.489 1.115 . . . . 0.0 113.152 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.8 mmm 52.69 45.08 29.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.816 1.247 . . . . 0.0 109.276 -168.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -114.6 146.39 40.86 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.869 1.668 . . . . 0.0 107.148 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.05 117.41 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.407 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -84.57 119.31 25.05 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.946 1.698 . . . . 0.0 107.047 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.2 t -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.0 36.01 10.96 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.334 1.054 . . . . 0.0 111.919 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.62 3.01 88.8 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.621 -1.1 . . . . 0.0 115.092 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -114.4 145.58 41.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.657 1.728 . . . . 0.0 108.868 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -68.33 141.58 55.76 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.03 163.41 16.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.707 0.803 . . . . 0.0 110.422 169.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -70.87 143.99 50.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 110.199 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -138.52 148.58 44.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 110.162 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.59 143.43 51.17 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.52 108.83 1.47 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -97.76 148.62 23.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.97 135.88 54.74 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.47 167.55 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 110.173 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -77.7 48.1 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.156 1.382 . . . . 0.0 110.554 175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.94 -34.13 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.233 2.213 . . . . 0.0 110.325 -171.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.86 -150.31 20.1 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -121.16 152.11 39.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -125.37 107.16 10.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.794 1.638 . . . . 0.0 106.898 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -91.32 102.7 15.41 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.92 146.43 24.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.674 1.189 . . . . 0.0 110.901 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -158.19 -173.91 4.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.636 1.975 . . . . 0.0 108.646 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 m -144.49 146.75 32.59 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 109.347 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.6 mt -142.18 133.27 25.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.97 -131.07 51.86 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -105.13 34.1 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.511 1.124 . . . . 0.0 110.851 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -131.11 144.32 51.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.733 1.213 . . . . 0.0 109.097 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.35 152.43 19.15 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.502 0.668 . . . . 0.0 109.219 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 m -135.15 151.94 51.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.577 1.551 . . . . 0.0 107.752 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 15.9 p90 -147.81 140.77 24.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.856 -0.527 . . . . 0.0 109.669 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.27 118.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -83.61 120.89 26.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 92.54 3.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.61 125.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.077 1.351 . . . . 0.0 109.373 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 124.496 1.118 . . . . 0.0 110.549 175.618 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.98 125.81 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -105.78 127.3 53.01 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -136.31 141.51 43.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.174 0.99 . . . . 0.0 108.597 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.55 131.1 36.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.427 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.89 142.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 169.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.0 130.86 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 t70 46.53 43.22 12.04 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.443 1.097 . . . . 0.0 111.448 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 63.69 6.53 2.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.709 2.404 . . . . 0.0 115.828 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -99.41 148.27 24.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.586 1.555 . . . . 0.0 109.918 173.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -91.02 137.31 32.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.525 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.3 mm -119.89 113.36 34.47 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.888 2.075 . . . . 0.0 106.929 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.92 147.06 33.8 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.096 2.53 . . . . 0.0 110.965 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 123.996 0.918 . . . . 0.0 110.493 175.899 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 121.48 0.657 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -117.49 137.85 52.26 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -120.98 149.59 42.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -140.41 151.83 45.23 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.72 1.608 . . . . 0.0 108.337 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -107.34 135.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.85 117.76 29.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -87.54 120.98 29.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 43.2 ttm -155.79 131.5 9.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -170.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 50.5 36.67 14.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 113.072 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.27 74.76 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.039 0.828 . . . . 0.0 113.975 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -108.39 170.62 7.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.489 1.916 . . . . 0.0 109.383 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -131.84 111.58 11.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -102.52 131.24 49.36 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -93.68 124.05 37.41 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.93 138.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.96 125.71 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -90.09 129.99 36.32 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -98.14 112.47 24.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.355 1.462 . . . . 0.0 107.722 168.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -74.91 -22.18 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.79 -0.569 . . . . 0.0 112.322 -170.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.48 -36.52 80.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.194 0.452 . . . . 0.0 111.207 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.49 -4.35 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 113.052 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.8 mtp 53.35 37.84 26.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.563 1.145 . . . . 0.0 109.564 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -92.34 147.53 22.84 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -129.97 119.42 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.451 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 15.3 m95 -85.42 133.52 34.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.495 1.918 . . . . 0.0 108.448 173.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -128.81 126.51 40.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 168.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 52.08 37.69 22.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.304 1.042 . . . . 0.0 111.981 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.87 2.05 90.64 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.379 -1.234 . . . . 0.0 115.617 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.41 148.12 44.82 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.878 1.839 . . . . 0.0 108.171 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -75.52 151.82 37.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.871 1.214 . . . . 0.0 110.189 173.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.26 167.67 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.23 1.412 . . . . 0.0 110.215 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.95 147.91 44.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.064 0.946 . . . . 0.0 110.358 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 p -138.3 148.83 45.06 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.665 1.186 . . . . 0.0 109.88 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.0 149.52 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.0 109.41 1.03 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.83 151.8 21.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.72 0.808 . . . . 0.0 109.262 170.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -123.99 140.15 53.26 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.87 167.44 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.726 1.61 . . . . 0.0 110.278 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.17 48.71 0.63 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.07 1.348 . . . . 0.0 110.606 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -160.15 -34.49 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.813 2.445 . . . . 0.0 110.276 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.98 -153.39 24.21 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -117.88 150.19 39.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -124.55 106.85 10.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.1 m -90.95 106.22 18.37 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.04 145.82 24.22 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.799 1.239 . . . . 0.0 110.51 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.47 -169.7 2.69 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.226 1.811 . . . . 0.0 108.423 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -150.15 148.2 28.67 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.927 -1.108 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 93.7 mt -141.1 130.69 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.36 -133.4 51.37 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.07 29.11 4.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.251 1.02 . . . . 0.0 111.654 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -124.22 142.97 50.8 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.56 1.144 . . . . 0.0 109.261 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 150.01 21.35 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -134.84 152.04 51.42 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.764 1.226 . . . . 0.0 108.073 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.42 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 14.2 p90 -147.0 141.74 26.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 168.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.94 120.59 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -87.16 114.84 24.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.58 91.86 3.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -87.77 126.22 41.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.017 1.327 . . . . 0.0 109.328 -169.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.535 1.134 . . . . 0.0 110.858 176.522 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.73 125.32 43.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -103.18 127.26 50.53 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -134.66 145.02 48.17 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.375 1.07 . . . . 0.0 108.494 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -93.98 130.41 40.1 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.42 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.81 142.48 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 169.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.31 133.19 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.821 1.248 . . . . 0.0 108.088 171.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t0 45.59 42.12 7.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.326 1.451 . . . . 0.0 111.659 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.47 17.64 10.93 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.475 2.31 . . . . 0.0 116.136 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -116.1 152.09 34.32 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.158 169.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -84.73 139.19 32.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.86 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.2 mm -119.53 118.78 32.02 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.358 1.863 . . . . 0.0 106.612 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 142.81 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 111.284 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 C--O 1.236 0.388 0 C-N-CA 124.532 1.133 . . . . 0.0 111.063 178.02 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.89 0.376 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -112.54 137.02 51.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 m -121.85 142.82 49.85 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -133.82 156.43 48.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.193 1.797 . . . . 0.0 107.542 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -124.44 134.4 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -117.94 123.66 46.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.3 113.47 25.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.9 mtm -146.43 138.49 24.92 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.274 1.029 . . . . 0.0 108.449 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.64 36.87 11.45 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.188 1.395 . . . . 0.0 113.249 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.84 -4.16 62.14 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.99 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.41 165.13 11.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.615 1.566 . . . . 0.0 110.348 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -119.67 125.19 48.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.01 123.51 50.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.926 1.291 . . . . 0.0 108.117 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -86.0 123.55 31.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.66 133.23 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 170.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.9 t -128.39 121.43 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.06 121.8 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.483 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 1.2 mm-40 -85.05 112.36 20.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.19 -30.28 62.15 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.969 -0.457 . . . . 0.0 111.908 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.95 -41.52 97.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.856 0.298 . . . . 0.0 110.782 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.38 -14.71 22.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.622 1.169 . . . . 0.0 113.178 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtp 52.79 42.67 31.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.343 1.457 . . . . 0.0 109.924 -168.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -107.13 145.32 32.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.54 1.136 . . . . 0.0 108.496 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -116.52 120.86 66.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.662 0.744 . . . . 0.0 109.823 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.483 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 12.0 m95 -93.84 130.11 40.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.054 1.342 . . . . 0.0 108.291 172.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.2 117.94 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.41 40.71 15.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.84 1.256 . . . . 0.0 111.356 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.12 -9.77 52.09 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.511 -1.161 . . . . 0.0 115.129 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -95.8 135.64 37.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.863 1.832 . . . . 0.0 108.226 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -75.09 147.9 40.21 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.56 1.073 . . . . 0.0 109.148 174.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.18 166.58 20.81 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.474 1.11 . . . . 0.0 109.771 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.51 145.98 48.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.156 0.583 . . . . 0.0 111.018 -172.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.92 150.86 48.47 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.843 1.657 . . . . 0.0 109.331 -178.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.6 137.54 52.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.71 100.62 1.62 Allowed Glycine 0 C--N 1.33 0.24 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.62 149.32 22.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.31 126.81 47.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.19 174.74 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.262 1.425 . . . . 0.0 109.59 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -83.64 44.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.896 1.278 . . . . 0.0 110.964 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.39 -31.58 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.872 1.669 . . . . 0.0 111.319 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.78 -157.88 30.42 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.3 150.19 26.19 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -130.73 105.15 7.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.3 m -86.63 99.82 12.0 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -84.29 146.18 27.89 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.922 1.289 . . . . 0.0 110.24 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -158.28 -175.51 5.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.057 1.743 . . . . 0.0 108.469 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -152.16 149.02 28.3 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.784 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -142.32 127.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.14 -126.86 43.33 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -102.68 25.09 9.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -121.07 145.08 48.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.062 1.345 . . . . 0.0 109.048 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.71 147.78 28.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.339 0.656 . . . . 0.0 109.244 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -135.47 151.51 50.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.12 1.368 . . . . 0.0 108.436 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -146.9 141.46 26.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.911 -0.493 . . . . 0.0 109.819 168.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.46 115.18 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -79.23 123.64 27.61 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 169.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.5 92.14 3.86 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 171.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.17 124.56 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.474 1.11 . . . . 0.0 108.214 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 119.137 0.88 . . . . 0.0 110.862 179.77 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 mm -101.42 120.85 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -97.16 130.61 44.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -139.1 143.55 38.32 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.159 0.983 . . . . 0.0 108.528 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -91.23 130.79 37.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.35 143.41 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.3 t -139.87 132.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.146 1.379 . . . . 0.0 107.715 173.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.68 37.65 13.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 111.868 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.6 t30 62.45 10.23 3.86 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.095 2.158 . . . . 0.0 115.295 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.54 149.81 21.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.04 1.336 . . . . 0.0 109.426 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.78 136.17 33.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.825 0.85 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.87 113.9 39.66 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.008 1.723 . . . . 0.0 107.04 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.55 149.4 30.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.072 2.515 . . . . 0.0 110.96 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--O 1.239 0.534 0 C-N-CA 124.264 1.026 . . . . 0.0 110.81 174.944 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.6 p . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.03 130.55 45.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.6 m -122.51 139.58 53.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -133.91 152.53 51.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.192 1.397 . . . . 0.0 107.57 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.03 140.01 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.21 132.89 55.54 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -106.49 109.97 22.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 170.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.0 mtm -146.18 140.86 26.93 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.311 1.045 . . . . 0.0 108.932 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t0 51.23 35.67 14.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.992 1.317 . . . . 0.0 112.738 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.75 -10.52 18.06 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.713 1.149 . . . . 0.0 113.883 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.57 166.52 13.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.405 1.482 . . . . 0.0 111.063 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.81 129.32 52.54 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.65 116.74 27.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.737 1.215 . . . . 0.0 108.161 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -91.19 117.43 29.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -96.26 132.96 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.0 t -127.97 123.71 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.43 122.64 32.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.16 109.72 20.12 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -67.68 -27.52 66.9 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.587 -0.696 . . . . 0.0 111.311 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.46 -30.13 70.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.68 -3.65 9.26 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 113.06 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtp 53.19 37.1 24.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.221 1.409 . . . . 0.0 110.77 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -91.86 146.03 24.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.9 p -117.68 113.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 122.172 0.987 . . . . 0.0 109.714 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.449 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 26.9 m95 -83.15 137.67 33.97 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 169.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.38 113.23 11.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 169.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 46.56 42.84 11.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.166 1.386 . . . . 0.0 111.216 -170.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.88 -12.69 28.44 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.786 1.184 . . . . 0.0 114.996 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.11 135.58 33.92 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.817 1.808 . . . . 0.0 108.254 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -76.87 120.02 21.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 mt -77.55 166.7 22.71 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.819 1.295 . . . . 0.0 111.273 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.65 147.89 39.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 112.934 -1.939 . . . . 0.0 107.062 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -144.73 150.55 37.46 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.075 0.95 . . . . 0.0 109.477 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.68 140.11 46.85 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.67 105.86 1.24 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 -172.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -95.74 152.25 18.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.417 0.687 . . . . 0.0 109.195 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.65 139.71 52.63 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -131.2 167.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.605 1.562 . . . . 0.0 110.079 176.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.01 28.05 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.967 1.707 . . . . 0.0 112.825 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' VAL . 32.2 t70 -141.87 -22.04 0.72 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.568 2.747 . . . . 0.0 111.768 -173.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -155.66 26.26 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.65 150.62 37.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -130.0 107.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.938 1.295 . . . . 0.0 107.714 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.2 m -93.85 104.4 16.47 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.4 146.63 24.53 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.092 1.357 . . . . 0.0 110.625 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.08 -174.39 4.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.224 1.809 . . . . 0.0 108.324 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -144.81 149.7 35.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.352 1.061 . . . . 0.0 108.96 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.6 mt -134.43 113.82 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.2 -135.15 50.3 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.87 -13.45 59.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.608 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -88.51 127.46 35.53 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.531 -0.731 . . . . 0.0 109.472 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.37 149.01 26.31 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 169.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.64 153.32 47.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.686 1.594 . . . . 0.0 108.448 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -147.69 143.67 27.79 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.763 -0.586 . . . . 0.0 109.66 168.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -88.29 117.95 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 169.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -84.55 117.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.62 89.88 3.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.38 126.84 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 109.095 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.539 0.548 0 CA-C-N 120.138 1.335 . . . . 0.0 110.476 175.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.9 mm . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.84 117.34 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -92.07 127.7 37.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -133.59 144.29 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.467 1.107 . . . . 0.0 108.237 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -94.22 129.61 40.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.4 142.35 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.7 t -137.22 131.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.031 1.332 . . . . 0.0 107.84 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t0 45.11 42.36 6.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.281 1.432 . . . . 0.0 111.682 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 64.56 17.09 10.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.711 2.404 . . . . 0.0 116.125 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.11 152.41 31.13 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.643 1.177 . . . . 0.0 111.027 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -85.86 138.82 31.77 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.727 1.211 . . . . 0.0 110.692 -172.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.65 118.44 33.47 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.228 1.811 . . . . 0.0 106.714 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.19 150.43 33.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.861 2.374 . . . . 0.0 111.002 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.238 0.476 0 C-N-CA 123.599 0.76 . . . . 0.0 110.423 172.721 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -125.65 132.52 52.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 m -112.42 142.93 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -132.9 162.33 31.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.856 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 t -128.81 135.32 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.97 117.64 29.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -88.45 114.1 24.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 169.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.5 mtm -146.35 137.26 24.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.446 1.098 . . . . 0.0 108.426 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.24 38.14 12.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.319 1.448 . . . . 0.0 113.22 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.91 -1.07 69.84 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.254 0.93 . . . . 0.0 114.176 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -105.6 166.04 10.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.087 1.755 . . . . 0.0 110.116 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -122.66 121.28 36.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -109.39 120.99 44.21 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.66 1.184 . . . . 0.0 108.308 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -78.06 145.11 36.05 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.9 mm -125.57 133.03 70.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.35 120.48 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -85.91 122.45 29.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -88.78 112.23 22.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -72.56 -21.02 61.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.533 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.69 -35.98 81.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.869 0.759 . . . . 0.0 111.601 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.25 -0.99 9.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.119 1.368 . . . . 0.0 113.285 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.4 mtp 52.72 39.52 28.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.727 1.211 . . . . 0.0 110.592 -169.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.96 144.7 26.62 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.428 1.091 . . . . 0.0 108.245 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -114.02 115.68 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 109.862 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.457 ' CZ3' ' HE2' ' A' ' 36' ' ' LYS . 51.7 m95 -83.2 115.31 21.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 169.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.53 128.47 55.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 52.68 34.95 17.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.542 0.737 . . . . 0.0 111.705 -170.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.25 77.51 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.425 1.012 . . . . 0.0 114.65 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -125.44 138.0 54.0 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.457 ' HE2' ' CZ3' ' A' ' 31' ' ' TRP 0.3 0.0 OUTLIER -75.71 146.42 40.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.733 1.606 . . . . 0.0 110.068 175.552 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.73 167.93 19.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.007 1.323 . . . . 0.0 110.16 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.48 148.34 49.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.6 0.714 . . . . 0.0 111.531 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -136.38 150.46 48.81 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.067 1.747 . . . . 0.0 108.99 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.31 139.76 52.24 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.49 107.35 1.62 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -96.86 151.15 19.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -117.44 139.59 50.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.401 0.681 . . . . 0.0 109.326 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.97 167.75 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.663 1.585 . . . . 0.0 110.023 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -76.94 49.74 0.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.171 1.388 . . . . 0.0 110.501 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.79 -34.98 0.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.902 2.481 . . . . 0.0 109.991 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.41 -151.58 23.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.75 148.2 40.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -125.83 107.26 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 m -91.03 103.34 16.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -87.29 147.08 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.911 1.284 . . . . 0.0 110.742 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.53 -178.99 7.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.591 1.957 . . . . 0.0 108.062 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 m -146.63 150.73 36.02 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.952 0.901 . . . . 0.0 109.186 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.99 108.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.34 -15.84 59.2 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.688 0.795 . . . . 0.0 112.425 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -85.88 120.81 27.69 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.63 146.4 25.75 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.634 0.73 . . . . 0.0 109.884 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.4 m -136.89 151.78 49.47 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.041 1.736 . . . . 0.0 108.445 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -148.66 142.17 25.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.837 -0.539 . . . . 0.0 109.818 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -88.1 119.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -88.75 102.45 15.02 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.28 88.14 6.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.56 134.87 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.263 1.825 . . . . 0.0 110.351 -169.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 123.762 0.825 . . . . 0.0 112.646 179.251 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.15 138.49 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.89 129.57 55.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.485 1.039 . . . . 0.0 108.307 172.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 147.71 51.16 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.81 130.43 44.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.431 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.52 143.29 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -140.65 132.35 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 125.009 1.324 . . . . 0.0 107.648 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 48.65 38.24 11.03 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.116 0.96 . . . . 0.0 111.971 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.9 t30 63.7 8.75 3.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.116 2.167 . . . . 0.0 115.428 -175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.25 149.4 21.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.126 1.37 . . . . 0.0 109.781 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.89 136.27 33.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.101 0.96 . . . . 0.0 110.119 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -120.19 116.58 32.4 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.895 1.678 . . . . 0.0 106.901 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.31 143.9 20.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.269 2.646 . . . . 0.0 111.383 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.237 0.424 0 C-N-CA 123.176 0.59 . . . . 0.0 110.666 179.606 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -110.21 130.5 55.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 m -121.64 142.63 49.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.492 0.663 . . . . 0.0 109.584 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -135.57 159.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.468 1.907 . . . . 0.0 106.941 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.42 141.36 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 169.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.51 134.2 46.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.053 1.341 . . . . 0.0 108.94 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -101.52 132.1 47.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.601 0.76 . . . . 0.0 109.278 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -138.24 133.08 32.73 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 56.28 -61.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.392 3.077 . . . . 0.0 115.975 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.97 15.17 0.08 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.323 1.916 . . . . 0.0 112.042 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -130.06 159.17 37.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.954 1.702 . . . . 0.0 109.179 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -121.1 130.93 53.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -110.02 109.51 20.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.656 1.182 . . . . 0.0 107.954 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -74.08 119.68 18.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 mm -96.6 131.2 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.63 116.38 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.94 122.83 31.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -82.59 113.27 20.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -71.75 -27.11 62.75 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.532 0.333 . . . . 0.0 111.634 -169.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.86 -45.63 41.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.38 0.537 . . . . 0.0 110.609 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.28 -17.07 28.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.172 0.989 . . . . 0.0 112.952 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.251 98.8 mmm 55.76 28.81 12.82 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.331 1.452 . . . . 0.0 111.357 -169.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.28 146.32 25.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.04 118.68 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -85.02 132.88 34.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.781 1.633 . . . . 0.0 108.1 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -118.22 116.3 26.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 168.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 46.39 42.4 10.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.859 1.264 . . . . 0.0 111.265 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.51 -11.36 39.29 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.616 1.103 . . . . 0.0 115.004 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.49 138.14 31.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.77 1.785 . . . . 0.0 108.588 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -68.94 145.9 53.24 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.8 163.64 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.944 0.898 . . . . 0.0 110.573 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.18 148.06 39.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.563 1.145 . . . . 0.0 110.285 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -140.62 149.41 42.28 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.399 1.08 . . . . 0.0 109.908 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.65 50.19 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.85 108.35 1.94 Allowed Glycine 0 C--N 1.331 0.263 0 N-CA-C 106.994 -2.442 . . . . 0.0 106.994 -174.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -94.55 148.96 21.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.38 137.16 52.38 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.585 0.754 . . . . 0.0 109.011 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.43 167.9 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.601 1.56 . . . . 0.0 109.919 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.7 47.88 0.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.071 1.348 . . . . 0.0 110.47 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -159.91 -34.9 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.274 2.23 . . . . 0.0 110.165 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.62 12.59 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -120.52 152.59 37.85 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.32 107.56 9.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.713 1.605 . . . . 0.0 106.948 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.9 m -93.93 102.93 15.04 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -89.76 148.15 23.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.907 1.283 . . . . 0.0 111.22 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -158.96 -177.63 6.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.907 2.083 . . . . 0.0 108.26 169.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.0 m -144.91 146.63 32.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.175 0.99 . . . . 0.0 109.709 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.0 mt -142.39 132.83 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.87 -127.19 44.68 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -109.57 36.48 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 110.526 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -131.86 145.99 51.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.043 1.337 . . . . 0.0 108.778 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.96 150.44 21.95 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.37 151.02 51.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.427 1.491 . . . . 0.0 107.839 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 29.7 p90 -148.66 140.64 23.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 121.804 -0.56 . . . . 0.0 110.285 168.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -87.51 117.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -84.96 127.88 34.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 170.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.46 96.52 4.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.63 125.18 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.104 0.962 . . . . 0.0 109.574 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.543 0.673 0 C-N-CA 124.473 1.109 . . . . 0.0 111.125 175.791 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.4 mm -88.29 113.07 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -95.74 129.18 43.04 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -137.51 140.19 40.97 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 tp -86.55 133.46 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.528 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -112.66 142.63 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 169.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.23 130.46 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.2 39.6 15.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.241 1.016 . . . . 0.0 111.97 -175.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 64.32 4.42 2.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.819 2.047 . . . . 0.0 115.006 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.3 147.21 23.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 120.449 -1.407 . . . . 0.0 109.189 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.95 133.55 35.6 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.371 0.668 . . . . 0.0 109.97 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.0 mm -117.28 111.99 39.88 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.193 1.797 . . . . 0.0 107.081 -175.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -73.23 152.58 50.45 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.908 2.405 . . . . 0.0 110.726 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 . . . . . 0 C--O 1.237 0.439 0 C-N-CA 124.243 1.017 . . . . 0.0 111.257 174.81 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.6 t70 55.19 -73.72 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.087 2.555 . . . . 0.0 113.684 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -81.12 66.41 6.65 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -98.12 -39.83 8.7 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.091 0.957 . . . . 0.0 110.586 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -85.79 20.41 2.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.005 0.922 . . . . 0.0 112.817 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 m -50.6 124.01 9.98 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.395 1.478 . . . . 0.0 109.579 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 24' ' ' GLU . 13.8 p -68.76 156.96 37.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.474 1.11 . . . . 0.0 111.365 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.67 138.31 49.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.6 m -119.89 142.97 48.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -132.69 152.68 51.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.011 1.325 . . . . 0.0 107.562 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.3 mt -124.1 119.46 29.51 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -92.4 113.52 25.82 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 mtm -146.07 137.34 24.68 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.404 1.082 . . . . 0.0 108.627 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.07 37.74 15.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.168 1.387 . . . . 0.0 113.102 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.22 -4.0 60.28 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.125 0.869 . . . . 0.0 114.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.08 164.87 11.6 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.84 1.656 . . . . 0.0 110.056 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -121.01 124.37 44.68 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -110.57 132.49 54.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.956 1.303 . . . . 0.0 108.352 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.38 131.94 37.15 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.4 mm -110.1 134.36 52.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.37 121.86 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.85 123.5 32.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.92 113.03 23.17 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -75.7 -18.02 59.75 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.831 -0.543 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.27 -35.71 79.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.18 0.445 . . . . 0.0 111.266 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.44 -0.07 8.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.267 1.427 . . . . 0.0 113.434 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.7 mmt 52.14 49.13 21.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.106 0.955 . . . . 0.0 109.267 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -117.53 142.51 47.09 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.211 1.404 . . . . 0.0 107.879 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.78 119.79 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.774 0.797 . . . . 0.0 108.913 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.445 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 20.9 m95 -85.93 129.39 34.85 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.298 1.839 . . . . 0.0 108.994 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.8 t -118.33 119.26 34.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 168.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 47.89 41.52 14.71 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.989 1.316 . . . . 0.0 111.691 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.22 -7.05 61.45 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.603 -1.11 . . . . 0.0 115.221 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.84 137.83 39.62 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.751 1.775 . . . . 0.0 107.539 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -72.93 147.5 45.22 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.967 1.258 . . . . 0.0 109.997 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pp -117.07 168.58 10.14 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.953 1.301 . . . . 0.0 110.302 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.05 145.41 48.27 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.073 0.949 . . . . 0.0 110.138 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -143.13 151.19 40.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.478 1.111 . . . . 0.0 109.875 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.44 136.18 48.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.43 96.22 1.24 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -86.66 146.02 26.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -111.52 134.25 53.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.35 167.56 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.196 1.399 . . . . 0.0 110.116 -172.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.85 49.24 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.241 1.416 . . . . 0.0 110.309 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -159.95 -36.57 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.37 2.268 . . . . 0.0 109.892 -169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.26 -132.18 3.65 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -120.76 151.54 39.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -129.97 106.48 8.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.6 m -85.76 100.1 11.79 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -84.36 145.44 28.22 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.71 1.204 . . . . 0.0 110.393 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -158.45 -178.25 7.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.14 1.776 . . . . 0.0 108.762 169.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -145.81 150.47 36.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.36 1.064 . . . . 0.0 109.108 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mt -133.66 111.67 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.0 -131.26 51.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -169.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -81.16 -10.5 59.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.609 0.764 . . . . 0.0 112.653 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.78 30.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -171.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.82 147.15 26.97 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 109.578 169.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -138.26 152.5 48.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.871 1.668 . . . . 0.0 108.725 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -148.65 141.32 24.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 121.725 -0.609 . . . . 0.0 109.648 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -88.71 114.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -75.94 126.85 31.78 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.52 88.69 2.98 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.98 123.33 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.755 1.222 . . . . 0.0 108.381 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -79.13 59.08 2.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.313 0.96 . . . . 0.0 109.908 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -72.57 -29.59 63.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.487 1.115 . . . . 0.0 111.643 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.44 144.6 48.66 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -75.34 -30.48 60.27 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.303 -0.528 . . . . 0.0 110.951 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.08 175.77 4.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.62 0.768 . . . . 0.0 109.254 173.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 1.42 4.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.65 176.23 8.89 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.03 1.732 . . . . 0.0 108.717 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.01 46.87 4.34 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp -87.94 127.48 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.57 120.63 37.69 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.057 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -100.3 127.75 46.53 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -139.3 140.31 37.55 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 108.704 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.2 131.85 34.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.82 142.81 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.42 133.3 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.3 t0 49.9 37.09 12.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.293 1.037 . . . . 0.0 111.874 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.2 t30 62.48 9.96 3.71 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.829 2.051 . . . . 0.0 115.444 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.52 150.54 20.21 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 125.063 1.345 . . . . 0.0 109.261 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.81 135.15 34.13 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.719 0.808 . . . . 0.0 110.059 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.8 mm -118.71 113.9 36.05 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.356 1.862 . . . . 0.0 106.922 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -74.64 151.43 41.44 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.948 2.432 . . . . 0.0 110.811 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -64.96 162.52 16.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.294 0.569 . . . . 0.0 109.828 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.2 pt -61.82 152.91 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.9 0.88 . . . . 0.0 112.203 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.81 26.01 6.26 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.209 1.404 . . . . 0.0 111.813 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.419 1.487 . . . . 0.0 109.961 179.175 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.44 134.89 35.6 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.731 -0.605 . . . . 0.0 109.836 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -137.64 151.5 48.36 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.49 1.116 . . . . 0.0 108.399 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p -68.18 -45.23 74.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.548 0.739 . . . . 0.0 110.114 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt 51.26 38.41 21.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.69 1.596 . . . . 0.0 111.589 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.36 127.72 33.5 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 24' ' ' GLU . 2.7 p -141.01 154.42 46.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.788 0.835 . . . . 0.0 110.759 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -121.39 136.95 54.9 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.0 m -128.43 141.96 51.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -135.66 159.65 40.96 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.874 1.67 . . . . 0.0 107.553 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -124.82 140.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.02 125.78 42.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.821 1.248 . . . . 0.0 108.425 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -84.5 121.11 27.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.4 ttm -158.02 140.29 14.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.414 1.086 . . . . 0.0 108.277 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 51.67 37.43 20.04 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.163 1.385 . . . . 0.0 113.118 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.02 8.69 83.38 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 123.94 0.781 . . . . 0.0 113.653 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -123.81 173.82 7.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.506 1.922 . . . . 0.0 109.584 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -121.92 122.3 39.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.91 127.12 53.15 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -79.6 139.8 37.35 Favored 'General case' 0 N--CA 1.46 0.054 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -114.72 130.62 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.61 117.07 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -85.46 122.77 30.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 169.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.8 OUTLIER -79.83 112.9 17.57 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 168.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -71.2 -31.6 67.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 119.205 -0.426 . . . . 0.0 112.095 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.38 -47.34 56.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.327 0.512 . . . . 0.0 110.556 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.66 -18.17 28.5 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.78 0.832 . . . . 0.0 112.946 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.258 51.8 mtp 55.44 30.27 14.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.444 1.497 . . . . 0.0 111.552 -169.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.48 152.91 21.57 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.32 115.77 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -85.28 122.65 29.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.581 1.552 . . . . 0.0 107.355 174.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 t -114.73 125.98 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 49.86 36.83 12.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.293 1.037 . . . . 0.0 111.591 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.51 0.51 84.14 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 118.541 -1.144 . . . . 0.0 115.255 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -113.78 146.38 39.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.825 1.812 . . . . 0.0 109.235 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -66.71 147.04 53.8 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.339 -0.85 . . . . 0.0 108.998 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.35 168.16 12.86 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.618 1.167 . . . . 0.0 110.197 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.16 145.39 44.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.306 1.042 . . . . 0.0 110.117 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -140.85 149.52 42.09 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 109.88 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.3 140.39 48.57 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.8 109.86 2.0 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 -175.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.26 149.06 25.07 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.538 0.735 . . . . 0.0 109.563 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.97 141.64 37.02 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.321 0.649 . . . . 0.0 109.521 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.13 166.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.753 1.621 . . . . 0.0 109.897 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -77.92 48.39 0.71 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.133 1.373 . . . . 0.0 110.443 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -161.31 -31.77 0.05 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.437 2.295 . . . . 0.0 110.856 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.8 -134.85 4.41 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -130.82 151.83 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.39 110.83 12.7 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.5 m -92.17 104.89 17.22 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.72 147.12 24.04 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.807 1.243 . . . . 0.0 110.666 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -157.51 -177.62 6.72 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.059 1.744 . . . . 0.0 108.635 169.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.93 147.54 31.84 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.346 1.058 . . . . 0.0 109.465 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.5 mt -143.67 130.53 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.98 -131.36 51.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.17 28.92 4.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.702 1.201 . . . . 0.0 111.536 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -124.29 149.26 46.73 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.968 1.307 . . . . 0.0 109.17 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 150.72 24.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 169.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.92 152.82 52.07 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.464 1.506 . . . . 0.0 108.318 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -147.68 143.45 27.64 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.686 -0.634 . . . . 0.0 109.6 168.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.84 117.49 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 169.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -83.07 115.8 22.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.19 90.59 3.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.98 122.24 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.02 1.328 . . . . 0.0 108.587 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -84.39 69.29 10.49 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.203 0.911 . . . . 0.0 108.884 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -73.4 -42.88 61.55 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.818 -0.551 . . . . 0.0 110.829 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.2 155.04 37.72 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.021 0.82 . . . . 0.0 111.758 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -80.92 -24.88 37.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.018 0.527 . . . . 0.0 111.25 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -67.23 151.38 47.62 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -53.63 -49.05 68.7 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.149 0.979 . . . . 0.0 111.221 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -84.92 8.16 18.55 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -170.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.23 41.68 1.83 Allowed Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.968 1.747 . . . . 0.0 114.572 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp -92.6 137.76 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 118.536 1.168 . . . . 0.0 108.785 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.0 mm -102.46 120.88 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -96.44 125.63 41.07 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -132.69 145.82 51.37 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.345 1.058 . . . . 0.0 108.547 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 tp -93.44 131.95 38.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.78 141.95 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.6 131.36 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.61 40.47 15.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.282 1.033 . . . . 0.0 111.796 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 66.77 1.36 2.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.857 2.063 . . . . 0.0 115.282 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.55 147.48 23.32 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 120.456 -1.403 . . . . 0.0 109.325 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.05 133.88 34.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.619 0.768 . . . . 0.0 109.822 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.1 mm -118.22 113.38 37.24 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.95 1.7 . . . . 0.0 107.285 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.19 155.16 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.391 2.727 . . . . 0.0 111.137 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -59.11 161.58 5.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.63 0.772 . . . . 0.0 110.897 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.6 pt -62.24 150.77 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.32 1.048 . . . . 0.0 111.845 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.83 104.79 5.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 169.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 123.081 0.552 . . . . 0.0 109.639 176.375 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -145.24 -177.84 5.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.956 1.303 . . . . 0.0 108.465 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? 57.75 30.1 18.41 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.426 1.891 . . . . 0.0 112.404 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.7 m -65.32 145.85 55.67 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.088 0.955 . . . . 0.0 110.52 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -68.19 -54.37 18.33 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m 64.96 -51.13 0.33 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.747 2.019 . . . . 0.0 114.089 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 24' ' ' GLU . 24.7 p -70.98 169.26 15.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.058 1.343 . . . . 0.0 111.634 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -120.44 132.4 55.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.0 m -119.51 143.04 47.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -136.29 156.18 49.03 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.121 1.368 . . . . 0.0 108.247 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -116.11 134.74 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt -121.62 110.38 15.92 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -82.55 111.25 18.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 53.0 mtm -147.53 139.8 24.46 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.565 1.146 . . . . 0.0 108.687 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 50.15 36.11 11.65 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.162 1.385 . . . . 0.0 112.914 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.97 -7.29 36.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.536 1.065 . . . . 0.0 113.718 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.55 171.09 9.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.715 1.606 . . . . 0.0 110.706 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -128.62 111.46 13.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.304 1.442 . . . . 0.0 107.17 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -99.07 129.14 45.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -88.42 135.88 33.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.03 133.76 62.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.8 t -131.67 122.19 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -88.14 127.4 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.424 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -97.01 113.32 24.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -69.39 -25.11 63.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -172.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -37.35 84.52 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.225 0.466 . . . . 0.0 111.494 -174.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.76 -5.54 11.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.096 1.358 . . . . 0.0 113.018 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 71.8 mtp 54.37 31.03 13.69 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.845 1.258 . . . . 0.0 110.353 -168.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.36 147.7 32.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 171.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.76 119.5 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.411 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 8.2 m95 -85.45 126.65 33.97 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.481 1.513 . . . . 0.0 107.908 172.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.43 121.37 44.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 46.42 38.94 5.87 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.054 1.341 . . . . 0.0 111.832 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.58 62.53 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.901 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.42 141.21 31.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.724 1.762 . . . . 0.0 108.618 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -69.28 143.97 53.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.21 164.79 17.21 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.944 0.898 . . . . 0.0 110.19 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.32 146.17 43.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.155 0.982 . . . . 0.0 110.243 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -139.72 149.85 44.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.624 1.17 . . . . 0.0 109.824 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.88 140.98 49.25 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.44 106.1 1.36 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.43 151.49 19.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.35 139.08 54.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.585 0.754 . . . . 0.0 109.057 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.12 167.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.424 1.49 . . . . 0.0 110.305 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.07 49.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.705 1.24 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -159.09 -35.12 0.06 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.614 2.366 . . . . 0.0 110.191 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.62 -153.06 23.71 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -118.24 150.83 38.78 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -126.01 106.74 9.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.55 1.54 . . . . 0.0 107.098 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 m -91.94 102.57 15.14 Favored 'General case' 0 N--CA 1.46 0.041 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -87.76 146.82 25.47 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.832 1.253 . . . . 0.0 110.662 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -157.54 -179.89 8.59 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.011 1.724 . . . . 0.0 108.68 169.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 m -145.76 150.77 36.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.191 0.997 . . . . 0.0 108.941 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.4 mt -133.01 110.85 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.89 -131.46 52.06 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.02 -9.99 59.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.478 0.711 . . . . 0.0 112.578 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.28 119.59 29.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -171.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.85 147.19 25.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 170.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.2 m -137.77 152.34 49.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.168 1.787 . . . . 0.0 108.685 -173.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -149.4 140.57 23.07 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.761 -0.587 . . . . 0.0 109.838 168.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 mt -87.71 120.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -87.16 122.9 31.59 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.32 93.53 4.16 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -90.18 125.5 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.377 1.071 . . . . 0.0 108.941 -169.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 m -79.81 45.54 0.71 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.368 1.067 . . . . 0.0 111.904 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 m -69.31 -53.83 17.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.487 1.115 . . . . 0.0 110.425 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.7 148.08 23.42 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -100.76 -7.35 23.81 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -69.78 169.37 13.12 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -52.84 -55.11 25.46 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.914 0.885 . . . . 0.0 111.133 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -90.2 17.22 7.31 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.092 0.473 . . . . 0.0 111.498 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.25 -17.95 77.79 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.602 1.096 . . . . 0.0 112.782 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.62 124.32 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.1 mm -88.78 115.03 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.98 127.87 41.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -135.21 144.19 46.81 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.72 130.58 41.18 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.4 142.75 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.77 132.43 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 107.565 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.3 37.71 12.08 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.084 0.954 . . . . 0.0 111.948 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.62 9.88 3.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.152 2.181 . . . . 0.0 115.542 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.7 150.8 19.97 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.232 1.413 . . . . 0.0 109.578 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.47 136.46 33.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.346 1.059 . . . . 0.0 110.227 -176.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.9 mm -120.65 116.16 31.94 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.3 1.84 . . . . 0.0 107.005 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.8 144.27 19.19 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 111.269 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.85 165.29 24.44 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.054 0.542 . . . . 0.0 111.312 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.9 pt -117.36 157.89 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 126.135 1.774 . . . . 0.0 110.194 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.32 27.0 2.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.145 1.378 . . . . 0.0 111.648 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.469 1.508 . . . . 0.0 110.036 179.719 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.15 160.71 37.54 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.489 1.515 . . . . 0.0 108.38 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -141.37 34.12 1.68 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.212 0.605 . . . . 0.0 110.706 171.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -65.12 153.23 41.47 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.135 0.574 . . . . 0.0 110.81 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.7 tttt 54.9 23.89 5.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.319 1.448 . . . . 0.0 112.551 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.42 HG22 ' HD2' ' A' ' 25' ' ' LYS . 16.1 m -103.25 100.86 10.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 169.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -130.13 153.46 48.49 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.909 0.862 . . . . 0.0 112.788 -168.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -118.32 129.53 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 168.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.8 m -112.52 145.42 40.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -133.92 161.42 34.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.459 1.504 . . . . 0.0 108.0 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.03 137.94 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.3 mt -121.57 113.22 19.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -81.06 122.14 26.95 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 168.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 58.3 mtt -130.42 -173.68 3.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.362 1.865 . . . . 0.0 108.079 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -51.1 90.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.603 1.561 . . . . 0.0 113.369 -169.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 13.12 79.13 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.214 1.388 . . . . 0.0 114.116 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -139.99 162.34 35.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.448 1.624 . . . . 0.0 111.123 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -128.61 119.88 25.58 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 125.612 1.565 . . . . 0.0 106.938 172.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.03 131.53 54.49 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.03 0.932 . . . . 0.0 109.239 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -80.75 145.93 31.27 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 mm -122.39 132.61 70.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.22 119.99 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -88.4 123.13 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -90.89 113.2 25.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 168.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 6' ' ' THR . 94.8 mttt -70.78 -19.98 62.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.128 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.18 -42.36 94.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.869 0.759 . . . . 0.0 111.591 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.42 -1.01 13.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.24 1.416 . . . . 0.0 112.449 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm 53.11 39.35 29.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.008 1.323 . . . . 0.0 109.954 -169.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.37 141.77 31.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.779 1.232 . . . . 0.0 109.098 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.45 116.76 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.837 0.827 . . . . 0.0 109.972 -173.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.433 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -85.18 115.27 22.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.1 m -118.48 125.87 50.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 49.14 39.35 15.1 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.138 0.975 . . . . 0.0 111.914 -174.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.13 3.55 88.39 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.307 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.59 147.26 46.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.541 1.67 . . . . 0.0 108.23 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 147.75 33.85 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.384 0.993 . . . . 0.0 109.551 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.9 166.57 23.01 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.487 1.115 . . . . 0.0 110.458 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.98 148.83 48.41 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.486 0.714 . . . . 0.0 111.675 -172.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 149.93 48.99 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.786 1.634 . . . . 0.0 109.15 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.6 140.54 52.69 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.51 106.98 1.29 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 107.38 -2.288 . . . . 0.0 107.38 -173.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -98.32 153.01 18.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 109.374 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -122.48 138.55 54.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.38 168.28 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.422 1.489 . . . . 0.0 110.325 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.01 48.35 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.061 1.345 . . . . 0.0 110.794 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -159.99 -35.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.502 2.321 . . . . 0.0 110.448 -172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.0 -153.65 24.29 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -118.45 152.41 35.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.57 109.73 10.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.767 1.227 . . . . 0.0 107.849 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 m -94.37 105.75 17.72 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -91.17 146.19 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.97 1.308 . . . . 0.0 110.836 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.01 -174.01 4.53 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.61 1.964 . . . . 0.0 108.701 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.1 m -145.71 146.58 31.31 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.53 1.132 . . . . 0.0 109.4 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.3 mt -142.39 130.12 20.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.46 -130.37 50.89 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -101.06 28.6 5.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.68 1.192 . . . . 0.0 111.548 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -128.52 144.31 51.12 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.65 1.18 . . . . 0.0 109.076 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.77 149.9 21.83 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.4 150.51 50.89 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.364 1.465 . . . . 0.0 108.212 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -146.82 140.36 25.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.3 mt -90.79 115.5 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 170.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -78.85 134.83 36.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.66 94.04 3.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.93 128.42 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.957 1.303 . . . . 0.0 109.539 -169.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.0 m -79.69 47.57 0.86 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.76 1.164 . . . . 0.0 112.436 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.2 m -73.56 -22.11 60.17 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.747 1.219 . . . . 0.0 113.394 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.18 42.86 49.41 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 118.746 0.703 . . . . 0.0 112.759 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -82.44 176.78 9.14 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.84 0.82 . . . . 0.0 110.556 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.87 -66.53 0.46 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.299 1.039 . . . . 0.0 112.665 -169.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -87.83 -70.9 0.6 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 118.64 0.655 . . . . 0.0 109.657 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -71.62 107.37 4.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.72 -58.51 7.57 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mp -87.22 125.09 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 169.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.8 mm -79.08 116.5 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -96.51 130.85 43.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.1 tp -93.34 130.72 38.99 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.84 140.59 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.35 132.22 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.583 1.153 . . . . 0.0 108.132 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.0 t0 45.53 42.35 7.87 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.337 1.455 . . . . 0.0 111.613 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.2 t30 64.52 18.21 11.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.563 2.345 . . . . 0.0 116.002 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -115.75 153.42 31.43 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 120.752 -1.218 . . . . 0.0 110.809 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -89.18 138.08 31.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.955 1.302 . . . . 0.0 110.793 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -121.55 118.09 29.88 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.859 2.064 . . . . 0.0 106.596 -177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.97 143.39 23.01 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.232 2.621 . . . . 0.0 111.357 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -70.46 160.7 31.91 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.351 0.596 . . . . 0.0 110.359 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.7 pt -117.46 161.03 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 126.475 1.91 . . . . 0.0 108.894 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 51.09 43.92 28.86 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.728 1.211 . . . . 0.0 111.878 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.311 1.844 . . . . 0.0 111.36 -176.189 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -74.8 -41.98 58.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.595 0.758 . . . . 0.0 111.301 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -75.77 149.89 37.87 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -70.88 -25.53 62.84 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.49 0.716 . . . . 0.0 112.438 -176.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 7' ' ' THR . 21.7 tptm 50.74 84.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.833 2.053 . . . . 0.0 110.887 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.9 m -61.16 -31.25 70.98 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.622 1.169 . . . . 0.0 113.097 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.2 p -131.34 152.73 50.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.546 -0.721 . . . . 0.0 110.368 -169.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -115.9 128.98 56.2 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.4 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.811 0.815 . . . . 0.0 109.249 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -135.07 157.03 47.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.032 1.333 . . . . 0.0 107.491 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.2 p -125.06 137.76 56.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 169.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.7 mt -122.16 125.53 46.33 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.833 1.253 . . . . 0.0 107.628 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -93.31 118.07 30.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.7 mtm -146.41 134.87 21.99 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.638 1.175 . . . . 0.0 108.416 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.29 37.5 11.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.983 1.313 . . . . 0.0 113.496 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.71 8.1 87.24 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.936 -0.925 . . . . 0.0 114.431 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -118.28 155.22 30.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.81 1.644 . . . . 0.0 110.042 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -107.88 123.52 48.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -111.05 122.66 48.46 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.212 1.405 . . . . 0.0 108.382 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -80.42 142.32 34.44 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -120.72 134.32 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.4 t -132.36 118.59 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -87.11 125.94 34.46 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.3 OUTLIER -87.79 112.8 22.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -70.01 -29.35 66.39 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.791 0.723 . . . . 0.0 111.787 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.42 -43.43 94.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.286 0.494 . . . . 0.0 110.996 -173.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.87 -11.68 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.639 1.176 . . . . 0.0 113.003 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.9 mtp 54.55 34.35 21.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 110.519 -169.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -93.13 150.89 20.19 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.28 117.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.53 121.84 30.47 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.74 1.616 . . . . 0.0 107.604 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.2 t -113.63 130.57 56.37 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 52.26 35.51 17.13 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.82 0.848 . . . . 0.0 111.6 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.43 10.17 82.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.209 0.909 . . . . 0.0 114.835 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -124.34 136.58 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.379 1.472 . . . . 0.0 107.221 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -72.18 142.58 49.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.595 1.543 . . . . 0.0 109.438 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -116.2 167.8 10.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.086 0.954 . . . . 0.0 110.989 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.29 146.35 43.25 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 110.352 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -139.55 150.39 45.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.445 1.098 . . . . 0.0 109.697 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.7 141.29 50.93 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.49 106.13 1.21 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -95.64 153.35 17.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -122.66 139.7 53.66 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.62 167.58 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.853 1.661 . . . . 0.0 110.086 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -76.55 48.49 0.55 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.8 1.286 . . . . 0.0 110.927 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -159.98 -33.61 0.06 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.851 2.46 . . . . 0.0 110.356 -171.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.2 -152.17 23.32 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.52 149.16 40.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -126.56 106.75 9.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 m -92.22 103.6 16.06 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -88.56 146.68 25.0 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.913 1.285 . . . . 0.0 110.335 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.82 179.74 8.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.893 1.677 . . . . 0.0 108.337 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 m -145.81 149.88 35.16 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.907 0.883 . . . . 0.0 108.903 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.7 mt -133.18 110.0 14.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.48 -131.67 52.17 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -81.22 -10.12 59.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.413 0.685 . . . . 0.0 112.803 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -88.8 121.34 31.07 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 147.04 25.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.482 0.658 . . . . 0.0 109.862 170.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -137.84 153.52 49.6 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.57 1.548 . . . . 0.0 108.508 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -148.09 143.08 26.91 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.692 -0.63 . . . . 0.0 109.798 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.4 mt -88.31 119.56 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -85.33 110.05 18.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.4 84.83 3.05 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.61 127.3 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.846 1.659 . . . . 0.0 108.881 -169.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -84.55 53.33 2.63 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.63 1.105 . . . . 0.0 110.273 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.1 m -74.57 -26.18 59.78 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.3 140.88 40.07 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 118.698 0.681 . . . . 0.0 111.766 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.79 -28.44 33.19 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.725 0.41 . . . . 0.0 111.322 175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -71.67 168.6 17.38 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -60.25 155.22 18.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 56.86 -124.19 1.8 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -169.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.53 31.69 49.58 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 119.536 1.062 . . . . 0.0 113.141 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.19 139.75 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.31 129.72 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -104.73 124.91 50.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -132.59 145.54 51.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.14 0.976 . . . . 0.0 108.775 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 tp -92.42 131.1 37.86 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.69 142.42 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 169.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -136.94 132.19 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.048 1.339 . . . . 0.0 107.978 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t0 45.4 42.21 7.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.239 1.415 . . . . 0.0 111.539 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.3 t30 64.02 17.33 10.54 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.553 2.341 . . . . 0.0 116.196 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.65 152.09 32.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.84 1.256 . . . . 0.0 110.546 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -88.74 137.96 31.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.372 1.069 . . . . 0.0 110.631 -169.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.49 112.3 37.43 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.611 1.964 . . . . 0.0 106.909 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.43 150.61 36.61 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.19 2.593 . . . . 0.0 110.821 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.67 157.71 6.91 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.569 0.748 . . . . 0.0 110.818 176.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.1 pt -58.82 153.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.392 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.12 25.99 5.81 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.328 1.451 . . . . 0.0 111.887 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.253 1.264 0 C-N-CA 125.467 1.507 . . . . 0.0 110.059 178.922 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -147.46 153.99 40.25 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.62 1.568 . . . . 0.0 107.902 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -111.6 44.39 1.36 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.83 1.252 . . . . 0.0 108.821 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m 53.2 39.82 30.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.267 1.427 . . . . 0.0 112.317 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -67.17 -28.9 68.49 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 121.534 -0.729 . . . . 0.0 111.152 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.3 m 66.96 -53.98 0.45 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.435 1.894 . . . . 0.0 112.554 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 24' ' ' GLU . 19.7 p -65.43 146.55 54.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 119.717 1.144 . . . . 0.0 110.661 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -89.49 125.36 35.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.5 m -108.6 148.6 30.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -136.5 159.52 41.53 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.825 1.65 . . . . 0.0 106.689 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.04 140.57 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.17 122.26 36.55 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.834 1.253 . . . . 0.0 107.987 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -91.91 117.81 30.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 56.7 mtm -146.64 134.8 21.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.817 1.247 . . . . 0.0 108.421 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.33 37.83 12.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.141 1.376 . . . . 0.0 113.339 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.3 8.73 87.04 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.236 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.13 155.76 29.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.987 1.715 . . . . 0.0 110.004 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.92 123.84 49.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -110.26 124.02 50.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.26 1.424 . . . . 0.0 107.978 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -84.38 141.34 30.93 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.0 mm -117.34 135.51 57.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.5 t -132.06 120.58 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.57 124.14 33.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.71 113.85 21.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -72.58 -26.41 61.7 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.724 -0.61 . . . . 0.0 111.696 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.09 -44.06 77.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.176 0.443 . . . . 0.0 111.287 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.19 -10.85 17.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 113.372 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.263 59.6 mtp 54.96 30.4 13.99 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.988 1.315 . . . . 0.0 111.861 -169.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.43 150.08 27.28 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.95 117.71 46.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.428 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.2 m95 -85.19 119.21 25.32 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.5 t -110.54 128.74 55.78 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 169.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 52.62 34.92 16.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.702 0.801 . . . . 0.0 111.576 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 11.17 82.15 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.233 0.921 . . . . 0.0 114.768 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -124.8 142.6 51.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.164 1.482 . . . . 0.0 108.187 -174.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -69.47 145.06 53.04 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.522 1.055 . . . . 0.0 108.427 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 pp -123.18 167.15 14.08 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.36 144.85 44.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.911 0.884 . . . . 0.0 110.189 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -140.93 149.58 42.05 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.225 1.01 . . . . 0.0 110.011 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.96 138.45 49.72 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.41 111.2 2.2 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -110.37 146.18 36.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.622 0.769 . . . . 0.0 109.87 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.45 142.46 30.04 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.55 166.34 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.693 1.597 . . . . 0.0 109.754 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.57 49.15 0.72 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.982 1.373 . . . . 0.0 110.231 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -159.87 -34.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.64 2.376 . . . . 0.0 110.292 -169.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.4 -130.07 2.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -171.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -131.85 152.2 51.18 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -129.3 117.3 20.43 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 m -95.84 105.58 17.61 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.87 145.36 25.2 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.815 1.246 . . . . 0.0 109.966 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -157.31 -177.81 6.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.507 1.523 . . . . 0.0 109.053 169.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.2 m -145.81 151.54 38.08 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.422 1.089 . . . . 0.0 108.507 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -132.5 108.58 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.44 -130.76 51.48 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -77.94 -16.21 58.37 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.555 0.742 . . . . 0.0 112.578 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -85.84 120.03 26.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.76 147.53 26.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.364 0.529 . . . . 0.0 109.796 170.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.86 153.07 46.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.731 1.612 . . . . 0.0 108.924 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -148.0 141.3 25.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.661 -0.649 . . . . 0.0 109.342 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.8 mt -88.55 117.76 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -81.74 128.11 33.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.35 90.9 3.39 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 t -87.53 121.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 124.103 0.961 . . . . 0.0 108.537 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 m -75.09 111.7 10.59 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.8 m -144.08 178.52 7.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.541 1.136 . . . . 0.0 110.379 -169.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.3 -157.23 33.05 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.561 0.601 . . . . 0.0 112.176 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -72.33 178.27 4.05 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.223 1.009 . . . . 0.0 109.532 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -60.83 -16.31 39.73 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -24.12 67.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.312 0.96 . . . . 0.0 112.388 170.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 58.28 104.21 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 129.593 3.157 . . . . 0.0 113.069 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.7 110.63 4.06 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 106.227 -2.749 . . . . 0.0 106.227 169.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.68 124.81 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -90.09 114.35 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.45 125.31 38.0 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -132.83 142.35 48.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.7 tp -94.25 130.33 40.55 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.22 141.96 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -139.07 132.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t0 49.54 37.49 12.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.049 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 62.86 10.17 4.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.774 2.03 . . . . 0.0 115.531 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -96.63 150.47 20.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.265 1.426 . . . . 0.0 109.672 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.22 137.44 32.33 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.263 1.025 . . . . 0.0 110.232 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mm -118.94 118.77 32.79 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.967 1.707 . . . . 0.0 107.952 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -68.12 141.44 52.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.611 2.874 . . . . 0.0 112.33 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.98 164.62 23.53 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.56 0.695 . . . . 0.0 110.622 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.3 pt -134.02 160.74 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 127.405 2.282 . . . . 0.0 108.233 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.15 23.21 9.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.475 1.11 . . . . 0.0 112.548 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 124.976 1.311 . . . . 0.0 109.742 177.674 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.79 -34.64 69.82 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.093 -1.005 . . . . 0.0 112.204 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -82.44 -7.22 59.64 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -66.3 145.39 55.8 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.346 0.975 . . . . 0.0 110.435 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -77.02 152.05 35.32 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 170.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m -129.63 90.17 2.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -130.08 146.16 51.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.568 0.747 . . . . 0.0 111.234 -170.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.76 131.1 55.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.0 m -116.64 141.19 48.52 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -131.21 153.69 49.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.601 1.56 . . . . 0.0 107.326 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -114.88 139.4 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.49 112.64 18.76 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.278 1.831 . . . . 0.0 106.591 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -92.44 113.21 25.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.7 mtm -147.31 137.29 23.09 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.43 1.092 . . . . 0.0 108.609 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.3 t70 49.54 37.76 13.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.197 1.399 . . . . 0.0 113.206 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.34 -7.02 48.97 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.518 1.056 . . . . 0.0 113.976 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -95.23 164.99 12.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.731 1.613 . . . . 0.0 110.219 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -123.38 124.44 42.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.8 132.47 54.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.676 1.591 . . . . 0.0 108.132 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.81 138.1 31.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 169.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.5 mm -116.36 131.4 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.3 117.62 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 170.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.1 tp -89.2 123.07 33.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -86.13 110.12 19.33 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 168.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -75.81 -24.76 55.93 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.92 -0.487 . . . . 0.0 111.446 -171.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.29 -42.02 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.134 0.424 . . . . 0.0 110.303 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.62 -14.29 22.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.919 1.288 . . . . 0.0 113.106 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm 52.19 49.71 19.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.317 1.447 . . . . 0.0 109.366 -169.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -123.34 141.97 51.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.372 1.469 . . . . 0.0 108.579 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.93 123.33 68.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 121.273 0.559 . . . . 0.0 110.221 -172.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.459 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.9 m95 -95.66 114.15 25.87 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.0 m -108.79 120.97 44.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 171.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 47.94 40.94 13.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.33 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.66 -4.41 60.61 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.767 -1.019 . . . . 0.0 114.891 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -111.8 144.21 41.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.446 1.623 . . . . 0.0 108.952 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.29 149.4 47.45 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 110.376 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.96 167.7 21.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.124 1.769 . . . . 0.0 108.41 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.39 143.5 53.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.147 0.499 . . . . 0.0 111.197 -170.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.6 151.08 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.173 1.789 . . . . 0.0 108.815 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.96 134.53 45.73 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.84 90.12 0.81 Allowed Glycine 0 C--N 1.329 0.157 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -78.6 141.43 38.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -106.67 136.11 47.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.91 166.45 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.608 1.163 . . . . 0.0 110.34 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.66 49.26 0.73 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.883 1.325 . . . . 0.0 110.318 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -161.36 -32.66 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.682 2.393 . . . . 0.0 110.874 -169.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.67 -132.99 4.23 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -127.98 151.35 49.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.15 106.59 8.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.8 m -84.52 101.03 11.76 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -85.66 144.52 27.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.774 1.23 . . . . 0.0 110.322 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.85 -178.34 7.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.15 1.78 . . . . 0.0 108.399 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.9 m -145.23 150.28 36.41 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.993 0.917 . . . . 0.0 109.048 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.6 mt -132.7 115.36 24.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.87 -132.5 52.59 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.14 -4.19 58.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 112.639 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -94.5 121.15 35.76 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -171.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.46 145.3 27.5 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.337 0.589 . . . . 0.0 109.576 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.55 152.3 50.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.482 1.513 . . . . 0.0 108.315 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 26.4 p90 -147.99 139.67 23.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 110.142 168.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mt -87.89 111.64 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -80.63 127.75 32.82 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -128.5 94.1 3.79 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -93.82 126.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.816 -169.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p -84.25 49.48 1.67 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.627 1.103 . . . . 0.0 111.764 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.2 m -110.78 141.69 43.78 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.594 1.158 . . . . 0.0 111.207 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.97 -163.13 38.1 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.135 0.874 . . . . 0.0 112.517 173.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 42.42 57.98 3.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.438 1.895 . . . . 0.0 112.738 169.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 50.22 44.76 26.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.355 1.462 . . . . 0.0 111.566 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? 62.09 -60.34 0.11 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 128.561 2.744 . . . . 0.0 114.038 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.53 -6.17 44.84 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.2 67.5 2.76 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.38 132.61 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mm -84.78 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -140.55 138.09 34.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.2 tp -88.99 131.04 35.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.6 mp -111.91 147.22 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.4 129.64 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.83 39.85 11.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.937 0.895 . . . . 0.0 111.572 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 65.9 2.35 2.17 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.76 2.024 . . . . 0.0 115.472 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -90.16 151.21 21.68 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.488 -1.382 . . . . 0.0 109.618 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -93.0 136.88 32.86 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.145 0.978 . . . . 0.0 110.538 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 mm -119.27 117.36 33.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.062 1.745 . . . . 0.0 107.01 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.68 152.51 37.74 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.162 2.575 . . . . 0.0 111.044 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.44 161.62 9.16 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.206 0.602 . . . . 0.0 109.398 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.7 pt -64.32 153.15 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.404 0.621 . . . . 0.0 112.125 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.93 103.95 4.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.035 176.412 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -70.62 143.27 51.54 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.194 0.598 . . . . 0.0 110.087 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -146.54 143.9 29.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.3 m -64.82 155.51 33.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.393 0.677 . . . . 0.0 110.83 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -139.66 152.55 46.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.841 1.256 . . . . 0.0 108.106 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.8 m -127.66 138.76 52.92 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.2 p -131.48 157.53 43.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.929 2.092 . . . . 0.0 107.789 175.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -121.71 130.23 53.29 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.7 m -123.51 142.29 51.16 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.827 0.704 . . . . 0.0 109.415 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -138.8 158.46 44.18 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 0.0 107.971 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 146.61 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.644 0.778 . . . . 0.0 109.298 169.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.55 156.01 46.47 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.623 1.169 . . . . 0.0 108.089 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -111.5 116.26 30.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtm -144.56 141.56 29.56 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.653 1.181 . . . . 0.0 108.2 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.6 t0 49.21 38.13 12.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.252 1.421 . . . . 0.0 113.546 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.94 6.44 85.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.977 -0.902 . . . . 0.0 113.937 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -118.15 162.8 17.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.149 1.78 . . . . 0.0 110.452 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -111.05 126.27 54.63 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.21 104.32 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.32 142.6 37.62 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 mm -125.57 131.47 72.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.51 120.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tt -87.94 124.52 33.78 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 169.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -89.29 108.48 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.96 1.704 . . . . 0.0 109.109 171.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -70.7 -26.7 63.53 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.055 0.389 . . . . 0.0 111.661 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.83 -39.94 94.38 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.407 0.283 . . . . 0.0 111.204 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.7 -11.28 17.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 113.218 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.3 42.4 30.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.298 1.439 . . . . 0.0 109.984 -168.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -105.26 160.84 14.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.913 1.285 . . . . 0.0 108.261 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -133.43 119.08 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.465 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 11.7 m95 -90.35 121.35 32.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.851 1.661 . . . . 0.0 109.078 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -102.79 116.03 31.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 168.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 46.13 39.78 6.41 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.32 1.048 . . . . 0.0 111.794 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.46 -7.8 67.22 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.312 -1.271 . . . . 0.0 115.343 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.23 140.98 30.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.106 1.953 . . . . 0.0 108.844 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -69.71 142.07 53.39 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.769 1.168 . . . . 0.0 108.442 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pp -114.66 166.16 12.02 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.836 0.854 . . . . 0.0 110.288 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.71 146.76 42.0 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.507 1.123 . . . . 0.0 109.979 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -142.87 150.24 39.59 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 110.091 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.36 134.24 43.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.47 90.32 0.75 Allowed Glycine 0 C--N 1.33 0.21 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -174.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.4 142.2 39.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -108.52 135.68 49.39 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.24 166.84 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 124.815 1.246 . . . . 0.0 110.174 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.71 49.34 0.75 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 123.005 1.383 . . . . 0.0 110.384 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -162.08 -33.27 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.536 2.335 . . . . 0.0 110.683 -169.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.29 -134.25 4.71 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -171.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -125.63 150.28 47.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.75 106.19 8.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -87.12 100.6 12.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -86.6 144.55 27.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.602 1.161 . . . . 0.0 110.798 -172.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.69 -177.01 6.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.367 1.867 . . . . 0.0 108.879 169.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -144.64 146.61 32.36 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.363 1.065 . . . . 0.0 109.662 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.95 132.5 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.98 -125.92 41.14 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -109.5 33.25 4.44 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.754 1.222 . . . . 0.0 110.714 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -129.53 144.87 51.45 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.178 1.391 . . . . 0.0 108.817 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.31 150.87 21.67 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.68 152.46 50.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.317 1.447 . . . . 0.0 108.295 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 24.2 p90 -148.69 140.41 23.64 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.785 -0.572 . . . . 0.0 109.647 168.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -88.29 114.13 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -81.96 126.82 32.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.25 92.12 3.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 121.74 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m -73.87 109.86 7.7 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.4 m -134.58 174.09 10.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.868 1.267 . . . . 0.0 110.544 -171.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.81 -174.54 48.11 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.85 146.37 50.56 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.952 1.301 . . . . 0.0 107.813 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 57.46 -74.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.769 2.027 . . . . 0.0 111.084 -169.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -69.83 130.29 41.87 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 169.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -92.01 112.54 24.51 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -100.26 111.76 4.26 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 106.377 -2.689 . . . . 0.0 106.377 169.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.46 122.47 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.3 mm -90.21 111.67 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -93.08 129.76 38.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -137.85 141.24 40.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.907 1.283 . . . . 0.0 108.012 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.9 tp -88.73 132.59 34.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.46 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.66 141.9 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.23 133.67 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.5 t0 49.59 37.75 13.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.413 1.085 . . . . 0.0 111.759 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.1 t30 62.72 9.66 3.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.027 2.131 . . . . 0.0 115.431 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.83 149.06 21.95 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.14 1.376 . . . . 0.0 109.387 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -91.13 133.96 34.92 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.457 0.703 . . . . 0.0 110.065 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.06 112.39 40.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.432 1.893 . . . . 0.0 106.801 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.28 152.02 55.14 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.824 2.349 . . . . 0.0 110.947 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -55.11 156.81 3.75 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.187 0.995 . . . . 0.0 110.484 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.1 pt -59.3 151.62 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.074 173.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 54.82 25.51 6.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.882 1.673 . . . . 0.0 114.977 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.253 1.247 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 169.671 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -81.17 -59.46 2.64 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 47.02 41.63 11.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.911 1.684 . . . . 0.0 113.073 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.7 m -63.03 155.1 28.64 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.8 -0.562 . . . . 0.0 110.73 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -140.82 143.45 34.83 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.281 1.432 . . . . 0.0 107.533 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.59 114.16 10.36 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -141.74 145.42 34.81 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.2 0.6 . . . . 0.0 111.304 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -117.41 135.61 53.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 m -114.68 147.61 39.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -134.55 161.35 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.379 1.472 . . . . 0.0 107.507 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.02 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.44 124.63 34.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.323 1.449 . . . . 0.0 108.581 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -87.63 125.71 34.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 ttm -156.03 132.47 10.19 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 49.91 38.94 17.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.108 1.363 . . . . 0.0 113.316 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 -1.34 74.81 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.109 0.861 . . . . 0.0 114.151 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -107.01 167.51 9.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.235 1.814 . . . . 0.0 110.031 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -121.42 124.14 43.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -105.41 118.44 36.56 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -86.73 142.37 28.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.05 133.86 67.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.0 t -133.07 119.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 tp -88.65 120.54 30.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -83.03 111.39 18.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 168.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.99 -26.8 60.65 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.181 -170.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.08 -43.58 86.96 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.106 0.412 . . . . 0.0 110.735 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.49 -13.75 24.27 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.518 1.127 . . . . 0.0 112.929 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mmm 52.35 45.62 28.15 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.08 1.352 . . . . 0.0 109.581 -169.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -115.83 141.61 47.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.835 1.254 . . . . 0.0 108.391 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.15 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.768 0.794 . . . . 0.0 109.705 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.451 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 22.9 m95 -85.53 111.51 20.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 169.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.1 m -108.5 117.65 34.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 48.01 40.89 14.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.143 1.377 . . . . 0.0 111.022 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.58 -9.31 36.42 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.591 1.091 . . . . 0.0 114.743 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.79 138.82 32.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.75 1.775 . . . . 0.0 108.821 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -71.07 141.33 50.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.9 165.9 24.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.984 0.914 . . . . 0.0 110.075 169.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.41 145.15 53.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.4 0.619 . . . . 0.0 111.167 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 p -134.36 147.82 50.59 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.845 1.658 . . . . 0.0 108.719 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.23 142.62 46.83 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 169.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.33 109.73 1.83 Allowed Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 107.155 -2.378 . . . . 0.0 107.155 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.45 148.52 25.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.07 134.39 55.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.68 167.54 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.548 1.539 . . . . 0.0 110.114 177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.95 48.41 0.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.016 1.326 . . . . 0.0 110.465 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.35 -34.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.204 2.202 . . . . 0.0 110.537 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.66 -150.73 20.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -175.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -121.02 152.98 37.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -127.19 109.83 12.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.794 1.638 . . . . 0.0 107.171 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.7 m -92.44 102.57 15.04 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -89.56 146.17 24.76 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.447 1.099 . . . . 0.0 110.958 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -158.47 -173.75 4.45 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.086 2.154 . . . . 0.0 108.231 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 m -146.57 149.24 33.19 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.534 1.134 . . . . 0.0 109.403 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -138.16 121.64 20.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.33 -134.17 52.42 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -170.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -83.37 -7.56 59.55 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.832 0.853 . . . . 0.0 112.384 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -95.33 133.35 39.35 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.69 150.69 24.95 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -134.71 150.76 50.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.407 1.483 . . . . 0.0 107.866 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.419 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 17.2 p90 -147.41 139.68 24.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.907 -0.496 . . . . 0.0 109.821 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.1 mt -88.41 117.73 32.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -84.36 124.2 31.02 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.9 91.64 3.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.6 126.02 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.324 1.05 . . . . 0.0 108.451 -169.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m -80.82 57.62 3.08 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.818 1.19 . . . . 0.0 109.958 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.8 m -71.9 -37.39 70.11 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.245 1.018 . . . . 0.0 111.159 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.09 132.7 26.04 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -95.38 -66.69 0.89 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.204 0.601 . . . . 0.0 110.098 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -77.63 -50.95 11.45 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -72.54 141.99 48.47 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.24 63.33 2.45 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.538 1.135 . . . . 0.0 110.547 169.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.95 74.48 1.68 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.85 123.58 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.17 118.02 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -98.66 124.48 43.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 m -133.47 140.34 47.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.241 1.016 . . . . 0.0 108.408 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 tp -89.33 133.48 34.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.419 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.44 141.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 169.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.83 131.97 43.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 49.48 38.33 14.16 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.398 1.079 . . . . 0.0 111.868 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.1 t30 62.79 9.6 3.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.014 2.125 . . . . 0.0 115.471 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.75 150.01 20.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.916 1.286 . . . . 0.0 109.192 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -95.02 134.24 37.93 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.769 0.828 . . . . 0.0 110.657 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.1 mm -121.98 113.73 31.27 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.47 1.908 . . . . 0.0 107.722 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.7 149.45 48.69 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.039 2.492 . . . . 0.0 111.201 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -70.04 166.6 19.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 111.384 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.55 161.11 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 126.926 2.09 . . . . 0.0 110.094 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.04 112.24 9.75 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 169.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.255 1.358 0 C-N-CA 123.561 0.744 . . . . 0.0 110.932 174.189 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -151.42 167.31 28.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.194 1.398 . . . . 0.0 108.517 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -75.41 144.55 42.15 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 170.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -71.49 155.46 40.56 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.424 0.69 . . . . 0.0 110.611 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -142.22 137.01 30.46 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 170.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.7 m -140.06 93.17 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -131.88 146.32 52.05 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -168.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -120.43 136.53 54.71 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.8 m -129.81 142.92 50.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.402 0.681 . . . . 0.0 109.284 -169.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -136.84 159.62 41.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.038 1.735 . . . . 0.0 107.629 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.13 141.58 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.224 1.01 . . . . 0.0 108.693 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.37 128.81 38.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.327 1.451 . . . . 0.0 109.079 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -83.78 128.94 34.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.8 mtt -144.44 129.65 18.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.087 1.355 . . . . 0.0 108.389 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.01 44.54 18.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 0.0 113.855 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.15 5.02 90.39 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.921 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -118.72 158.88 24.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.896 1.678 . . . . 0.0 109.987 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -115.38 123.7 49.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -108.57 128.28 54.68 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.018 0.927 . . . . 0.0 108.571 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -80.4 147.43 31.01 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mm -122.02 131.28 73.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.96 119.09 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.9 121.89 30.85 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.81 112.97 20.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -71.87 -31.28 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.97 0.908 . . . . 0.0 111.993 -169.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.75 -46.49 62.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.124 0.42 . . . . 0.0 110.262 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.83 -17.22 33.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.065 0.946 . . . . 0.0 112.57 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.0 mtp 53.41 42.17 32.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.258 1.423 . . . . 0.0 109.884 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -106.66 145.45 31.96 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.056 1.343 . . . . 0.0 107.981 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -114.34 116.94 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.932 0.873 . . . . 0.0 109.618 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -85.67 111.14 19.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.0 m -114.85 127.52 55.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 49.08 36.73 9.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.123 0.969 . . . . 0.0 111.609 -171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.2 5.8 85.61 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.207 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.78 148.12 45.06 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.878 1.839 . . . . 0.0 109.352 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -69.63 144.53 52.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.77 166.79 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.342 1.057 . . . . 0.0 110.309 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.5 140.61 57.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.576 0.751 . . . . 0.0 111.129 -174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.94 151.9 49.56 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.965 1.706 . . . . 0.0 108.466 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.06 135.83 46.76 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.77 95.58 1.28 Allowed Glycine 0 C--N 1.331 0.257 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.29 145.52 28.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -107.45 136.45 47.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.45 167.5 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.141 1.376 . . . . 0.0 109.962 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.78 49.4 0.76 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.249 1.42 . . . . 0.0 110.533 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -160.73 -36.39 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.664 2.386 . . . . 0.0 110.025 -170.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.0 -124.03 1.63 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -127.5 150.97 49.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -129.3 106.38 8.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 172.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.4 m -86.26 101.53 13.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -85.7 145.7 27.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.775 1.23 . . . . 0.0 110.557 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -157.33 -176.32 5.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.736 2.014 . . . . 0.0 108.205 169.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -146.77 150.72 35.89 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.347 1.059 . . . . 0.0 109.099 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.31 122.74 25.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.9 -131.68 52.17 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -87.58 -4.17 58.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.183 0.993 . . . . 0.0 112.458 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -98.52 130.49 45.1 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 109.448 -169.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.1 151.14 27.15 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.182 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -135.32 150.8 50.07 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.749 1.619 . . . . 0.0 107.372 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.99 140.54 26.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.864 -0.522 . . . . 0.0 109.723 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.11 113.99 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -78.57 125.8 29.86 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.58 90.31 3.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -80.12 122.63 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 m -79.11 45.41 0.63 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.591 1.087 . . . . 0.0 111.961 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.8 m -56.13 144.21 30.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.068 1.347 . . . . 0.0 108.962 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.07 -11.81 52.84 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.434 -170.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 52.16 -97.3 0.06 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 126.512 1.925 . . . . 0.0 112.124 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -68.59 -34.84 76.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.419 0.554 . . . . 0.0 110.569 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -77.05 139.46 40.04 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -83.51 58.69 4.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.071 0.948 . . . . 0.0 110.835 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.01 37.02 3.47 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.187 1.375 . . . . 0.0 111.613 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.69 124.71 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.66 116.37 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -97.1 126.89 42.57 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -135.54 144.15 46.11 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.36 1.064 . . . . 0.0 108.46 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 tp -90.97 132.37 36.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.32 141.72 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.45 132.79 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t0 50.31 37.31 14.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 111.816 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 62.43 9.61 3.47 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.045 2.138 . . . . 0.0 115.614 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.27 147.66 22.97 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 120.679 -1.263 . . . . 0.0 109.371 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -90.57 133.67 34.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.685 0.794 . . . . 0.0 110.061 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.1 mm -119.36 113.77 35.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.134 1.774 . . . . 0.0 107.44 -174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.31 155.32 36.96 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.197 2.598 . . . . 0.0 111.149 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -58.51 161.4 4.56 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.758 0.823 . . . . 0.0 110.841 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt -63.42 149.84 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.261 1.025 . . . . 0.0 112.085 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.35 93.31 9.36 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.252 1.196 0 C-N-CA 123.493 0.717 . . . . 0.0 109.744 175.93 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.92 140.02 56.46 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.912 0.885 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -149.11 147.1 28.09 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 108.274 175.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.1 m -60.55 148.53 37.67 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.521 0.728 . . . . 0.0 110.583 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.44 117.56 19.02 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.5 m -69.04 -33.9 74.34 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.224 0.61 . . . . 0.0 111.862 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.445 HG22 ' HA ' ' A' ' 24' ' ' GLU . 25.9 p -127.07 165.88 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.693 0.758 . . . . 0.0 110.972 -169.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -124.11 129.28 50.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 169.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.8 m -114.27 145.75 41.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -136.64 162.6 32.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.281 1.433 . . . . 0.0 107.551 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.79 147.05 26.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 169.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mp -135.67 153.78 51.5 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.022 0.929 . . . . 0.0 108.661 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -106.1 119.3 38.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 71.4 mtm -144.42 137.79 27.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.756 1.222 . . . . 0.0 108.161 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.91 37.34 9.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 0.0 113.538 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.41 10.64 86.04 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.771 -1.016 . . . . 0.0 114.256 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.73 150.95 47.28 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.371 1.586 . . . . 0.0 110.231 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -98.15 122.81 41.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -106.75 113.6 27.19 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -80.73 142.6 33.67 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 mm -122.07 133.69 67.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.2 t -131.62 119.94 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.04 127.43 35.4 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 169.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -94.34 112.36 24.15 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -68.07 -25.0 65.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.454 -0.307 . . . . 0.0 111.66 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.83 -36.6 83.72 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.835 0.454 . . . . 0.0 111.88 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.74 -2.38 9.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.145 1.378 . . . . 0.0 113.018 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 99.3 mmm 53.97 33.0 16.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.902 1.281 . . . . 0.0 110.789 -169.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -88.9 146.12 25.12 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.84 117.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.403 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 9.2 m95 -85.38 122.6 29.76 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.636 1.574 . . . . 0.0 107.454 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.04 118.14 36.02 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 42.47 48.95 4.63 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.128 1.771 . . . . 0.0 112.564 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.28 -4.11 86.13 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.604 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -113.8 142.73 45.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.786 1.793 . . . . 0.0 109.366 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -68.37 149.02 49.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 171.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pp -126.29 165.55 18.77 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.283 1.033 . . . . 0.0 110.55 169.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.35 146.57 40.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 110.199 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 p -140.33 151.09 44.76 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.458 1.103 . . . . 0.0 109.958 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.22 138.18 43.34 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.19 97.02 1.21 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -87.03 143.14 27.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.82 134.13 43.17 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.35 -179.11 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.653 1.581 . . . . 0.0 108.765 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.69 8.88 8.83 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.76 14.16 0.55 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.523 1.129 . . . . 0.0 113.357 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.93 -149.27 17.54 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 120.672 -1.267 . . . . 0.0 112.176 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.3 m -131.34 154.88 48.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -126.61 107.11 9.9 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.9 m -83.87 99.89 10.63 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -85.77 145.4 27.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.737 1.215 . . . . 0.0 110.722 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -158.85 -178.92 7.6 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.392 1.877 . . . . 0.0 108.945 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 m -144.7 147.42 32.99 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 109.522 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.5 mt -141.39 133.78 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.38 -123.3 32.77 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -113.33 36.83 3.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.769 1.228 . . . . 0.0 110.492 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.57 141.65 49.73 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.273 1.429 . . . . 0.0 108.213 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.34 149.2 23.39 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 169.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 m -135.6 152.19 51.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.537 1.535 . . . . 0.0 108.191 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -149.25 141.65 24.22 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 121.859 -0.525 . . . . 0.0 109.89 168.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.61 115.03 27.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -79.16 98.84 6.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.75 82.64 7.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.96 129.81 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 m -88.42 38.04 0.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.236 0.925 . . . . 0.0 111.038 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 m -66.27 160.74 23.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.704 1.202 . . . . 0.0 111.821 -173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.13 -140.24 35.58 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.62 127.01 29.31 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -67.43 -38.05 83.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 119.413 -0.327 . . . . 0.0 111.224 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -73.25 124.26 25.31 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 58.22 -10.14 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.435 2.694 . . . . 0.0 116.194 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.49 25.85 1.98 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.225 1.393 . . . . 0.0 113.73 -175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.54 134.24 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.7 mm -77.45 -43.51 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.28 -169.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 63.5 m80 53.23 102.91 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.75 2.02 . . . . 0.0 112.407 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -126.3 141.27 51.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.792 0.837 . . . . 0.0 109.123 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.6 tp -88.46 131.43 34.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.412 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.89 142.87 22.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 131.2 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.94 43.82 10.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.463 1.105 . . . . 0.0 111.442 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.4 t30 65.17 4.53 2.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.6 2.36 . . . . 0.0 115.746 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.93 143.71 26.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.11 1.364 . . . . 0.0 109.806 174.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -87.05 136.07 33.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.145 0.978 . . . . 0.0 110.539 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -119.62 114.64 34.21 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.449 1.9 . . . . 0.0 107.01 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.68 146.94 34.74 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.371 2.714 . . . . 0.0 111.16 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.5 165.06 25.77 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.323 0.583 . . . . 0.0 111.43 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.6 pt -128.07 175.7 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 126.456 1.903 . . . . 0.0 110.677 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 59.13 29.05 18.53 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.134 1.774 . . . . 0.0 114.285 170.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.252 1.209 0 C-N-CA 123.925 0.89 . . . . 0.0 108.602 169.511 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -147.57 147.05 29.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.157 1.383 . . . . 0.0 109.154 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -147.16 149.31 32.73 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 p -81.03 -1.62 44.72 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.478 1.111 . . . . 0.0 113.605 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -62.23 132.09 51.58 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.7 m -134.17 128.14 33.43 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -136.39 158.53 44.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.616 0.766 . . . . 0.0 111.617 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -125.44 134.57 52.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 169.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -128.37 141.04 51.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.479 0.657 . . . . 0.0 109.694 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -136.32 151.93 50.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.301 1.44 . . . . 0.0 107.47 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.28 141.77 37.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.935 0.894 . . . . 0.0 109.035 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.65 125.83 35.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.127 1.371 . . . . 0.0 108.692 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -85.08 127.41 34.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 41.1 ttm -158.0 134.71 9.77 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.924 1.29 . . . . 0.0 108.189 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.95 37.93 18.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.109 1.364 . . . . 0.0 113.313 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.18 8.8 85.52 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.914 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -120.54 164.05 17.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.15 1.78 . . . . 0.0 109.806 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -113.31 124.2 51.93 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -109.04 128.64 55.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -88.69 132.89 34.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.85 133.11 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.18 131.3 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.4 tp -99.57 125.29 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB2' ' HE1' ' A' ' 31' ' ' TRP . 12.0 mt-10 -87.14 115.58 24.63 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.813 -2.292 . . . . 0.0 104.813 168.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.69 -33.33 73.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.12 -43.19 78.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 117.75 0.25 . . . . 0.0 110.529 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.38 -15.03 29.61 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.215 1.006 . . . . 0.0 112.964 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 52.84 38.88 27.86 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.323 1.449 . . . . 0.0 110.57 -169.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.52 139.99 38.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.37 1.068 . . . . 0.0 108.296 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -113.11 116.3 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 122.106 0.955 . . . . 0.0 109.967 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m95 -93.34 105.01 17.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.948 2.099 . . . . 0.0 105.915 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -109.4 123.27 49.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 51.28 36.24 15.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 0.0 111.13 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.44 -2.47 62.37 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 118.571 -1.127 . . . . 0.0 114.895 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.71 143.75 37.41 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.778 1.789 . . . . 0.0 109.273 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -68.89 146.68 52.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -137.47 166.26 24.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.851 1.261 . . . . 0.0 109.011 169.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.55 144.55 49.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.047 0.539 . . . . 0.0 111.017 -173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -135.5 149.2 49.44 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.693 1.597 . . . . 0.0 109.146 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.39 136.98 54.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.18 95.32 1.15 Allowed Glycine 0 C--N 1.33 0.214 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.91 142.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.26 132.31 55.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.76 167.29 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.079 1.352 . . . . 0.0 110.159 -172.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.93 49.86 0.82 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.261 1.424 . . . . 0.0 109.968 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -162.54 -32.06 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.47 2.308 . . . . 0.0 110.851 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.68 2.5 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -127.43 151.54 48.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.74 106.68 8.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -84.2 102.27 12.48 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -88.1 143.62 26.96 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.516 1.127 . . . . 0.0 110.579 -175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -159.79 -172.43 3.66 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.073 2.149 . . . . 0.0 108.339 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 m -145.29 151.22 38.0 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 0.0 108.818 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.8 mt -136.98 124.08 30.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.15 -133.37 52.7 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -86.29 -3.86 59.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.174 0.989 . . . . 0.0 112.672 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -98.05 132.61 43.45 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.305 -0.872 . . . . 0.0 109.097 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.55 149.86 28.46 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 169.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.5 m -137.02 152.28 49.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.204 1.402 . . . . 0.0 108.009 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 25.3 p90 -146.63 139.59 25.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.958 168.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.3 mt -88.19 113.7 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -80.56 128.85 34.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.79 93.56 3.87 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.95 128.32 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.591 1.157 . . . . 0.0 108.755 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.6 m -74.83 33.47 0.1 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.762 1.225 . . . . 0.0 113.975 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -66.15 155.01 38.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.768 0.827 . . . . 0.0 109.525 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.76 -152.33 52.54 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -68.42 135.88 52.41 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -72.05 -17.22 62.03 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.721 -0.612 . . . . 0.0 112.197 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -67.99 -54.7 16.5 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.021 0.828 . . . . 0.0 110.629 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -143.47 -0.69 1.07 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.33 -12.99 80.01 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.467 1.03 . . . . 0.0 113.395 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -47.73 126.47 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 127.613 2.365 . . . . 0.0 109.764 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.1 mm -87.67 120.02 36.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -98.97 130.85 45.35 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -140.21 139.92 35.74 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.791 1.236 . . . . 0.0 108.412 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.81 133.58 33.63 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.461 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -112.2 141.96 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.31 132.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 49.63 37.88 13.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.405 1.082 . . . . 0.0 111.85 -175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 62.66 8.83 3.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.985 2.114 . . . . 0.0 115.464 -174.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -94.24 148.02 22.61 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.059 1.344 . . . . 0.0 109.399 171.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -90.26 134.03 34.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.469 0.708 . . . . 0.0 110.116 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.2 mm -118.04 114.52 37.05 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.137 1.775 . . . . 0.0 108.226 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.26 148.04 88.35 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.91 3.073 . . . . 0.0 112.171 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.52 156.98 5.52 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.558 0.743 . . . . 0.0 110.293 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.8 pt -59.03 153.17 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.41 0.684 . . . . 0.0 111.778 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.85 93.78 9.56 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.494 0.718 . . . . 0.0 109.688 175.424 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.72 -40.38 69.47 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 122.9 0.48 . . . . 0.0 111.442 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -77.18 142.21 39.74 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -72.34 156.15 39.4 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.313 0.645 . . . . 0.0 110.591 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.72 137.51 52.09 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -135.13 92.47 2.87 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -136.47 147.46 47.18 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.921 0.888 . . . . 0.0 110.344 -173.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.05 125.58 54.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -120.31 144.43 47.84 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -140.09 159.39 42.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.878 1.671 . . . . 0.0 108.042 174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.49 137.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 168.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.15 123.69 43.92 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.557 1.143 . . . . 0.0 108.155 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.478 ' CD2' HD21 ' A' ' 18' ' ' ASN . 3.7 t-80 -91.91 121.27 33.35 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 170.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 39.6 mtt -107.44 -163.96 0.94 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.06 1.344 . . . . 0.0 108.573 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.47 -27.79 57.93 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.531 1.133 . . . . 0.0 113.593 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.84 17.89 0.12 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.114 -0.825 . . . . 0.0 113.976 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -140.81 155.85 46.28 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.791 1.237 . . . . 0.0 108.957 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.478 HD21 ' CD2' ' A' ' 13' ' ' HIS . 8.1 m-80 -120.0 114.56 22.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.38 115.28 30.09 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.3 mtm-85 -79.82 139.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.0 mm -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 t -133.17 118.75 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -83.72 106.64 15.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.357 1.463 . . . . 0.0 107.297 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -72.27 -26.67 62.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.382 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.97 -42.76 72.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.175 0.443 . . . . 0.0 110.523 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.98 -16.17 25.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.495 1.118 . . . . 0.0 113.056 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.83 50.21 19.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.82 1.648 . . . . 0.0 110.473 -169.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -116.52 159.32 22.26 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.283 1.433 . . . . 0.0 108.369 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.69 117.98 36.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.404 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 10.4 m95 -88.87 125.55 34.98 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.976 1.711 . . . . 0.0 108.198 171.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.6 t -115.87 128.07 55.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 168.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.14 35.04 12.25 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.116 0.966 . . . . 0.0 111.894 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.05 87.77 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.412 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.05 143.19 45.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.081 1.941 . . . . 0.0 108.563 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -72.18 141.89 49.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.756 1.162 . . . . 0.0 109.16 175.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.82 169.4 9.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.694 0.798 . . . . 0.0 111.491 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.8 145.67 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.599 1.16 . . . . 0.0 110.075 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 p -141.86 149.86 40.82 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.376 1.07 . . . . 0.0 109.646 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.59 139.68 49.24 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.9 104.93 1.19 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -90.0 149.81 22.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.0 139.41 52.54 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.73 167.91 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.491 1.516 . . . . 0.0 110.134 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -76.5 49.9 0.63 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.062 1.345 . . . . 0.0 110.486 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -160.22 -35.75 0.05 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.86 2.464 . . . . 0.0 109.849 -170.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.28 -150.97 22.43 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.04 148.46 38.83 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -123.59 107.28 11.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -94.02 105.0 17.02 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -90.49 146.65 23.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.062 1.345 . . . . 0.0 111.055 -172.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -157.7 -179.59 8.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.867 2.067 . . . . 0.0 108.185 169.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m -144.34 146.55 32.63 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.101 -0.999 . . . . 0.0 109.949 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.4 mt -143.23 131.33 19.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.28 -130.3 50.82 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -104.75 32.0 4.4 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.66 1.184 . . . . 0.0 111.053 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -129.58 146.57 51.37 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.748 1.219 . . . . 0.0 109.271 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.05 150.37 22.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 109.515 170.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.53 151.62 51.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.777 1.631 . . . . 0.0 108.294 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.501 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 23.2 p90 -148.48 142.79 26.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.954 -0.466 . . . . 0.0 110.079 168.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.7 mt -88.05 118.78 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -89.54 101.73 14.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.23 91.14 7.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.85 129.58 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.872 1.669 . . . . 0.0 109.192 -169.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 m -82.35 33.55 0.41 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.829 1.195 . . . . 0.0 112.262 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -60.09 -25.62 65.56 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.031 1.332 . . . . 0.0 114.307 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.88 -20.22 79.77 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.21 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 50.52 38.34 18.3 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.306 1.442 . . . . 0.0 112.191 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -143.15 165.93 26.07 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.78 1.632 . . . . 0.0 107.722 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -57.85 127.44 32.06 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 56.95 21.46 6.22 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.933 1.693 . . . . 0.0 113.398 -176.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.39 33.56 2.73 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.223 1.392 . . . . 0.0 112.343 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.51 131.19 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.0 135.12 26.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -110.11 126.65 54.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -132.01 142.47 49.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.18 131.58 37.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.501 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.84 143.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.4 t -138.49 130.44 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 48.68 39.74 14.26 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.058 0.943 . . . . 0.0 111.754 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 64.79 3.71 2.13 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.86 2.064 . . . . 0.0 115.001 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -89.89 147.24 23.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.369 -1.457 . . . . 0.0 109.195 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.76 134.28 34.87 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.717 0.807 . . . . 0.0 110.125 -175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.9 mm -119.24 114.76 34.7 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.816 1.646 . . . . 0.0 108.287 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -67.71 143.37 61.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.049 3.166 . . . . 0.0 111.962 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.85 161.16 13.19 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.284 0.634 . . . . 0.0 109.887 171.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 pt -69.72 153.94 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.47 0.708 . . . . 0.0 111.679 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.54 25.44 6.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.055 1.342 . . . . 0.0 111.957 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.391 1.476 . . . . 0.0 109.955 178.526 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 121.172 0.511 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.62 153.44 51.65 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.869 1.668 . . . . 0.0 108.511 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -137.88 149.75 46.53 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.412 1.085 . . . . 0.0 108.496 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.3 m -81.89 45.96 0.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.757 1.223 . . . . 0.0 112.003 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -65.45 -37.13 85.96 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.234 -0.916 . . . . 0.0 111.103 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 m 52.11 70.39 0.56 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.174 1.39 . . . . 0.0 110.506 -175.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.4 p -137.9 144.43 41.33 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.741 1.216 . . . . 0.0 109.883 -174.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.85 131.69 54.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -110.49 149.19 30.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -135.19 163.82 29.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.994 1.718 . . . . 0.0 107.196 169.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.12 140.81 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.33 44.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.099 1.359 . . . . 0.0 108.954 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -101.49 125.9 48.2 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.85 0.86 . . . . 0.0 109.018 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.26 139.89 27.44 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.13 0.972 . . . . 0.0 109.059 170.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 45.32 45.97 10.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.657 1.583 . . . . 0.0 114.003 169.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.08 -1.31 80.58 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.042 -0.866 . . . . 0.0 114.313 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -109.77 159.64 17.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.74 1.616 . . . . 0.0 110.429 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -119.77 130.29 54.88 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -110.04 107.07 16.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 107.747 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -73.5 129.69 38.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.1 mm -108.78 136.35 44.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.41 118.82 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.2 tp -88.36 128.53 35.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HA ' HG22 ' A' ' 7' ' ' THR . 44.7 mm-40 -85.5 109.46 18.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 169.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -72.24 -30.98 65.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.15 0.886 . . . . 0.0 111.865 -169.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.49 -42.83 74.26 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.714 0.234 . . . . 0.0 111.047 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.2 -17.0 23.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -173.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mmm 55.6 28.36 11.8 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.943 1.697 . . . . 0.0 112.464 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.79 149.55 25.66 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.05 125.12 67.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -97.22 138.09 35.25 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.669 1.187 . . . . 0.0 107.947 174.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -120.99 119.8 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 45.78 41.82 8.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.596 1.558 . . . . 0.0 112.038 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.25 6.71 75.8 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.019 -0.879 . . . . 0.0 114.412 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.24 152.08 23.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.121 1.46 . . . . 0.0 107.74 173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.91 148.19 28.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 pp -129.99 165.04 22.96 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.18 0.992 . . . . 0.0 110.793 170.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.76 148.08 35.02 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.963 1.305 . . . . 0.0 110.436 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -139.28 149.16 43.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.268 1.027 . . . . 0.0 109.981 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.94 141.68 50.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.99 106.47 1.21 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.08 149.26 21.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -121.27 138.58 54.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.406 0.682 . . . . 0.0 109.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.15 167.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.468 1.507 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.03 48.53 0.6 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.057 1.343 . . . . 0.0 110.594 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -159.88 -31.46 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.862 2.465 . . . . 0.0 110.713 -171.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.42 -151.93 23.35 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -122.25 151.03 41.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -125.94 106.95 10.0 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.554 1.542 . . . . 0.0 107.095 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.8 m -92.32 103.54 15.97 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -90.23 147.26 23.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.788 1.235 . . . . 0.0 111.12 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.54 -178.33 7.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 108.37 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.3 m -145.07 149.55 35.28 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.291 1.036 . . . . 0.0 109.375 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.5 mt -134.05 111.21 14.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.65 -134.0 51.48 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -169.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -78.19 -14.09 59.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 112.462 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -88.19 126.74 35.3 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.61 150.1 24.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.617 0.722 . . . . 0.0 109.311 169.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -137.15 151.87 49.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.566 1.546 . . . . 0.0 107.919 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.432 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 15.9 p90 -148.18 142.17 25.89 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 168.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.16 120.43 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -85.66 118.23 25.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 170.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.43 92.36 4.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 172.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.18 129.26 41.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.271 1.428 . . . . 0.0 110.735 -168.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.6 m -81.17 33.28 0.34 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.746 1.219 . . . . 0.0 112.713 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -69.89 -41.32 74.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.08 0.952 . . . . 0.0 110.68 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.22 -168.12 37.27 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -58.44 135.34 57.23 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.136 -0.626 . . . . 0.0 109.467 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.6 -19.59 64.46 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.724 -0.61 . . . . 0.0 112.598 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -66.33 -58.52 5.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.907 0.776 . . . . 0.0 109.679 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -147.8 3.72 0.74 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -90.15 14.54 61.93 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.266 0.936 . . . . 0.0 113.566 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.24 127.14 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.645 1.578 . . . . 0.0 107.97 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.15 126.57 40.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -106.8 122.73 46.97 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -133.02 141.09 48.07 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.402 1.081 . . . . 0.0 108.523 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -88.43 133.13 34.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.432 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.84 141.04 28.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 169.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -138.18 132.38 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 49.97 37.54 14.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.064 0.935 . . . . 0.0 111.882 -176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.8 t30 62.56 10.17 3.91 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.927 2.091 . . . . 0.0 115.407 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.58 149.13 21.78 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.986 1.315 . . . . 0.0 109.217 171.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -93.21 134.59 35.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.826 0.85 . . . . 0.0 110.094 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.8 mm -121.19 113.67 32.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.532 1.933 . . . . 0.0 107.548 -173.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.91 147.83 44.54 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.158 2.572 . . . . 0.0 110.932 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -69.59 164.73 22.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.363 1.065 . . . . 0.0 111.012 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.85 158.24 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 127.016 2.126 . . . . 0.0 109.408 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.53 25.88 4.76 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.156 1.382 . . . . 0.0 111.629 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.2 m . . . . . 0 C--O 1.255 1.388 0 C-N-CA 125.269 1.428 . . . . 0.0 109.902 179.218 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.31 134.11 37.53 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 122.789 0.436 . . . . 0.0 109.866 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -138.19 150.53 46.85 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.539 1.136 . . . . 0.0 108.476 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m -66.35 147.33 53.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.124 0.57 . . . . 0.0 110.572 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.03 138.83 52.48 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 m -136.87 125.03 23.01 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.57 150.26 40.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.038 0.535 . . . . 0.0 110.387 -169.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.6 129.08 55.12 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 169.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.1 m -120.8 143.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -135.19 155.02 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.214 1.806 . . . . 0.0 107.213 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.41 122.73 66.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 168.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.0 tp -115.69 123.2 47.75 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.332 1.053 . . . . 0.0 109.081 -169.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -91.17 135.5 33.74 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.7 mtt -139.39 106.88 5.56 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 61.81 -33.95 0.1 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.617 3.167 . . . . 0.0 116.849 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.75 -32.28 0.03 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.5 2.0 . . . . 0.0 110.154 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -77.01 156.93 31.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.165 0.986 . . . . 0.0 110.167 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -131.76 115.97 16.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -105.76 122.11 45.42 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.389 1.076 . . . . 0.0 108.563 -176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -73.44 138.61 45.3 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -117.26 132.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.94 117.88 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -86.06 121.13 28.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -82.04 113.03 19.64 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 168.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.75 -24.54 56.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 119.116 -0.468 . . . . 0.0 111.254 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.93 -44.3 69.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.712 0.687 . . . . 0.0 110.131 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.14 -15.4 24.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.489 1.115 . . . . 0.0 113.152 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.8 mmm 52.69 45.08 29.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.816 1.247 . . . . 0.0 109.276 -168.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -114.6 146.39 40.86 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.869 1.668 . . . . 0.0 107.148 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.05 117.41 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.407 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 18.4 m95 -84.57 119.31 25.05 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.946 1.698 . . . . 0.0 107.047 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.2 t -113.94 126.24 54.93 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.0 36.01 10.96 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.334 1.054 . . . . 0.0 111.919 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.62 3.01 88.8 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.621 -1.1 . . . . 0.0 115.092 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -114.4 145.58 41.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.657 1.728 . . . . 0.0 108.868 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -68.33 141.58 55.76 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.03 163.41 16.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.707 0.803 . . . . 0.0 110.422 169.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -70.87 143.99 50.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 110.199 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -138.52 148.58 44.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 110.162 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.59 143.43 51.17 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.52 108.83 1.47 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -97.76 148.62 23.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.97 135.88 54.74 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.47 167.55 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 110.173 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -77.7 48.1 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.156 1.382 . . . . 0.0 110.554 175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.94 -34.13 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.233 2.213 . . . . 0.0 110.325 -171.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.86 -150.31 20.1 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -121.16 152.11 39.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -125.37 107.16 10.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.794 1.638 . . . . 0.0 106.898 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -91.32 102.7 15.41 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.92 146.43 24.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.674 1.189 . . . . 0.0 110.901 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -158.19 -173.91 4.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.636 1.975 . . . . 0.0 108.646 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 m -144.49 146.75 32.59 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 109.347 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.6 mt -142.18 133.27 25.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.97 -131.07 51.86 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -105.13 34.1 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.511 1.124 . . . . 0.0 110.851 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -131.11 144.32 51.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.733 1.213 . . . . 0.0 109.097 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.35 152.43 19.15 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.502 0.668 . . . . 0.0 109.219 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 m -135.15 151.94 51.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.577 1.551 . . . . 0.0 107.752 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 15.9 p90 -147.81 140.77 24.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.856 -0.527 . . . . 0.0 109.669 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mt -88.27 118.75 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -83.61 120.89 26.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 92.54 3.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.61 125.78 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.077 1.351 . . . . 0.0 109.373 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 m -81.44 49.77 1.35 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.496 1.118 . . . . 0.0 110.549 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -65.26 159.42 23.84 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.133 1.373 . . . . 0.0 111.574 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.32 -146.46 33.17 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.653 0.644 . . . . 0.0 111.667 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.04 177.79 4.76 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.252 1.021 . . . . 0.0 110.546 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -69.26 -14.72 63.11 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -58.77 156.13 11.7 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.859 0.754 . . . . 0.0 109.522 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.19 53.8 1.53 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.668 1.187 . . . . 0.0 112.709 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.81 49.13 2.8 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.794 1.664 . . . . 0.0 111.111 173.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.65 128.11 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 mm -86.98 125.81 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -105.78 127.3 53.01 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -136.31 141.51 43.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 124.174 0.99 . . . . 0.0 108.597 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.55 131.1 36.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.427 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.89 142.08 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 169.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.0 130.86 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 t70 46.53 43.22 12.04 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.443 1.097 . . . . 0.0 111.448 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 63.69 6.53 2.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.709 2.404 . . . . 0.0 115.828 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -99.41 148.27 24.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.586 1.555 . . . . 0.0 109.918 173.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -91.02 137.31 32.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.525 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.3 mm -119.89 113.36 34.47 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.888 2.075 . . . . 0.0 106.929 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.92 147.06 33.8 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.096 2.53 . . . . 0.0 110.965 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.66 164.02 8.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.996 0.918 . . . . 0.0 110.493 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.4 pt -67.12 153.55 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.745 0.818 . . . . 0.0 111.744 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.82 25.78 5.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.091 1.357 . . . . 0.0 111.687 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.252 1.21 0 C-N-CA 125.568 1.547 . . . . 0.0 110.031 179.103 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.61 139.71 57.9 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.509 0.724 . . . . 0.0 111.243 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -141.59 155.63 45.74 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.832 1.253 . . . . 0.0 108.847 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 m -62.48 154.39 28.67 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.651 0.78 . . . . 0.0 110.257 173.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -74.79 120.44 20.34 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.1 m -76.51 -41.71 45.88 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.867 0.467 . . . . 0.0 109.881 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -70.76 155.62 40.54 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.317 1.047 . . . . 0.0 111.122 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -117.49 137.85 52.26 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -120.98 149.59 42.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -140.41 151.83 45.23 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.72 1.608 . . . . 0.0 108.337 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -107.34 135.4 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -119.85 117.76 29.0 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -87.54 120.98 29.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 43.2 ttm -155.79 131.5 9.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -170.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 50.5 36.67 14.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 113.072 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.27 74.76 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.039 0.828 . . . . 0.0 113.975 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -108.39 170.62 7.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.489 1.916 . . . . 0.0 109.383 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -131.84 111.58 11.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -102.52 131.24 49.36 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -93.68 124.05 37.41 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.93 138.88 23.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.96 125.71 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -90.09 129.99 36.32 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -98.14 112.47 24.42 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.355 1.462 . . . . 0.0 107.722 168.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -74.91 -22.18 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.79 -0.569 . . . . 0.0 112.322 -170.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.48 -36.52 80.71 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.194 0.452 . . . . 0.0 111.207 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.49 -4.35 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.303 1.441 . . . . 0.0 113.052 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.8 mtp 53.35 37.84 26.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.563 1.145 . . . . 0.0 109.564 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -92.34 147.53 22.84 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -129.97 119.42 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.451 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 15.3 m95 -85.42 133.52 34.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 126.495 1.918 . . . . 0.0 108.448 173.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -128.81 126.51 40.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 168.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 52.08 37.69 22.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.304 1.042 . . . . 0.0 111.981 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.87 2.05 90.64 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.379 -1.234 . . . . 0.0 115.617 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -121.41 148.12 44.82 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.878 1.839 . . . . 0.0 108.171 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -75.52 151.82 37.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.871 1.214 . . . . 0.0 110.189 173.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.26 167.67 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.23 1.412 . . . . 0.0 110.215 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.95 147.91 44.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.064 0.946 . . . . 0.0 110.358 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 p -138.3 148.83 45.06 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.665 1.186 . . . . 0.0 109.88 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.0 149.52 45.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.0 109.41 1.03 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.83 151.8 21.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.72 0.808 . . . . 0.0 109.262 170.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -123.99 140.15 53.26 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.87 167.44 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.726 1.61 . . . . 0.0 110.278 178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -77.17 48.71 0.63 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.07 1.348 . . . . 0.0 110.606 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -160.15 -34.49 0.06 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.813 2.445 . . . . 0.0 110.276 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.98 -153.39 24.21 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 m -117.88 150.19 39.6 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -124.55 106.85 10.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.1 m -90.95 106.22 18.37 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -92.04 145.82 24.22 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.799 1.239 . . . . 0.0 110.51 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.47 -169.7 2.69 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.226 1.811 . . . . 0.0 108.423 171.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -150.15 148.2 28.67 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.927 -1.108 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 93.7 mt -141.1 130.69 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.36 -133.4 51.37 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.07 29.11 4.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.251 1.02 . . . . 0.0 111.654 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -124.22 142.97 50.8 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.56 1.144 . . . . 0.0 109.261 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 150.01 21.35 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -134.84 152.04 51.42 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.764 1.226 . . . . 0.0 108.073 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.42 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 14.2 p90 -147.0 141.74 26.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 168.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.94 120.59 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -87.16 114.84 24.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.58 91.86 3.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -87.77 126.22 41.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 125.017 1.327 . . . . 0.0 109.328 -169.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -81.6 50.46 1.49 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.535 1.134 . . . . 0.0 110.858 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.8 m -67.86 159.58 30.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.89 1.276 . . . . 0.0 111.776 -177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.63 -164.06 54.51 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.147 0.88 . . . . 0.0 112.707 174.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -65.08 153.89 39.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.98 0.912 . . . . 0.0 109.496 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -73.59 82.85 1.53 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.943 0.897 . . . . 0.0 108.835 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 21.97 2.28 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.697 1.599 . . . . 0.0 111.719 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 54.66 54.65 8.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.118 1.767 . . . . 0.0 112.622 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -98.08 52.61 1.24 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.597 1.094 . . . . 0.0 110.384 171.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.01 129.14 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -90.73 125.32 43.54 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -103.18 127.26 50.53 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -134.66 145.02 48.17 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.375 1.07 . . . . 0.0 108.494 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -93.98 130.41 40.1 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.42 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -110.81 142.48 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 169.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.31 133.19 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.821 1.248 . . . . 0.0 108.088 171.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t0 45.59 42.12 7.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.326 1.451 . . . . 0.0 111.659 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.47 17.64 10.93 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.475 2.31 . . . . 0.0 116.136 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -116.1 152.09 34.32 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.158 169.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -84.73 139.19 32.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.86 -171.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.2 mm -119.53 118.78 32.02 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.358 1.863 . . . . 0.0 106.612 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 142.81 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 111.284 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -69.84 165.84 20.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.532 1.133 . . . . 0.0 111.063 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.7 pt -134.06 162.2 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 126.974 2.11 . . . . 0.0 109.139 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.28 24.63 3.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.017 1.327 . . . . 0.0 111.897 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.25 1.091 0 C-N-CA 126.15 1.78 . . . . 0.0 107.979 -176.204 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -68.45 143.79 54.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.809 0.844 . . . . 0.0 111.072 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -143.21 144.99 32.39 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.693 1.197 . . . . 0.0 108.1 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -61.55 156.99 18.29 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.121 0.569 . . . . 0.0 109.647 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -67.79 122.13 17.45 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.6 m -140.01 92.32 2.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -170.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.71 147.9 38.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.58 0.752 . . . . 0.0 111.43 -170.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -112.54 137.02 51.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 m -121.85 142.82 49.85 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -133.82 156.43 48.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.193 1.797 . . . . 0.0 107.542 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -124.44 134.4 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -117.94 123.66 46.33 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.3 113.47 25.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.9 mtm -146.43 138.49 24.92 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.274 1.029 . . . . 0.0 108.449 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.64 36.87 11.45 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.188 1.395 . . . . 0.0 113.249 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.84 -4.16 62.14 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.99 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -101.41 165.13 11.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.615 1.566 . . . . 0.0 110.348 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -119.67 125.19 48.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.01 123.51 50.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.926 1.291 . . . . 0.0 108.117 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -86.0 123.55 31.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.66 133.23 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 170.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.9 t -128.39 121.43 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.06 121.8 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.483 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 1.2 mm-40 -85.05 112.36 20.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 168.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.19 -30.28 62.15 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.969 -0.457 . . . . 0.0 111.908 -169.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.95 -41.52 97.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.856 0.298 . . . . 0.0 110.782 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.38 -14.71 22.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.622 1.169 . . . . 0.0 113.178 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtp 52.79 42.67 31.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.343 1.457 . . . . 0.0 109.924 -168.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -107.13 145.32 32.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.54 1.136 . . . . 0.0 108.496 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -116.52 120.86 66.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.662 0.744 . . . . 0.0 109.823 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.483 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 12.0 m95 -93.84 130.11 40.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.054 1.342 . . . . 0.0 108.291 172.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.2 117.94 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 48.41 40.71 15.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.84 1.256 . . . . 0.0 111.356 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.12 -9.77 52.09 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.511 -1.161 . . . . 0.0 115.129 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -95.8 135.64 37.26 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.863 1.832 . . . . 0.0 108.226 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -75.09 147.9 40.21 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.56 1.073 . . . . 0.0 109.148 174.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.18 166.58 20.81 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.474 1.11 . . . . 0.0 109.771 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.51 145.98 48.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.156 0.583 . . . . 0.0 111.018 -172.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.92 150.86 48.47 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.843 1.657 . . . . 0.0 109.331 -178.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.6 137.54 52.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.71 100.62 1.62 Allowed Glycine 0 C--N 1.33 0.24 0 N-CA-C 106.81 -2.516 . . . . 0.0 106.81 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -90.62 149.32 22.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.31 126.81 47.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.19 174.74 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.262 1.425 . . . . 0.0 109.59 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -83.64 44.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.896 1.278 . . . . 0.0 110.964 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.39 -31.58 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.872 1.669 . . . . 0.0 111.319 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.78 -157.88 30.42 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.3 150.19 26.19 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -130.73 105.15 7.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.3 m -86.63 99.82 12.0 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -84.29 146.18 27.89 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.922 1.289 . . . . 0.0 110.24 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -158.28 -175.51 5.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.057 1.743 . . . . 0.0 108.469 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -152.16 149.02 28.3 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.784 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -142.32 127.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.14 -126.86 43.33 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -102.68 25.09 9.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -121.07 145.08 48.17 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.062 1.345 . . . . 0.0 109.048 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.71 147.78 28.17 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.339 0.656 . . . . 0.0 109.244 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -135.47 151.51 50.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.12 1.368 . . . . 0.0 108.436 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -146.9 141.46 26.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.911 -0.493 . . . . 0.0 109.819 168.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.46 115.18 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -79.23 123.64 27.61 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 169.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.5 92.14 3.86 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 171.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.17 124.56 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.474 1.11 . . . . 0.0 108.214 -169.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 m -81.9 46.79 1.03 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.137 0.88 . . . . 0.0 110.862 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.1 m -65.97 -35.72 81.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.347 1.059 . . . . 0.0 112.657 -169.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.66 15.23 80.73 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 119.231 -0.761 . . . . 0.0 113.702 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -100.26 10.81 40.68 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.764 1.282 . . . . 0.0 112.582 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -153.31 166.88 31.22 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.192 0.997 . . . . 0.0 108.631 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -54.72 147.59 14.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 68.83 -3.19 1.5 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.052 2.141 . . . . 0.0 113.515 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.08 -51.83 2.86 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.075 1.798 . . . . 0.0 114.247 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.23 138.1 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.9 mm -101.42 120.85 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -97.16 130.61 44.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 m -139.1 143.55 38.32 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.159 0.983 . . . . 0.0 108.528 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.9 tp -91.23 130.79 37.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.35 143.41 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.3 t -139.87 132.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.146 1.379 . . . . 0.0 107.715 173.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.68 37.65 13.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 111.868 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.6 t30 62.45 10.23 3.86 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.095 2.158 . . . . 0.0 115.295 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.54 149.81 21.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.04 1.336 . . . . 0.0 109.426 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.78 136.17 33.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.825 0.85 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.87 113.9 39.66 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.008 1.723 . . . . 0.0 107.04 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.55 149.4 30.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.072 2.515 . . . . 0.0 110.96 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.69 155.65 5.58 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.264 1.026 . . . . 0.0 110.81 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.4 pt -67.26 158.17 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.613 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.61 101.97 4.48 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.109 0.564 . . . . 0.0 109.886 176.397 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -149.45 163.69 37.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.95 1.3 . . . . 0.0 108.786 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -82.17 124.94 30.34 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -139.5 153.48 47.5 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.699 1.2 . . . . 0.0 109.565 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -155.19 161.49 41.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.194 1.397 . . . . 0.0 109.028 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.6 m -134.79 157.77 45.89 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.494 1.118 . . . . 0.0 108.613 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 24' ' ' GLU . 1.6 p -129.34 158.79 38.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.983 1.713 . . . . 0.0 109.299 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -130.03 130.55 45.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.6 m -122.51 139.58 53.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -133.91 152.53 51.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.192 1.397 . . . . 0.0 107.57 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.03 140.01 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.21 132.89 55.54 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -106.49 109.97 22.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 170.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.0 mtm -146.18 140.86 26.93 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.311 1.045 . . . . 0.0 108.932 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t0 51.23 35.67 14.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.992 1.317 . . . . 0.0 112.738 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.75 -10.52 18.06 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.713 1.149 . . . . 0.0 113.883 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.57 166.52 13.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.405 1.482 . . . . 0.0 111.063 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -121.81 129.32 52.54 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.65 116.74 27.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.737 1.215 . . . . 0.0 108.161 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -91.19 117.43 29.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -96.26 132.96 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.0 t -127.97 123.71 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.43 122.64 32.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.16 109.72 20.12 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -67.68 -27.52 66.9 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.587 -0.696 . . . . 0.0 111.311 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.46 -30.13 70.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.68 -3.65 9.26 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.514 1.526 . . . . 0.0 113.06 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtp 53.19 37.1 24.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.221 1.409 . . . . 0.0 110.77 -169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -91.86 146.03 24.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.9 p -117.68 113.94 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 122.172 0.987 . . . . 0.0 109.714 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.449 ' HE1' ' CG ' ' A' ' 24' ' ' GLU . 26.9 m95 -83.15 137.67 33.97 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 169.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.38 113.23 11.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 169.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 46.56 42.84 11.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.166 1.386 . . . . 0.0 111.216 -170.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.88 -12.69 28.44 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.786 1.184 . . . . 0.0 114.996 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.11 135.58 33.92 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.817 1.808 . . . . 0.0 108.254 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -76.87 120.02 21.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.0 mt -77.55 166.7 22.71 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.819 1.295 . . . . 0.0 111.273 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.65 147.89 39.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 112.934 -1.939 . . . . 0.0 107.062 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 p -144.73 150.55 37.46 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.075 0.95 . . . . 0.0 109.477 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.68 140.11 46.85 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.67 105.86 1.24 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 -172.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -95.74 152.25 18.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.417 0.687 . . . . 0.0 109.195 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.65 139.71 52.63 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -131.2 167.15 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.605 1.562 . . . . 0.0 110.079 176.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.01 28.05 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.967 1.707 . . . . 0.0 112.825 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' VAL . 32.2 t70 -141.87 -22.04 0.72 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.568 2.747 . . . . 0.0 111.768 -173.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.7 -155.66 26.26 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -116.65 150.62 37.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -130.0 107.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.938 1.295 . . . . 0.0 107.714 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.2 m -93.85 104.4 16.47 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -89.4 146.63 24.53 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.092 1.357 . . . . 0.0 110.625 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.08 -174.39 4.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.224 1.809 . . . . 0.0 108.324 170.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -144.81 149.7 35.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.352 1.061 . . . . 0.0 108.96 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.6 mt -134.43 113.82 17.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.2 -135.15 50.3 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.87 -13.45 59.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.353 0.661 . . . . 0.0 112.608 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -88.51 127.46 35.53 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.531 -0.731 . . . . 0.0 109.472 -169.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.37 149.01 26.31 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 169.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.64 153.32 47.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.686 1.594 . . . . 0.0 108.448 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -147.69 143.67 27.79 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.763 -0.586 . . . . 0.0 109.66 168.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -88.29 117.95 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 169.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -84.55 117.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.62 89.88 3.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.38 126.84 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 109.095 -169.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -83.77 54.91 3.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.138 1.335 . . . . 0.0 110.476 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.8 m -72.52 -36.25 68.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.85 0.86 . . . . 0.0 111.488 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.42 138.85 22.36 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -79.25 -27.94 42.39 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.121 0.569 . . . . 0.0 111.067 175.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -63.39 155.44 28.94 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.011 0.924 . . . . 0.0 109.657 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -57.09 141.75 44.84 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 56.21 37.36 28.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.797 1.239 . . . . 0.0 111.061 -175.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.87 21.74 10.79 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.855 1.217 . . . . 0.0 113.488 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.9 mm -68.98 137.0 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.048 0.939 . . . . 0.0 109.422 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.84 117.34 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -92.07 127.7 37.63 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -133.59 144.29 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.467 1.107 . . . . 0.0 108.237 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -94.22 129.61 40.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.4 142.35 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.7 t -137.22 131.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.031 1.332 . . . . 0.0 107.84 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t0 45.11 42.36 6.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.281 1.432 . . . . 0.0 111.682 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.0 t30 64.56 17.09 10.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.711 2.404 . . . . 0.0 116.125 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -114.11 152.41 31.13 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.643 1.177 . . . . 0.0 111.027 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -85.86 138.82 31.77 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.727 1.211 . . . . 0.0 110.692 -172.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.65 118.44 33.47 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.228 1.811 . . . . 0.0 106.714 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.19 150.43 33.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.861 2.374 . . . . 0.0 111.002 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -56.84 158.0 5.11 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.599 0.76 . . . . 0.0 110.423 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.9 pt -59.91 154.31 3.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.584 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.83 93.73 9.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.255 1.353 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.905 175.228 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -149.76 147.25 27.8 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.821 1.248 . . . . 0.0 108.969 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -135.37 147.91 49.21 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.625 1.17 . . . . 0.0 108.875 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.4 m -64.42 146.35 54.64 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.408 0.683 . . . . 0.0 110.68 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -80.32 158.56 26.06 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 169.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.34 125.97 28.69 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -177.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -146.6 157.51 43.73 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.031 1.332 . . . . 0.0 109.061 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -125.65 132.52 52.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 m -112.42 142.93 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -132.9 162.33 31.87 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.856 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 t -128.81 135.32 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.97 117.64 29.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -88.45 114.1 24.72 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 169.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.5 mtm -146.35 137.26 24.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.446 1.098 . . . . 0.0 108.426 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.24 38.14 12.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.319 1.448 . . . . 0.0 113.22 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.91 -1.07 69.84 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.254 0.93 . . . . 0.0 114.176 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -105.6 166.04 10.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.087 1.755 . . . . 0.0 110.116 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -122.66 121.28 36.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -109.39 120.99 44.21 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.66 1.184 . . . . 0.0 108.308 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -78.06 145.11 36.05 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.9 mm -125.57 133.03 70.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.35 120.48 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 tp -85.91 122.45 29.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -88.78 112.23 22.95 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -72.56 -21.02 61.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.533 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.69 -35.98 81.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.869 0.759 . . . . 0.0 111.601 -175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.25 -0.99 9.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.119 1.368 . . . . 0.0 113.285 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.4 mtp 52.72 39.52 28.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.727 1.211 . . . . 0.0 110.592 -169.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.96 144.7 26.62 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.428 1.091 . . . . 0.0 108.245 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -114.02 115.68 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.623 0.725 . . . . 0.0 109.862 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.457 ' CZ3' ' HE2' ' A' ' 36' ' ' LYS . 51.7 m95 -83.2 115.31 21.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 169.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 67.2 m -116.53 128.47 55.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 52.68 34.95 17.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.542 0.737 . . . . 0.0 111.705 -170.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.25 77.51 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.425 1.012 . . . . 0.0 114.65 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -125.44 138.0 54.0 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' HE2' ' CZ3' ' A' ' 31' ' ' TRP 0.3 0.0 OUTLIER -75.71 146.42 40.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.733 1.606 . . . . 0.0 110.068 175.552 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.73 167.93 19.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.007 1.323 . . . . 0.0 110.16 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.48 148.34 49.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.6 0.714 . . . . 0.0 111.531 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -136.38 150.46 48.81 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.067 1.747 . . . . 0.0 108.99 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.31 139.76 52.24 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.49 107.35 1.62 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -96.86 151.15 19.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -117.44 139.59 50.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.401 0.681 . . . . 0.0 109.326 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.97 167.75 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.663 1.585 . . . . 0.0 110.023 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -76.94 49.74 0.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.171 1.388 . . . . 0.0 110.501 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.79 -34.98 0.06 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.902 2.481 . . . . 0.0 109.991 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.41 -151.58 23.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -115.75 148.2 40.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -125.83 107.26 10.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 m -91.03 103.34 16.06 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -87.29 147.08 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.911 1.284 . . . . 0.0 110.742 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -157.53 -178.99 7.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.591 1.957 . . . . 0.0 108.062 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 m -146.63 150.73 36.02 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.952 0.901 . . . . 0.0 109.186 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.99 108.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.34 -15.84 59.2 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.688 0.795 . . . . 0.0 112.425 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -85.88 120.81 27.69 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.63 146.4 25.75 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.634 0.73 . . . . 0.0 109.884 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.4 m -136.89 151.78 49.47 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.041 1.736 . . . . 0.0 108.445 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 16.3 p90 -148.66 142.17 25.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 121.837 -0.539 . . . . 0.0 109.818 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -88.1 119.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -88.75 102.45 15.02 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.28 88.14 6.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.56 134.87 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.263 1.825 . . . . 0.0 110.351 -169.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m -88.61 28.7 1.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.762 0.825 . . . . 0.0 112.646 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.2 m -66.04 -37.02 84.81 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.66 1.184 . . . . 0.0 111.407 -173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.33 33.42 4.33 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.671 1.129 . . . . 0.0 111.748 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.8 mttm 71.01 173.37 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.715 2.006 . . . . 0.0 110.87 -169.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.34 178.34 7.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.695 1.198 . . . . 0.0 111.132 -169.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.7 tttp 50.93 -119.22 1.37 Allowed 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 126.34 1.856 . . . . 0.0 110.266 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.94 -21.51 64.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.619 1.099 . . . . 0.0 111.858 -169.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.14 -8.18 53.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.348 0.975 . . . . 0.0 114.652 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.3 mt -63.73 133.73 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.282 1.433 . . . . 0.0 109.426 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.15 138.49 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.89 129.57 55.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.485 1.039 . . . . 0.0 108.307 172.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -133.89 147.71 51.16 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.81 130.43 44.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.431 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -111.52 143.29 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -140.65 132.35 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 125.009 1.324 . . . . 0.0 107.648 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t0 48.65 38.24 11.03 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.116 0.96 . . . . 0.0 111.971 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.9 t30 63.7 8.75 3.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.116 2.167 . . . . 0.0 115.428 -175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -95.25 149.4 21.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.126 1.37 . . . . 0.0 109.781 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.89 136.27 33.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.101 0.96 . . . . 0.0 110.119 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -120.19 116.58 32.4 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.895 1.678 . . . . 0.0 106.901 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.31 143.9 20.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.269 2.646 . . . . 0.0 111.383 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -69.17 162.61 26.68 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.176 0.59 . . . . 0.0 110.666 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.2 pt -113.26 154.47 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 126.016 1.726 . . . . 0.0 109.654 169.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.05 26.35 4.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.138 1.375 . . . . 0.0 111.631 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 C--O 1.256 1.439 0 C-N-CA 125.518 1.527 . . . . 0.0 110.07 179.562 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.75 143.73 51.15 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.154 0.582 . . . . 0.0 110.23 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -147.5 142.58 27.09 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -65.33 137.93 57.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.102 0.561 . . . . 0.0 109.791 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -74.9 132.61 41.59 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.4 m -139.42 91.99 2.54 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -139.6 148.21 42.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -110.21 130.5 55.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 m -121.64 142.63 49.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.492 0.663 . . . . 0.0 109.584 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -135.57 159.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.468 1.907 . . . . 0.0 106.941 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.42 141.36 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 169.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.51 134.2 46.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.053 1.341 . . . . 0.0 108.94 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -101.52 132.1 47.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.601 0.76 . . . . 0.0 109.278 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -138.24 133.08 32.73 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 56.28 -61.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.392 3.077 . . . . 0.0 115.975 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.97 15.17 0.08 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.323 1.916 . . . . 0.0 112.042 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -130.06 159.17 37.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.954 1.702 . . . . 0.0 109.179 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -121.1 130.93 53.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 169.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -110.02 109.51 20.11 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.656 1.182 . . . . 0.0 107.954 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -74.08 119.68 18.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 169.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 mm -96.6 131.2 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.63 116.38 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.94 122.83 31.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -82.59 113.27 20.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -71.75 -27.11 62.75 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.532 0.333 . . . . 0.0 111.634 -169.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.86 -45.63 41.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.38 0.537 . . . . 0.0 110.609 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.28 -17.07 28.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.172 0.989 . . . . 0.0 112.952 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.251 98.8 mmm 55.76 28.81 12.82 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.331 1.452 . . . . 0.0 111.357 -169.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -88.28 146.32 25.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.04 118.68 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -85.02 132.88 34.27 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.781 1.633 . . . . 0.0 108.1 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -118.22 116.3 26.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 168.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 46.39 42.4 10.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.859 1.264 . . . . 0.0 111.265 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.51 -11.36 39.29 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.616 1.103 . . . . 0.0 115.004 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.49 138.14 31.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.77 1.785 . . . . 0.0 108.588 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -68.94 145.9 53.24 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.8 163.64 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.944 0.898 . . . . 0.0 110.573 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.18 148.06 39.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.563 1.145 . . . . 0.0 110.285 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -140.62 149.41 42.28 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.399 1.08 . . . . 0.0 109.908 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.65 50.19 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.85 108.35 1.94 Allowed Glycine 0 C--N 1.331 0.263 0 N-CA-C 106.994 -2.442 . . . . 0.0 106.994 -174.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -94.55 148.96 21.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -116.38 137.16 52.38 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.585 0.754 . . . . 0.0 109.011 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.43 167.9 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.601 1.56 . . . . 0.0 109.919 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.7 47.88 0.64 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.071 1.348 . . . . 0.0 110.47 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -159.91 -34.9 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.274 2.23 . . . . 0.0 110.165 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.62 12.59 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -120.52 152.59 37.85 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -129.32 107.56 9.62 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.713 1.605 . . . . 0.0 106.948 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.9 m -93.93 102.93 15.04 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -89.76 148.15 23.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.907 1.283 . . . . 0.0 111.22 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -158.96 -177.63 6.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.907 2.083 . . . . 0.0 108.26 169.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.0 m -144.91 146.63 32.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.175 0.99 . . . . 0.0 109.709 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.0 mt -142.39 132.83 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.87 -127.19 44.68 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -109.57 36.48 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 110.526 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -131.86 145.99 51.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.043 1.337 . . . . 0.0 108.778 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.96 150.44 21.95 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.37 151.02 51.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.427 1.491 . . . . 0.0 107.839 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CZ ' HG21 ' A' ' 78' ' ' ILE . 29.7 p90 -148.66 140.64 23.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 121.804 -0.56 . . . . 0.0 110.285 168.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.5 mt -87.51 117.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -84.96 127.88 34.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 170.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.46 96.52 4.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.63 125.18 44.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.104 0.962 . . . . 0.0 109.574 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -79.22 49.48 0.97 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.473 1.109 . . . . 0.0 111.125 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 m -66.15 160.54 23.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.086 1.354 . . . . 0.0 111.307 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.44 -148.43 37.21 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 123.57 0.605 . . . . 0.0 111.675 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -71.37 173.02 8.39 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.002 0.921 . . . . 0.0 110.642 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 -67.67 -26.7 66.33 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.804 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -59.21 145.65 42.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.98 107.67 0.9 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.271 1.028 . . . . 0.0 111.444 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -145.26 43.82 0.92 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.24 1.876 . . . . 0.0 108.477 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.36 128.87 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.4 mm -88.29 113.07 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -95.74 129.18 43.04 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.5 m -137.51 140.19 40.97 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 tp -86.55 133.46 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.528 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 1.7 mp -112.66 142.63 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 169.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.23 130.46 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t0 49.2 39.6 15.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.241 1.016 . . . . 0.0 111.97 -175.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 64.32 4.42 2.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.819 2.047 . . . . 0.0 115.006 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -90.3 147.21 23.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 120.449 -1.407 . . . . 0.0 109.189 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.95 133.55 35.6 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.371 0.668 . . . . 0.0 109.97 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.0 mm -117.28 111.99 39.88 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.193 1.797 . . . . 0.0 107.081 -175.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -73.23 152.58 50.45 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.908 2.405 . . . . 0.0 110.726 176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -54.25 156.94 2.89 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.243 1.017 . . . . 0.0 111.257 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 pt -60.64 155.64 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.406 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.13 103.07 4.84 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.254 1.309 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.149 176.477 . . . . . . . . 0 0 . 1 stop_ save_